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Summary
Secondarymetaboliteshaveforcenturiesbeenusedasdrugsandinspiringstructuralleadsinthe
pursuit for new potent drugs. The main sources for secondary metabolites are marine and
terrestrialplants,bacteria,andfilamentousfungi.Duringthepastdecadethegenomesofseveral
filamentousfungiandbacteriahavebeensequencedopeningnewpossibilitiesforfurtheranalysis
ofthesecondarymetabolitepotentialoftheorganisms,anddirectingthefocusofnaturalproduct
chemiststowardstheelucidationofbiosyntheticpathwaysofthemetabolites.Thereby,aidingin
identifying the genes encoding for the enzymes responsible for constructing these complex
molecules.
TheaimofthisPh.D.studyhasbeentoexplorethesecondarymetabolitepotentialofimportant
filamentousfungiandlinkspecificmetabolitestotheirsynthasegenesandbiosyntheticpathways.
Throughoutthisstudythreeimportantfilamentousfungihavebeenexamined;Aspergillusoryzae,
A. niger and A. nidulans. A. oryzae and A. niger are used in the fermentation industry for
productionofvariousproductssuchassake,misoandsoysaucefromA.oryzaeandorganicacids
aswellasenzymesforA.oryzae.AtthesametimeA.niger isalsoan importantcontaminantof
cropsandfeedduetothepossibilityofmycotoxinsorothermetabolitesendingupinhumanand
animalfood.A.nidulansisamodelorganismforgeneticstudiesandvasteffortshavebeenused
inthedevelopmentofamolecularplatformusedforstudyingthegeneticoftheorganism.
TheworkwithA.oryzaeandA.nigerfocusedondiscoveryofthesecondarymetabolitepotential
ofthesetwofilamentous fungi.Severalnewmetaboliteswere isolatedandstructureelucidated
from A. oryzae including; 13Ͳdesoxypaxilline a tremorgenic intermediate of the aflatrem
biosynthesisseeninA.flavus,dideͲand14ͲdeacetylparasiticolideA,andthenovelnonͲribosomal
peptidesditryptoleucineandoryzamideA1Ͳ2whicharevariantsofknownA. flavusmetabolites.
FromastrainofA.nigeranew isomerofthemycotoxingroupoffumonisins, fumonisinB6was
isolatedandcharacterizedthroughNMRͲspectroscopy.
Due toA.nidulans’ roleasaplatform forgenetic studiesemphasiswasputon identifyingand
linkingmetabolites to theirsynthasegenes.To identifynovelmetabolitesofA.nidulansseveral
attempts, both chemical and genetic, were made to activate the secondary metabolites
production. The study was initiated with the creation of a deletion library of 32 putative
polyketide synthase genes encoding for the enzymes responsible for catalyzing theproduction
polyketides.Toinitiatesecondarymetaboliteproductionthesestrainswerecultivatedonseveral
complexmedia.Thestudy linkedaustinolanddehydroaustinoltotheirsynthasegeneaswellas
providing new insights into two already partly identified biosynthetic pathways;
monodictyphenoneandorsellinicacid.
To enhance secondarymetabolite production in A. nidulans overexpression of a transcription
factor belonging to a polyketide gene cluster identified in the deletion library resulted in the
isolationofseveralmetabolitesincludingcichorine,nidulol,4ͲhydroxyͲ3,6ͲdimethylͲ2Ͳpyroneand
thenovelmetabolitescichonidulolanddemethylcichonidulol.Adeletionstudyofthesurrounding
genes led to a proposed biosynthetic pathway towards these 3Ͳmethylorsellinic acid derived
metabolites.
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Astudywhich includedanotherstrainofA.nidulansandthedeletionofaglobalregulatorgene
challenges on complexmedia resulted in the isolation of asperuginA andB,which through a
deletionstudywerelinkedtotheirsynthasegene,andnidubenzalAandB.Thestudyendswitha
report on the production of the insect juvenile hormones in A. nidulans provoked by the
heterologousexpressionofaregulatorygeneofA.niger.
In conclusion this PhD study has added to the knowledge of the chemical diversity of three
importantfilamentousfungithroughactivationofsilentgenesthroughtheuseofcomplexmedia
andgenomemodifications.

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Sammenfatning
Sekundære metabolitter er i løbet af de sidste mange århundrede blevet brugt som
medikamenterogsominspirationtilsynteseafnyebiologiskpotentestoffer,derkanbrugestilny
medicin. Hovedkilderne til sekundære metabolitter i naturen er planter, bakterier og
skimmelsvampebådefralandogmarintophav.Genomerneafflereskimmelsvampeogbakterier
ergennemdetsidsteårtiblevetsekventeret,hvilketharåbnetopforforskningenipotentialetaf
sekundæremetabolitter i disse organismer. Dette har for naturstofkemikeremedført et øget
fokuspåudredningafbiosyntesenfordissemetabolitter,ogdertil identificeringafgenernesom
koderfordeenzymer,derkatalysererkonstruktionenafdissekompleksemetabolitter.
Formålet med dette PhD studie var at udforske potentialet for en selektion af de vigtige
skimmelsvampesproduktion af sekundæremetabolitterog kortlægge sammenhængenmellem
identificeredemetabolitter og syntesegenerne. Igennem dette studie er Aspergillus oryzae, A.
niger,ogA.nidulansblevetundersøgt.A.oryzaeogA.nigerbliverbrugtifermenteringsindustrien
tilproduktionafdiverseprodukter,bl.a.sake,misuogsojasovsforA.oryzaesogorganiskesyrer
samtenzymerforA.nigersvedkommende.DerudovererA.nigerogsåenudbredtkontaminantaf
bådefoderogafgrøder,hvilketøgerrisikoenforatmykotoksinerogandremetabolitterkanendei
både mennesker og dyr. A. nidulans bliver brugt som en modelorganisme til genetiske og
biologiske studier via en stor og mangeårig indsats, der har muliggjort effektiv genetisk
transformationidenneognuogsåandreAspergilli.
FokusiarbejdetmedA.nigerogA.oryzaeharværetpåudforskningafpotentialetafsekundære
metabolitter i disse to skimmelsvampe. Hertil er flere nye metabolitter fra A. oryzae blevet
oprenset og strukturbestemt, blandt andre 13Ͳdesoxypaxilline, som er et mellemprodukt i
biosyntesenafdentremorgenemetabolitaflatrem,dideͲog14ͲdeacetylparasiticolideA,derer
mellemprodukter fra biosyntesen af parasiticolide A samt ditryptoleucine og oryzamid A1Ͳ2,
varianter af kendte metabolitter fra A. flavus. Derudover er en ny isomer fra fumonisin
mykotoksingruppenfundetogstrukturbestemtudfraenA.nigerstamme.
MedhenblikpåA.nidulans’rollesommodelorganismeforgenetiskestudier,blevhovedvægten
lagtpåat identificerenyemetabolitterogefterfølgendekobledem tilgener.Bådekemiskeog
genetiskemetoder er blevet anvendt til at aktivere produktionen af sekundæremetabolitter.
Studiet startede med konstruktionen af et deletionsbibliotek for de 32 gener, der via
bioinformatiske studier var blevet forudsagt til at kode for polyketidsyntase enzymer, der
syntetiserer polyketider, en storog vigtig gruppe inden fornaturstoffer.  For at få en varieret
produktionafpolyketiderblevstammernedyrketpåforskelligekompleksevækstmedier. Idette
studieblev austinologdehydroaustinol koblet tilderes syntasegen,og flerenye aspekterblev
tilføjettildeallerededelvistbeskrevnebiosynteseveje:monodictyphenonogorsellinsyre.
I forsøget på at øge produktionen afmetabolitter i en interessant biosyntese gengruppe i A.
nidulans, blev et regulatorisk gen overudtrykt. Dette medførte en øget produktion af flere
metabolitter inklusivcichorine,nidulol,4ͲhydroxyͲ3,6ͲdimethylͲ2Ͳpyroneogdenyemetabolitter
cichonidulologdemethylcichonidulol.Vedhjælpafenstorseriegendeletioner,ogefterfølgende
kemisk analyse af mutanterne, kunne vi opstille et forslag til biosyntesen af de 3Ͳ
methylorsellinsyre afledte metabolitter. Et andet studie afrapporteret i denne afhandling
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
inkluderedeetvildtypeisolatafA.nidulans,ogherblevdetonyemetabolitternidubenzalAogB
isoleretogstrukturbestemt.DerudoverblevasperuginAogBgennemetnytgendeletionsstudie,
derpåvirkedetilgængeligheden ikromatin,koblettiletsyntasegen.Afhandlingensluttermedet
studie,hvoriproduktionenaf juvenilehormoneIIIblevaktiveretvedheterologekspressionafet
regulatoriskgenfraA.nigerkombineretmeddyrkningpåkompleksemedier.
DettePhDstudieharbidragettilvidenomdenkemiskediversitetaftre,påhversinmådevigtige,
skimmelsvampe, og arbejdet demonstrerer hvorledes avanceret kemisk analyse og effektive
gensplejsningsværktøjsammenspillertilatkortlæggedenfascinerendesekundæremetabolismei
skimmelsvampe.
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Abbreviations
ACP  AcylCarrierProtein
AT  acyltransferase
BPC  BasePeakChromatogram
CLC  ClaisenCyclase
CMB  CenterforMicrobialBiotechnology
CY20  CzapekYeastsucrose
CYA  CzapekYeastAgar
CYAs  CzapekYeastAgarsalt
DAD  DiodeArrayDetection
DH  Dehydratase
DMSO  Dimethylsulfoxide
DQFͲCOSY  DoubleͲquantumfilteredcorrelatedspectroscopy
DTU  TechnicalUniversityofDenmark
ESI  ExtractedIonChromatogram
ER  EnoylReductase
H2BC  Heteronucleartwobondcorrelation
HMBC  Heteronuclearmultiplebondcorrelation
HR  HighlyReduced
HSQC  Heteronuclearsinglequantumcoherence
iPKS  iterativePolyketidesynthase
KR  ɴͲketoreductase
KS  ɴͲketosynthase
MM  Minimalmedium
MS  MassSpectrometry
MS/MS  TandemMassSpectrometry
MT  Methyltransferase
NMR  NuclearMagneticResonance
NR  NonͲReduced
NRP  NonͲRibosomalPeptide
NRPS  NonͲRibosomalPeptideSynthetase
Oex  Overexpression
OSMAC  OneStrainManyCompounds
PK  Polyketide
PKS  PolyketideSynthase
PR  PartiallyReduced
PT  ProductTemplate
qRTͲPCR  quantitativeReverseTranscriptionPolymeraseChainReaction
RT  RaulinͲThom
RTO  RaulinͲThomOatmeal 
SAM  SͲadenosylmethionine
SAT  StarterͲunitACPTransacylase
TE  Thioesterase

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TOF  TimeofFlight
UHPLC  UltraHighPressureLiquidChromatography
UV  UltraViolet
YE  YeastExtract
YES  YeastExtractSucrose 
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1Background
Naturalproducts (orsecondarymetabolites)have forcenturiesbeenusedasdrugsor inspiring
structuralleadsinthepursuitfornewpotentdrugs.Themainsourcesforsecondarymetabolites
aremarine and terrestrial plants, bacteria, and filamentous fungi. Secondarymetabolites are
classifieddependingontheirstructuralscaffold.Theseclasses includeamongotherspolyketides
(PKs), nonͲribosomal peptides (NRPs), terpenoids, alkaloids and hybrid metabolites of the
differentclasses.Thefunctionofsecondarymetabolitesintheirhostshasnotyetbeenexploited
to its fullest;however, they seem tohave several functions includingdefense, communication,
andsignaling (Calvo2002,Fox2008,Kempken2010,Rohlfs2010).Secondarymetaboliteshave,
especiallyafterthediscoveryofthepenicillinsin1929(Fleming1929),beenusedasinspirationin
thediscoveryofnewpharmaceuticalcandidates. Infact,astudybyNewmanandCraggshowed
that 34 % of all smallͲmolecule new chemical entries between 1981 and 2010 were natural
productsorderivedthereofandfurther25%weremimicsofnaturalproducts(Newman2012).
ThefilamentousfungiwithintheAspergillusfamilyare importantduetoboththeirvastusesas
industrialworkhorses (A.niger) (Schuster2002)andasmodelorganisms forgeneticstudies (A.
nidulans)(Pontecorvo1953,Chiang2010a),butalsoduetotheirprevalenceasfoodcontaminants
(A. niger) (Perrone 2007, Nielsen 2009). A. niger is both an industrial workhorse for the
productionofcitricacidandvariousenzymes (Schuster2002)aswellasacontaminantof food
andfeedsonwhichitcanproducethemycotoxinsochratoxinandthefumonisins(Perrone2007,
Nielsen2009).TheAspergillussectionincludesothermycotoxinanddrugproducingspeciessuch
asA.flavus(aflatoxin)andA.terreus(lovastatin(mevinolin)),respectively(Hoffmeister2007).
 Table1.1OverviewoffullygenomesequencedAspergillusspecies
Species Strain References
A.aculeatus ATCC16872 DOEJointGenomeInstitute2012a
A.awamori IFO4308 NCBI2012a
A.carbonarius ITEM5010 DOEJointGenomeInstitute2012b
A.clavatus NRRL1 Fedorova2008
A.fischerianus NRRL181 Fedorova2008
A.flavus NRRL3357 CenterforIntegratedFungalResearch2012
A.fumigatus Af293 Nierman2005
A.fumigatus A1163 Fedorova2008
A.nidulans FGSCA4 Galagan2005
A.niger CBS513.88 Pel2007
A.niger ATCC1015 Baker2006,Andersen2011
A.oryzae RIB40 Machida2005
A.sojae NBRC4239 NCBI2012b
A.terreus NIH2624 BroadInstitute2012
Duringthepastdecade,thegenomeofseveralAspergillusspecieshavebeenfullysequencedand
becomeavailableforthepublic,table1.1.Theavailabilityofgenomesequenceshaveledtoashift
innaturalproductresearchfromdiscoveryofnewdrugͲlikemetabolitestolinkingmetabolitesto
the responsible genes as well as further elucidation of biosynthetic pathways (Walsh 2010).
Detailedinformationonthegeneticandenzymaticworkinanorganismenablethepossibilityof
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productionofspecificallydesignedmetabolitesandchemicalscaffolds(syntheticbiology),provide
informationfortheoptimizationoffungiascellfactoriesandenableheterologousexpressionof
genes(Fisch2011,Heneghan2011,Liu2011,Pickens2011,Wong2012).
Genomesequenceshave,throughbioinformaticsstudies,revealedthatthenumberofsecondary
metabolite synthase genes far exceeds the number of metabolites known. For example, A.
nidulansappears tocontainasmanyas32polyketidesynthases (PKSs)ofwhich,until recently,
onlyninegeneclustershavebeenidentifiedandlinkedtometabolites(paper1).Theinformation
fromthebioinformaticstudiesrevealsthatthesecondarymetabolitepotentialbyfarexceedsthe
known secondary metabolite pool. This huge, untapped potential for secondary metabolite
productionhas ledtocollaborationsbetweenmolecularbiologistsandnaturalproductchemists
to explore the full potential of filamentous fungi through genomemining, optimized chemical
screening,andotheradvancedtechniquestowardsactivationofsilentgenes(Sanchez2012).
TheaimofthisPh.D.studyhasbeentoexplorethesecondarymetabolitepotentialofimportant
filamentous fungi, to link specific metabolites to their synthase genes and elucidate the
biosynthetic pathways. The work presented in the following chapters includes exploring the
chemistryofA.oryzae(paper2)bycomparisonofthemetabolicprofilestoA.flavusandisolation
andcharacterizationofseveralnewmetabolites.Thisisfollowedbyisolationandcharacterization
ofanewfumonisinanalogue isolatedfromA.niger(paper3).Todiscoverthehiddensecondary
metabolic potential ofA. nidulans attempts have been performed to activate the silent genes
throughbothmediavariationandgeneticmodifications.Theactivationofgeneshas led to the
identification of several new metabolites being identified, isolated and structure elucidated
(paper 4Ͳ7). Several of these metabolites have been linked to their biosynthetic genes. An
overviewoverthegeneswhichatthetimehadbeenlinkedtopolyketidesinA.nidulansisgivenin
paper1.
Altogetherthisthesisconsistsof6chapterswherechapter1givesbackgroundinformationforthe
Ph.D. study. Chapter 2 gives a general introduction toproductionof secondarymetabolites in
filamentous fungi and ways of activating silent genes. Chapter 3 gives an overview of the
experimentalwork and a short introduction to experimental procedures used throughout the
work.Inchapter4theresultsarepresentedanddiscussedandchapter5isanoveralldiscussion
andconclusionsoftheworkpresented.Thereferencesareinchapter6.Thepaperspresentedin
thisthesisareintheaccompanyingappendix(paper1Ͳ7)wherepaper5and6areroughdrafts.

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2 Production of secondary metabolites in filamentous fungi  
This section will focus on the production of secondary metabolites in filamentous fungi including 
biosynthesis, regulation and activation of genes.  
2.1 Biosynthesis of secondary metabolites 
Secondary metabolites are divided into classes according to their biosynthetic origin. The 
following sections will describe some of the general biosynthetic features of three main classes of 
secondary metabolites including examples of metabolites from A. nidulans. The focus will be on 
PKs, however, general characteristics on NRPs, terpenoids and examples of hybrid metabolites 
will be described.    
2.1.1 Polyketides 
PKs are one of the most important classes of secondary metabolites and are produced by several 
terrestrial and marine organisms including bacteria, plants and fungi. Though the structures of PKs 
are highly diverse they share a common biosynthetic origin of the carbon skeleton which is 
synthesized from small activated carboxylic acids such as acetate, propionate and butyrate. The 
carbon skeleton is biosynthesized by polyketide synthases (PKSs). PKSs can be divided into three 
types, type I, II, and III based on their catalytic organization; however, only the iterative type I PKS 
(iPKS) has been reported in A. nidulans. The iPKS repeat the use of a single module, containing 
several catalytic domains, until the growing chain has reached the desired length.     
Fungal PKSs are generally type I iPKSs. The fungal iPKSs can, based on their catalytic domains, be 
divided into three classes: non-reducing (NR), highly reducing (HR) and partially reducing (PR) 
(Bingle 1999, Nicholson 2001, Kroken 2003). The difference between the three classes reflects 
their ability to reduce the β-keto carbon of the growing carbon chain. The reduction occurs in the 
catalytic domains of the iPKS-enzymes.  
 
Figure 2.1 Chain extension of the PK chain in iPKSs through Claisen-like condensations of the extender and 
starter unit. The synthesis is started by binding a starter unit, here acetyl-CoA, to the KS domain and loading 
of the extender unit, here malonyl-CoA, to the ACP domain, releasing the CoA. The KS catalyzes the claisen-
like condensation extending the polyketide chain by an acetate unit (marked in red) whereby CO2 is 
released. To start another extension the polyketide chain is transferred back to the KS domain and the ACP 
domain is loaded with a new extender unit. Abbreviations: KS: β-ketosynthase, ACP: Acyl carrier protein. 
Three fundamental domains are in general found in all filamentous fungal iPKSs; β-ketosynthase 
(KS), acyltransferase (AT) and the acyl carrier protein (ACP). The KS catalyzes the C-C bond 
formation through Claisen-type condensations. The ACP domain is responsible for transiently 
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holding the growing acyl chain, hereby allowing the loading of the extender units. AT recognizes 
the acyl extender units which are transferred from CoA onto KS and transferred to the growing PK 
chain through Claisen-like condensations catalyzed by KS, figure 2.1. The iterative use of the three 
domains results in a NR-PK.  
In partially reduced and highly reduced PKSs, reduction occurs through the β-ketoreductase (KR) 
domain that reduces the β-ketone to a hydroxyl group. Loss of the hydroxyl group can occur by 
the elimination of water through the dehydratase (DH) domain which can be followed by 
hydrogenation catalyzed by the enoyl reductase (ER), figure 2.2a. 
 
Figure 2.2 Functional domains which may be present in a PKS. The reaction schemes show examples of the 
general reactions of the PKS domains a) reduction of ketone to saturation catalyzed by the KR, DH, ER 
domains. b) methylation catalyzed by the MT domain. Abbreviations: ACP: Acyl carrier protein, KR: 
ketoreductase, DH: dehydratase, ER: enoyl reductase, MT: methyltransferase, SAM: S-adenosylmethionine   
Another domain which can be present in the reducing PKSs is the methyltransferase domain (MT) 
which is responsible for C-methylation of the growing PK chain, using S-adenosylmethionine 
(SAM) as a carbon-donor. The degree of eventual reductions and modifications, and their 
positions in the PK product, is always the same for the individual PKSs; however, it is presently 
unknown how deployment of the basic modifying domains are programmed into the PKS.  
The NR-PKSs do not contain the reducing domains, however, they contain an N-terminal starter 
unit-ACP transacylase (SAT) domain, which is responsible for selecting the starter unit (Crawford 
2008a), and an internal product template (PT) domain, which is responsible for folding and 
cyclization of the NR-PK backbone (Crawford 2008b, Crawford 2009, Crawford 2010). The number 
of iterations within the PKS and thereby the display of functional groups and size of the final 
product is likely determined by the size of the active site cavity in the iPKS (Yadav 2009). The 
iterative nature of the iPKSs makes it difficult to predict the structure of the final product of the 
iPKSs both with respect to the degree of saturation, methylation pattern and size; however, 
domain swapping experiments by Fisch and co-workers (Fisch 2011) are starting to reveal the 
programming of the iPKSs (Fisch 2011).    
Once the final length of the PK backbone has been achieved, the PK chain is released from the 
PKS, catalyzed by either a thioesterase (TE), a Claisen cyclase (CLC) or by other accessory enzymes 
(Du 2010).  
a)
b)
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The product coming directly from the PKS rarely seems to be the only product in the biosynthesis, 
but usually undergoes further modifications by tailoring enzymes which can range from small 
changes (methylations, reductions, oxidations) to large modifications including ring formation and 
condensations with other metabolites. The PKS genes tend to reside in gene clusters where the 
genes responsible for further modifications, e.g. genes encoding monooxygenases, O-
methyltransferase, dehydrogenases, are present.  
For a more detailed description on polyketides than the one given here, reviews by Cox (Cox 
2007), Hertweck (Hertweck 2009) and Crawford (Crawford, 2010) can be consulted.  
An example of a complex PK biosynthesis found in several Aspergillus species including A. nidulans 
is sterigmatocystin (Rank 2011). Sterigmatocystin is an intermediate in the biosynthesis of the 
aflatoxins which are among the most carcinogenic mycotoxins. Research into the biosynthesis and 
biological function of aflatoxin and sterigmatocystin intensified with the Turkey X disease caused 
by aflatoxins in the middle of the last century (Blount 1961) and it is therefore one of the most 
extensively studied biosynthesic pathways and there are several reviews for further reading (Yu 
2004, Yabe 2004). The proposed biosynthesis of sterigmatocystin in A. nidulans can be seen in 
figure 2.3. The gene cluster consists of 27 genes (Brown 1996) where stcA is a NR-PKS which codes 
for the enzyme that catalyzes the condensation of the starting unit hexanoyl-CoA and seven 
malonyl-CoA extender units into the PK backbone, which is followed by cyclization and release of 
norsolorinic acid anthrone (Yu 1995). Several enzymatic steps are required for converting 
norsolorinic acid anthrone to sterigmatocystin which include oxidations, reductions, O-
methylations and Bayer-Villiger oxidation (Yabe 1993, Yabe 1991, Keller 1994, Trail 1994, Keller 
1995, Kelkar 1996, Silva 1996, Kelkar 1997, Chang 2000, Keller 2000, Watanabe 2002, Sakuno 
2003, Chang 2004, Ehrlich 2005, Henry 2005, McDonald 2005, Cary 2006, Ehrlich 2010). For a 
more detailed description see paper 1.  
Even though the biosynthesis of sterigmatocystin has been studied extensively all the biosynthetic 
steps are still not accounted for. This highlights that the biosynthesis of secondary metabolites 
can be very complex and difficult to decipher.   
2.1.2 Non-ribosomal peptides 
NRPs are another large group of secondary metabolites produced in microorganisms. They are 
made up of amino acids which are linked by a non-ribosomal peptide synthethase (NRPS) through 
condensations. The NRPSs are single multimodular enzymes where each module includes several 
catalytic domains. The modules contain the necessary domains; adenylation, peptidyl carrier 
protein and condensation. The adenylation domain is specific for each amino acid which is 
recognized, adenylated, and loaded onto the peptidyl carrier protein domain where the 
condensation domain catalyzes the formation of the peptide bond between the two amino acids. 
The number of modules corresponds to the number of amino acids in the final product and their 
order in the metabolite follows the order of the adenylation domains. Other catalytic functions 
that may be present in an NRPS includes epimerization, peptide cyclization and N-methylation 
domains. The amino acids are produced from two pathways. The aliphatic amino acids are 
produced from the central carbon metabolism whereas the aromatic amino acids are derived 
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from shikimic acid, figure 2.4. Shikimic acid can also be incorporated into secondary metabolites 
and may be recognized for the substitution pattern of the three hydroxyl-groups on the ring.  
 
Figure 2.3 Proposed biosynthesis taken from Klejnstrup 2012 (paper 1). StcA contains SAT, KS, AT, PT, ACP 
and TE/CLC domains. *Indicates a proposed, but not confirmed, enzyme. Multiple arrows indicate that the 
number of enzymatic steps is unknown.  
The emericellamides, figure 2.7 are examples of secondary metabolites of a combined PKS and 
NRPS origin produced by A. nidulans. The product of the PKS is loaded onto the NRPS which 
consist of five modules each responsible for addition of an amino acid (glycine, valine, isoleucine, 
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alanine and alanine) to the metabolite backbone followed by release and cyclization (Chiang 
2008).   
Beside NRPS genes there are also NRPS-like genes present in the genomes. These genes share the 
catalytic domains found in NRPSs but are missing the condensation domain necessary for peptide-
bond formation (von Döhren 2009). So far products of two NRPS-like genes in A. nidulans have 
been identified, terrequinone A (Bok 2006, Balibar 2007, Schneider 2008), which does not have a 
peptide bond in its structure, and microperfuranone, without a nitrogen atom in its structure (Yeh 
2012), figure 2.4.  
 
Figure 2.4 Structures of shikimic acid, microperfuranone and terrequinone A     
For reviews on the biosynthesis of NRPs and the shikimic pathway please see reviews by 
Fischbach (Fischbach 2006), Koglin (Koglin 2009), Du (Du 2010), and Matthias (Matthias 2010) and 
Dewick and Knaggs respectively (Dewick 1998, Knaggs 2003). 
 
2.1.3 Terpenoids 
Terpenoids is a group of natural products made up of activated C5 isoprene units; dimethylallyl 
diphosphate (DMAPP) and isopentenyl diphosphate (IPP), which are condensed in a head to tail 
fashion, figure 2.5, in the terpene synthases. These carbon-chains can then undergo several 
modifications like cyclization, reduction or oxidations to reach the final product. DMAPP and IPP 
are derived by the mevalonate (Miziorko 2011) and the methylerythritol phosphate pathways 
(Rohmer 2008).  
 
Figure 2.5 Structure of an isoprene unit and example of linking of two isoprene units in a head to tail 
fashion. The two isoprene units in the monoterpene is highlighted in bold.   
The biosynthetic potential of terpenoids in A. nidulans has not yet been exploited to its fullest. In 
fact, only one terpene, ent-pimara-8(14),15-diene, have, so far, been identified and linked to a 
gene cluster which includes a putative geranylgeranyl-diphosphate (GGPP) synthase, AN1593, and 
a pimaradiene synthase, AN1594 (figure 2.6) (Broman 2012). The DDPP-synthase is responsible 
for the formation of geranylgeranyl-PP formation and AN1594 catalyzes the cyclization reactions 
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into the final product (Broman 2012). In the figure the head to tail linking of the isoprene 
backbone can be seen.    
 
Figure 2.6 Folding and cyclization of the terpene ent-pimara-8(14),15-diene as proposed by Broman and co-
workers (Broman 2012). The four isoprene units in geranylgeranyl-PP is highlighted in bold.    
For further reading of the details of the biosynthesis of terpenoids please consult review by 
Dewick (Dewick 2002) and Oldfield (Oldfield 2012).  
2.1.4 Hybrid metabolites 
Hybrid metabolites are metabolites where different parts of the molecule originate from different 
biosynthetic routes. In A. nidulans both the emericellamides and the aspyridones, figure 2.7 are 
hybrid metabolites which have a PK and NRP part they are; however, produced by different types 
of enzymes. Aspyridone is a PK-NRP which is assembled from the activity of a single fusion 
enzyme, whereas the biosynthesis of the emericellamides requires a PKS and a NRPS where the 
product from the PKS acts as the starter unit in the NRPS (Bergmann 2007, Chiang 2008). A 
further discussion of the biosynthesis of the emericellamides and aspyridones can be found in 
paper 1.    
 
Figure 2.7 The structures of aspyridone A and B and emericellamide A, C, D, E and F produced by A. 
nidulans.  
Meroterpenoids is another group of natural products of mixed biosynthetic origin where one or 
more parts are derived from terpenoids. The meroterpenoids can be divided into two main 
classes, PK-terpenoids and non-PK-terpenoids. As the name indicates this division is based on 
whether the non-terpenoid part of the molecule is PK derived or derived from other biosynthetic 
routes, e.g. from the shikimate route (Geris 2009).  
In A. nidulans austinol and dehydroaustinol are examples of PK-meroterpenoids. The biosynthesis 
of 3,5-dimethylorsellinic acid, the PK, is catalyzed by AusA and then prenylated by the 
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prenyltransferase AusN (Nielsen 2011, Lo 2012). The meroterpenoid then undergoes several 
modifications to the products austinol and dehydroaustinol, figure 2.8 (Lo 2012).  
 
Figure 2.8 The structures of 3,5-dimethylorsellinic acid, austinol and dehydroaustinol. The carbon skeleton 
of 3,5-dimethylorsellinic acid incorporated into austinol and dehydroaustinol is presented in bold.  
Isoprene units can be linked to PKs and NRPs by a prenyltransferase (dimethylallyl tryptophan 
synthases DMAT) through either O-C or C-C bonds. Emericellin, figure 2.9 is a mixed terpenoid and 
PK metabolite which is produced in the monodictyphenone pathway in A. nidulans. The origin of 
the two isoprene units arise from two separate prenyltransferases, XptA and XptB, and are 
coupled to the PK through a C-O and a C-C bond, respectively (Sanchez 2011).  
 
Figure 2.9 Structure of emericellin. The carbon skeleton of the two isoprene units is highlighted in bold. 
2.2 Genetics of secondary metabolite biosynthesis 
To understand the biosynthesis of secondary metabolites, one of the important tasks is to target 
genes encoding the enzymes that catalyze steps within the biosynthetic pathways. Due to the 
availability of fungal genome sequences, the search for genes coding for these enzymes can be 
intensified among the thousands of genes, e.g. the 11223 genes in the A. nidulans genome 
(Arnaud 2012). In this section the prediction of gene function, regulation and activation of genes 
related to secondary metabolite biosynthesis in filamentous fungi will be introduced with a focus 
on A. nidulans.   
2.2.1 Prediction of gene function 
It is possible to identify putative secondary metabolite genes within genome sequences, through 
computational analysis. Automated annotations and manual validations of predictions are already 
present for several of the Aspergillus genomes. Therefore Blast analysis on amino acid sequences 
of predicted protein activities will offer a list of homologous targets and their respective loci, 
especially due to their functional domains which can be highly homologous. As the gene function 
prediction is based on available knowledge on genes and protein activity, it is important to stress 
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that these predictions need to be confirmed through follow-up experiments, unless sequence 
homology and coverage of sequence is high. Still sequence analysis of the genomes gives a 
qualified putative overview of the gene functions. In table 2.1 the number of secondary 
metabolite synthase genes which have been predicted in the literature for the fully genome 
sequenced strains of A. niger, A. oryzae, A. flavus and A. nidulans, using a BlastP analysis 
approach. The total amount of synthase genes exceeds the number of known biosynthetic 
pathways. For example A. nidulans are predicted to contain 32 PKS genes (Nielsen 2011) of which 
17 have been linked to metabolites (Brown 1996, Watanabe 1998, Watanabe 1999, Bergmann 
2007, Chiang 2008, Szewczyk 2008, Bok 2009, Chiang 2009a, Schroeckh 2009, Nielsen 2011, Ahuja 
2012) indicating a large potential for new metabolites, even in one of the most studied fungi.        
Table 2.1: Overview of the predicted number of synthase genes in the fully genome sequenced strains of A. 
flavus,  A. nidulans,  A. oryzae, and A. niger. *These numbers includes NRPS- or PKS-like genes.  
Species PKS* NRPS* Hybrid Reference 
A. flavus 28 32 2 Cleveland 2009 
A. nidulans 32 27 1 von Döhren 2009, Nielsen 2011 
A. niger (ATCC 1015) 33 15 9 Sanchez 2012 
A. niger (CBS 513.88) 39 33 7 Sanchez 2012 
A. oryzae 27 32 2 Cleveland 2009 
In filamentous fungi genes linked to biosynthesis of a given secondary metabolite tend to cluster, 
which enables the discovery of genes encoding tailoring enzymes both through Blast analysis but 
also the use of techniques like microarray and qRT-PCR (quantitative reverse transcription 
polymerase chain reaction) can assist in discovering connections between the expression of genes 
and gene clustering in the genome. Microarray is applicable for the overview of the expression 
level of genes in a genome under specific conditions. The data can be used to analyze whether 
genes are downregulated, unaltered, or upregulated at certain conditions or between different 
strains. Hereby, it is possible to establish connections between large groups of genes at the same 
time. In qRT-PCR, the strength is the ease of measuring for example relative expression of a gene 
in a mutant strain compared to the expression in a reference strain, or in one strain at different 
growth parameters. In the latter case, the overview is limited to genes chosen for the study.    
Due to the fact that the total amount of synthase genes and thereby biosynthetic pathways far 
exceeds the number of known genes different terms to distinguish between unknown and not 
expressed genes and pathways has been developed. Orphan biosynthetic genes are defined as 
biosynthetic loci for which the corresponding metabolite(s) is/are unknown whereas silent 
pathways are pathways where the genes are not expressed under the given growth conditions 
(Gross 2007).  
2.2.2 Activation of silent genes 
With the recent recognition of the high percentage of orphan secondary metabolite genes several 
different techniques of activating biosynthetic genes have been explored. In this section some of 
the activation techniques, with relations to the methods used in this thesis, will be described with 
emphasis on A. nidulans. These approaches include the One Strain MAny Compounds (OSMAC) 
method, epigenome manipulations, gene regulation, and co-cultivation.  
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2.2.2.1 One strain – many compounds 
One classic way to activate the production of secondary metabolites is to vary the growth 
conditions. The principle behind the method, named one strain – many compounds (OSMAC) by 
Zeeck and co-workers, is to expose the microorganism to other cultivating conditions than the 
standards used in laboratories (Fuchser 1997, Schiewe 1999, Höfs 2000, Bode 2002). There are 
several factors which can be altered for example temperature, pH, culture vessel, aeration, 
cultivation time, light intensity and media composition including carbon and nitrogen sources and 
salt concentration. All these factors can influence the biosynthesis of secondary metabolites in 
several places including transcription, translation and enzyme inhibition or activation (figure 
2.10), however, the understanding of the exact mechanisms for the change in metabolic profile 
due to change in culture conditions is usually not completely understood and therefore difficult to 
predict (Bode 2002). 
   
Figure 2.10. Storage of information in the cells. a) DNA is folded up on the histones into nucleosomes which 
coil up and are packed into the chromosome. b) The DNA is transcriped into mRNA which is translated into 
proteins which in the case of PKS and NRPSs are enzymes catalyzes the formation of a product.   
 
Figure 2.11 Structure of orsellinic acid, F-9775A and F-9775B.  
The use of the OSMAC approach which included 20 different culture conditions of an A. nidulans 
strain, led to the activation of the orsellinic acid cluster resulting in the production of orsellinic 
acid and compounds derived thereof including F-9775A and F-9775B, figure 2.11 (Sanchez 2010). 
In another study by Scherlach and co-workers an A. nidulans strain was cultivated under 45 
a) 
b) 
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different culture conditions, which resulted in the isolation of two novel metabolites, aspernidine 
A and B, figure 2.12 (Scherlach 2010). 
 
Figure 2.12 The structure of aspernidine A and B. 
Interestingly these two examples of the use of the OSMAC approach have cultivated the strains 
used many conditions to activate the production of these metabolites. In 2011 Nielsen and co-
workers showed the metabolic profile of an A. nidulans reference strain grown on seven complex 
media displayed large differences in the production of metabolites including the orsellinic acid 
derived compounds (Nielsen 2011).  
2.2.2.2 Discovery of secondary metabolites through genome mining 
The elucidation of the secondary metabolite production potential can, as stated above, be 
initiated through genome mining. This strategy is confined to genome sequenced species, and 
involves the search in the genome for genes which are predicted to have enzymatic activities that 
are associated with production of secondary metabolites. This enables subsequent systematic 
genetic manipulations and validation through chemical analysis. This includes deletion and/or 
overexpression of genes in connection to secondary metabolite gene clusters or regulatory genes. 
The regulatory genes can act globally within the fungus or within a single secondary metabolite 
gene cluster.   
Epigenetic manipulations of global regulatory genes 
The presence and possibilities of manipulation techniques of global regulators have been a vast 
challenge; however, several advances have increased the interest in epigenetic manipulations 
where examples of some of these manipulations will be described below (Keller 2005, Yu 2005a , 
Cichewicz 2009, Scherlach 2009).  
The presence of secondary metabolite clusters in silent areas of the chromosomes, e.g. near 
telomeres and centromeres, suggests that chromatin remodeling factors can influence the 
expression of genes responsible for secondary metabolite production. Regulation of gene 
expression by chromatin regulation is directed by modifications of the histones through e.g. 
methylation, which closes, and acetylation, which opens the histones, since it is thought that 
histone modifications may control interactions of histones with transcriptional activators and 
repressors (Jenuwein 2001). 
In 2004 Bok and Keller reported the LaeA protein, a putative methyl transferase with homology to 
histone methyltransferases, as a global regulator of secondary metabolism in Aspergillus species, 
however, the mechanism of gene activation remains elusive (Bok 2004, Bayram 2012). Deletion of 
laeA resulted in a significantly decreased production of secondary metabolites in A. nidulans 
including sterigmatocystin and penicillin (Bok 2004). The importance of LaeA was further 
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strengthened as it was shown to be part of the conserved velvet complex, which is a major factor 
for regulation of fungal development hereby coupling the triggering of secondary metabolism to 
central fungal biology (Bayram 2008).  
Another example of chromatin regulated gene expression came from the deletion of a histone 
deacetylase, hdaA, which led to significant increase in production of penicillin and norsolorinic 
acid (intermediate in sterigmatocystin biosynthesis, figure 2.3) (Shwab 2007).  
The SUMO protein is also a chromatin regulating gene which has been shown to have an effect on 
secondary metabolism. It is an ubiquitin-like protein which is added to many proteins including 
histones posttranslationally (reviewed in Verger 2003, Gill 2004, Johnson 2004). A. nidulans 
contains one sumO encoding gene (Wong 2008) which upon deletion was shown to give a 
decrease in the production of secondary metabolites such as austinol, dehydroaustinol and 
sterigmatocystin as well as an increase in asperthecin production (Szewczyk 2008). Ten NR-PKSs 
were identified by genome mining and a deletion series of these in the sumOΔ background was 
performed and the PKS for asperthecin biosynthesis was identified (Szewczyk 2008).  
 
Figure 2.13 Structures of asperthecin, emodin and monodictyphenone. 
Investigation of other possible chromatin-level regulation of secondary metabolite biosynthesis in 
A. nidulans led Bok and co-workers to delete cclA, an ortholog to the BRE2 yeast gene, encoding 
an enzyme partner of the COMPASS transcriptional regulator complex conserved in eukaryotes, 
which both falicilitate and represses chromatin-mediating processes through methylation of the 
histone tails (Bok 2009). Deletion of cclA showed an altered chemical profile compared to the 
reference strain where two secondary metabolite gene clusters were activated and afterwards 
identified through deletions studies of mdpG and orsA which catalyzed the biosynthesis of 
monodictyphenone, figure 2.13, and several emodin analogs, as well as F9775A and F9775B, 
respectively (Bok 2009).   
Transcription factor manipulations 
Secondary metabolite gene clusters share common regulation of its member genes that can be 
activated or repressed by transcriptional regulators. Therefore activation or repression of the 
transcriptional regulators for example transcription factor offers a convenient way to control the 
expression of whole cluster by one genetic operation. Thus in studies based on mining genomes, 
the presence of a transcription factor within the cluster has been the driver in characterizing the 
gene cluster. Asperfuranone and the aspyridones are examples of metabolites discovered through 
genome mining in A. nidulans followed by activation of transcription factors (Bergmann 2007, 
Chiang 2009a). Chiang and co-workers noticed that a NR-PKS encoding gene, afoE, and afoG a 
gene coding for a HR-PKS were located close to each other on chromosome VIII. Since no product 
had ever been detected from activity of this locus, and due to the rare constellation of two 
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neighbor PKSs, the authors speculated whether a novel metabolite could be identified. A putative 
transcription activator, afoA, was found near the PKSs and the authors replaced the upstream 
sequence of afoA, estimated to be the native promoter, with an inducible promoter, alcA, which 
led to the production of asperfuranone (Chiang 2009a). 
Bergmann and co-workers identified a putative transcription factor in the genome and 
overexpressed it under the control of an inducible promoter, alcA. They demonstrated by 
Northern blot analysis that six of the nearest neighbor genes were upregulated on inductive 
medium and detected the production of aspyridones and two intermediates (Bergmann 2007). In 
a recent study the promoters of the NR-PKS genes and other genes necessary for NR-PKS product 
formation or release were also replaced with alcA, leading to the identification of several NR-PKSs 
(Ahuja 2012).   
The above mentioned studies illustrated the action of local acting transcription factors; however, 
it has also been reported that a transcription factor associated with a cluster can act on genes 
outside the cluster. Bergmann and co-workers showed that overexpression of a transcription 
factor on chromosome II of A. nidulans led to the activation of the asperfuranone gene cluster on 
chromosome VIII (Bergmann 2010). Another example is the transcription factor that regulates 
sterigmatocystin biosynthesis in A. nidulans and aflatoxin biosynthesis in A. flavus and A. 
parasiticus, aflR, also acts on genes outside the cluster (Price 2006). 
For further reading on the regulation of secondary metabolite biosynthesis see reviews by 
Hoffmeister (Hoffmeister 2007), Palmer (Palmer 2010), Fox (Fox 2008), Strauss (Strauss 2011), Yin 
(Yin 2011).   
2.2.2.3 Other methods and combinations of activation strategies 
There are several other methods for activation of secondary metabolite production. One method 
is to mimic growth conditions resembling known natural environments. This is utilized in the 
OSMAC approach as described, and also in co-cultivation of microorganisms, which might induce 
the production of new secondary metabolites due to the influence of the different organisms to 
each other. The co-cultivation of A. nidulans with 58 soil-dwelling actinomycetes led to the 
activation of the orsellinic acid cluster resulting in the production of orsellinic acid and 
compounds derived thereof including F-9775A and F-9775B (Schroeckh 2009).  
In section 2.2.2.2 molecular methods for altering the epigenome was presented. However, 
chemical methods which have similar effects are beginning to emerge. The research on chemical 
epigenetic modifiers focuses on the inhibition of DNA methyltransferases and histone deacetylase 
which modifies DNA and histones resulting in changes in the folding of DNA (Cichewicz 2010). A 
screening of nine DNA methyltransferase and histone deacetylase inhibitors against 12 fungal 
species, by Cichewicz and co-workers, led to production of new or enhanced levels of secondary 
metabolites in 11 species (Williams 2008). A study by the same group which tested inhibitors of a 
DNA methyl transferase (5-azacytidine) and a histone deacetylase (suberoylanilide hydroxamic 
acid) on A. niger, figure 2.14, led to increased transcriptional rates of all but seven of the total 55 
PKSs, NRPSs and hybrid PKS-NRPSs clusters (Fisch 2009). One of the new metabolites identified 
was the novel metabolite nygerone A, figure 2.14 (Henrikson 2009).    
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Figure 2.14 The structures of 5-azacytidine, suberoylanilide hydroxamic acid and nygerone A. 
Several of the above mentioned strategies have an effect on the production of the same 
metabolites. As mentioned in the previous sections several orsellinic acid derived compounds 
were discovered in A. nidulans through both co-cultivation, histone-modification and the OSMAC 
approach (Bok 2009, Schroeckh 2009, Sanchez 2010, Nielsen 2011).  
For further reading on activation of secondary metabolite gene clusters there are several reviews 
present in the literature (Gross 2007, Chiang 2009b, Scherlach 2009, Brakhage 2011, Chiang 2011, 
Winter 2011, Yin 2011). 
  
29
2 Production of secondary metabolites in filamentous fungi 
 
16 
 
 
30
PhD thesis 
Marie Louise Klejnstrup 
 
 
17 
 
3 Overview over experimental work 
The figure below gives an overview of the experimental work performed over the past three 
years. The work in this thesis has been focused on Aspergillus niger, A. oryzae and A. nidulans. The 
results are presented and discussed in chapter 4 and the experimental sections can be found in 
the papers 2-7. The outcome of the work at the external stay at the University of Southern 
California was not as expected and is therefore not ready for publication yet. Since paper 1 is a 
review it is not listed in figure 3.1. Paper 5 and 6 are rough drafts; however, further experiments 
need to be conducted prior to submission.    
 
Figure 3.1 Experimental overview over the work for duration of the past three years. . Abbreviations: Oex: 
overexpression, PKS: polyketide synthase.  
The aim of the work presented in this thesis has been to link secondary metabolites to genes; 
however, to do this several experiments and analysis needs to be performed. This includes 
bioinformatics, molecular biology, chemical analysis, isolation of metabolites and structure 
elucidation. My part of have consisted of the latter; chemical analysis, isolation and structure 
elucidation. 
3.1 Linking of secondary metabolites to genes 
This section will briefly outline the tools and instruments applied in the thesis. The experimental 
descriptions are presented in the paper 2-7; however, examples will be included in chapter 4.  
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3.1.1 Targeted genetic manipulations including deletions and over-
expressions 
Most of the strains analyzed in this work were genetically modified. The host strains used for 
genetic transformation in A. nidulans had been disrupted in the non-homologous end-joining 
pathway enabling efficient gene targeting (Nielsen 2008), referred to as the reference strain in 
this thesis. This was supported by the development of versatile tools to construct DNA substrates, 
e.g. fusion PCR and USER cloning technology. The mutant strains analyzed were gene deletions, 
point mutations or overexpressions where the gene of interest has been moved to an insertion 
site under the control of a constitutive or inducible promoter (Nielsen 2006, Nielsen 2008, Nielsen 
2011, Hansen 2011).     
3.1.2 Metabolome analysis 
The chemical analysis of all the strains has been performed on three instruments. A UHPLC 
(Dionex RSLC Ultimate 3000) equipped with a Kinetex C18 column coupled with diode array 
dectection (DAD), throughout the thesis called UHPLC-DAD. Two TOF-MSs; a LCT oaTOF mass 
spectrometer (Micromass), equipped with a Phenomenex C18 column and diode array detection, 
and a MaXis 3G QTOF (Bruker Daltronics) coupled to a Dionex Ultimate 3000 UHPLC system 
equipped with a Kinetex C18 column, throughout the thesis called LC-TOF-MS (LC-DAD when DAD 
detection in reported) and UHPLC-TOF-MS respectively.  
The approach in the metabolome analysis has been to compare mutant strains with the reference 
strain to detect metabolites either appearing or disappearing. Generally the strains have been 
analyzed in UHPLC-chromatograms (210 nm) and, in some cases, both positive and negative 
ionization mode, enabling the identification of metabolites which could only be detected in one of 
the techniques. When interesting peaks had been identified, the metabolite data was compared 
to the literature, and the metabolite database Antibase (Laatsch 2010) in order to identify already 
reported metabolites. The MaXis UHPLC-TOF-MS was acquired during the study and provided 
invaluable information on both the molecular formula and isotope pattern due to the high mass 
accuracy (1 ppm) .  
3.1.3 Isolation and structure elucidation  
The approach described above was done in micro-scale where plugs from a colony was extracted 
and analyzed (Frisvad 1987, Smedsgaard 1997). When the metabolome analysis of the mutants 
revealed new interesting metabolites the cultivations were scaled up to allow isolation and 
structure elucidation. The biomass was extracted and metabolites were isolated using different LC 
techniques with various column material including normal phase, reverse phase and size exclusion 
chromatography. The structures of the isolated metabolites were solved using 1D and 2D NMR-
spectroscopy. The NMR spectra were acquired using standard experiments on either a Varian 
Unity Inova 500 MHz spectrometer placed at DTU Chemistry and/or on a Bruker Avance 800 MHz 
spectrometer at the Danish Instrument Center for NMR Spectroscopy of Biological 
Macromolecules.  
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4 Results and Discussion 
The experimental work performed for the past three years have focused on the industrially 
important filamentous fungi; A. oryzae and A. niger and the genetic model organism A. nidulans. 
The results of the work will be presented in this section starting with the exploration of A. oryzae 
wildtype chemistry including several new metabolites and comparison of these to A. flavus 
metabolites (paper 2). The next section (4.2) will focus on the work done with A. niger where a 
new fumonisin analog was isolated and characterized through NMR spectroscopy (paper 3). 
Section 4.3 describes the results of the A. nidulans work. This included the analysis of a deletion 
library of 32 putative PKSs encoding genes including activation of genes using several complex 
media and linking of austinol and dehydroaustinol to their synthase gene (section 4.3.1, paper 4). 
This was followed by identification of several new A. nidulans metabolites through activation of a 
transcription factor, and a proposed biosynthetic pathway through deletion studies (section 4.3.2, 
paper 5). The last part of this section (4.3.3) focus on the novel metabolites, nidubenzal A and B 
and the linking of asperugin A and B to their PKS encoding gene (section 4.3.3.1, paper 6) and the 
juvenile hormones (section 4.3.3.2, paper 7) which were isolated after activation through genetic 
modifications combined with the use of complex media. The biosynthetic origin of asperugin A 
and B was identified by reference to the deletion library followed by genetic modifications.        
4.1 Aspergillus oryzae  
Aspergillus oryzae is one of industry’s most used workhorses and has been used for centuries in 
food fermentation for the production of for example sake, miso, soy sauce and other traditional 
Asian foods (Machida 2008a). A. oryzae is also a widely used organism for production of amylase, 
lipases and proteases, and, more recently, also for heterologous expression of secondary 
metabolite genes and non-fungal proteins (Punt 2002, Meyer 2008, Fisch 2011). For many years, 
A. oryzae, has been suspected to be a domesticated form of A. flavus, a plant and mammalian 
pathogenic saprophyte, capable of producing some of the most carcinogenic compounds known, 
the aflatoxins, figure 4.1. Genetic work and subsequent genome sequencing of strains of both 
species have verified the tight link between the species (Geiser 1998, Geiser 2000, Machida 2005, 
Yu 2005b, Abe 2006, Kobayashi 2007, Machida 2008a).  
 
Figure 4.1 The structure of aflatoxin B1. 
The availability of the sequenced strains of A. oryzae (RIB40 (ATCC 42149)) (Machida 2005) and A. 
flavus (NRRL 3357) (Yu 2005b) have led to comparison of the two genomes. The comparison 
shows high homology: 99.5% genome homology and 98% at the protein level (Rokas 2007). The 
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high homology could lead one to expect A. oryzae to produce most of the metabolites found in A. 
flavus (Machida 2008a, Machida 2008b, Machida 2005, Payne 2006, Yu 2008) and the preliminary 
bioinformatics studies performed along with the genome sequencing reported roughly the same 
number of predicted genes: 28 PKSs, 32 NRPSs and 2 hybrid PKS-NRPSs for A. flavus and 27 PKSs, 
32 NRPSs and 2 hybrid PKS-NRPS for A. oryzae with two NRPSs apparently unique for each strain 
(Cleveland 2009). However, published metabolic data indicated a very low chemical correlation 
between the two strains (Laatsch 2010). Most of the predicted genes for secondary metabolites 
of A. oryzae (or A. flavus) have not been linked to specific metabolic products. Only genes of the 
most important toxins: aflatoxin (Yu 2008, Lee 2006, Tominaga 2006), cyclopiazonic acid (Tokuoka 
2008, Chang 2009) and aflatrem (Nicholson 2009) have been annotated in both species which 
leaves much to be explored.  
The aim of the work in this section was to perform an initial comparative investigation of the 
small molecule chemistry from the two genome sequenced strains of A. oryzae (RIB40) and A. 
flavus (NRRL 3357) along with isolation and structure elucidation of new metabolites from A. 
oryzae, in order to get further insights into possible homologies in secondary metabolite 
production for these two important and related species. The results are described and discussed 
below and further experimental details can be found in paper 2.   
4.1.1 Comparison of secondary metabolite profiles of A. oryzae and A. flavus 
For the analysis of A. oryzae RIB40 (and A. flavus NRRL 3357) chemistry, we investigated a series 
of solid media cultivated at 25°C in the dark for 7 and 14 days followed by micro-scale extractions 
(Frisvad 1987, Smedsgaard 1997) and subsequently analysis with HPLC-DAD-MS for investigation 
of optimal secondary metabolite production conditions. The screening indicated the greatest 
chemodiversity and metabolite production from CYA, YES and WATM agar. 
The comparison of the secondary metabolite profiles of the two strains showed a high degree of 
chemical difference on all media as illustrated in figure 4.2 for the WATM medium. The major 
metabolite repetitions between the two genome sequenced strains were merely kojic acid and 
ergosterol as well as a number of minor metabolites (not analyzed here), which seemed to be 
shared between the two strains. Altogether, this is in sharp contrast to the high gene homology; 
however, it reflects the difference in metabolic published data (Laatsch 2010).  
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Figure 4.2 ESI+ (electrospray ionization) BPC (base peak chromatogram) of micro scale extract from WATM 
after seven days of incubation, bottom: A. oryzae RIB40, top: A. flavus NRRL3357. Besides kojic acid (shown 
in box) and analogues in the beginning of the chromatograms and ergosterol in the end (not shown), there 
are very few identical compounds between the genetically almost identical strains. Note that aspirochlorine 
is only detectable in negative ionization mode, and therefore not visible in these chromatograms. The 
oryzamides, ditryptoleucines and the parasiticolides are reported here. (figure taken from paper 2).   
Several previously reported metabolites of A. oryzae were dereplicated and we found that the 
RIB40 strain did not produce detectable levels (LC-MS) of cyclopiazonic acid (Orth 1977) (as also 
noted by Tokuoka et al. (Tokuoka 2008)), asperfuran (Pfefferle 1990), sporogen AO1 (Tanaka 
1984a, Tanaka 1984b), maltoryzine (Iizuka 1962) or aspergillomarasmine A (Robert 1962, Barbier 
1963), under these growth conditions. The RIB40 strain did produce kojic acid (Manabe 1984, 
Bentley 2006) and aspirochlorin (Sakata 1982, Sakata 1983, Sakata 1987, Monti 1999, Klausmeyer 
2005), figure 4.3 and a series of potentially new metabolites of which some were isolated and 
structure elucidated. These metabolites included the parasiticolites, ditryptoleucine, oryzamide 
A1-2 and 13-desoxypaxilline.  
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Figure 4.3 Structures of known metabolites from A. oryzae. 
4.1.1.1 13-desoxypaxilline 
During fermentation of the chemically potent RIB40 strain, we have been interested in the 
tremorgenic compounds, allegedly coupled to fungal sclerotia (Wicklow 1982, Gloer 1988, Gloer 
1989, Staub 1992, Staub 1993, Tepaske 1989a, Tepaske 1989b, Tepaske 1990, Tepaske 1992) and 
whether these could be found in A. oryzae as they have been in A. flavus. The RIB40 strain 
produces large and abundant sclerotia, especially on WATM agar, a fact not widely announced in 
literature although sclerotia have been observed in A. oryzae sporadically (Raper 1965, Wicklow 
2007, Jin 2010). No sclerotia were observable after 14 days on YES agar, but although these 
metabolites are often characterized as sclerotial metabolites, there is not a strict correlation 
between the biosynthesis of these metabolites and the formation of sclerotia, as also noted by 
Wilson (Wilson 1966), and this extract was used for the described isolations.  
We isolated the aflatrem precursor 13-desoxypaxilline which was originally isolated from 
Penicillium paxilli (Springer 1975, Longland 2000, Bilmen 2002, Sabater-Vilar 2003, Sheehan 
2009). Aflatrem is a known metabolite of A. flavus and was discovered by Wilson and Wilson in 
1964 (Wilson 1964) and structure elucidated by Gallagher et al. (Gallagher 1978, Gallagher 1980). 
13-desoxypaxilline was present in several media micro-scale extracts including YES, CYA, OAT and 
WATM. It was isolated from the above mentioned YES extract and the structure was confirmed by 
LC-MS, LC-MS/MS and NMR analysis. It was investigated through HPLC-DAD and LC-MS/MS 
whether alfatrem or other intermediates in the biosynthetic pathway were present in the 
extracts, however, none of the proposed intermediates towards aflatrem or aflatrem itself, figure 
4.4 could be detected and only one sample (WATM, 7d) showed traces of paspaline, a precursor 
for 13-desoxypaxilline. 
The discovery of 13-desoxypaxilline as the end-product of A. oryzae RIB40 is in agreement with 
the analysis of Nicholson et al., who showed that a frameshift mutation in the atmQ gene 
presumably accounts for the 13-desoxypaxilline not being converted into paspalicine and 
paspalinine (Nicholson 2009). This mutation is therefore likely responsible for terminating the 
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aflatrem biosynthesis in RIB40 prematurely. Contrary to our discovery, Nicholson et al. did not 
find the aflatrem gene cluster of RIB40 to be transcribed during their fermentations (Nicholson 
2009).  
 
Figure 4.4 The final steps in the proposed biosynthesis of aflatrem (in A. flavus). A. oryzae RIB40 
biosynthesis stops at 13-desoxypaxilline (Nicholson 2009).  
A second extract was made from 100 plates of a 14 day old A. oryzae culture grown on WATM 
agar with abundant sclerotia formation to validate the findings from the YES extract. The analysis 
of the WATM extract showed 13-desoxypaxilline as a major metabolite alongside other 
sclerotium-related metabolites, such as aflavinines (based on UV – data not shown) which were 
unfortunately not isolated in pure and large enough quantities for NMR analysis.  
The isolated 13-desoxypaxilline is a member of the paspalitrem tremorgens, a widely distributed 
group of metabolites that have been isolated from several genera: Penicillium, Eupenicillium, 
Claviceps, Emericella, Aspergillus and Phomopsis (Cole 1981, Steyn 1985, Bills 1992). Besides the 
tremorgenic activity in animals, these metabolites have been shown to be insecticides (Steyn 
1985), which is believed to be their ecological function together with aflatoxin and cyclopiazonic 
acid for protection of the sclerotia against fungivorous insects (Wicklow 1982, Gloer 1988).  
4.1.1.2 Parasiticolides 
In addition to 13-desoxypaxilline, two new analogues of parasiticolide A were also isolated. The 
metabolites showed, through LC-MS and NMR analysis, to be dide- and 14-deacetyl analogues 
and are most likely precursors to the sesquiterpene parasiticolide A (also called astellolide A), 
figure 4.5. The shift values of all the parasiticolide analogues correlated with the published data 
for parasiticolide A, except for the missing signals of the acetate units and their minor influence 
on the chemical shift values of adjacent protons and carbons (see paper 2 for NMR details) 
(Hamasaki 1975, Gould 1981). Several different extraction procedures were tested to verify the 
correctness of the compounds as genuine metabolites and not in vitro degraded parasiticolide A 
products, but all samples showed only dide- and 14-deacetyl parasiticolide A and no traceable (LC-
MS) levels of parasiticolide A ifself, even with different non-acidic extraction procedures. 
Parasiticolide A have been isolated from A. flavus var. columnaris once (Shiomi 2002) and was 
originally isolated and characterized from A. parasiticus (Fukuyama 1975, Ishikawa 1984) and later 
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also from a mutant of Emericella variecolor (Gould 1981). Recently parasiticolides have been 
detected in the newly described species A. arachidicola and A. minisclerotigenes (Pildain 2008). 
There have to our knowledge not been published any toxic studies on the parasiticolides, but the 
related peniopholides from the fungus Peniophora polygonia have been reported to have 
antifungal properties (Ayer 1992).  
 
Figure 4.5 Structures of Parasiticolide A, and 14-deacetyl parasiticolide A, dideacetyl parasiticolide A. 
According to our observations parasiticolides are more often detectable metabolites of A. oryzae 
than of A. flavus under the same fermentation conditions, suggesting that the pathway is partly 
silenced for A. flavus and may need to be activated under otherwise normal growth conditions. It 
is interesting that parasiticolide A is scarcely observed in A. flavus, when it is an important 
product of A. oryzae and also of A. parasiticus. We also isolated and elucidated a formyl variant of 
parasiticolide A; however, it was not possible to exclude the possibility of in vitro chemistry due to 
the formic acid added during the ethyl acetate extraction, so the correctness of this metabolite 
remains tentative (Hamasaki et. al. used benzene to extract parasiticolide A (Hamasaki 1975)).   
To further verify these observations, a MS/MS method was used to analyze several different 
microscale extracts of A. oryzae RIB40 for parasiticolide A. Trace amounts of parasiticolide A could 
be measured, indicating a complete transformation into the end product. The small amount of 
parasiticolide A in RIB40 (roughly 1:1000 ratio compared to 14-deacetyl parasiticolide A, 
presuming the same response factor) might be the result of spontaneous acetylation involving the 
first acetylating enzyme. When the gene cluster responsible for the biosynthesis of these 
metabolites is mapped, it is likely that the gene responsible for the last (specific) acetylation will 
be found to be mutated.  
4.1.1.3 Ditryptoleucine and oryzamide A1-2 
Four new A. flavus related NRP metabolites were also isolated from A. oryzae RIB40. The 
metabolites showed, through structure elucidating by 1H, DQF-COSY, HSQC and HMBC NMR data, 
to be two isomeric metabolites named ditryptoleucine related to the ditryptophenalines (Springer 
1977, Barrow 1993, Oleynek 1994, Barrow 1994), figure 4.6, and two indole-enamides named 
oryzamide A1-2 (cis- and trans-isomers) structurally similar to the antibiotic miyakamide B1-2 
(Shiomi 2002), figure 4.7. 
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Figure 4.6 Structures of ditryptoleucine (A. oryzae metabolite) and ditryptophenaline (A. flavus metabolite). 
The diketopeperazine ditryptoleucine was isolated in two variants with 1H-NMR shifts varying 
around the C-C dimeric bond, but with the same base structure. This unspecific dimerization is in 
line with previously isolated compounds (Barrow 1994). A hybrid between the ditryptophenaline 
and ditryptoleucine was isolated from an Aspergillus sp. as WIN 64745, with both a phenylanaline 
and leucine moiety, but with no N-methylation (Barrow 1993). These compounds were tested and 
proved antagonistic against substance P at the NK1 receptor (Movassaghi 2008). Intriguingly, 
these new A. oryzae metabolites have apparently exchanged phenylalanine with leucine 
compared to the similar A. flavus metabolites, indicating either a common trait in the 
domestication process or coupling between the two pathways. 
 
Figure 4.7 Structures of oryzamide A1-2 and the miyakamides B1-2.  
It proved difficult to unambiguously isolate the cis- and trans-isomers of oryzamide A in a pure 
form due to isomerization around the double bond. Due to this difficulty the structure elucidation 
has been performed on mixtures of compounds. It is evident from the structure elucidation that 
oryzamides A1-2 only differ in the configuration around the double bond of the enamine as evident 
from the size of the coupling constant. Marfey analysis of the amino acid derived compounds only 
established the presence of L-tyrosine in the oryzamides. The oryzamides A1-2 are variants of the 
miyakamides B1-2 (Shiomi 2002). The phenylalanine in the miyakamides has been substituted with 
leucine in the oryzamides. However, this exchange of phenylalanine and leucine has often been 
found for compounds produced within the same species. Penicillium polonicum produces both 
fructigenine A (also called puberulione and rugulosuvine A) containing phenylalanine and 
fructigenine B (also called verrucofortine) containing leucine (Arai 1989, Frisvad 2004a, Frisvad 
2004b). We could also detect two slightly later eluting compounds in the A. oryzae RIB40 extracts 
likely to be further indole-enamides having phenylalanine incorporated instead of tyrosine as 
evident from LC-DAD-MS analysis (data not shown) as also seen for the miyakamides (Shiomi 
2002).   
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4.1.2 Summary and part conclusion 
The tremorgenic 13-desoxypaxilline have been isolated from A. oryzae RIB40 and verified under 
several different growth conditions contrary to previous studies. We believe that 13-
desoxypaxilline is the end-product of the aflatrem biosynthesis for the RIB40 strain which 
correlated well with the results of Nicholson et al. (Nicholson 2009) who described a mutation in 
the gene responsible for further modifications of 13-desoxypaxilline in A. oryzae RIB40.  
The new metabolites dide- and 14-deacetyl parasiticolide A were also found as genuine products 
from the RIB40 strain where parasiticolide A was only detected in trace amounts using a LC-
MS/MS method. This indicates that a defective acetylation of the 14-deacetyl parasiticolide A and 
the small amount of parasiticolide A in RIB40 could be the result of spontaneous acetylation in the 
cell cytosol.  
The new NRPs ditryptoleucine and oryzamide A1-2 appear to be natural variants of known A. flavus 
metabolites. They share the exchange of a phenylalanine for a leucine, although they are believed 
to originate from two unrelated pathways. As for 13-desoxypaxilline, dide- and 14-deacetyl 
parasiticolide A are almost certainly products of a prematurely ended biosynthesis, here 
parasiticolide A. Further analysis of the genomes of A. oryzae and A. flavus could give possible 
candidates for the NRPS genes responsible for the production of ditryptoleucine and oryzamide 
A1-2. After identification of the synthethase genes it could be interesting to investigate whether 
the aminoacid exchange is due to genetic mutations.    
Altogether the finding contribute to understanding why the overall chemical profiles of A. oryzae 
(RIB40) and A. flavus (NRRL 3357) appear quite different since some of the end-products usually 
seen in A. flavus are apparently not reached in A. oryzae or the metabolites differ in one 
incorporated amino acid. Whether the different chemical profiles are merely the result of 
different regulation or are a result of genuine mutations, as with 13-desoxypaxilline, remains to 
be settled. A. oryzae RIB40 is clearly a chemically potent strain, and as more of its chemistry is 
unfolded it is likely to be revealed that most of the biosynthetic pathways of A. flavus will be 
found more or less functional which correlates to the high degree of homology between the two 
strains.  
The findings above shows that genome comparisons are an important tool to explore the 
chemical potential of different strains, however, a regulatory difference or mutations (small or 
large) in the genome can lead to large chemical differences between species who seem alike.  
4.2 Aspergillus niger 
Aspergillus niger is another industrially important filamentous fungus used in the fermentation 
industry to produce organic acids such as citric acid and gluconic acid as well as enzymes such as 
amylases and lipases (Schuster 2002). Besides the uses in the fermentation industry A. niger is 
also a contaminant of crops and feed distributed worldwide, including corn, peanuts, onions, 
apples, grapes, raisins, mangos and dried meat products (Perrone 2007, Nielsen 2009). 
Due to the vast importance of A. niger, both as contaminant and its uses in fermentations, the 
genome of two strains of A. niger have been sequenced (Baker 2006, Pel 2007) giving the 
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possibility of searching the genomes for secondary metabolites gene clusters. The next section 
describes how the genome sequences revealed the presence of a mycotoxin (fumonisin) gene 
cluster known from other species making researchers look for and report the production of 
fumonisins in A. niger. We have identified, isolated, and structure elucidated a new fumonisin 
isomer (paper 3). 
4.2.1 Fumonisin production in A. niger 
The sequencing of the genome of A. niger revealed the presence of a fumonisin-like gene cluster 
in two different isolates, ATCC 1015 (Baker 2006) and CBS 513.88 (Pel 2007). The fumonisins are a 
group of HR-PKs produced by Fusarium verticilloides and other Fusaria (Bezuidenhout 1988, 
Gelderblom 1988, Marin 2004). Several analogues of fumonisin have been reported, however, 
fumonisin B1, B2 and B3 of the B-series are the most abundant in nature and are all carcinogenic 
(Gelderblom 1993, Rheeder 2002, Bartók 2006). The B-series analogues contain a terminal 2-
amino-3-hydroxy motif on an eicosane backbone and two hydroxyl groups esterified with 
tricarboxylic acids. There had not, at the time of the publications of the genome sequences, been 
any reports of fumonisin production in A. niger. Therefore, after the discovery of the putative 
fumonisin gene cluster, Frisvad et al. (Frisvad 2007) investigated the possibility of fumonisin 
production in A. niger. They reported detection, through LC-MS comparisons to standards, of 
fumonisin B2 (FB2) from four strains of A. niger including the two fully genome sequenced strains 
(ATCC 1015 and CBS 513.88) and ATCC 9029 and NRRL 326 (Frisvad 2007) Later it was reported 
that A. niger could also produce fumonisin B4 (Nielsen 2009, Noonim 2009). The ability of A. niger 
to produce fumonisins gave speculations to whether this could be an overlooked health risk, since 
A. niger is used in industrial fermentations and is a common contaminant of feed and foods due 
to the possibility of fumonisins ending up in the final products (Frisvad 2007).  
4.2.1.1 Isolation and NMR characterization of fumonisin B2 and B6 from A. niger 
Further analysis of the A. niger strains revealed the ability of A. niger to produce another isomer 
besides fumonisin B2 and B4 with the same elemental composition as fumonisin B1 and iso-
fumonisin B1 but with a different retention time. We isolated and characterized this isomer, 
named fumonisin B6, from A. niger NRRL 326, along with fumonisin B2 which were NMR 
characterized to validate that fumonisin B2 from A. niger is identical to that reported in several 
Fusarium species.  
 
Figure 4.8 The structures of fumonisin B1, iso-B1, B2, B3, B4 and B6. 
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The structure of fumonisin B6 were solved based on DQF-COSY, HSQC, HMBC and H2BC NMR 
experiments along with comparison to literature values of fumonisin B1 (Savard 1994a) and iso-B1 
(MacKenzie 1998). Unambiguous assignment of the proton and carbon resonances of fumonisin 
B6 could be obtained for most of the resonances. However due to spectral overlap individual 
assignment of C7-C9 was not possible. The two tricarboxylic acid side chains were assigned as two 
separate spin systems with only minor chemical shift differences. The attachment of the C29-C34 
side chain to the backbone structure were confirmed by the presence of an HMBC correlation 
between H15 and C29, whereas the position of the C23-C28 side chain is based on the chemical shifts 
of H14/C14 and comparison with the assignment obtained from fumonisin B1 and iso-B1. The 
backbone fragments C1-C6 and C10-C20 were unambiguously assigned and only showed minor 
deviations compared to fumonisin B1 and iso-B1. Fumonisin B1 and iso-B1 have OH-groups 
attached to C3, C5, and C10 and to C3, C4, and C10, respectively, whereas fumonisin B6 has OH-
groups at C3, C4, and C5 (figure 4.8). Chemical shift values of 1.25 ppm for H10 and 27.5 ppm for C10, 
DQF-COSY connectivities from H11 to H10 and HMBC correlations from H9 to C10 and from H10 to C9, 
confirm that no OH-group is bound at this position due to the large upfield shift of the resonances 
when compared to fumonisin B1, where H10 and C10 resonances at 3.62 and 69.8 ppm, 
respectively. DQF-COSY connectivities can be traced along the backbone from H3 at 3.64 ppm, H4 
at 3.46 ppm, and H5 at 3.71 ppm to H6 at 1.53/1.59 ppm. In addition HMBC correlations can be 
seen from H4 to C2/C5 and from H3 to C4, confirming the presence of the third OH-group at C4 in 
the structure. The chemical shifts obtained for H4/C4 of 3.46 ppm/74.9 ppm compared to 3.65 
ppm/72.2 ppm as seen in iso-fumonisin B1 and equivalently for H5/C5 of 3.71 ppm/71.4 ppm 
compared to 3.84 ppm/68.4 ppm for fumonisin B1 is in agreement with the proposed structure of 
fumonisin B6.  
The NMR data of the isolated fumonisin B2 and the authentic standard from Fusarium were 
compared to establish whether they were identical. The chemical shifts were comparable except 
for the shifts of the two tricarboxylic acid side chains. The differences could be explained by a 
difference in the structural fold of the fumonisin B2 between the two samples, likely to be caused 
by differences in pH and thereby overall level of protonation of the four carboxylic acid 
functionalities. The fact that fumonisin B2 does have a unique globular folded structure has 
previously been addressed by Beier and Stanker (Beier 1997). The fumonisin B2 from A. niger was 
purified on a cation exchange column and to ensure that the two samples had been subjected to 
the same purification protocol the standard fumonisin B2 were also run over the column. The 
NMR spectra of the two fumonisins were now identical. The coupling constants for the protons in 
the amino terminal (C2-C5) and the attachment of the side chains (C14 and C15) in the fumonisins 
from A. niger and Fusarium showed that they are of the same size, proving that the relative 
stereochemistry for these parts of the backbone are the same. The stereochemistry at position C12 
and C16 could not be determined from the data due to chemical shifts overlap. The optical 
rotation of fumonisin B2 from A. niger was similar to that known from Fusarium; however, with 
several stereocenters in the molecule this is not a direct proof of identical stereochemistry. The 
data points toward identical stereochemistry of the two fumonisins; however, a genetic 
comparison of the fumonisin gene cluster in the two genera revealed several differences in the 
placement and orientation of the different involved biosynthetic genes (Baker 2006) which could 
lead to differences in the stereochemistry in the final product. 
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4.2.3 Summary and part conclusion 
Two fumonisin isomers were isolated and structure elucidated from an extract of A. niger where 
one was a new analogue. The absolute stereochemistry of both fumonisin B2 and B6 still needs to 
be determined either through crystallization or derivation studies. The production of fumonisins 
in A. niger is an example of how the genome sequences followed by the prediction of gene 
function revealed the possible production of a mycotoxin in a species, which is present in both 
food and feeds and which is used in the industry. The reason for the fumonisins not having been 
reported in A. niger before may be that it was not expected for them to be produced and that the 
extraction and detection methods are different from other mycotoxins.  
4.3 Aspergillus nidulans  
Aspergillus nidulans is one of the most significant biological model systems in the fungal kingdom. 
This was pioneered by Pontecorvos’ (Pontecorvo 1953) work in the middle of the last century, 
which demonstrated that A. nidulans, in addition to the asexual state, also proliferate via sexual 
and parasexual life cycles giving an ideal platform for genetic studies. Due to the wide uses of A. 
nidulans as a model organism, efficient tools for targeted gene transformations have been 
developed (Nayak 2006, Nielsen 2006, Nielsen 2008) and the availability of the genome 
sequences has facilitated the possibilities of genome mining (Galagan 2005). Prior to the release 
of the genome sequence the research of secondary metabolism in A. nidulans was focused on a 
few biosynthetic pathways whereas the focus have now been shifted towards discovery and 
linking of metabolites to the silent genes.  
The aim of the work in this section was to discover and link new secondary metabolites, especially 
PKs, of A. nidulans to their synthase genes. The strategies for activation of the secondary 
metabolite genes were the OSMAC approach, where the reference strain was grown on up to 
eight different media (section 4.3.1, paper 4), and through genetic modification (section 4.3.2, 
paper 5). These two approaches were combined and led in two studies to the discovery of 
metabolites not previously described from A. nidulans (section 4.3.3, paper 6 and 7). The results 
are described and further experimental details can be found in the papers.  
4.3.1 Discovery and linking of polyketides to their PKS through a deletion 
library 
As described in section 2.2.2 there are several ways to activate secondary metabolite genes in 
filamentous fungi. Due to previous experience at CMB with cultivating filamentous fungi at 
various media conditions we decided to use the OSMAC approach to possible enhance secondary 
metabolite production of A. nidulans (Frisvad 1981, Frisvad 1983, Filtenborg 1990, Frisvad 2007). 
Reports of novel metabolites from A. nidulans for example the aspoquinolones (Scherlach 2006) 
and aspernidine A and B (Scherlach 2010) indicated that this was a reasonable approach.  
Three base media, Czapek yeast agar (CYA), Raulin-Thom (RT) and yeast extract (YE), were chosen 
and these were varied through the addition of salt (CYAs), sucrose (YES, CY20) and oatmeal (RTO). 
In addition a minimal media (MM) was used, giving eight different media in total. The media were 
selected based on the knowledge at CMB to ensure exploration of different growth conditions. 
43
4 Results and discussion 
 
30 
 
The reference strain, IBT29539 were cultivated on the eight media and inoculated for seven days 
at 37°C in the dark.  Figure 4.9 show cultures of the strain on the different media. 
 
Figure 4.9 The reference strain cultivated on eight different media: RTO, RT, CY20, CYAs, CYA, YES, YE and 
MM. 
The cultures appear quite different at the different cultivation conditions. To analyze the 
metabolite production micro-extraction was performed (Frisvad 1987, Smedsgaard 1997) and the 
extracts were analyzed by both UHPLC-DAD and LC-TOF-MS. The UHPLC analysis revealed a 
diverse production of secondary metabolites on the eight different media, figure 4.10. 
 
Figure 4.10 UHPLC-DAD chromatograms (210 nm) of extracts of the reference strain cultivated on eight 
different media compositions demonstrate the difference in secondary metabolite production. From 
bottom to top: MM, YE, YES, CYA, CYAs, CY20, RT and RTO. Note that the emericellamides are not visible in 
the UHPLC chromatogram (210 nm); however, they were detected in ESI+ and ESI- in all media except YE.     
44
PhD thesis 
Marie Louise Klejnstrup 
 
 
31 
 
The secondary metabolite production was highly diverse and formed the basis for isolation and 
characterization of several metabolites which will be elaborated on the following sections. The 
metabolic profiles of MM and YE were considered to be redundant and these two media were 
therefore not used for further screening.  
To investigate whether any of the metabolites in figure 4.10 were PKs we decided on a strategy to 
make a global deletion library where all 32 putative PKS encoding genes, as defined from the 
annotation of the genome databases at the Broad Institute of Harvard and MIT and the 
Aspergillus Genome Database at Stanford (Arnaud 2012), were deleted leaving us with 32 strains 
to be analyzed on the six chosen media. The deletion samples were prepared using the same 
micro-extraction procedure as for the reference strain. Since the deletion of a PKS gene should 
abolish the production of the metabolite, we hypothesized that comparison of a deletion strain to 
the reference would show missing peaks. To verify the approach we included deletions of genes 
which had already been linked, by others, to metabolites. Figure 4.11 show the UHPLC 
chromatogram of the reference strain compared to a deletion of stcA which is the PKS gene 
responsible for the biosynthesis of the sterigmatocystin backbone (Yu 1995). It is seen that the 
large peak at 4.6 minutes disappears. To confirm this result the same strains are analyzed with LC-
TOF-MS where an extracted ion chromatogram of the [M+H]+ of sterigmatocystin, 325 (±0.5 Da), 
disappeared in the deletion strain (data not shown).    
 
Figure 4.11 UHPLC chromatogram of the stcAΔ strain compared to the reference strain on CYA.   
This analysis was also performed on the remaining eight PKS encoding genes which, at the time, 
had been linked to metabolites. Metabolites representing three, beside sterigmatocystin, of the 
eight gene clusters could be detected: monodictyphenone, orsellinic acid and emericellamide. In 
agreement with previously published data the metabolites were absent in the corresponding 
single PKS gene deletion mutant strains; mdpG (Bok 2009), orsA (Schroeckh 2009) and easB 
(Chiang 2008), respectively (data not shown). Beside the secondary metabolite effect seen in 
these four strains, the strain carrying the wAΔ mutation formed white conidiospores, figure 4.12. 
Formation of the white spores occurred as it fails to produce the naphthopyrone, YWA1, the 
precursor of green conidial pigment (Watanabe 1998, Watanabe 1999).  
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Figure 4.12 The wAΔ strain on RTO, YES and CY20 medium.  
The compounds resulting from the remaining three PKS gene clusters were originally identified 
through activation of the gene clusters by controlled expression of the transcription factor gene 
(Bergmann 2007, Chiang 2009) or by deletion of the sumO gene (Szewczyk 2008) and were not 
expressed under our growth conditions.  
The metabolic profiles of the remaining 24 strains were compared to the reference strain on all 
media to uncover novel genetic links between PKS genes and PKs. The UHPLC-DAD 
chromatograms were first compared and the interesting peaks were afterwards identified on the 
LC-TOF-MS. The measured m/z was used to perform dereplication by use of the natural product 
database AntiBase (Laatsch 2010) which contains around 37000 metabolites. The hits were 
subsequently sorted based on the UV-data and reports in the literature. The novel and linked 
metabolites were isolated and structure elucidated through NMR analysis. UHPLC-DAD was 
chosen as the initial analysis based on the conjugated nature of PKs and better separation of 
metabolites than on the LC-TOF-MS. When a metabolite had been identified in the reference 
strain and corresponding peak was missing in a deletion strain, it was confirmed by HR-MS data 
through an extracted ion chromatogram. Through the comparison, several PKs which could be 
linked to PKS genes were identified; arugosin and shamixanthones (mdpG), orsellinic acid 
(AN7903 and orsA) as well as austinol and dehydroaustinol (AN8383) as described in detail below.   
4.3.1.1. Identification of the austinol/dehydroaustinol synthase gene 
The meroterpenoids austinol and dehydroaustinol and related metabolites were first isolated 
from A. ustus by Simpson and co-workers in 1982 (Simpson 1982) and reported from A. nidulans 
in 2007 (Márquez-Fernández 2007). Austinol and dehydroaustinol are examples of a group of 
meroterpenoids which Simpson and co-workers through labeling studies showed to be derived 
from the polyketide 3,5-dimethylorsellinic acid (Simpson 1981, Scott 1986, Geris 2009), however, 
the genes responsible for the production was not identified.  
In this study production of austinol and dehydroaustinol was observed on all the six media used 
for screening of the deletion library. The structures of austinol and dehydroaustinol were 
confirmed through LC-TOF-MS and for dehydroaustinol through extraction, purification and NMR 
analysis. Interestingly we noticed that on RTO five of the single PKS deletion strains, AN0523Δ, 
pkbAΔ (AN6448Δ), AN7022Δ, ausAΔ (AN8383Δ) and adpAΔ did not produce austinol and 
dehydroaustinol, figure 4.13 indicating a cross regulation of austinol and dehydroaustinol 
production involving these five genes. When the rest of the media was examined it was only ausA 
which failed to produce austinol and dehydroaustinol, see figure 4.13 for YES medium.  
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Figure 4.13 UHPLC-DAD chromatograms (210 nm) showing the presence of austinol and dehydroaustinol in 
AN0523Δ, pkbAΔ (AN6448Δ), AN7022Δ, ausAΔ (AN8383Δ) and adpAΔ compared to the reference strain on 
RTO and YES medium.  
To confirm that the loss of austinol and dehydroaustinol production was directly due to the ausA 
deletion rather than to silencing of another gene caused by chromatin changes provoked by the 
orsA deletion, a point mutation which has been shown to disrupt the enzymatic activity of the PKS 
production was created (Evans 2008). Like with the ausAΔ strain the production of austinol and 
dehydroaustinol was completely abolished on all six media (data not shown) showing that AusA is 
directly involved in the production of austinol and dehydroaustinol. To identify the product of  
AusA we overexpressed the gene by creating a strain which expressed ausA controlled by an 
inducible promoter, alcA, in integration site I (Hansen 2011). On inductive medium the LC-TOF-MS 
analysis showed a large peak eluting at around 6 minutes which was also present in the reference 
strain in small amounts but not produced in the deletion strain, figure 4.14. 
 
Figure 4.14 Extracted ion chromatograms of 3,5-dimethylorsellinic acid (m/z 195 (±0.5 Da) [M-H]-) of a) the 
reference strain and ausAΔ on RTO medium and b) the reference strain and the ausA overexpression strain 
(Oex) on induction medium (glycerol with threonine).  
a)
b)
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The metabolite was purified and the structure was elucidated by NMR to be 3,5-dimethylorsellinic 
acid which is therefore believed to be the first step in the biosynthesis of austinol and 
dehydroaustinol as shown in figure 2.8 in section 2. This result confirms the results of the labeling 
experiments performed by Simpson and co-workers 30 years ago (Simpson 1981, Scott 1986). 
After our publication Lo and co-workers have shown that the conversion of 3,5-dimethylorsellinic 
acid into austinol and dehydroaustinol is catalyzed by enzymes whose genes are present in two 
separately located gene clusters (Lo 2012).  
4.3.1.2 Linking of arugosin to the monodictyphenone gene cluster  
The deletion which gave the most prominent change in metabolite profile was mdpGΔ which, in 
an earlier study by Bok and co-workers, had been activated through epigenetic modulation of the 
chromatin landscape by the deletion of cclA resulting in the linking of eight emodin analogues to 
MdpG (Bok 2009, Chiang 2010b). Figure 4.15 show a segment of the UHPLC chromatogram of 
mdpGΔ and the reference strain on RTO medium where the largest differences are observed.  
 
Figure 4.15 UHPLC-DAD chromatogram (210 nm) from four to eight minutes of the reference strain 
(bottom) and mdpGΔ (top) on RTO medium. The deletion eliminates the production of arugosin H, arugosin 
A, emericellin, shamixanthone and epi-shamixanthone as well as some unidentified peaks.  
Several peaks disappeared, the most prominent being the broad peak which elutes at 7.2 
minutes. This compound had a characteristic UV-spectrum, figure 4.16a, and through analysis of 
the adducts present in the MS-spectrum, figure 4.16b, the peak was identified to have an m/z 
425.214 for [M+H]+. A search in the AntiBase database (Laatsch 2010) tentatively gave 32 possible 
hits based on the molecular ion. To narrow the possible number of candidates the fragment 
pattern was investigated and an ion of m/z 357.161 was also observed which corresponds to 
[M+H-C5H8]+ where C5H8 could correspond to a prenyl group. This information excluded 
metabolites of the 32 candidates to four, arugosin A, B, C and variecoxanthone C since they were 
the only compounds containing a labile prenyl group. The arugosins had the same UV-
chromophore as reported in the literature (Ballantine 1970, Kawahara 1988a).    
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Figure 4.16 a) UV-spectrum of arugosin A b) MS-spectrum of arugosin A, top: ESI+ bottom: ESI-. 
A large scale extraction of the reference strain on RTO medium was made for isolation of arugosin 
A. The NMR data were in agreement with the data reported in the literature (Kawahara 1988a) of 
the hemiacetal form of arugosin A except that in DMSO-d6 the equilibrium is shifted completely to 
the open form. In contrast the NMR data, in methanol-d4, figure 4.17, showed that arugosin A 
exists in an equilibrium between the open and closed form, explaining the broad peak observed in 
the UHPLC-chromatograms. Arugosin A had not previously been reported from A. nidulans but 
from A. rugulosus and A. silvaticus (Ballantine 1970, Kawahara 1988a).   
  
Figure 4.17 1H-NMR spectrum of arugosin A in a) methanol-d4 and b) DMSO-d6.  
a)
b)
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Further investigations of the metabolites disappearing in the mdpGΔ strain revealed a minor peak 
which could be assigned as a mono-prenylated arugosin with a [M+H]+ of m/z 357.131, arugosin 
H, figure 4.18. The MS data did not show fragments due to loss of a prenyl, as in the case of 
arugosin A, indicating that the peak is a precursor to arugosin A and that arugosin H is C-
prenylated since this is less labile than an O-prenyl. Arugosin H have along with arugosin G been 
reported from Emericella nidulans var. acristata (Krajl 2006) Emericellin and shamixanthone have 
previously been reported from A. nidulans (Márquez-Fernández 2007) and labeling studies have 
shown that the arugosins are precursors for emericellin and the shamixanthones but have not 
established a genetic link (Ahmed 1992), as done in this study. A recent paper of Simpson 
(Simpson 2012) have elaborated on the information published, both through chemical and 
genetic studies and proposed a biosynthesis of the shamixanthones combining recent findings 
with the information from the biosynthesis established through labeling studies 20 years ago 
(Ahmed 1992).   
 
Figure 4.18 Structures of arugosin H, emericellin, shamixanthone and epishamixanthone.   
The mdpG gene cluster is responsible for the biosynthesis of a family of structurally similar 
compounds which is not unusual (Walsh 2002, Kroken 2003, Frisvad 2004b, Amoutzias 2008).  
4.3.1.3. Linking of orsellinic acid derived metabolites to the orsellinic acid gene 
cluster to and AN7903 
One of the most studied PK families in A. nidulans is the products derived from the PK of the PKS 
encoding orsA, orsellinic acid. The metabolites F-9775A and F-9775B, lecanoric acid, gerfelin, C10-
deoxy-gerfelin, diorcinol, orcinol cordyol C, violaceol I, violaceol II, sanghaspirodin A and 
sanghaspirodin B have all been shown to be linked to orsA (Bok 2009, Schroeckh 2009, Sanchez 
2010, Nahlik 2010, Nützmann 2011, Scherlach 2011). 
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Figure 4.19 Structures of orsellinic acid, lecanoric acid, F-9775A, F9775B, violaceol I, and violaceol II.  
In this study orsellinic acid, lecanoric acid, F-9775A, F-9775B, violaceol I and violaceol II, figure 
4.19, were present in the extracts from the reference strains on the complex media and the 
production was abolished in the orsAΔ strain. Interestingly the metabolites which disappear in the 
orsAΔ strain also disappear in the AN7903Δ strain. This result does not contradict the original 
assignment of orsA as the PKS gene responsible for production of orsellinic acid. AN7903 is larger 
than orsA and contains a methyl-transferase domain, which is not required for orsellinic acid 
production. Schroeckh et al. (Schroeckh 2009) observed that both AN7903 and orsA were 
upregulated when orsellinic acid was induced by co-cultivation with Streptomyces hygroscopicus, 
which could indicate either cross-talk between the two clusters or induction of expression of both 
clusters due to interactions. What appears to be trace amounts of orsellinic acid could be 
detected in both the AN7903Δ and the orsAΔ strains. The source of the orsellinic acid remains 
elusive but could be produced by other PKSs. Ahuja and co-workers reported the production of 
orsellinaldehyde from PkfA (Ahuja 2012). It is interesting to note that in most of the strategies for 
activating secondary metabolite production through epigenetic modifications, both chemical and 
molecular, in A. nidulans the products of the orsellinic acid cluster seems to be activated.  
4.3.2 Characterization of the 3-methylorsellinic acid gene cluster  
Aspergillus nidulans has been shown to produce at least four variants of orsellinic acid; orsellinic 
acid (OrsA (Schroeckh 2009)), 3-methylorsellinic acid (Hansen 2011), 3,5-dimethylorsellinic acid 
(AusA (Nielsen 2011)) and orsellinic acid aldehyde (PkfA (Ahuja 2012)). The detection of 3-
methylorsellinic acid reported by Hansen et al. (Hansen 2011) led us to examine the extracts of 
the reference strain used for creation of the PKS deletion library described in section 4.3.1. The 
extracts of the deletion library was analyzed on the LC-TOF-MS; however, due to the better mass 
accuracy and sensitivity of the newly acquired UHPLC-TOF-MS this instrument was used for the 
extract analysis. We found 3-methylorsellinic acid to be produced in trace amounts on CYA, CY20 
and RT medium and of the 32 deletions it was only in AN6448Δ (pkbAΔ) that production failed. 
Figure 4.20 shows EICs of a 3-methylorsellinic acid [M+H]+ (m/z 183.06483±0.001) standard, and 
the reference and pkbAΔ strains cultivated on CYA medium. This data corresponds to the recently 
published findings by Ahuja and co-workers that the PKS PkbA is required to produce 3-
methylorsellenic acid along with cichorine (Ahuja 2012).  
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Figure 4.20 EIC of 3-methylorsellinic acid [M+H]+ (calc. m/z 183.06483±0.001) (UHPLC-TOF-MS)) of a 
standard, the reference and pkbAΔ strains on CYA medium cultivated for seven days at 37°C.  
As production of 3-methylorsellinic acid was relatively low under our cultivation conditions we 
searched the genome sequence for neighboring genes predicted to encode for transcriptional 
regulation. AN6446 was predicted to have DNA binding activity and we speculated that this could 
be a cluster-specific transcription factor and constructed an AN6446 overexpression strain 
(AN6446-Oex) in IS1 (Hansen 2011). The overexpression of AN6446 clearly had an effect on A. 
nidulans, since the AN6446-Oex compared to the reference displayed a decrease in pigmentation 
of conidia to a dusty green appearance and a light brown center of the colony after seven days 
growth on MM, figure 4.21.  
 
Figure 4.21 The reference strain compared to the AN6446-Oex strain cultivated on MM at 37°C for three, 
five days, and seven days.  
To analyze the metabolite production micro-extraction was performed (Frisvad 1987, Smedsgaard 
1997) and the extracts were analyzed by UHPLC-TOF-MS, figure 4.22. The strains were extracted 
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after three, five, and seven days to test the effect of growth time on the production of secondary 
metabolites.  
    
 
Figure 4.22 UHPLC-TOFMS ESI+ BPC of the micro-extracts of the reference and AN6446-Oex strains 
cultivated on MM media at 37°C for a) three, b) five, and c) seven days. The metabolites isolated in this 
study are marked. *This metabolite is the sideophore triacetylfusarine.    
a)
b)
c)
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The UHPLC-TOF-MS analysis revealed several new peaks appearing on the AN6446-Oex strain 
compared to the reference indicating that the overexpression had indeed turned on the likely 3-
methylorsellinic acid biosynthetic pathway. 3-methylorsellinic acid was present in trace amounts 
in the AN6446-Oex strain. The metabolic profile seemed to be rather similar for the three 
different days although new peaks were apparently more dominant after seven days and the peak 
at 4.1 which was identified to be the siderophore triacetylfusarine was less dominant. 
Consequently the strains were grown for seven days throughout the study. Moreover this showed 
that MM medium was a suitable growth medium for isolation of candidate metabolites. 
A large scale extract of 200 petri dishes carrying the AN6446-Oex strain was thus prepared for 
isolation and structure elucidation of several metabolites. In figure 4.23, the UHPLC-TOF-MS ESI+ 
BPC of the large extract compared to the micro-extracts is shown. 
 
Figure 4.23 UHPLC-TOF-MS ESI+ BPC of the micro-extract (bottom) and 200 plate extract (top) of the 
overexpression of AN6446-Oex strain cultivated on MM medium for seven days at 37°C.  
Sample preparations and cultivation conditions of a large number of plates could influence the 
loss of metabolites observed; however, further analysis revealed more metabolites than visible in 
the chromatogram as cichorine were present in very high concentrations. Isolation and structure 
elucidation revealed the presence of several metabolites; cichorine, demethylnidulol and 4-
hydroxy-3,5-dimethyl-2-pyrone and two dimers of cichorine and nidulol/demethylnidulol, named 
cichonidulol and demethylcichonidulol figure 4.24. Throughout the study several deletion strains 
were constructed where some of these will not be mentioned further; however, nidulol and 3-
methylorsellinic acid was isolated from two of these, AN6444Δ and AN6445Δ respectively. 
Cichorine and 3-methylorsellinic was recently reported to be the products of the overexpression 
of the AN6448 PKS (Ahuja 2012). Cichorine has previously been isolated from A. silvaticus 
(Kawahara 1988b) and Alternaria cichorii (Stierle 1993) whereas nidulol have been reported from 
A. nidulans (Aucamp 1968), A. silvaticus (Fujita 1984), and Emericella desertorum (Nozawa 1987).   
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Figure 4.24 Structures of metabolites isolated and elucidated throughout this study. 3-methylorsellinic acid, 
cichorine, demethylcichorine, nidulol, demethylnidulol, cichonidulol, demethylcichonidulol, 4-hydroxy-3,6-
dimethyl-2-pyrone.  
The structures were elucidated using 2D NMR spectroscopy, where especially heteronuclear 
HSQC and HMBC spectra were extensively used due to the absence of proton-proton couplings 
and low proton density of the metabolites. For further details on NMR analysis and 1D spectra see 
paper 5. In addition the results were in accordance with chemical shift values reported in 
literature for cichorine (Monreau 2005), 3-methylorsellinic acid (Ahuja 2012), demethylnidulol (El-
Feraly 1985), and 4-hydroxy-3,6-dimethyl-2-pyrone (Savard 1994b).  
The resemblance of the molecular formulas of cichorine (C10H11NO3) and nidulol (C10H10O4) and 
initial comparison of the 1H-spectra that suggested these metabolites could be related. The main 
issue in structure elucidation of these two metabolites was whether the carbonyl was situated on 
C7 or C8. The problem was solved by comparison of the carbon chemical shift of cichorine to the 
shifts reported in the literature obtained after total synthesis of cichorine (Moreau 2005). For all 
the metabolites key HMBC correlations from H5 to C7 and/or C8 and from H7/H8 to the carbons 
present in the aromatic ring, figure 4.25, aided in the structure elucidation. A NOESY correlation 
between H8 and H10 in cichorine which were missing in nidulol confirmed the difference in the two 
structures.   
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Figure 4.25 Key HMBC correlations of cichorine, nidulol, cichonidulol and 4-hydroxy-3,6-dimethyl-2-pyrone.  
As these metabolites are biosynthetic derivatives of 3-methylorsellinic acid it was expected that 
the carbonyl would be present at C8. These structures indicate that more enzymatic activities are 
involved in the biosynthesis due to the oxidations at C7.  
The UV spectrum of demethylnidulol was identical to the one of nidulol and the molecular 
formula C9H8O4 showed that the difference between the two metabolites was a carbon and two 
protons. Through analysis of the NMR-spectra it was confirmed that the two metabolites were 
related and that the difference was the methylation of C3 in nidulol which is not present in 
demethylnidulol.  
Table 4.1 13C-chemical shifts (ppm) of 3-methylorsellinic acid, cichorine, nidulol, demethylnidulol, and 
cichonidulol. All data were obtained in DMSO-d6 and referenced to the solvent peak at 39.5 ppm. 
ID 3-methyl-
orsellinic acid 
Cichorine Nidulol Demethyl-
nidulol 
Cichonidulol 
1/1’ 103.7/- 123.1/- 107.2/- 92.9/- 121.3/116.1 
2/2’ 163.0/- 153.6/- 157.5/- 159.6/- 153.6/153.8 
3/3’ 107.7/- 118.9/- 117.5/- 101.1/- 120.5/115.3 
4/4’ 159.7/- 156.3/- 162.7/- 168.8/- 156.9/158.1 
5/5’ 109.9/- 102.9/- 103.0/- 103.2/- 103.4/102.4 
6/6’ 139.4/- 131.9/- 148.6/- 151.4/- 131.0/139.5 
7/7’ 23.4/- 169.8/- 68.2/- 66.9/- 167.1/71.7 
8/8’ 173.8/- 43.1/- 168.5/- 178.1/- 43.2/83.5 
9/9’ 7.9/- 9.1/- 8.2/- -/- 9.3/8.6 
10/10’ -/- 58.9/- 53.9/- 53.9/- 59.0/59.2 
Through analysis of the large scale AN6446-Oex extract we noticed two small peaks eluting 
around five minutes which had UV-spectra that resembled those of nidulol and cichorine. These 
metabolites were present in small amounts in the large extract and based on the molecular 
formular of these metabolites C20H21NO6 and C19H19NO6 we speculated whether they could be 
dimers of cichorine, 3-methylorsellinic acid, nidulol or demethylnidulol through condensation and 
formation of e.g. an ester as seen with the formation of lecanoric acid in the orsellinic acid 
pathway (Schroeckh 2009). 2.0 mg of C20H21NO6 and 0.6 mg of C19H19NO6 were isolated from the 
extract and the structure of C19H19NO6 was elucidated based on 2D NMR analysis to be a dimer of 
cichorine and nidulol, named cichonidulol. Analysis of the HMBC spectrum revealed that the link 
of the two molecules was not through an ester formation but interestingly through a C-N bond 
formed apparently with the loss of a carbonyl in nidulol. A search of the literature showed that 
cichonidulol and demethylnidulol were novel metabolites with a new base carbon skeleton. The 
metabolite which showed the closest resemblance was the plant metabolite, capaurine, which 
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contains the C-N condensation bond between two ringsystems; however, the nitrogen containing 
ring is a six membered ring and the substitution patterns of are quite different (Manske 1945).     
Table 4.1 lists the 13C-chemical shifts of the above mentioned isolated metabolites where it is 
seen that the largest differences in shift values occur around at C1 and C6 which differs depending 
on the position of the carbonyl.  
The final metabolite isolated was 4-hydroxy-3,6-dimethyl-2-pyrone whose chemical shifts were in 
accordance with shifts reported in the literature (Savard 1994b). This metabolite is quite different 
from the above mentioned having a completely different carbon skeleton. Consequently this 
metabolite was either a product of pkbA or we could have activated another PKS encoding gene.  
To verify that AN6446 had an activator effect on the surrounding genes, relative gene expression 
measurement by qRT-PCR analysis was performed. A deletion of AN6446, which displayed the 
same phonotype, as the reference was added to the analysis with the hypothesis that this would 
have the inverse effect from the overexpression strain minimizing the risk of picking false cluster 
members. AN6446-Oex and AN6446Δ strains compared to the reference strain was performed for 
all predicted genes in the range AN6435-AN6457, figure 4.26.  
 
Figure 4.26 Results of the qRT-PCR analysis of AN6446-Oex and AN6446Δ on the genes from AN6435-
AN6457 compared to the reference strain. An expression of 1 means unaltered expression, over 1 means 
higher expression and below 1 means lower expression. These data show that AN6444, AN6446, AN6447, 
AN6448, AN6449, AN6450 and AN6451 are upregulated in the overexpression strain and downregulated in 
the deletionstrain indicating that the pkbA cluster contains these genes.   
The average fold change of three runs of all 25 genes in the AN6446Δ and AN6446-Oex strains 
compared to the reference is shown in figure 4.26. A level of one means unaltered expression 
whereas a level below means lower expression and above means higher. For a gene to be a 
putative cluster member one criterion was to have fold change above one for the AN6446-Oex 
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and close to zero for the AN6446Δ strains. Deviation from one or both of these criteria made us 
disregard the candidate as a cluster member based on the gene expression data.  
Based on this analysis the values of the genes AN6444, AN6447, AN6448, AN6449, AN6450 and 
AN6451 along with AN6446 were considered as cluster candidates. To verify the results and to 
determine the biosynthetic role of the enzymes encoded by these genes we constructed deletions 
of all the 25 initial candidate genes in the AN6446-Oex background. The six most distant genes of 
AN6446 were deleted in triplets (AN6435-AN6437, AN6438-AN6440, AN6452-AN6454 and 
AN6455-AN6457) and the remaining as singular mutants.  
To see whether AN6446 had regulatory effects on secondary metabolite production outside the 
cluster, a full cluster deletion (AN6435-AN6457) in the overexpression strain was constructed as 
well. Lastly to confirm the role of PkbA as the 3-methylorsellinic acid producing PKS an 
overexpression of this gene was constructed.  
 
Figure 4.27 The appearance of the AN6446-Oex, pkbA-Oex, AN6446-Oex AN6435-6437Δ, AN6446-Oex 
AN6438-6440Δ, AN6446-Oex AN6441Δ, AN6446-Oex AN11920Δ, AN6446-Oex AN11921Δ, AN6446-Oex 
AN6443Δ, AN6446-Oex AN6444Δ, AN6446-Oex AN6445Δ, AN6446-Oex AN6446Δ, AN6446-Oex AN6447Δ, 
AN6446-Oex AN6448Δ, AN6446-Oex AN11922Δ, AN6446-Oex AN6449Δ, AN6446-Oex AN6450Δ, AN6446-
Oex AN6451Δ, AN6446-Oex AN6452-6454Δ, AN6446-Oex AN6455-6457Δ and AN6446-Oex AN6435-6457Δ 
strains cultivated on MM medium for seven days at 37°C.  
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The phenotypes of the constructed strains can be compared in figure 4.27. The deletion of the 
genes, predicted to form the gene cluster of PkbA, indeed stood out from the others in the 
phenotype display. The phenotypes varied greatly, indicating altered metabolism in the respective 
strains. To investigate which metabolites originated from this cluster and if correlated with the 
phenotype of the mutant strains micro-extraction was performed (Frisvad 1987, Smedsgaard 
1997) and the extracts were analyzed by UHPLC-TOF-MS. In figure 4.28, 4.29 and 4.30 ESI+ BPC of 
all the extracts can be seen.  
 
Figure 4.28 UHPLC-TOF-MS ESI+ BPC of the micro-extracts of the (from bottom to top) reference AN6446-
Oex, AN6446-Oex AN6435-6437Δ, AN6446-Oex AN6438-6440Δ, AN6446-Oex AN6441Δ, AN6446-Oex 
AN11920Δ, AN6446-Oex AN11921Δ, AN6446-Oex AN6435-6457Δ strains cultivated on MM medium for 
seven days at 37°C. The metabolites identified in the AN6446-Oex strain are missing in all the deletions.   
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In figure 4.28 the strains where all the metabolites of the cluster had disappeared and the 
AN6446-Oex strain are depicted. In all the deletions from AN6435 to AN11921 all the key 
metabolites shown in the AN6446-Oex strain are missing. Since the qRT-PCR data did not support 
these belonging to the cluster we speculate that this links to local chromosomal aberration due to 
change in the strain. Inactivating one or some of these genes instead with point mutations would 
test this hypothesis.  
Moreover, the phenotypes of these strains were very similar as the metabolic profiles were. The 
strains all showed the same differences from the reference strain, namely the massive production 
of the siderophore triacetylfusarinine.  
In the whole cluster deletion strain, AN6446-Oex AN6435-6457Δ, all metabolite production is 
eliminated including 4-hydroxy-3,6-dimethyl-2-pyrone strongly indicating that this metabolite is 
also a product of the cluster. However, eliminated production may reflect the deletions of 
AN6435 to AN11921. A cluster deletion from AN6444 to AN6451 would be an alternative. A 
thorough investigation of the PKS deletion library described in section 4.3.1 revealed trace 
amounts of 4-hydroxy-3,6-dimethyl-2-pyrone on CYA medium in the reference strain. The 32 
deletions on CYA medium were analyzed for 4-hydroxy-3,6-dimethyl-2-pyrone and it was only in 
pkbA that production failed.   
 
Figure 4.29 UHPLC-TOF-MS ESI+ BPC of the micro-extracts of the (from bottom to top) AN6446-Oex, 
AN6446-Oex AN6443Δ, AN6446-Oex AN6445Δ, AN6446-Oex AN11922Δ, AN6446-Oex AN6452-6454Δ, 
AN6446-Oex AN6454-6457Δ strains cultivated on MM medium for seven days at 37°C. The figure illustrates 
that these genes are not involved in the pkbA gene cluster in agreement with the qRT-PCR data.  
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The extracts depicted in figure 4.29 are the strains of which the chromatograms mimic the profile 
of AN6446-Oex. The colonies of these strains in figure 4.27 resembled the overexpression strain, 
and the results are in agreement with the qRT-PCR data, which excluded these genes to be part of 
the 3-methylorsellinic acid gene cluster.    
 
Figure 4.30 UHPLC-TOF-MS ESI+ BPC of the micro-extracts of the AN6446-Oxe, AN6448-Oex, AN6446-Oex 
AN6444Δ, AN6446-Oex AN6446Δ, AN6446-Oex AN6447Δ, AN6446-Oex pkbAΔ, AN6446-Oex AN6449Δ, 
AN6446-Oex AN6450Δ and AN6446-Oex AN6451Δ strains cultivated on MM medium for seven days at 37°C. 
*This metabolite is the sideophore triacetylfusarine. The figure illustrated that these genes indeed are part 
of the 3-methylorsellinic acid gene cluster.   
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The BPC chromatograms of the micro-extracts of the deletion strains predicted through the qRT-
PCR analysis to belong to the 3-methylorsellinic acid cluster are depicted in figure 4.30. Detection 
of the metabolites isolated in this study are listed in table 4.2 along with there are several 
additional peaks appearing in the chromatograms; however, the structures of these have not yet 
been identified.   
Table 4.2 Detection of metabolites (through EIC+) in the micro-extracts of the deletion and overexpression 
strains constructed and identified as belonging to the 3-methylorsellinic clusters in this study; (from bottom 
to top) AN6446-Oex, AN6448-Oex, AN6446-Oex AN6444Δ, AN6446-Oex AN6447Δ, AN6446-Oex pkbAΔ, 
AN6446-Oex AN6449Δ, AN6446-Oex AN6450Δ, AN6446-Oex AN6451Δ. Parenthesis indicates that the 
metabolites are present in trace amounts. astrain having AN6446-Oex allele. *A metabolite eluting close to 
cichorine with a small mass difference makes further analysis needed for clarification.**Eluting at 2.9 
minutes.***Eluting at 4.7 minutes.   
Metabolite AN6446
-Oexa 
pkbA 
 -Oexa 
 AN6444Δa AN6447Δa  pkbAΔa AN6449Δa AN6450Δa  AN6451Δa 
3-methyl-
orsellinic acid 
 
(+) 
 
+ 
 
+ 
 
+ 
 
- 
 
+ 
 
(+) 
 
+ 
Cichorine* + + - - - - + - 
Nidulol + + - - - - + - 
Demethyl-
nidulol 
+ - + - (+) - + - 
Cichonidulol (+) - - - - - - - 
Demethyl-
cichonidulol 
- - - - - - - - 
4-hydroxy-3,6-
dimethyl-2-
pyrone 
 
+ 
 
+ 
 
+ 
 
(+) 
 
- 
 
+ 
 
+ 
 
+ 
C9H10O3 - - - + - - - - 
C9H10O4 - - - + - (+) - (+) 
C10H12O3** - - - - - + - - 
C10H12O3*** + - - - - + - + 
C10H12O4 - - - - - + - + 
C15H19NO5 + (+) - - - + + - 
 
In the deletion of pkbA in the AN6446-Oex strain the isolated metabolites are all, except 
demethylnidulol, missing confirming that these metabolites are part of the 3-methylorsellinic acid 
gene cluster. Demethylnidulol was detected in trace amount and could be due to the conversion 
of orsellinic acid into the product. A double deletion strain of orsA and pkbA could verify this 
hypothesis.  
AN6450 is predicted to encode an oxidoreductase, and showed in the qRT-PCR analysis to be 
regulated by AN6446; however, the metabolite profile of AN6446-Oex AN6450Δ was equal to that 
of AN6446-Oex indicating that either it does not take part in the biosynthesis, or the product of 
this enzymatic step was undetected. Interestingly, AN6451 is predicted to encode a transporter of 
the Major Facilitator Superfamily and this deletion mutant is heavily impared in growth. This 
indicated that some compartmentalization of the biosynthesis may occur and failure to transport 
either 3-methylorsellinic acid or 4-hydroxy-3,6-dimethyl-2-pyrone, or even other products in the 
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pathway may be toxic for the fungus, at least under the artificial conditions that overexpression of 
AN6446 offers.  
Table 4.3 Predicted function of the genes identified as belonging to the 3-methylorsellinic acid cluster. 
Gene Predicted function 
AN6444 NRPS-like 
AN6446 Transcription factor 
AN6447 O-methyltransferase 
pkbA PKS 
AN6449 Cytochrome P450 
AN6450 Oxidoreductase 
AN6451 Transporter 
 
Based on the metabolic profile of the deletion strains a biosynthetic pathway from 3-
methylorsellinic acid to cichonidulol is proposed, figure 4.31. 4-hydroxy-3,6-dimethyl-2-pyrone 
disappears in the AN6446-Oex pkbAΔ strain and are only present in trace amounts in the AN6446-
Oex AN6447Δ strain. As oppose to 3-methylorsellinic acid the polyketide backbone seems to be C6 
and not C8 and may be a shunt of PkbA. If the methylation pattern in the assembly of the 
polyketide backbones of 3-methylorsellinic acid and 4-hydroxy-3,6-dimethyl-2-pyrone were the 
same one would expect the latter to be methylated at C5 and not C3 as is observed based on 
careful investigation of the 2D NMR-spectra. This shows that there are several differences 
between the assembly of the two metabolites. Other metabolites with the same UV-spectrum as 
4-hydroxy-3,6-dimethyl-2-pyrone were detected in the deletion strains but have not yet been 
isolated. Ahuja and co-workers (Ahuja 2012) isolated two products of the PkgA enzyme, 
dehydrocitreoisocoumarin and 6,8-dihydroxy-3-(2-oxopropyl)-isocoumarin where the difference 
of the polyketide backbone also was the incorporation of one less Mal-CoA in the latter.  
The first step of the biosynthesis is likely to be oxidation and reduction of 3-methylorsellinic acid. 
The proposed intermediates are the 3-methylorsellinic acid in which the carboxylic acid has been 
reduced to an aldehyde (C9H10O3) and the 6-methyl oxidized (C9H10O3) compound. Due to the 
appearance of metabolites identified by LC-MS to have these molecular formulas in the AN6447Δ 
strain the next step is proposed to be O-methylation of the 2-OH catalyzed by the enzyme 
encoded by AN6447. This metabolite could then undergo ring closure to form nidulol. The C7-
carbonyl of nidulol, silvaticol, has also been reported in the literature isolated from A. silvaticus 
(Fujita 1984) and Kawahara and co-workers (Kawahara 1988b) suggest quadrilineatin as the 
intermediate before ring closure thereby explaining that both metabolites nidulol and silvaticol 
are present in A. silvaticus. Neither silvaticol nor quadrilineatin have been detected in any of the 
examined extracts yet.    
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Figure 4.31 Proposed biosynthetic route of the elucidated metabolites of the pkbA cluster. The metabolites 
in brackets are proposed intermediates which have been detected through MS-analysis except for the 
dialdehyde (C10H10O4) which have not been detected.    
The metabolic profile of the AN6446-Oex AN6449Δ and AN6446-Oex AN6451Δ appear to be 
similar. Several peaks appear in these two deletions where the molecular formula for one of these 
is equal to the proposed methylated product of AN6447 (C10H12O4) indicating that these enzymes 
are involved in the next steps of the biosynthesis. The roles for these two enzymes in the 
biosynthesis are still unknown but identification of the intermediates could provide helpful 
answers. AN6449 encodes for a cytochrome P450 which could be responsible for the oxidation of 
the C10H12O4 to quadrilineatin proposed in figure 4.31 which could then undergo further 
modifications to cichorine.  
In the AN6444Δ strain the production of several metabolites have terminated including cichorine 
and other nitrogen containing metabolites for example a metabolite eluding at 4.2 minutes with 
the molecular formular C15H19NO5 (identified through UHPLC-TOF-MS). The role of AN6444 
strongly indicates contribution of the nitrogen to the molecule and ring closure. As no new 
intermediates were detected in the extracts the exact role of the enzyme remains elusive. The 
nitrogen incorporated in the structure could arise from either transamination as seen in the 
biosynthesis of amino acids or from an amino acid which reacts with quadrilineatin. This reaction 
could yield a lactam where the rest of the amino acid is still attached to the nitrogen followed by 
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decarboxylation as seen for erinacerin A, figure 4.32, where the residual part of decarboxylated 
phenyalalanine is attached to the lactam-N (Yaoita 2005). The above mentioned metabolite, 
C15H19NO5, which was present in the AN6446-Oex and AN6446-Oex AN6449Δ strains could indeed 
resemble the product, figure 4.32, of these reactions if the amino acid was 2-aminoadipic acid. 
Bioinformatic analysis of AN6444 supports this hypothesis since it predicts the adenylation 
domain of AN6444 to encode for 2-aminoadipic acid. This amino acid residue would then have to 
be cleaved from the molecule to reach cichorine. A way to test this hypothesis is to do feeding 
experiments with labeled 2-aminoadipic acid. Aspernidine A and B (not detected in these extracts) 
(figure 4.34) are two other metabolites reported from A. nidulans where a nitrogen is 
incorporated into aromatic part of the structure and is proposed to be derived from an orsellinic 
acid (Scherlach 2010). The nitrogen of these metabolites could also arise from AN6444 or other 
NRPS-like enzymes.      
 
Figure 4.32 The structure of erinacerin A, 2-aminoadipic acid and proposed structure of C15H19NO5. 
It remains unknown whether the dimers, cichonidulol and demethylcichonidulol, were 
biosynthesized by an enzyme or the dimerization occurred non-enzymatically. Due to the small 
production of the metabolites in the overexpression strain the data obtained is not sufficient for 
identifying the potential enzyme.  
Altogether this study has through qRT-PCR and subsequent chemical analysis identified the genes 
belonging to the 3-methylorsellinic acid gene cluster. Several metabolites have been isolated, 
structure elucidated and linked to the gene cluster e.g. nidulol, cichonidulol, demethylcichonidulol 
and 4-hydroxy-3,6-dimethyl-2-pyrone. The function of AN6447 has been shown to be O-
methylation and data strongly suggests that AN6444 is involved in the incorporation of a nitrogen 
atom into the structure which might occur through an aminoadipic intermediate. Several 
interesting intermediates have been identified through UHPLC-TOF-MS analysis and remain to be 
isolated and structure elucidated to shed more light over the biosynthesis. A shunt product of the 
PKS have been identified and through analysis of the PKS deletion library and data of the strains 
constructed in this work it have been linked to PkbA.   
4.3.3 Genetic activation with regulatory genes combined with complex 
media 
The work in the previous sections indicated that it is possible to activate secondary metabolite 
production through both genetic and OSMAC approaches. However, as there were still a lot of 
silent genes we decided to look into combining these approaches of activation. In this section two 
examples of metabolites not previously reported from A. nidulans are described.  
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4.3.3.1 Identification and linking of A. nidulans metabolites to genes through a 
combined approach of complex media and genetic modifications  
Due to the availability of the PKS deletion library, described in section 4.3.1 we wanted to identify 
possible PK candidates to isolate, structure elucidate and, if possible, link to their synthase genes. 
Linking of metabolites present in small quantities in the reference strain could be possible due to 
the possibility of comparison with an isolated standard. As seen in the previous study of the 3-
methylorsellinic acid gene cluster the disappearing of a small peak helped identify a candidate for 
genetic studies, resulting in the discovery and linking of a family of both known and previously 
undescribed metabolites to their synthase genes. In the search of new secondary metabolites of 
A. nidulans we investigated the IBT culture collection at CMB. 
The strain chosen for this study was IBT24909 which was cultivated on 200 plates of CYAs for 13 
days at 25°C for optimal production of 1, 2, and 3. The LC-DAD chromatogram at 210 nm of the 
extract can be seen in figure 4.33.   
 
Figure 4.33 LC-DAD chromatogram (210 nm) of 200 plate extract of IBT24909 cultivated on CYAs for 13 
days. The two peaks 1 and 2 were identified as potential PKs. The large peak at 10.5 minutes is 
sterigmatocystin.   
After inspection of the chromatogram two rather large peaks, 1 and 2, were identified as putative 
PKs based on their UV-spectra, figure 4.33, which had absorption maxima at wavelengths over 
300 nm indicating that the metabolite or part of it contained a highly conjugated system. 
 
Figure 4.34 UV-spectra of a) 1 and b) 2. 
a) b)
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Analysis of the LC-TOF-MS data revealed an [M+H]+ of 343.231 and 387.219 of 1 and 2, 
respectively. A search of the Antibase database (Laatsch 2010) (tolerance ± 0.05 Da) gave 29 hits 
for 1 and 54 hits for 2 where several contained conjugated double bonds which could explain the 
absorption in the UV-spectra. So to be able to identify the metabolites they were isolated and 
structure elucidated by 2D NMR (DQF-COSY, HSQC, HMBC, H2BC and NOESY). 
 
Figure 4.35 Structures of nidubenzal A and B (1), asperugin A, B (2), and C, and aspernidine A and B 
NMR analysis of 1 revealed that two isomers, that we named nidubenzal A and B, figure 4.35, 
were present in the solution in a 5:1 ratio. The difference of the chemical shift values of the two 
isomers were small and only visible for H1’/C1’ and in the aromatic moiety of the molecule, figure 
4.36.  
 
Figure 4.36 1H-NMR spectrum of nidubenzal A and B in DMSO-d6. Which illustrates the two metabolites 
present in the solution. 
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The structure of the farnesyl side chain was deduced based on DQF-COSY, HSQC, HMBC and H2BC 
(for detailed NMR data see paper 6) correlations and comparison with literature data from the 
related structures aspernidine A and B (Scherlach 2010). The attachment of the farnesyl side chain 
to the two isomers was based on HMBC correlations of H1’ into the aromatic ring, figure 4.37. It 
had not been possible to see the two different isomers in any of the HPLC/UHPLC analysis due to 
co-elution; however, NMR analysis revealed the presence of them. Nidubenzal A has been 
reported in a synthetic screening library (Aurora Fine Chemicals LLC); however, neither nidubenzal 
A nor B has previously been reported from nature.     
 
Figure 4.37 Key HMBC correlations of nidubenzal A and B 
The structure of 2 was also solved through 2D-NMR analysis (DQF-COSY, HSQC, and HMBC) which 
identified it to be asperugin B a metabolite previously isolated from the related fungus A. 
rugulosus (Ballantine 1967). Two other asperugins, A and C, have been isolated from A. rugulosus 
(Ballantine 1964, 1965, and 1971) and through LC-TOF-MS-analysis we tentatively identified 
asperugin A (3), figure 4.33, but not asperugin C in the A. nidulans IBT24909 extract. We have not 
yet been able to isolate asperugin A in quantities sufficient for NMR-analysis. In 2005 An et al. (An 
2005) reported production of asperugin A and B (also with B as the major product), as well as 
violaceol, in a strain where cosmid-size DNA from slow growing fungi was cloned and introduced 
into A. nidulans. During the course of this study Scherlach et al. reported the characterization of 
aspernidine A and B isolated from A. nidulans (Scherlach 2010); however, we were not able to 
trace these metabolites through LC-TOF-MS analysis of our extract. 
All the isolated metabolites, nidubenzal A and B, asperugin A-C and the related aspernidines, 
seem to be hybrid metabolites which consist of a farnesyl side chain and an aromatic moiety, 
which may be of PK origin. The aromatic nature of the metabolites indicated that the pathway 
could be initiate with formation of a NR-PK catalyzed by a NR-PKS. The products of the NR-PKS 
could be orsellinic acid or even more likely orsellinaldehyde, figure 4.38, which have, just recently, 
been shown to be a metabolite of A. nidulans from the AN3230 (PkfA) NR-PKS (Ahuja 2012). The 
only difference between the aromatic part of asperugin A and B, and aspernidine A and B, are an 
O-methylation indicating that the two metabolites in each group are derived from the same 
biosynthetic pathway. Scherlach et al. (Scherlach 2010) suggests that the aspernidines are formed 
by either orsellinic acid or the corresponding aldehyde which traps ammonia nitrogen in an 
intermediary aldehyde, where oxidoreduction and condensation steps leads to the isoindolinone 
moiety as suggested for cichorine in the previous section. The precursor of the aromatic moiety of 
asperugin C could also be orsellinaldehyde which, in a shunt pathway, will be methylated instead 
of oxidated. The two new metabolites nidubenzal A and B differs in the aromatic moiety which 
containing seven carbons instead of the eight of the backbone of the other metabolites. This 
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could indicate a different biosynthetic pathway or a decarboxylation from a C8-PK product. We 
speculated whether these metabolites might be a product of the shikimic acid pathway since the 
substitution pattern resembles protocatechuic acid, figure 4.38, a shunt product from the 
biosynthesis of shikimic acid, differing only by the aldehyde in the place of the carboxylic acid. 
 
Figure 4.38 Structures of orsellinaldehyde, protocatechuic acid and 2-ethyl-4,6-dihydroxy-3,5-
dimethylbenzaldehyde 
Since the metabolites might be of PK origin we went back to the reference strain used in section 
4.3.1 to see if whether trace amounts of the metabolites could be detected in EICs on any of the 
media.    
Nidubenzal A and B were present in small quantities on the CYAs medium and analysis of the 
deletion library identified two PKS deletions, ausAΔ and AN11191Δ, where the production of 
nidubenzal A and B seemed to have been abolished. 
Asperugin A could not be detected in any of the strains whereas asperugin B could be traced. The 
same procedure for identification of putative PKSs as for the nidubenzals was done and six PKS 
candidates were identified, AN0523 (pkdA), AN11191, AN3230 (pkfA), ausA, AN6791, and 
AN9005. Due to the small quantities of metabolites present in the extract it was, in some cases, 
difficult to determine the presence of the metabolites. It has recently been reported that AN3230 
produces orsellinaldehyde and AN0523 2-ethyl-4,6-dihycroxy-3,5-dimethylbenzaldehyde, figure 
4.38 (Ahuja 2012). ausA, pkfA and pkdA are NR-PKSs whereas AN11191, AN6791 and AN9005 are 
PR-PKSs (Sanchez 2012). These results gave several possible genes so we were not able to link the 
metabolites to their synthase genes. 
At the same time as this study a strain where the cclA gene had been deleted activated the 
production of the asperugins and nidubenzals. It had already been shown that this deletion strain 
increased the production of secondary metabolites in A. nidulans (Bok 2009). We wanted to 
investigate whether challenging the cclAΔ strain on complex media could activate even more 
secondary metabolite production.   
Figure 4.39 show the phenotypical appearance of the cclAΔ strain compared to the reference 
strain when grown on the same eight media as used initially in the deletion study. It is evident 
that the fungus was affected by the deletion, and as the reference strain it responded differently 
to the different medium conditions. Generally it seems that the cclAΔ strains grow slower than 
the reference. To analyze the metabolite production micro-extraction was performed (Frisvad 
1987, Smedsgaard 1997) and the extracts were analyzed by both UHPLC-DAD and UHPLC-TOF-MS. 
The UHPLC analysis revealed a diverse and different production of secondary metabolites on the 
eight media compared to the reference strain, figure 4.40. 
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Figure 4.39 The reference strain compared to the cclAΔ strain cultivated for seven days at 37°C on RTO, RT, 
CY20. CYAs, CYA, YES, YE, and MM medium. 
In all of the media except YE and CYAs there seemed to be an activation of secondary metabolite 
production. It was especially noticeable that many of the metabolites produced in the cclAΔ strain 
are derived from the orsellinic acid and monodictyphenone pathway, which was also the gene 
clusters activated by Bok et al. (Bok 2009). Arugosin A which was linked to the monodictyphenone 
pathway in section 4.3.1.2 seemed to disappear in the cclAΔ strain whereas intermediates in this 
pathway, for example emodin, seemed to accumulate. Most noticeable for our study, and what is 
focused on in this section, was the increased production of asperugin A and B as well as 
nidubenzal A and B on several of the media; YES, CY20, CYAs, CYA, RTO and MM, figure 4.41.  
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Figure 4.40 UHPLC-DAD chromatograms (210 nm) of micro-extracts of the cclAΔ strain cultivated on eight 
different media compositions for seven days at 37°C compared to the reference strain. From top to bottom 
RTO, RT, CY20, CYAs, CYA, YES, YE and MM.*This peak corresponds to an internal standard of 
chloroamphenicol added to the extracts. The concentration of chloroamphenicol is the same in all the 
samples. Metabolites were identified through comparison with standards or based on exact mass and UV-
data.  
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Figure 4.41 UHPLC-DAD chromatograms (210 nm) from seven to eight minutes of micro-extracts of the 
cclAΔ on the eight different media shows the production of nidubenzal A and B, and asperugin A and B. 
From top to bottom: RTO, RT, CY20, CYAs, CYA, YES, YE and MM. 
The increased production of asperugin A and B, and nidubenzal A and B in this strain allowed for 
creating double deletions of cclA and the candidate PKS genes identified previously. Therefore 
cclA was deleted in the respective PKS gene deletions identified previously. Both the NR- and PR-
PKSs were included in the study since they might have an effect on asperugin production. It was 
originally thought that these products could be derived from orsellinic acid, and due to the 
activation of several orsellinic acid derived metabolites in the cclAΔ strain, a deletion of cclA in 
orsAΔ was also constructed. As described previously we wondered whether nidubenzal A and B 
could be shikimic derived so a deletion of the qutC gene which has been shown to encode for an 
enzyme, dehydroshikimic acid dehydratase that catalyzes the production of protocatechius acid 
from 3-dehydroshikimic acid in A. nidulans were included in the study (Lamb 1992).  
 
Figure 4.42 UHPLC chromatograms (210 nm) of micro-extracts of the qutCΔcclAΔ, ausAΔcclAΔ, 
AN11191ΔcclAΔ and cclAΔ strains after cultivation for seven days at 37°C on CY20 medium. The other parts 
of the chromatogram were also identical.  
The double deletion mutants made were analyzed on both UHPLC-DAD and UHPLC-TOF-MS on all 
eight media. As seen in figure 4.42 nidubenzal A and B were present in all the deletion strains and 
on the different media; however, spore-PCR analysis of the AN11191ΔcclAΔ strain showed 
presence of WT AN11191 nuclei indicating this strain was not suited for analysis. A new double 
deletion based on the original confirmed AN11191Δ strain is in progress of being constructed. As 
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the qutCΔcclAΔ strain also produced nidubenzal A and B it indicates that they are derived from 
either AN11191 or an alternative route to protocatechuic acid exists in A. nidulans.  
 
Figure 4.43 EIC of a) asperugin A (calc. [M-H]- 401.23225±0.002]) and b) asperugin B (calc. [M+H]+ 
387.21660±0.002]) of micro-extracts of the (from top to bottom) pkdAΔcclAΔ, pkfAΔcclAΔ, ausAΔcclAΔ, 
AN6791ΔcclAΔ, AN9005ΔcclAΔ and cclAΔ strains after cultivation on CY20 medium for seven days at 37°C.  
The EICs of asperugin A and B in the double deletion mutants and the reference strain can be seen 
in figure 4.43. As the AN11191ΔcclAΔ strain was not correct it have been removed from the study; 
however, a correct strain will be included in the analysis for the presence of the asperugins. As 
can be seen in the figure production of asperugin A and B are abolished in the pkfAΔcclAΔ strain 
and this was consistent on the eight analyzed media. Ahuja et al. (Ahuja 2012) recently showed 
that overexpression of this PKS with an inducible promoter led to the production of 
orsellinaldehyde. Further biosynthesis of orsellinaldehyde to the asperugins would require several 
tailoring enzymes catalyzing oxidation of a methyl to an aldehyde, oxidation of the aromatic ring, 
a terpene synthase and an O-methyltransferase. As suggested by Scherlach et al. (Scherlach 2010) 
further modifications to the aromatic moiety of the metabolites could lead to the biosynthesis of 
the aspernidines. This biosynthetic pathway resembles in some ways the proposed biosynthesis of 
the cichorine gene cluster. Preliminary bioinformatics studies indicated the presence of O-
methyltransferase, prenyltransferase, oxidase, cytochrome P450, and monooxidase enzymatic 
functions surrounding the pkfA gene. Construction of the double deletions of cclA and the 
surrounding genes to determine the biosynthetic pathway of these metabolites including 
identifying intermediates are ongoing. In the AN6791ΔcclAΔ stain it appears that the production 
of asperugin A and B have increased compared to the other strains. This is interesting due to the 
fact that the deletion was constructed based on analysis of the deletion library where the 
metabolites were missing in the single deletion strain, AN6791Δ. This phenomena is seen in 
a) b)
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several media (YES, CY20, CYAs and MM); however, the reason for this apparently increase in 
production is so far unknown. 
 
Figure 4.44 UHPLC chromatograms (210 nm) of micro-extracts of the orsAΔcclAΔ strain compared to the 
cclAΔ strain on CY20 medium.   
As mentioned a double deletion of orsA and cclA were included in the study. As seen from figure 
4.44 the deletions did not abolish the production of the asperugins; however, the metabolites 
which have been shown to be derived from the orsellinic acid biosynthetic pathway were indeed 
absent in the double deletion strain (Bok 2009, Schroeckh 2009, Sanchez 2010, Nahlik 2010). 
In this study two novel metabolites nidubenzal A and B have been isolated. Asperugin A and B 
have been linked to the PKS encoding gene AN3230. Deletions of the AN3230 gene cluster is 
underway and deletions to link nidubenzal A and B to a gene is undergoing.   
4.3.3.2 Activation of juvenile hormone production in A. nidulans 
As all the genetic modifications described so far have been in the A. nidulans genome we decided 
to investigate whether heterologous expression of regulatory genes from other filamentous fungi 
could induce secondary metabolite production in A. nidulans, using A. niger as a test case. As we 
have seen a significant difference in secondary metabolite production on different complex 
cultivation media we tested these strains on five media; MM, CYAs, RTO, YES and OAT (oatmeal 
agar).  
The genes selected for expression was identified based on a collection of microarray experiments 
from A. niger grown under diverse conditions to identify regulatory genes associated with 
predicted secondary metabolite gene clusters using a local co-expression algorithm. Seven genes 
associated with predicted gene clusters containing either PKSs or NRPSs were identified. All seven 
genes belonged to the binuclear zinc finger class which is often associated with secondary 
metabolism in filamentous fungi (MacPherson 2006). The seven genes were expressed 
individually in A. nidulans (Hansen 2011) and incubated on the five media for seven days at 37°C 
and micro-extraction was performed (Frisvad 1987, Smedsgaard 1997) and the extracts were 
analyzed by both UHPLC-DAD and UHPLC-TOF-MS. Of the 35 combinations of strains and growth 
media only one strain, grown on CYAs, had a significant impact on secondary metabolite 
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production, resulting in an increased production of several metabolites not previously identified 
from A. nidulans, figure 4.45. The gene which was expressed in the strain was renamed (from 
est_fge1_pg_C_150220, Broad annotation) Secondary Metabolism associated Regulatory protein 
A (SmrA). BLAST analysis revealed that smrA did not have a potential ortholog in A. nidulans. 
 
Figure 4.45 UHPLC-HRMS ESI+ BPC of the reference strain (bottom) and the strain where smrA (top) is 
expressed grown on CYAs at 37°C for seven days.  
To purify the induced products we made a large extract and in this extract X2 was the dominant 
peak (data not shown). As X1 and X2 had a similar UV-chromatogram, a mass difference of 
27.9948 (CO), and similar adduct patterns in their mass spectra, figure 4.46, it was speculated that 
these structures were related and both were purified.    
 
Figure 4.46 Mass spectra of X1, X2, JH-III and methyl-farnesoate. 
The structures were elucidated using the following 2D NMR experiments; DQF-COSY, HSQC and 
HMBC. X1 was identified to be methyl (2E,6E)-10,11-epoxid-3,7,11-trimethyl-2,6-dodecadienoate 
(Kuhnz 1981) and X2 was indeed a formylated analogue of X1, figure 4.47.  As formic acid was 
added to both the micro extraction and the large extract, a new micro extract was prepared 
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without formic acid. X2 was not produced in this extract and must therefore result from chemical 
modification resulting from the presence of formid acid in the extraction process.  
 
Figure 4.47 The structures of X1, X2, juvenile hormone III and methyl-farnesoate 
The NMR data of X1 indicates that two diastereomers were present in the sample. The 1H- and 
13C-chemical shifts differ most in the reduced end of X1 where a stereocenter (C10) is present. The 
chemical shifts of H1/C1 to H5/C5 are identical. The difference of chemical shifts of the two methyl 
groups (H12/C12 and H13/C13) and the two CH2 groups next to the stereocenter are due to the 
presence of the chiral center. The two diastereomers present in the X1 solution must be due to 
the presence of X1 in both the E- and Z-conformation at the C6 and C7 double bond. The presence 
of both an E and a Z double bond conformation could a result from chemical modifications due to 
the presence of formic acid in the extraction process.   
As the structure of X1 resembled juvenile hormone III, a hormone thought to be unique for 
insects with essential developmental roles (Wilson 2004, Gilbert 2000) and the crustacean 
hormone methyl-farnesoate (Nagaraju 2007) we searched for these metabolites in our extract. 
The two metabolites were putatively identified through extracted ion chromatograms of the 
calculated [M+H]+ (juvenile hormone III: 267.1955 and methyl-farnesoate: 251.2006) of the 
metabolites and putatively identified both metabolites (juvenile hormone III: 267.1957 and 
methyl-farnesoate: 251.2007). The mass spectra of these two metabolites resembled the spectra 
of X1 and X2, figure 4.46; however, to confirm the structure of the metabolites an authentic 
sample of juvenile hormone III was compared to the extract and it confirmed that the metabolite 
was present. An attempt was made to purify both juvenile hormone III and methyl-farnesoate; 
however, obtaining sufficient amounts of methyl-farnesoate for NMR analysis was not possible 
and the juvenile hormone was unstable and had degraded before an NMR analysis was possible. 
As methyl-farnesoate was thought to be volatile we analyzed the production of volatiles in the 
mutant strain by GC-MS and were able to confirm the production of methyl-farnesoate through 
comparison with the Xcalibur software package (Thermo Scientific). Further GC-MS analysis of 
volatiles collected by the mutant strain showed that methyl-farnesoate was a major metabolite of 
the volatile fraction in both the smrA expression strain, and in the reference strain whereas 
juvenile hormone III and X1 were undetectable. Indicating that juvenile hormone III is retained in 
the fungus. The strongest metabolite induction was observed when A. nidulans was grown on 
CYAs (high salt concentration); however, data from the UHPLC-TOF-MS indicated presence of 
juvenile hormone III and increased levels of X1 production on YES media (data not shown). 
The biological function of juvenile hormone III and methyl-farnesoate in A. nidulans have not yet 
been explored; however, they may serve as part of a defense strategy against insects and/or 
other predators since fungal secondary metabolites are known to play an important role in 
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fungal/insects interactions (Kempken 2010, Rohlfs 2011).  As A. nidulans is generally believed to 
inhabit a variety of ecological niches, including dead plant materials, it is likely that competing 
insects will be part of the natural environment. However, it cannot be excluded that the 
metabolites can serve hormonal functions. It has been demonstrated that the juvenile hormone 
precursor farnesol (Cao 2009) in Candida albicans both regulates the transition from yeast to 
filamentous growth (Hornby 2001) and regulates induction of apoptosis in competing fungal 
species (Dinamarco 2011). To test the biological function of these metabolites it could be 
interesting to either feed the metabolites to the growing fungi or to test this new strain towards 
insects.  
The biosynthetic origin of these metabolites is likely to be terpenoids with farnesol as the 
precursor where a methylation and oxidation occurs in one end of the molecule. Afterwards an 
epoxid, juvenile hormone III is produced, the ring is opened and the diol, X1, is formed. Bromann 
et al. have identified several putative terpene synthases in A. nidulans which could be involved in 
the production of these metabolites (Broman 2012). qRT-PCR of the putative terpene synthases 
and the SmrA strain could give an indication of possible biosynthetic origin which then could be 
followed up by deletion studies to determine the biosynthetic origin.  
4.3.4 Summary and part conclusion 
Cultivation of A. nidulans under different media compositions have led to the activation of several 
biosynthetic pathways, including austinol, monodictyphenone, and orsellinic acid. Through the 
creation of a deletion library austinol and dehydroaustinol was linked to the PKS ausA and several 
metabolites were contributed to the monodictyphenone (arugosin A and H) and orsellinic acid 
(violaceols) pathways.  
Overexpression of a transcription factor led to the activation of a biosynthetic pathway where 3-
methylorsellinic acid and several derivatives, nidulol, cichorine, cichonidulol, and 
demethylcichonidulol were produced. Through the qRT-PCR analysis and the creation of a 
deletion study a cluster of seven genes were identified. Based on metabolite screening a 
biosynthetic pathway of the metabolites have been proposed which includes a putative NRPS-like 
encoding gene that is suspected to be involved in the incorporation of a nitrogen atom to the 
structure.  
Further analysis of A. nidulans cultivated on complex media led to the identification of asperugin 
A and B, and the novel metabolites; nidubenzal A and B. Through analysis of the PKS deletion 
library several PKSs were identified as putative synthase encoding genes. The combination 
deletion of the cclA gene and the putative PKS genes led to the linking of asperugin production to 
AN3230 where work is still in progress for the nidubenzals.    
Heterologous expression of a transcription factor from A. niger led to the identification of the 
juvenile hormone III produced from A. nidulans. Clarification of the distribution of the juvenile 
hormones in filamentous fungi as well as their biological function in A. nidulans will improve our 
understanding of fungal/insect interactions. The finding that heterologous expression of 
transcription factors may influence secondary metabolism is of general relevance for activation of 
secondary metabolite production.  
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5 Overall discussion and conclusion 
In summary the work performed during the last three years have contributed to the chemical 
knowledge of several important filamentous fungi including identifying several novel metabolites; 
oryzamid A1-2, ditryptoleucine, fumonisin B6, nidubenzal A and B, cichonidulol, and 
demethylcichonidulol as well as linking of several metabolites of A. nidulans to their synthase 
genes; austinol and dehydroaustinol, asperugin A and B, the arugosins, and finally elaboration on 
the biosynthetic pathway of cichorine and nidulol. The work have been an example of the 
advantages of the close collaboration of two fields; molecular biology and natural product 
chemistry, which have led to discoveries that neither could have achieved separately.      
The study on the genetic important filamentous fungus A. nidulans has contributed to and 
elaborated on the understanding of secondary metabolism activation and biosynthesis. The 
availability of the genome of A. nidulans has changed the focus of research into the area of 
secondary metabolites from elucidation of the biosynthetic pathway of a few important 
metabolites to the search for new metabolites (Walsh 2009). Figure 5.1 shows the distribution of 
the 32 putative PKSs of A. nidulans on the eight chromosomes. The products of the PKSs marked 
in green were known at the beginning of this PhD study ((Brown 1996, Watanabe 1998, Watanabe 
1999, Bergmann 2007, Chiang 2008, Szewczyk 2008, Bok 2009, Chiang 2009b, Schroeckh 2009, 
Nielsen 2011), the ones in black have been reported during the course of this PhD (Nielsen 2011, 
Ahuja 2012, Lo 2012), and the results of this study have contributed to the knowledge of the 
biosynthetic pathways of the clusters marked by black circles (papers 4-6). The products of the 
genes in red have not yet been identified.  
As the figure shows, progress in mapping of the PKS encoding genes in A. nidulans has intensified 
in the recent years and many academic groups have added to the knowledge, illustrating the 
competitive nature of the field. Even though intense efforts have been made, there is still a lot of 
work to be performed before the complete potential of secondary metabolite biosynthesis of A. 
nidulans is elucidated. The results, both in this PhD and in the literature, indicate that attempts to 
affect gene regulation including the OSMAC approach and genetic modifications, have a tendency 
to activate some of the same gene clusters especially the orsellinic acid, monodictyphenone, and 
austinol clusters (Bok 2009, Schroeckh 2009, Chiang 2010b, Sanchez 2010, Nahlik 2010, Nielsen 
2011, Nützmann 2011, Sanchez 2011, Scherlach 2011, Lo 2012). This may indicate that these 
metabolites are important to the fungus and a change from normal conditions (both cultivation 
and genetic) causes the fungus to react by producing other metabolites. 
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Figure 5.1 Overview of the distribution of the 32 putative PKSs in A. nidulans. The products of the genes 
shown in green were known when this study started, the once in black have been elucidated in the course 
of this study where results of this study have contributed to and/or discovered the once in the black circles. 
The products of the PKSs in red have not yet been identified. Dark grey circles and ends symbolize 
centromeric regions, respectively, and should not be considered to scale.  
In this thesis the focus have been on combining genetic modifications with the OSMAC approach 
and through these attempts the discovery of several new metabolites have added to the chemical 
knowledge of these fungi. One of the more interesting results is the detection of the juvenile 
hormone III in A. nidulans (paper 7) which is known to have a biological function against insects 
and/or other predators. Further studies of the biological function of these and other secondary 
metabolites against the fungus itself could add to the knowledge of secondary metabolism and 
aid in the discovery process through cultivations under more natural conditions than the lab 
media (for example co-cultivation). Other metabolites which have been discovered in A. nidulans 
through the use of OSMAC in this thesis is the arugosins (Nielsen 2011), asperugin A and B (paper 
6) and the novel metabolites nidubenzal A and B (paper 6). These results confirm the potential of 
challenging the fungus through differing of the cultivation conditions. Several methods of 
activation of silent genes have been reported in the literature. The individual exchange of the PKS 
promoters with an inducible promoter by Ahuja et al. have, recently, shown promising results 
both with respect to PKS and NRPSs (Ahuja 2012, Yeh 2012). 
The discovery of new secondary metabolites has been focused on activation of silent genes and 
thereby, hopefully, new products can be formed. Even if the optimal strategies are found and 
even more effort is put into secondary metabolite discovery, it may not be possible to discover 
the products of all secondary metabolite synthase genes and clusters. This may be due to 
mutations in the genes which can have an effect on the transcription or translation of DNA and 
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RNA, respectively, in turn providing a non-functional enzyme. The mutations can have an effect 
on several steps in the assembly for example they may not be able to release the product, catch 
the substrate, or the folding may be incorrect. This was the case for A. oryzae where we showed 
that 13-desoxypaxilline was the final product in the biosynthetic cluster of aflatrem (paper 2) 
which confirmed the reports of Nicholson et al. (Nicholson 2009), who observed a mutation in the 
atmQ gene responsible for the next steps of the biosynthesis of aflatrem in A. flavus.  
Another area which could be relevant to explore in the search for silent secondary metabolites is 
the extraction of the metabolites. Methods for secondary metabolite extraction have been 
developed and implemented as standard procedures in several laboratories. However, some 
metabolites, for example the fumonisins in A. niger (paper 3), went undetected because the 
extraction procedures are different from most other metabolites.  
Even though a biosynthetic pathway is expressed it does not mean that the metabolites are 
detected. The detection of different metabolites depends of the analytical methods used. Two 
methods of combined separation and detection, UHLPC-DAD and HPLC-TOF-MS, were used 
throughout this study. In both methods some metabolites may not be detected. The 
emericellamides and the fumonisins does not absorb UV-light so they are not detected in a DAD 
detector whereas metabolites, which do not ionize, will not be detectable through LC-MS. During 
the course of this study, a new UHPLC-TOF-MS instrument was implemented which enhanced the 
detection of metabolites and provided valuable information, for example better predictions of the 
molecular formula due to improved mass accuracy and isotope pattern, in the identification of 
metabolites. 
The discovery of the production of 3-methylorsellinic acid in A. nidulans was more prominent on 
the new instrument and it was not until this new data was available that the metabolite could be 
confirmed to be present in the reference strain. The availability of a more sensitive instrument 
also reveals the difficulty of determining whether a metabolite is present or production have been 
eliminated. This raises the question of the influence of the detection limit and if the metabolites, 
which cannot be detected, are due to the concentration falling below the detection limit of the 
instruments, or the loss of production. As in the case of nidubenzal A and B, several PKS 
candidates were identified even on the most sensitive instrument and it was not until a method of 
enhancing the metabolite production was found that it was possible to confirm the PKS gene 
AN3230 to be responsible for PK biosynthesis. Cichonidulol and demethylcichonidulol were 
isolated from a 200 plate extract in quantities sufficient for NMR analysis; however, only 
cichonidulol could be detected in the micro-scale extracts of the strain indicating that either the 
metabolites were produced in too small amount for detection, the cultivation conditions might 
have been slightly different in one of the experiments, or variations in extraction methods.  
The availability of more sensitive and precise instruments also opens up to new methods of data 
analysis. Multivariate data analyses, which can decipher between co-eluting peaks and identify 
small variations in large amounts of date are tools which can be useful in future analysis (Toh 
2010, Gao 2012, Tian 2012). However, for these programs to be able to give as correct results as 
possible it is important to be able to perform controlled experiments, especially, if data obtained 
over longer periods of time are compared. This is both in terms of variations of cultivation (media, 
temperature fluctuations, time), extraction procedures, and data acquisition. The sensitive TOF-
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MS instruments are useful for these methods of data analysis and identification of small 
differences (for example appearance or disappearances of peaks); nonetheless, to confirm the 
metabolite structures a substantial amount of material is needed. Bioinformatic analysis can aid in 
the structure elucidation especially in the case of NRPs due to the modular nature of NRPSs 
(Koglin 2009, Matthias 2010); however, in the case of PKs it is still difficult to predict structures 
based on the iPKS (Crawford 2010). It is even more difficult when several tailoring enzymes are 
present in the secondary metabolite clusters due to the possibility of the biosynthesis of several 
isomers. Fragmentation patterns of metabolites can assist in the structure elucidation as seen in 
the example of arugosin A though further structural studies, for example NMR-spectroscopy or X-
ray crystallography, may be necessary.   
The identification of new secondary metabolites and linking these to genes have, especially since 
the availability of the genome sequences focused on creating conditions for activation of silent 
gene clusters in the fully genome sequences strain. Another approach could be to identify 
metabolites in other high-producer strains of the same species and afterwards use advanced data 
analysis programs to discover these metabolites in the genome sequenced strain. Since the 
genome sequenced strain of for example A. nidulans is a strain, which have been used in the lab 
for decades, the strain may have lost the ability to produce more secondary metabolites than 
needed due to the lack of natural competition in the surroundings. An example of the use of 
another strain of A. nidulans in this PhD has been the discovery of nidubenzal A and B, and 
asperugin A and B which were isolated from a strain from the IBT culture collection and 
afterwards found to be produced in trace amounts in the lab strain. Another advantage from this 
approach is the possibility to predict the steps in the biosynthetic pathway and thereby predict 
which functionalities the tailoiring enzymes should hold. Due to the clustering of the synthase and 
tailoring genes, genome mining could predict possible gene cluster candidates which could then 
be a target for genetic studies, thereby minimizing the amount of genetic work.   
Discovery of the full biosynthetic potential of filamentous fungi can have several purposes. First, 
as many medical drugs are secondary metabolites or derivatives thereof (Newman 2012) the 
discovery of new structures enhances the possibilities of discovering new drugs. Second, the 
possibilities of synthetic biology where swapping of domains or genes can result in the production 
of designed metabolites. Third, it can help identify possible pathogenic species as the genes can 
reveal the possibility of mycotoxin production, as the example of fumonisin production of A. niger 
where a new analogue fumonisin B6 which have not been reported from Fusarium was identified 
(paper 3).  Fourth, for the filamentous fungi used for industrial purposes, it is easier to identify a 
new metabolite appearing in a process when the full potential is known. A lot of the genetic work 
performed on filamentous fungi has been focused on A. nidulans. The strategies and genetic tools 
developed in this fungus can be transferred into other organisms since the price of genome 
sequencing is decreasing and within the reach of individual laboratories (Nowrousian 2010).  
Due to the vast interest in A. nidulans there are several groups working in this area. During this 
study several groups have published results of the same biosynthetic pathways, for example 
orsellinic acid (Bok 2009, Schroeckh 2009, Sanchez 2010, Nahlik 2010, Nützmann 2011, Scherlach 
2011), austinol (Nielsen 2011, Lo 2012) and monodictyphenone (Bok 2009, Chiang 2010b, Sanchez 
2011). Due to the complexity of the secondary metabolism it has been possible for the groups to 
contribute with new information on already discovered biosynthesis. For example three papers on 
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the monodictyphenone pathway in A. nidulans were published (Bok 2009, Chiang 2010b, Sanchez 
2011) before the report of the arugosin intermediates was linked to mpdG as intermediates in the 
biosynthesis of the shamixanthones in this study (paper 4). The results of these works along with 
labeling studies (Ahmed 1992) have led to a detailed biosynthetic pathway proposed by Simpson 
(Simpson 2012). The examples above, illustrated, that even when the product of a PKS has been 
identified, the full potential of a biosynthetic pathway may not have been fully elucidated.  Ahuja 
et al. reported linked the production of 3-methylorsellinic acid and cichorine to PkbA; however, 
overexpression of a transcription factor led the isolation of several metabolites including the two 
novel metabolites cichonidulol and demethylnidulol (paper 5).  
The work in this thesis illustrates the enormous potential of secondary metabolism in filamentous 
fungi which gives discoveries of new metabolites of previously silent pathways and where new 
discoveries adds to the pool of knowledge, and at the same time, challenges researchers to go in 
different directions in the search of novel metabolites.     
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Abstract: Secondary metabolites are small molecules that show large structural diversity 
and a broad range of bioactivities. Some metabolites are attractive as drugs or pigments 
while others act as harmful mycotoxins. Filamentous fungi have the capacity to produce a 
wide array of secondary metabolites including polyketides. The majority of genes required 
for production of these metabolites are mostly organized in gene clusters, which often are 
silent or barely expressed under laboratory conditions, making discovery and analysis 
difficult. Fortunately, the genome sequences of several filamentous fungi are publicly 
available, greatly facilitating the establishment of links between genes and metabolites. 
This review covers the attempts being made to trigger the activation of polyketide 
metabolism in the fungal model organism Aspergillus nidulans. Moreover, it will provide 
an overview of the pathways where ten polyketide synthase genes have been coupled to 
polyketide products. Therefore, the proposed biosynthesis of the following metabolites will 
be presented; naphthopyrone, sterigmatocystin, aspyridones, emericellamides, asperthecin, 
asperfuranone, monodictyphenone/emodin, orsellinic acid, and the austinols. 
Keywords: secondary metabolites; polyketides; polyketide synthases; gene clusters; 
biosynthesis; Aspergillus nidulans 
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1. Introduction 
Aspergillus nidulans, teleomorph Emericella nidulans, is one of the most significant biological 
model systems in the fungal kingdom. This was pioneered by Pontecorvos’ [1] work in the middle of 
the last century, which demonstrated that A. nidulans, in addition to the asexual state, also proliferate 
via sexual and parasexual life cycles, hence, offering an ideal platform for genetic studies. Related 
species in the genus Aspergillus include important industrial cell factories, A. niger and A. oryzae, species 
that cause allergic diseases, A. clavatus, as well as opportunistic pathogens, such as A. fumigatus. 
A common feature of aspergilli and filamentous fungi in general is their capacity to produce 
secondary metabolites (SMs). As opposed to the primary metabolites, SMs are not essential for cellular 
growth, but provide fungi, as well as bacteria and plants, with a competitive advantage in nature,  
e.g., by serving as agents for chemical warfare or as signal molecules. Hence, an impressive range of 
compounds with broad ranging bioactivities has evolved. SMs can be divided into four main chemical 
classes: Polyketides (PK), terpenoids, shikimic acid derived compounds, and non-ribosomal peptides 
(NRP). Moreover, hybrid metabolites composed of moieties from different classes are common, as in 
the meroterpenoids, which are fusions between PKs and terpenes. Hybrid molecules significantly add 
to the complexity and variety of the fungal metabolomes. 
In addition to their likely important ecological roles in their natural biological niches, SMs also 
have a considerable impact on human life. For instance aflatoxins, ochratoxins, and fumonisins act as 
mycotoxins by having a detrimental effect on humans and livestock, whereas others are beneficial and 
serve as food additives, pigments, cholesterol-lowering drugs, immunosuppressants, antibiotics and 
anticancer agents. The different aspects of SM action and application have spurred a tremendous 
interest in fungal secondary metabolites, which is further underlined by the fact that around 63% of all 
small molecule drugs, which reached the market from 1981–2006 were inspired by natural products or 
derivatives thereof [2]. 
In filamentous fungi, the competitive race in SM development and the cost of producing and 
secreting complex compounds have resulted in the evolution of a multifaceted regulation of SM 
biosynthesis to avoid unnecessary use of resources. This hampers their discovery since production of 
most SMs is not induced under laboratory conditions. Analysis of full genome sequences of eight 
different aspergilli have demonstrated that for the majority of genes that putatively encode enzymes for 
SM production, the product is not known or detected. In this review, we will provide highlights of the 
use of genome mining, sophisticated molecular biological and chemical tools to trigger the production 
of SMs from cryptic gene clusters and discuss how these techniques have accelerated our 
understanding of PK production and regulation in A. nidulans. 
1.1. Polyketide Biosynthesis in A. nidulans 
PKs in fungi are synthesized by the use of acyl-CoA units. They act as the general substrates for 
large multi-domain enzymes named polyketide synthases (PKSs), which resemble eukaryotic fatty-acid 
synthases (FASs) in domain architecture. PKSs are divided into three types of PKSs based on their 
catalytic organization, however, only the iterative type I PKS (iPKS) has been reported in A. nidulans. 
The iPKS repeat the use of a single module containing several catalytic domains until the growing 
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chain of acyl-CoA units block further elongation. For descriptions of PKSs in general, excellent 
reviews by Crawford [3], Hertweck [4] and Cox [5] can be consulted. The most commonly encountered 
catalytic activities in fungal PKSs will be addressed as a general introduction to fungal PKSs in the 
following three paragraphs. 
Three fundamental domains are found in all iPKSs in A. nidulans like in filamentous fungi in 
general; ȕ-ketosynthase (KS), acyltransferase (AT), and the acyl carrier protein (ACP). The KS 
catalyzes the C–C bond formation via decarboxylation reactions through Claisen condensations 
between thioesters. The ACP domain is responsible for transiently holding the growing acyl chain, hereby 
allowing the loading of malonyl extender units. The acyl groups are transferred from CoA by AT onto 
KS and ACP. The iterative use of the three domains results in a non-reduced PK, a ȕ-keto thioester. 
Additional domains can be present in the PKS allowing the introduction of further chemical complexity. 
iPKSs in fungi can, based on their catalytic domains, be classified as non-reducing (NR-PKSs), 
partially reducing (PR-PKSs), or highly reducing (HR-PKSs) [6]. This is based on their ability to 
reduce the ȕ-keto carbon. In PR- and HR-PKSs, reduction occurs through the ȕ-ketoreductase (KR) 
domain that converts the ȕ-ketone to a hydroxyl group. The resulting hydroxyl can go all the way to 
saturation by elimination of water through the dehydratase (DH) domain followed by hydrogenation by 
enoyl reductase (ER). In addition, reducing PKSs can also possess a methyltransferase domain (MT) 
responsible for C-methylation of the growing PK chain, using S-adenosylmethionine (SAM) as a 
carbon-donor. The degree of modifications and their position in the PK product is always the same for 
the individual PKSs. However, it is presently unknown how deployment of the various modifying 
domains is programmed into the PKS enzyme. 
NR-PKSs differ in domain architecture from reducing PKS by not having any of the reducing 
domains and by having an N-terminal starter unit-ACP transacylase (SAT) domain and an internal 
product template (PT) domain. The SAT domain is responsible for selecting the starter unit to be 
extended by the enzyme [7], while the PT domain is responsible for folding and cyclization of the  
non-reduced PK backbone [3,8]. The number of iterations within the PKS and thereby the display of 
functional groups and the size of the final product is likely determined by the size of the active site cavity in 
the iPKS [9]. Once the length of the final product has been achieved, the PK chain is released from the 
PKS, catalyzed by either a thioesterase (TE), a Claisen cyclase (CLC) domain if present, or by accessory 
enzymes. A more detailed discussion on PKS release mechanisms is reviewed by Du and Lou [10]. 
It should be noted that it currently is impossible to reliably predict the product of iPKSs based on 
their amino acid sequences and domain architecture. This is in part due to the inability to predict the 
number of iterations performed by the iPKS and in part due the lack of understanding of how 
deployment of tailoring domains in individual iterations are programmed into the enzyme. 
Interestingly, the PKS encoding gene tends to reside in clusters of genes coding for a broad range of 
enzymatic activities. The compound coming directly from the PKS rarely seem to be the final product 
in the biosynthesis, but usually undergoes further modifications by tailoring enzymes from small 
decorations to drastic and large intervention and couplings. 
Through inspection of the genome sequence (genome mining), the latest estimate of genes encoding 
PKSs in A. nidulans is 32 open reading frames (ORFs) [11] (Figure 1), indicating that the number of 
PK containing end products in A. nidulans should count at least 32 plus stable intermediates. The 
compounds detected under a given condition do not necessarily reflect the final outcome of a PK 
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pathway, since the presence of intermediates and shunt products depends on other downstream 
enzymes and regulation. 
Figure 1. An overview of the relative distribution of the 32 putative polyketide synthases 
(PKS) open reading frames (ORFs) on the eight chromosomes of A. nidulans. Green and 
red AN numbers represent assigned and unassigned PKS genes, respectively. Dark grey 
circles and ends symbolize centromeric and telomeric regions, respectively, and should not 
be considered to scale. 
 
At present, a total of nine PKS genes have been coupled to the polyketome (collection of PKs and 
their synthesis) in A. nidulans, and numerous endeavors are currently attempting to unveil the mechanisms 
of PK metabolism in this model fungus. The pathways described in this review will follow in 
chronological order with respect to the discovery from PK to genes. For each of the PK gene clusters 
that have been linked to products so far we will focus on the PK compounds, their discovery, genetics 
as well as their biosynthetic pathway: Naphthopyrone, sterigmatocystin, aspyridones, emericellamides, 
asperthecin, asperfuranone, monodictyphenone (emodin), orsellinic acid, and the austinols. 
2. Naphthopyrone 
Spores from A. nidulans are characterized by a dark grey-green macroscopic appearance. This is 
due to deposition of pigments in the conidial wall as shown by ultrastructure studies using transmission 
electron microscopy (TEM) [12]. The responsible pigment is based on the PK-naphthopyrone YWA1 
and the function of the pigment layer has been shown to include quenching of reactive oxygen species [13] 
and increased resistance to UV radiation [14]. The work on naphthopyrone synthesis in A. nidulans has 
paved the way for understanding iPKS domain structure. 
The study of conidial pigmentation in A. nidulans has been extremely valuable for genetic screens. 
The first pigment mutant recorded in literature was the spontaneous white alba (wa) strain reported by 
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Yuill in 1939 [15]. In addition to the white mutant class, yAí mutants producing yellow conidia were 
discovered. These available color variants served as easy recognizable markers (green, white, and 
yellow) that allowed the establishment of fundamental genetic tools in A. nidulans [1]. Interestingly, 
sexual crossing showed that the wAí mutation masked the effect of the yAí mutation (epistatic) [1,16]. 
Clutterbuck and co-workers [16] proposed that WA synthesized the yellow pigment that was observed 
in yA mutants and that the YA enzyme converted this compound into the green conidial pigment. In 
1967, Agnihotri and co-workers [17] found that the wild type strains if grown under copper limiting 
conditions could mimic the yellow phenotype of the yAí strain. yA (AN6635) and wA (AN8209) were 
isolated and mapped to loci, chromosome I and II respectively, by complementation of a cosmid based 
library in 1989 and 1990, respectively [18,19]. Later, cross-feeding experiments performed by 
Clutterbuck [16] revealed that the yA phenotype was caused by the lack of a copper dependent 
extracellular laccase (p-diphenol oxidase). The wA functionality in pigment formation was confirmed 
by gene-deletion studies [19]. The lack of clustering of the two A. nidulans conidial pigment genes 
also became evident by their different expression patterns and the finding that they are controlled by 
different regulatory systems [20,21]. The yA gene is expressed in phialide cells and primary sterigmata 
(metulae) [18], and controlled by BrlA and AbaA [21], while wA is expressed only in phialides [22] 
and controlled by WetA [20]. Interestingly, none of the genes are expressed in the conidia. 
Characterization of the WA PKS was accomplished by Northern blotting, which revealed that wA 
encoded a 7.5 kb large transcript [19], and sequencing of the locus [22]. Re-sequencing of the 3ƍ region in 
1998 led to a revised gene model of the PKS with the following domain structure KS-AT-ACP-CLC. 
This novel CLC domain [23] catalyzed release of the product and cyclization of the second aromatic 
ring of YWA1 via a Claisen condensation reaction [24]. 
Heterologous expression of wA in A. oryzae resulted in the production of the yellow compound, as 
observed in yAí mutants, which was identified to be the heptaketide naphthopyrone named YWA1 [25]. 
In 2002, wA was used for constructing a collection of chimeric PKSs (cPKS) by mixing its domains 
with those of Colletotrichum lagenarium pks1, known to produce the tetraketide 1,3,6,8-
tetrahydroxynaphthalene (T4HN). One of the resulting cPKSs, SW-B, produced several new 
compounds including both tetra- and pentaketides [26]. The results prompted a reanalysis of the two 
PKSs, which revealed the existence of two previously overlooked conserved domains; an N-terminal 
and a central domain. These domains were later identified as a SAT and PT domain, respectively, thus 
providing the full domain structure SAT-KS-AT-PT-ACP-CLC [3,7,8]. With the organization within 
WA in mind, the biosynthetic pathway can be envisioned as condensations of an acetyl-CoA with six 
malonyl-CoA units in six successive reactions resulting in the formation of YWA1 [25] (Figure 2). 
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Figure 2. Biosynthetic pathway for formation green conidial pigment in A. nidulans  
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YWA1 is then believed to be dimerized or polymerized by the YA laccase into the green conidial 
pigment(s) via phenolic oxidative coupling. However, to date no one has succeeded in characterizing 
the chemical structure of the green conidial pigmentation in detail. As the final product remains 
elusive, it is impossible to predict if other tailoring enzymes further modify the YWA1 backbone or 
reactions occur with other metabolites or cellular components, e.g., the cell wall. 
3. Sterigmatocystin 
Sterigmatocystin, a PK, was first partially purified from a Sterigmatocytis sp. in 1948 by Nekam 
and Polgar [27]. Hatsuda and co-workers [28,29] successfully isolated sterigmatocystin in 1954 from 
A. versicolor. The correct relative structure was determined in 1962 by Bullock et al. [30]. By 
performing degradative experiments it was shown that the stereochemistry of sterigmatocystin was the 
same as that of aflatoxin [31], which had the absolute stereochemistry determined in 1967 [32]. The 
absolute stereochemistry of sterigmatocystin was confirmed via crystallography [33,34]. 
The aflatoxins are among the most carcinogenic mycotoxins and the research in aflatoxin and 
sterigmatocystin intensified with the Turkey X disease caused by aflatoxins in the middle of the last 
century [35]. Aflatoxins are reported to be produced only by a few aspergilli. A. nidulans does not 
produce aflatoxins, as the biosynthesis stops at sterigmatocystin, a late, yet stable precursor of the 
pathway. Sterigmatocystin is a powerful mycotoxin, though it is estimated to be 150 times less 
carcinogenic than the most potent aflatoxin, B1 [36]. Fungi that are able to produce aflatoxins and/or 
sterigmatocystin are common contaminants of food, feed, and indoor environments and may be 
mammalian and plant pathogens [37,38]. Due to the high toxicity and prevalence of sterigmatocystin 
and aflatoxins, they are likely the most extensively studied examples of secondary metabolism in fungi 
both in terms of biosynthesis and biological function, and there are several excellent and 
comprehensive reviews for further reading on aflatoxin biosynthesis [39,40]. Studies on the 
biosynthesis of aflatoxin and sterigmatocystin have been carried out in several fungi (A. flavus,  
A. nidulans and A. parasiticus) and some of the assigned gene functions in A. nidulans are proposed 
based on gene homology to these two other species. 
The biosynthetic cluster of sterigmatocystin in A. nidulans was first characterized by Brown and  
co-workers in 1996 [41]. They identified a 60 kb region in the A. nidulans genome responsible for the 
synthesis of sterigmatocystin. The cluster contains 27 genes named stcA-X (Figure 3), reflecting their 
order of appearance on the chromosome [41]. 
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Figure 3. The sterigmatocystin gene cluster. The black arrows are predicted stc ORFs, 
while light grey arrows are genes with unassigned functions. 
 
The PKS catalyzing the production of the PK backbone of sterigmatocystin was identified by Yu and 
co-workers in 1995 [42] and originally named pksST, but was later renamed to stcA by Brown et al. [41] 
to simplify nomenclature. Besides the PKS, the stc gene cluster is predicted to contain two 
transcription factors (aflR, aflJ), six monoxygenases (stcB, stcC, stcF, stcL, stcM, stcS, stcW), two 
dehydrogenases (stcG, stcV), an esterase (stcI), an O-methyltransferase (stcP), two ketoreductases 
(stcE, stcU), a VERB synthase (stcN), an oxidase (stcO), a monooxydase/oxidase (stcQ), a Baeyer-
Villiger oxidase (stcR), a fatty acid synthase composed by the two subunits HexA and HexB (encoded 
by stcJ and stcK, respectively), and five unassigned genes (stcD, stcH, stcR, stcT, stcX), which may 
also be part of the cluster [39–41,43–47]. 
The stc cluster is a relatively large gene cluster, and studying the gene regulation has led to 
important discoveries. The two TFs were found to be present within the cluster. The AflR is a Zn2Cys6 
TF that regulates transcription of the stc locus in A. nidulans [41,48], while AflJ (also named AflS) 
have been shown to have a role in the regulation of aflatoxin biosynthesis in A. flavus and is likely to 
have a similar function in A. nidulans [49]. Interestingly, Bok and Keller [50] discovered a novel 
regulator (LaeA) of secondary metabolism in A. nidulans in a mutant screen for loss of aflR 
expression. Deletion of laeA resulted in a significantly decreased production of different classes of 
SMs like sterigmatocystin and penicillin. LaeA, a putative methyl transferase was moreover acting in a 
feedback loop with AflR since overexpression of aflR downregulates laeA expression, and 
overexpression of laeA could not increase production of sterigmatocystin [50]. LaeA was shown to be 
a part of the conserved Velvet complex, which is important for regulation of fungal development and 
secondary metabolism [51]. Another hint on chromatin regulated gene expression came from the 
deletion of a histone deacetylase, hdaAǻ, which led to significant increase in the expression of two stc 
cluster genes, stcU and aflR compared to the reference [52]. 
Applying this strategy of deleting and overexpressing genes encoding global epigenetic regulators 
has paved the way for novel discoveries in secondary metabolism. Moreover the alternative of utilizing 
a chemical epigenetic approach through epigenetic modifier molecules has proven successful in 
activating gene clusters in A. niger [53]. 
The first step in the biosynthesis of sterigmatocystin (Figure 4) is the production of hexanoate by 
the FAS units, StcJ and StcK [41]. Watanabe and Townsend [54] showed that the hexanoyl-CoA is not 
an intermediate freed from the complex, indicating that hexanoate is transferred directly to the SAT 
domain of the PKS. The PK backbone is assembled by StcA by condensation of the starter unit, 
hexanoyl-CoA and seven malonyl-CoA extender units followed by cyclization and release of 
norsolorinic acid anthrone [42]. The oxidation of norsolorinic acid anthrone to norsolorinic acid may 
be catalyzed by stcM, a monooxygenase ortholog to hypC that converts norsolorinic acid anthrone to 
norsolorinic acid in A. parasiticus [43]. Norsolorinic acid is the first stable intermediate in the 
biosynthesis of sterigmatocystin and is converted into averantin by StcE, reducing the hexanoate 
ketone to an alcohol [41,55,56]. 
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Figure 4. Proposed biosynthesis of sterigmatocystin. StcA contains starter unit-ACP 
transacylase (SAT), ȕ-ketosynthase (KS), acyltransferase (AT), product template (PT), acyl 
carrier protein (ACP) and thioesterase/claisen cyclase (TE/CLC) domains. *Indicates a 
proposed, but not confirmed, enzyme. Multiple arrows indicate that the number of 
enzymatic steps is unknown. 
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Yabe et al. [55] showed that 5ƍ-hydroxyaverantin is a step towards aflatoxin in A. parasiticus and a 
later study showed that the oxidation of averantin into 5ƍ-hydroxyaverantin is catalyzed by StcF [57]. 
The conversion of 5ƍ-hydroxyaverantin to 5ƍ-oxyaverantin is likely catalyzed by StcG [39,44]. In a study in 
A. parasiticus by Yabe and co-workers it was shown that both (1ƍS, 5ƍS)- and (1ƍS, 5ƍR)-hydroxyaveratin are 
formed in the conversion of averatin to 5ƍ-oxyaveratin [58]. Disruption of aflH in A. parasiticus 
resulted in the accumulation of 5ƍ-hydroxyaverantin, however, small amounts of O-methylsterigmatocystin 
present suggested that other enzymes may be involved in the reaction [44,59]. The gene(s) responsible 
for the conversion of 5ƍ-oxyaverantin to averufin have not been identified [39,60]. 
Individual disruption of StcB and StcW resulted in elimination of sterigmatocystin and 
accumulation of averufin, indicating that both enzymes catalyze the conversion of averufin to  
1-hydroxyversicolorone [57]. It was not possible for the authors to determine why two 
monooxygenases were required for this reaction step [57]. No gene products have been identified as 
being responsible for the conversion of 1-hydroxyversicolorone to versiconal hemiacetal acetate. StcI 
is thought to catalyze the reaction from 1-hydroxyversicolorone to versiconal based on studies of the 
ortholog AflJ in A. parasiticus, though other genes capable of this reaction may be present in  
A. nidulans [44,61]. 
Deletion of stcN did not result in the production of sterigmatocystin or other intermediates [44]. 
However, StcN show homology to AflK and the versicolorin B synthase, Vbs, in A. parasiticus, indicating 
that the biosynthetic step from versiconal to versicolorin B may be catalyzed by StcN [39,44,62]. StcL 
was shown by Kelkar et al. [63] to catalyze the conversion of versicolorin B to versicolorin A. 
Inactivation of stcL resulted in accumulation of dihydrosterigmatocystin, leading to a branching of the 
sterigmatocystin biosynthesis as seen in the aflatoxin biosynthesis. Addition of versicolorin A to the 
mutant gave production of sterigmatocystin, and that indicated that this enzyme functions before 
versicolorin A [63]. 
Keller and co-workers [64,65] showed that StcU and StcS are involved in the conversion of 
versicolorin A to demethylsterigmatocystin. Individual disruption of stcU and stcS led to the 
accumulation of versicolorin A and eliminated production of sterigmatocystin in A. nidulans [64,65]. 
Henry and Townsend [45] studied the same step in the aflatoxin biosynthesis in A. parasiticus and 
proposed an oxidation-reduction-oxidation mechanism, involving at least a ketoreductase AflM and a 
monooxygenase AflN, orthologs to stcU and stcS, respectively. Ehrlich et al. [46] and Cary et al. [47] 
identified two enzymes, AflY, a Baeyer-Villiger oxidase and AflX, an oxidoreductase, to be involved 
in the conversion of versicolorin A to demethylsterigmatocystin in A. parasiticus and A. flavus, 
respectively. aflX and aflY are homologous to stcQ and stcR, which suggests that these genes might be 
involved in the biosynthetic step from versicolorin A to demethylsterigmatocystin [46,47]. 
The final step in the biosynthesis of sterigmatocystin is the methylation of demethylsterigmatocystin 
catalyzed by StcP [66]. The conversion of sterigmatocystin to aflatoxin involves two additional 
biosynthetic steps; an O-methylation of sterigmatocystin by aflP followed by involvement of aflQ to 
produce aflatoxin [39]. Slot and Rokas have recently showed that the sterigmatocystin gene cluster in 
Podospora anserina was horizontally transferred from Aspergillus, which shows that transfer of large 
metabolite clusters between fungi are possible [67]. 
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4. Aspyridone 
Aspyridone is a PK-NRP hybrid and a fascinating example on how PK-NRP compounds in  
A. nidulans can be assembled from the activity of a single fusion enzyme. The aspyridones have shown 
to display moderate cytotoxicity [68]. The responsible gene cluster was discovered by Bergmann and 
co-workers [68] using a genome mining approach. Using the Aspergillus genome sequence, they 
identified a SM gene cluster, which contained a putative TF (AN8414/apdR) that the authors 
hypothesized could trigger activation of the genes in the cluster. Accordingly, the authors 
overexpressed the TF under the control of an inducible alcA promoter by integrating it randomly in the 
genome. In agreement with the hypothesis, it was demonstrated by Northern blot analysis that six of 
the nearest neighbor genes were up-regulated in this strain on inductive medium, and that the 
aspyridones and two intermediates or shunt products could also be detected. Prediction of the catalytic 
potential for the six upregulated genes (apdA, apdB, apdC, apdD, apdE, and apdG) combined with the 
structure of the accumulating compounds allowed the authors to propose a model for the biosynthesis 
of aspyridones including an assignment of the involved enzymes (Figure 5). 
Figure 5. Proposed biosynthesis of aspyridone A and B. (a) Based on proposed 
biosynthesis by [68,72,73]; (b) Based on results by Halo et al. [78] Multiple arrows 
indicate that the number of enzymatic steps is unknown.  
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apdA was deleted by Chiang et al. [69] and confirmed to be involved in aspyridone biosynthesis as 
reported by Bergmann et al. [68]. 
The structure of aspyridone A and B suggested that their synthesis involved both PKS and NRPS 
activity. Indeed, analysis of the AN8412 structure revealed domains characteristic for a HR-PKS as 
well as NRPS in one ORF spanning more than 11 kb. This is a special subclass of reducing PKSs, 
where the PKS has been directly fused with a single NRPS module at the Cƍ-terminal end. This 
architecture allows for the incorporation of amino acids or carboxylic acids into the carboxylic end of 
the growing PK chain. Only one of these fusion enzymes has been found in A. nidulans, but has been 
reported in other fungi [70,71]. Since AN8412 is the first enzyme to act in the pathway, the gene was 
named apdA. ApdA catalyzes the assembly of the PK-amino acid backbone of the aspyridones by three 
Claisen condensations of malonyl-CoA, and KR-DH-ER-MT carries out full reduction of the ȕ-keto 
and the methylations, which are required. However, as ApdA lacks a functional ER domain, the ER 
activity is most likely provided by ApdC, a homolog to an enoyl reductase (LovC) from the lovastatin 
biosynthetic gene cluster [68]. The resulting triketide is transferred to the NRPS module, where it is 
linked to tyrosine [68]. Bergmann and co-workers listed the domains through protein homology in the 
NRPS as condensation (C), adenylation (A), peptidyl carrier protein (PCP) and reductase domain 
(RED).The release of the PKS-NRPS hybrid product was proposed to be a NADPH-dependent 
reductive release followed by an intramolecular Knoevenagel condensation and enzymatic oxidation [68]. 
Biochemical studies of the role of ApdA and ApdC in the biosynthetic pathway of the aspyridones 
have been performed by Liu et al. [72] and Xu et al. [73]. Liu and co-workers [72] defined the NRPS 
module as C-A-T-R with the latter two being thiolation and reductase, which is an alternative to the 
more frequent C-A-T-TE found in these modules. However, this reductase domain (R*) in the NRPS 
module of ApdA is not the standard SDR superfamily dehydrogenase since tyrosine in the Ser-Tyr-Lys 
catalytic triad is mutated suggesting a redox-independent condensation reaction and the release of a 
tautomer of preaspyridone from ApdA by a Dieckmann cyclization, which was first shown by Halo 
and co-workers [74]. This result has been confirmed by Xu et al. who expressed the apdA and apdC 
genes in Saccharomyces cerevisiae and Escherichia coli, respectively [73]. The purified enzymes 
(ApdA and ApdC) were incubated in the presence of cofactors and building blocks and the 
predominant product was preaspyridone [73]. 
The formation of preaspyridone into aspyridone A and B was proposed by Bergmann et al. [68], 
(and outlined in Figure 5a) using the predicted functions of the remaining genes of the apd gene 
cluster. The proposed biosynthesis involved ApdB and ApdE which shows similarity to cytochrome 
P450 oxygenases and cytochrome P450 alkane hydroxylases, respectively, and were believed to 
catalyze the formation of hydroxypreaspyridone [68]. Based on the study of pyridone rearrangement in 
metabolites related to aspyridone it was suggested that ApdE or ApdB were involved in the pyridone 
rearrangement [68,75–77]. Moreover, aspyridone A was hypothesized to be converted into aspyridone 
B by ApdD, a putative FAD-dependent monooxygenase, which is related to other ring hydroxylases [68]. 
Aspyridone has a similar structure to other pyridines isolated from fungi, e.g., tenellin whose 
biosynthetic gene cluster also has been identified [75,76]. The proposed biosynthesis of aspyridone 
was, as described above, based on predicted gene functions and not isolated intermediates. However, a 
study on the biosynthesis of the related metabolite tenellin by Halo and co-workers [78] showed that 
the suggested biosynthesis may be incorrect and an alternative biosynthesis was suggested (as shown 
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in Figure 5b). In this biosynthesis preaspyridone is not converted into hydroxyaspyridone but ring 
expanded by ApdE to aspyridone A similar to the biosynthesis of tenellin [78]. Halo et al. also showed that 
the hydroxylated metabolite of pretenellin is a shunt metabolite as it could not be converted into tenellin. 
5. Emericellamides 
The emericellamides are other examples of hybrid compounds that are formed between PKs and 
NRPs. In this case the biosynthesis requires a PKS and a NRPS rather than a fusion PKS-NRPS as 
used in the production of the aspyridones. Emericellamides are cyclic depsipeptides and a total of five 
variants, A, C–F, of these metabolites have been found in A. nidulans. Initially, emericellamide A and 
B were isolated and described from an unidentified marine-derived Emericella strain in a screen due to 
their antibacterial activity against methicillin-resistant Staphylococcus aureus [79]. 
In order to discover novel natural products, Chiang and co-workers [69] searched the genome 
sequence of A. nidulans for NRPS gene candidates. Subsequently, six of these genes were randomly 
chosen and deleted by gene targeting. One of the resulting mutants, AN2545ǻ, showed a metabolite 
profile where emericellamide A was missing. Furthermore, HPLC profiles and dereplication using 
mass spectrometry and database searches revealed four additional compounds, which disappeared in 
the mutant metabolite profile. Since these compounds had not previously been described in  
A. nidulans, they were purified and their structures solved by NMR analysis revealing that they were 
novel analogues of emericellamide A and B, thus named emericellamide C–F [69]. 
To investigate whether AN2545, now called easA, defines a gene cluster encoding all necessary 
enzymatic activities in the emericellamide biosynthetic pathway, the genes from AN2542 to AN10325, 
a total of ten, were deleted [69]. Most of these gene deletions did not affect emericellamide production 
as judged by LC-MS analysis, demonstrating that they do not participate in the biosynthesis. However, 
the emericellamides were absent in four of the deletion strains, now named easA-easD, indicating that 
these genes are involved in the pathway. 
Bioinformatic analysis of the three additional genes suggested that they all encode activities that are 
relevant for emericellamide biosynthesis. Specifically, easB (AN2547), a PKS, easC (AN2548), an 
acyl transferase, and easD (AN2549), an acyl-CoA ligase. Based on these putative activities, the 
authors proposed a biosynthetic pathway for emericellamide production (Figure 6). In this model, the 
biosynthesis is initiated by EasB, a HR-PKS composed of the domains KS-AT-MT-DH-ER-KR-ACP. 
Since the PK component of the different emericellamide variants differ with respect to chain length 
and methylation pattern, it indicates that iterativity of this PKS is flexible [69]. 
Next, the PK carboxylic acid is converted to a CoA thioester by the acyl-CoA ligase, EasD, loaded 
onto the acyltransferase EasC, and then transferred to the thiolation (T) domain of EasA. This NRPS is 
a multi-modular enzymatic assembly containing 18 domains grouped into five modules. Among those, 
the authors propose that the first T domain is responsible for accepting the incoming PK from EasC 
(Figure 6). Moreover, the remaining domains fit well with the fact that five amino acids are 
incorporated into emericellamides. The authors note that this NRPS does not contain a TE domain at 
the end of module 5, indicating that this enzymatic activity is not necessary for cyclization of the 
emericellamides [69]. 
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Figure 6. Proposed biosynthesis of the emericallamides. The order of the 
methyltransferase (MT) and dehydratase (DH) domain as suggested by Chiang et al. [69], 
however a BLASTp analysis suggests a swapping of the MT and DH domains. The NRPS, 
EasA, contains 18 (T, E (epimerization), C, A) domains grouped into five modules. 
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6. Asperthecin 
Asperthecin is a PK compound that was first isolated from A. quadrilineatus by Howard and 
Raistrick in 1955 [80], however, the structure was not fully determined until six years later [81]. 
Initially, various chemical derivatizations and spectroscopic data determined a partial structure of 
asperthecin [80]. Neelakantan and co-workers [82] reduced the number of possible structures to two, 
and further derivatizations of asperthecin by Birkinshaw and Gourlay resulted in the final structure [81]. 
A. quadrilineatus is a member of the A. nidulans group, therefore Howard and Raistrick [80] extended 
the search of asperthecin to additional members of the A. nidulans group. No other was as rich in 
asperthecin production as A. quadrilineatus, yet small amounts of crystallized asperthecin could be 
obtained from cultures of A. nidulans and A. rugulosus indicating that production of asperthecin was 
possible in other aspergilli [80]. 
About 50 years later, Szewczyk and co-workers [83] used a molecular genetics approach to find the 
gene cluster responsible for the production of asperthecin in A. nidulans. Since many aspects of the 
regulation in the polyketome were unknown, the authors speculated whether sumoylation had an 
effect. SUMO is a small ubiquitin-like protein which is post-translationally added to proteins in the 
cell, as it plays a role in regulating transcription. A. nidulans contains one SUMO encoding gene, 
sumO [84], deletion of which led to a decrease in the production of SMs such as austinol, 
dehydroaustinol, and sterigmatocystin, and an increase in the production of a metabolite identified to 
be asperthecin, whereas the production of emericellamides were not affected [83]. Due to the aromatic 
structure of asperthecin, Szewczyk et al. [83] studied the domain prediction in 27 putative PKS-protein 
sequences using the A. nidulans genome sequence and available tools, in order to identify potential 
producers of non-reduced PKs. Ten NR-PKSs were identified and a deletion series of all NR-PKS 
genes was performed in the sumO¨ background [83]. While nine of the PKS-deletion strains still 
produced asperthecin, the AN6000 (aptA) PKS-deletion strain failed to synthesize asperthecin [83]. 
With the notion that most end compounds in PK biosynthesis are made by a clustered gene collective, 
six candidate genes surrounding aptA were picked in an attempt to identify the apt biosynthetic cluster. 
Two of these genes, aptB (AN6001) and aptC (AN6002), were found to be required for asperthecin 
production [83]. One strain (AN5999ǻ) had a significantly lower production of asperthecin compared 
to the reference strain, but asperthecin was still present in the metabolite extracts, and as the strain 
showed poor growth, it was not included in the apt gene cluster. 
Interestingly, AptA was shown to have SAT-KS-AT-PT-ACP domains, but lack a TE/CLC  
domain [83,85–88]. Independent groups have used this case as a model system to study the mode of PK 
release, and two alternating mechanisms for the biosynthesis of asperthecin are shown in Figure 7 [86,87]. 
The first model suggests the formation of the PK backbone by condensations of one acetyl-CoA and 
seven malonyl-CoA units [86], with the ȕ-lactamase AptB releasing the octaketide from AptA [83]. 
This assumption was based on a study by Awakawa and co-workers [85] in A. terreus, where there was 
a release of atrochrysone carboxylic acid from the atrochrysone carboxylic acid synthase (ACAS) 
lacking a TE/CLC domain, in the presence of the atrochrysone carboxylic ACP thioesterase (ACTE), a 
member of the ȕ-lactamase superfamily [85]. The unstable atrochrysone carboxylic acid then 
undergoes a series of reactions; decarboxylation, dehydration, and various oxidations where the 
monooxygenase AptC is believed to be involved, and in the end yielding asperthecin [86]. 
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Figure 7. Proposed biosynthesis of asperthecin (a) As suggested by Chiang et al. [86];  
(b) Based on proposed biosynthesis by Li et al. [87]. AptA contains SAT, KS, AT, PT and 
ACP domains. Multiple arrows indicate that the number of enzymatic steps is unknown. 
 
In another approach, Li et al. [87] introduced aptA, aptB, and aptC into S. cerevisiae, which 
resulted in the production of a nonaketide (here called preasperthecin), and not the octaketide as 
proposed by Chiang et al. [86]. Expressing aptA and aptB without aptC resulted in a product identical 
to preasperthecin except for the lack of C2-OH, confirming that AptC is responsible for this step [87]. 
Expression of aptA and aptC alone did not lead to the production of preasperthecin or any other 
traceable compounds, confirming that AptB is needed for release of the PK from AptA [87]. These 
results were confirmed by an in vitro assay after expressing aptA, aptB and aptC in E. coli [87]. 
Further insight into AptA functionality came from expressing the AptA-PT domain in E. coli, and 
combining it with the Gibberella fujikuroi PKS4, which can produce nonaketide products in vitro [88]. 
The experiment revealed that AptA-PT can catalyze C6-C11 cyclization, and most likely also the  
C4-C13 cyclization. Further, a spontaneous C2-C15 cyclization was followed by a C1-C17 
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esterification [88]. The apt gene cluster appears likely to consist of additional genes, which are 
responsible for the conversion of preasperthecin into asperthecin. 
7. Asperfuranone 
Asperfuranone is an example of a novel PK metabolite discovered through genetic mining in  
A. nidulans, as this compound had not previously been reported in the literature before Chiang and  
co-workers [89] in 2009. Asperfuranone was later shown to possess bioactive properties as it inhibited 
proliferation of human non-small A549 cancer cells [90]. Investigating the loci containing putative 
PKS gene clusters, Chiang and co-workers [89] noticed that a NR-PKS gene (AN1034, afoE) and a 
HR-PKS gene (AN1036, afoG) were located close to each other on chromosome VIII. Since no 
products had ever been detected from activity of this locus, and due to the rare constellation of two 
neighbor PKSs, the authors speculated whether a novel metabolite could be revealed. A putative 
transcriptional activator (AN1029, afoA) was found near the PKS and the authors replaced the 
upstream sequence of afoA, estimated to be the native promoter, with the inducible alcA promoter [89]. 
This indeed turned on the expression of the cluster, since asperfuranone and a precursor metabolite 
were detected. The structure of asperfuranone was determined based on one- and two-dimensional 
NMR experiments and the absolute configuration by a modified Mosher’s method, whereas the 
precursor preasperfuranone had already been determined in the literature [89,91]. With these two 
compounds being identified, a gene-deletion strategy was performed to map the other genes assigned 
to the afo gene cluster, which involved twelve surrounding genes including the two PKSs [89]. Four 
deletion strains afoD¨, afoE¨, afoF¨, and afoG¨ fully eliminated asperfuranone production whereas 
afoB¨ and afoC¨ strongly reduced production of asperfuranone [82]. The deletions confirmed that 
both afoE and afoG were responsible for the production of asperfuranone, and that the deletion of 
afoD, encoding a putative hydroxylase, resulted in the production of preasperfuranone [89]. Deletion 
of afoB reduced the production of asperfuranone and due to a high homology to efflux pumps, Chiang 
and co-workers [89] suggested that it was responsible for the transport of asperfuranone out of the cell. 
With the gene cluster and predicted functionalities of the gene products defined, a biosynthetic 
pathway of asperfuranone was proposed (Figure 8) [89]. The assembly of the primary reduced 
tetraketide is synthesized by AfoG from one acetyl-CoA, three malonyl-CoA, and two SAM. The 
tetraketide is transferred to the SAT domain of AfoE and extended with four malonyl-CoA and one 
SAM [89]. The octaketide is released from AfoE after aldol condensation and reductive release from a 
C-terminal reductase (R) domain, which resembles a reductive release mechanism to generate the 
aldehydes described by Bailey et al. [92], forming the aldehyde preasperfuranone [89]. The 
biosynthetic steps from preasperfuranone to asperfuranone are uncharacterized and the suggestions are 
not based on identified metabolites [89]. Accumulation of preasperfuranone in the afoDǻ suggested 
AfoD to be the next enzyme in the biosynthesis of asperfuranone. The deletions of afoF, encoding a 
putative FAD/FMN-dependent oxygenase and afoC, initially believed to code for a homologue to 
citrinin biosynthesis oxidoreductase, did not reveal any intermediates, the order of reactions and the 
exact enzymatic functions for AfoF and AfoC have not been determined. In afoC¨, the production of 
asperfuranone was not fully eliminated, which Chiang and co-workers [89] suggested could be due to 
other enzymes catalyzing the reaction, however less efficiently. 
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Figure 8. Proposed biosynthesis of asperfuranone. The highly reducing (HR)-PKS, AfoG, 
contains KS, AT, DH, CM, ER, KR, and ACP domains whereas the NR-PKS, AfoE, 
contains SAT, KS, AT,PT, ACP, CM , and R domains. The only intermediate isolated in 
the biosynthesis is preasperfuranone [89]. Multiple arrows indicate that the number of 
enzymatic steps and reaction order is unknown.  
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Other puzzling discoveries have been made in connection to the asperfuranone production. When 
trying to activate a cryptic NRPS gene cluster containing two NRPSs, inpA (AN3495) and inpB 
(AN3496), by overexpression of a regulatory gene, scpR (AN3492), Bergmann et al. [93] also 
activated asperfuranone. This is an interesting example of a regulatory gene located on chromosome II 
that activates the afo cluster located on chromosome VIII [93]. Lui et al. [94] have attempted to 
engineer the production of a new metabolite by swapping the SAT domain of AfoE with the  
StcA-SAT. This led to the production of a new metabolite though having the same length as the native 
AfoE product, asperfuranone [94]. 
8. Monodictyphenone/Emodin 
The PK monodictyphenone was first reported in A. nidulans in 2005 [95] and the genes behind the 
production of monodictyphenone were mapped four years later [96]. This discovery not only enabled 
the establishment of a biosynthesis model for monodictyphenone in A. nidulans, it has subsequently 
revealed that more than ten different stable products among different classes of related polyketides can 
be linked to monodictyphenone biosynthesis [11,96–98]. These metabolites count monodictyphenone, 
emodin and the emodin derivates 2-hydroxyemodin, 2-aminoemodin, Ȧ-hydroxy emodin, and emodic 
acid. Moreover, the arugosins and prenyl-xanthones are also coupled to the pathway [11,98]. The 
compound emodin has been studied for more than a century [99], and is an anthraquinone found in a 
wide array of both plants and fungi [100,101]. Emodin and several derivatives (e.g. emodic acid) have 
been shown to possess anti-bacterial and cancer preventive properties [102–106]. 
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The presence of the SM clusters in silent areas of chromosomes, e.g. near telomeres and 
centromeres, suggests that chromatin remodeling factors can influence the expression of genes 
responsible for SMs. As rationalized by Bok and co-workers [96], removal of histone-tail methylation 
could open heterochromatic regions for transcription. The authors deleted an ortholog, cclA, to the 
yeast BRE2 gene, encoding an enzyme partner of the COMPASS transcriptional regulator complex 
conserved in eukaryotes, which rendered A. nidulans defective in di- and trimethylation of lysine 4 of 
the histone 3 tails (H3K4). The cclA deletion was established in a mutant strain, stcJǻ, to avoid 
interference of high amounts of sterigmatocystin in purification of other metabolites. The effect was 
striking as the loss of CclA in HPLC analysis showed an altered chemical landscape compared to the 
stcJǻ reference [96]. 
As the compounds appearing were UV-active suggesting high conjugation likely due to aromaticity, 
the ten NR-PKSs investigated in the asperthecin and asperfuranone studies were individually deleted in 
the cclAǻ stcJǻ double deletion background. This screen revealed six products that all were linked to 
one PKS, AN0150 (mdpG) [96]. Delineation of the cluster was achieved by inspecting the genome 
sequence for possible cluster candidates followed by Northern blotting for gene-expression analysis in 
the cclAǻ stcJǻ, where the products were detected. The cluster was found to span 12 putative ORFs 
(AN10021-AN10023 (mdpA-L)) [97] of which two genes AN0147 (mdpD) and AN10035 (mdpI), did 
not show altered expression from the reference [96,97]. The mdp-cluster candidates were also deleted 
in the cclAǻ stcJǻ mutant strain to confirm the expression analysis data and to draw the borders of the 
cluster [97]. The authors suggest that two transcriptional activators are present within the cluster; 
MdpE as a main activator (homologue to AflR) and that MdpA is a co-activator. The mdp locus is 
located near the telomere of chromosome VIII, and activation of the genes in the cclAǻ strain supports 
the hypothesis of epigenetic regulation in these areas through chromatin remodeling [96]. 
Two groups cultivated A. nidulans on complex growth media, which revealed six additional 
metabolites. First Sanchez et al. [98] discovered that emericillin, variecoxanthone A, shamixanthone, 
and epi-shamixanthone were also products of the mdp cluster, and subsequently Nielsen and co-
workers [11] added arugosin A and H to the pathway. Since these PKs are prenylated, a BLAST search 
of the A. nidulans genome sequence was performed and pathway-candidate genes were deleted. Two 
prenyl transferases encoded by xptA and xptB, and one neighbor GMC oxidoreductase encoded by 
xptC, were found to be involved in the pathway, though they were located on other chromosomes than 
the mdp cluster (for cluster overview see Sanchez et al. [98]). This is an intriguing example of  
SM-cluster members located on more than one chromosome, however, prenyl transferases are known 
to have broad substrate specificity, and it is currently not known whether they are involved in other 
processes than prenyl-xanthone formation [98]. 
MdpG synthesizes the main PK backbone. Since MdpG lacks a CLC/TE domain, MdpF, a putative 
zinc dependent hydrolase, is believed to catalyze the release of the PK from MdpG [97]. The 
mechanism is believed to follow the case of ACAS and ACTE as introduced previously in the 
asperthecin section. Awakawa and co-workers [85] demonstrated that the direct product of the 
ACAS/ACTE is not emodin anthrone as proposed earlier [107,108], but more likely atrochrysone 
carboxylic acid (Figure 9). Atrochrysone carboxylic acid was not observed in vitro, instead the 
decarboxylated product atrochrysone was the major product in the assays and therefore proposed to be 
an intermediate to emodin, as suggested by Couch and Gautier [109]. Conversion of atrochrysone to 
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emodin requires dehydration (forming emodin anthrone) and a final oxidation (Figure 9), however, 
Awakawa and co-workers [85] observed small amounts of both emodin anthrone and emodin in vitro 
showing that these reactions may occur non-enzymatically. Based on these observations, Chiang and 
co-workers [97] proposed that mdpH encodes a decarboxylase, catalyzing the conversion of 
atrochrysone carboxylic acid to atrochrysone. The deletion of mpdH resulted in accumulation of a 
shunt product endocrocin produced via endocrocin anthrone. Enzymes responsible for dehydration of 
atrochrysone or modification of emodin into the observed derivatives have not yet been identified. 
Figure 9. Proposed biosynthesis of emodin. MdpG contains SAT, KS, AT, PT, and ACP domains. 
 
The first stable intermediate following emodin towards the prenyl-xanthones is monodictyphenone 
[97,98], and gene-deletion studies points to at least the five following enzymes are involved; a 
dehydratase (MdpB), a ketoreductase (MdpC), a glutathione S transferase (MdpJ), an oxidoreductase 
(MdpK), and a Baeyer-Villiger oxidase (MdpL) [97]. The mechanism has been proposed to be 
analogous to the conversion of versicolorin A to demethylsterigmatocystin which is known to proceed 
through oxidation-reduction-oxidation catalyzed by a cytochrome P450 monooxygenase (VerA) and a 
ketoreductase (StcU) [45,65,110]. However, none of the above mentioned Mdp enzymes appear to be 
homologous to VerA, and the role of the individual enzymes has not been investigated further [97]. 
The biosynthesis of the six monodictophenone derived metabolites is based on hydroxylation 
(MdpD), C-prenylation (XptA), O-prenylation (XptB), and carboxylic acid reduction (unidentified 
enzyme) [11,98]. Central in the pathway is the hydroxylation of C2 in monodictyphenone 
accompanied by reduction of the carboxylic acid. The carboxylic acid is suggested by Sanchez and co-
workers [98] to be reduced to a hydroxy group, the B-ring is closed by dehydration and the 
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intermediate is O-prenylated at C2 to yield variecoxanthone A, which in turn is C-prenylated to 
emericillin (Figure 10). The final known step in prenyl-xanthone biosynthesis gives rise to the 
stereoisomers shamixanthone and epishamixanthone and is catalyzed by XptC [98]. Alternatively, 
Nielsen and co-workers include synthesis of arugosins by partially reducing the carboxylic acid to an 
aldehyde, followed by C-prenylation, yielding arugosin H and O-prenylation to give arugosin A. 
Subsequent reduction of the aldehyde to a hydroxyl group, and ring closure by dehydration then gives 
emericillin and shamixanthones [11]. 
Figure 10. Suggested biosynthesis of the shamixanthons from emodin. Multiple arrows 
indicate that the number of enzymatic steps are unknown. 
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9. Orsellinic Acid 
In addition to the mdp cluster, the loss of CclA also led to the discovery of another gene cluster 
driven by an NR-PKS [96]. Two PK products, the cathepcin K inhibitors F-9775A and F-9775B, first 
isolated from Paecilomyces carneus [111], were detected and mapped to AN7909. Following this 
discovery, Schroeckh and co-workers [112] found the primary metabolite from AN7909 (orsA) to be 
orsellinic acid, an archetypal metabolite [113]. Moreover, the metabolite lecanoric acid typically found 
in lichens and produced by mycobiots such as Umbilicaria antarctica [114] was linked to OrsA [112]. 
Following the initial observations, the number of detected metabolites from the orsA gene cluster has 
expanded to gerfelin, a C10-deoxy-gerfelin, diorcinol, orcinol, cordyol C, and violaceol I and II [115,116]. 
The biosynthetic activities of the orsA cluster are as yet not elucitated, and this illustrates the need for 
applying different eloquent strategies to trigger production of these metabolites. 
The deficiency in methylation of H3K4 in the cclAǻ strain resulted in activation of both mdp and 
ors gene clusters. Expression analysis revealed that the annotated ORFs from AN7909-AN7915 were 
possible cluster members, hereby indicating candidates for a gene cluster [96]. The ors gene cluster, 
orsB-orsE, was identified by Schroeckh and co-workers [112] as four additional ORFs spanning 
AN7911-AN7914, which was confirmed by Sanchez et al. [115], who deleted all genes from AN7901 
to AN7915. Interestingly, the neighbor PKS to the ors locus, AN7903, was deleted by Nielsen et al. [11] 
and the resulting strain failed to produce F-9775A and B like AN7909ǻ under the conditions tested. 
Schroeckh and co-workers [112] defined orsA-E using gene-expression analysis through both an 
Aspergillus secondary metabolism array (ASMA) and relative expression analysis in quantitative 
reverse-transcriptase PCR (qRT-PCR). The induction of orsA was achieved by co-cultivating with a 
soil bacterium, Streptomyces rapamycinicus (initially named S. hygroscopicus) and extracting mRNA 
from the fungus [112]. This response on SM level was further investigated by Nützmann and  
co-workers [117]. Since the loss of H3K4 methylation induced gene expression in ors locus [96], the 
rationale was that the transcriptional activation of silent secondary-metabolism genes by acetylation of 
lysines on histone tails, especially H3K9, is equally important and the search for histone acetyl 
transferases (HATs) in the genome sequence was commenced [117]. Forty HATs were found and 
deleted, and only four proved to be essential. Of the 36 deletions of nonessential HATs in A. nidulans, 
the deletions of gcnE and adaA, both essential core parts of the multi-subunit Saga/Ada complex, an 
important complex for HAT activity in A. nidulans, significantly lowered the ors transcripts 
investigated [117]. Thus, Saga/Ada plays a role in the response to S. rapamycinicus and loss of this 
complex downregulated orsellinic acid metabolites, as well as sterigmatocystin, terrequinone, and 
penicillin [117]. 
Four additional orsellinic acid derived compounds were found in a defect COP9 signalosome (CSN) 
mutant strain [116]. The multiunit CSN complex is found in higher eukaryotes, albeit with different 
functional roles depending on the tissues. In A. nidulans the CSN is required for fruiting body 
formation and is not essential for asexual growth. By deleting csnE; orcinol, cordyol C, and violaceol 
I+II were produced, and the genes orsA-orsE were shown to be differentially expressed [116]. The link 
of the violaceol metabolites to ors was confirmed by Nielsen and co-workers [11] who applied an 
OSMAC strategy on their reference strain and compared this to their deletion library. 
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Very little is known about the biosynthesis of the metabolites of the ors locus. One acetyl-CoA and 
three malonyl-CoA units can yield a C8 aldol intermediate, and as proposed by Nielsen et al. [11], this 
can lead to the tetraketide orsellinic acid through loss of water and enolization and to the C7 compound 
orcinol by decarboxylation and enolization. Oxidation of orcinol in the para position then leads to  
5-methyl-benzene-1,2,3-triol which is believed to either dimerize with the loss of water to give 
violaceol I and II, Figure 11, or to give F-9775A+B, Figure 12, in an unknown series of synthesis 
steps. Another outcome is the formation of lecanoric acid by dimerization of orsellinic acid. Though 
the steps in the pathway have been hypothesized, most steps are not accounted for. It has been reported 
that OrsA having the domains SAT-KS-AT-PT-ACP-TE is responsible solely to form orsellinic acid. 
OrsA, OrsB, and OrsC seem to be sole responsible for F-9775A+B formation. Moreover, it has been 
shown that gerfelin and a C10-deoxy derivative of gerfelin accumulate in orsBǻ, whereas diorcinol 
was found in high amounts in the orsCǻ strain [115]. Gerfelin, C10-deoxy gerfelin and cordyol C are 
all dimers built up of two of the three suggested monomer units, orsellinic acid, orcinol and  
5-methylbenzene-1,2,3-triol. 
Recently Scherlach and co-workers [118] continuously cultivated A. nidulans under nitrogen-
limitation and carbon-limitation. At nitrogen limiting conditions in continuous cultivations two novel 
products, denoted as spiroanthrones, were found. They could not be detected at batch cultivation. The 
metabolites were based on anthraquinone and orsellinic acid derived phenols. The induced expression 
of both mdpG and orsA confirmed increased activity under the N-limiting continuous cultivation 
conditions. 
10. Austinol and Dehydroaustinol  
The meroterpenoids austinol and the related compound dehydroaustin were first isolated from  
A. ustus by Simpson and co-workers in 1982 [119], where the structure of austinol was elucidated by 
1H and 13C NMR. Austinol and dehydroaustinol are just two examples out of many meroterpenoids 
that are derived from 3,5-dimethyl orsellinic acid as presented in the excellent review by Geris and 
Simpson [120]. 
The two austinols were detected for the first time in A. nidulans four years ago [121], where it was 
further substantiated that austinol was indeed of partly PK origin. Deletion of the phosphopantheteinyl 
transferase (PPTase) cfwA/npgA in A. nidulans resulted in a strain that among many other compounds 
did not produce austinol and dehydroaustinol [121]. The PPTase is responsible for attaching the 
phosphopantetheine moiety to the acyl carrier domain of the PKSs and NRPSs, thus it is an activator of 
the enzyme complexes. Hence, the abolition of austinol and dehydroaustinol production in the PPTase 
deficient strain strongly suggests a PK origin of these compounds. 
In 2011, Nielsen and co-workers [11] discovered the PKS responsible for synthesis of the PK part 
of austinol and dehydroaustinol in A. nidulans. A deletion library of all 32 putative PKS genes in  
A. nidulans was created and screened using an OSMAC approach [122] to enable activation of 
different clusters on different media. One single strain deleted in AN8383 (ausA) failed to produce 
austinol and dehydroaustinol [11]. This discovery was supported by the introduction of a point 
mutation at the phosphopantetheine attachment site, thus abolishing activation of the enzyme by the 
PPTase to ensure the loss of austinols was not an indirect effect e.g., at chromatin level. The ausAǻ 
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strain was complemented by re-introducing the ausA gene into the deletion strain. Introducing the gene 
under control of the inducible alcA promoter revealed that 3,5-dimethyl orsellinic acid (3,5-MOA) was 
indeed the precursor for austinol and dehydroaustinol in A. nidulans, as shown experimentally via 
labeling studies by Simpson and co-workers 20 years earlier [11,123,124]. 
Figure 11. Proposed biosynthesis of orsellinic acid and its derivatives of orsellinic acid. 
The enzymes that catalyze the individual reactions in the biosynthesis of the metabolites 
are so far unknown and biosynthesis is proposed based on the observed metabolites.  
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Figure 12. The proposed enzymes involved in the biosynthesis of F-9775A and F-9775B 
of the figure here. 
 
A more detailed understanding of the biosynthesis of the austinols has not been established yet. 
However, it is well established that 3,5-dimethyl orsellinic acid is synthesized from condensation of an 
acetyl-CoA unit with 3 malonyl-CoA units to form the PK backbone, which is methylated twice, 
catalyzed by AusA. The PK part is then alkylated with farnesyl pyrophosphate to form a transient 
intermediate (Figure 13), which can then act as a precursor for several similar meroterpenoids, such as 
andibenins, austin, berkeleyones and andrastins [120]. Recently we tentatively identified neoaustin and 
austinolide in A. nidulans extracts by LC-MS analysis (unpublished data), which makes us hypothesize 
that the biosynthesis towards the austinols involves (i) oxidation and acyl shift in the D ring (ii) 
lactonization from the substituent groups of the D ring, a Baeyer-Villiger type oxidation and 1,2 alkyl 
shift in the A ring to give neoaustin. Neoaustin is subsequently oxidized in the D ring by another 
Baeyer-Villiger type oxidation to give austinolide that upon further oxidation and ring condensation 
leads to austinol and dehydroaustinol, Figure 13. 
11. Concluding Remarks 
Secondary metabolism represents chemical diversity and span in biological functionality to the 
extreme. As shown above, individual compound classes can even form hybrid molecules to other 
compound classes. There is a high commercial interest in discovery and utilization of SMs in general 
as drugs or additives, or to avoid mycotoxins in food and feeds. Mapping PK biosynthesis to genes in 
A. nidulans as presented in this review involves great complexity. One challenge is to find and activate 
the genes required to produce the compounds. As shown, it takes in-depth understanding of fungal 
biology, nutrient sensing, chromatin remodeling, as well as analysis on all levels from DNA to 
metabolites to unveil cryptic gene clusters and their products. Moreover, the majority of the pathways 
described in this review have been elucidated in a relatively short time span. This has been possible 
due to bioinformatics. The availability of the genome sequence, as well as resources and tools in, e.g., 
Aspergillus Comparative Database (ACD), Aspergillus Genome Database (AspGD), and the Central 
Aspergillus REsource (CADRE) have been key aids to perform the extensive genome mining. 
The ability to predict enzymatic function based on gene sequences has proven fruitful in 
characterization of secondary metabolism, since this has revealed the location of e.g., PKS genes. 
Additionally, the presence of gene cluster specific TFs was utilized in activation of silent SM clusters 
both in the case of aspyridones and asperfuranone. The asperfuranone biosynthesis is moreover an 
example of a previously unknown compound, with a potential to be a novel drug, has been found in a 
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well-known filamentous fungus. Another case of a metabolite with attractive properties is emodin, 
which has been known for more than a century, but just recently had the biosynthetic machinery 
uncovered in A. nidulans. Both asperthecin and the emericellamides were firstly discovered and 
isolated from less well described aspergilli, however, after the compounds were observed in  
A. nidulans, the candidates for responsible genes in biosynthesis were found in a few months. The 
study of conidial pigment biosynthesis in A. nidulans has contributed to our basic understanding of 
fungal development and PKS organization, and provided researchers with an easy assayable marker 
system for genetic studies. Interestingly, the structure of the final pigment(s) still remains unknown 
after more than 70 years of research, underlining the difficulties in elucidating structures of highly 
polymerized PKs. 
Figure 13. Proposed biosynthesis of austinol and dehydroaustinol. All genes in the 
biosynthesis of austinol and dehydroaustinol, except AusA, are unknown. 
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Epigenetic regulation through chromatin remodeling has shown to be involved in activation of 
several SM gene clusters. Conserved chromatin remodeling factors have influenced both local 
activation of some SM clusters and more global responses within the genome. Gene clusters producing 
sterigmatocystin, orsellinic acid, emodins, and austinols have shown to respond to specific factors. The 
presence of SM producing genes outside gene clusters, e.g., in prenyl-xanthone production, is probably 
more common than observed so far. Moreover, cross-talk between pathways is frequently observed, as 
more pathways become known. This can open a discussion whether common pools of intermediates or 
enzymes can exist. In addition, the compartmentalization of SM production is an area to be explored. 
Furthermore, controlling compartmentalization of production as well as secretion will influence yields 
and downstream applications which are important factors for exploiting SM production commercially. 
Existing compounds can be modified genetically to add/remove chemical groups on existing drugs, 
mix moieties from different SM classes or species by for example domain swapping, and to 
considerably increase/abolish a specific production. 
Altogether the recent uncovering of secondary metabolism in A. nidulans is an illustrative example 
of strong interdisciplinary efforts requiring strong expertise within chemistry, biology, microbiology, 
molecular genetics, protein chemistry, computer science, and engineering. Ultimately, the efforts 
described in this review can form the basis for uncovering of the specific biological roles of the 
chemical arsenal in the fungus. 
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Abstract: Aspergillus oryzae and A. flavus are important species in industrial 
biotechnology and food safety and have been some of the first aspergilli to be fully genome 
sequenced. Bioinformatic analysis has revealed 99.5% gene homology between the two 
species pointing towards a large coherence in the secondary metabolite production. In this 
study we report on the first comparison of secondary metabolite production between the 
full genome sequenced strains of A. oryzae (RIB40) and A. flavus (NRRL 3357). 
Surprisingly, the overall chemical profiles of the two strains were mostly very different 
across 15 growth conditions. Contrary to previous studies we found the aflatrem precursor 
13-desoxypaxilline to be a major metabolite from A. oryzae under certain growth 
conditions. For the first time, we additionally report A. oryzae to produce parasiticolide A 
and two new analogues hereof, along with four new alkaloids related to the A. flavus 
metabolites ditryptophenalines and miyakamides. Generally the secondary metabolite 
capability of A. oryzae presents several novel end products likely to result from the 
domestication process from A. flavus. 
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1. Introduction 
Aspergillus oryzae is one of industry’s most used “workhorses” and has been used for centuries in 
food fermentation for the production of e.g., sake, soy sauce and other traditional Asian foods [1].  
A. oryzae is also a widely used organism for production of amylase, lipases and proteases and more 
recently also for heterologous expression of secondary metabolite genes and non-fungal proteins [2–4]. 
For many years, A. oryzae has been suspected to be a domesticated form of A. flavus, a plant and 
mammalian pathogenic saprophyte, capable of producing some of the most carcinogenic compounds 
known: the aflatoxins. Genetic work and subsequent genome sequencing of strains of both species 
have verified the tight link between the species [1,5–8]. 
The relationship of the two species has resulted in extensive screening of the toxic potential of  
A. oryzae, but no genuine evidence of aflatoxin production in validated A. oryzae isolates has ever 
been shown. Other important toxins, known from A. flavus, have on the other hand been shown in  
A. oryzae: 3-Nitropropionic acid [9] and cyclopiazonic acid (CPA) [10] along with kojic acid [11,12] 
(Figure 1). Additional metabolites previously reported from A. oryzae are asperfuran [13], sporogen 
AO1 [14,15], maltoryzine [16], and aspergillomarasmine A [17,18]. Aspirochlorine has been found in 
A. flavus, A. oryzae and A. tamarii [19–23] (Figure 1). For reviews on the safety and taxonomy of  
A. oryzae, see [7,24–26]. 
Figure 1. Known compounds from Aspergillus flavus or A. oryzae. 
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The few predicted differences between the genomes of A. oryzae and A. flavus (ca. 99.5% genome 
homology and 98% at the protein level for RIB40/ATCC 42149 and NRRL 3357 [27]), could lead one 
to expect A. oryzae to produce most of the metabolites found in A. flavus [1,28–31], but published 
metabolic data indicates a very low chemical correlation [32]. It is with reference to the established 
genetic heritage of A. oryzae from A. flavus remarkable that maltoryzine, sporogen AO1, asperfuran 
and aspergillomarasmine A have never been unambigously identified in A. flavus. Though research on 
A. flavus chemistry has focused primarily on toxic compounds, one would expect that these 
metabolites should be part of its chemical potential as they are for the domesticated A. oryzae. The 
preliminary bioinformatic studies in conjunction with the genome sequencing shows roughly the same 
number of predicted genes: 32 Polyketide synthases (PKSs) and 28 non-ribosomal synthases (NRPSs) 
for A. flavus and 32 PKSs and 27 NRPSs for A. oryzae with 2 NRPSs apparently unique for each  
strain [33]. The exclusiveness of these genes in terms of end product has yet to be verified chemically. 
Most of the predicted genes for secondary metabolites of A. oryzae (or A. flavus) have not been 
mapped to specific metabolic products, despite the genome sequencing of RIB40 in 2005 [27]. Only 
genes of the most important toxins: Aflatoxin [31,34,35], CPA [36,37] and aflatrem [38] have been 
fully annotated in both species, which leaves much to be explored. The full chemical potential of either 
species is unknown and epigenetic modifiers [39–43] may be necessary, alongside with the use of 
different growth conditions to aid triggering the full potential of secondary metabolite expression in 
these two closely related species. 
The aim of the current work has been to perform an initial comparative investigation of the 
chemistry from the two genome sequenced strains of A. oryzae (RIB40) and A. flavus (NRRL 3357), in 
order to get further insights into possible homologies and differences in secondary metabolite 
production for these two important species. 
2. Results and Discussion 
2.1. De-Replication of A. oryzae RIB40 
For the analysis of A. oryzae RIB40 chemistry, we investigated a series of solid media (YES, 
YESBEE, DRYES, CYA, CYAS, CY20, CY40, DUL, GAK, GMMS, MEA, OAT, PDA, TGY, 
WATM (see Methods and Materials for explanation) cultivations with micro-scale extractions [44,45] 
and subsequently analyzed with HPLC-DAD-MS for selection of optimal conditions. The different 
media were tested on a collection of A. oryzae (RIB40, IBT 28103) and A. flavus (NRRL 3357, IBT 
23106, IBT 3642) and these strains were cultivated at 25 °C in the dark for 7 and 14 days. The media 
screening for A. oryzae and A. flavus indicated the greatest chemodiversity and metabolite production 
from CYA, YES and WATM agar for our purpose. 
The comparison of the secondary metabolite profiles of the two strains, NRRL 3357 and RIB40, 
exposed a surprisingly high degree of chemical difference on all media as illustrated in Figure 2 and 
Table 1 for the WATM medium. The major metabolite repetitions between the two genome sequenced 
strains were merely kojic acid and ergosterol, like a number of minor metabolites (not analyzed here) 
seemed to be shared between the two strains. Altogether, this is in sharp contrast to the high gene 
homology, particularly for the secondary metabolite genes. 
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Figure 2. ESI+ BPC chromatogram of 7 day micro scale extract from WATM, bottom:  
A. oryzae RIB40, top: A. flavus NRRL 3357. Besides kojic acid (shown in box) and analogues 
in the beginning of chromatogram and ergosterol in the end (not shown), there are very few 
identical compounds between the genetically almost identical strains. Note that aspirochlorine 
is only detectable in negative ionization, and therefore not visible in this chromatogram. 
 
Table 1. LC-MS de-replication of some of the important secondary metabolite pathways 
from the two full genome sequenced siblings, A. flavus (NRRL 3357) and A. oryzae 
(RIB40). Based on 7 day fermentation on solid WATM agar in the dark. (+) indicates the 
presence of these types of compounds in A. flavus based on UV spectroscopic analysis.  
* New compounds reported here for the first time. 
Metabolite A. flavus NRRL 3357 A. oryzae RIB40 
Kojic acid + + 
Aflatoxin + - 
Aflavinines (+) + 
Aflatrem + 13-desoxypaxilline 
Miyakamides (+) Oryzamides * 
Aspirochlorine - + 
Cyclopiazonic acid + - 
Ditryptophenaline + Ditryptoleucine * 
Parasiticolide A - 14-deacetyl parasiticolide A * 
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Known metabolites to A. oryzae were de-replicated and we found that the RIB40 strain did not 
produce detectable levels (LC-MS) of CPA (as also noted by Tokuoka et al. [36]), asperfuran, 
sporogen AO1, maltoryzine or aspergillomarasmine under these growth conditions. It did, however, 
produce kojic acid and aspirochlorine and a series of potentially new metabolites of which some were 
isolated, structurally characterized and reported here. 
2.2. New Metabolites to A. oryzae RIB40 
During fermentation of the chemically potent RIB40 strain, we have been interested in the 
tremorgenic compounds, allegedly coupled to fungal sclerotia [46–54] and whether these could be 
found in A. oryzae as they have been in A. flavus. The RIB40 strain produces large and abundant 
sclerotia, especially on WATM agar, a fact not widely announced in literature although sclerotia have 
been observed in A. oryzae sporadically [55–57]. No sclerotia were observable after 14 days on YES 
agar, but although these metabolites are often characterized as sclerotial metabolites, there is not a 
strict correlation between the biosynthesis of these metabolites and the formation of sclerotia, as also 
noted by Wilson [58], and this extract was used for the described isolations. 
Here, we report the discovery of the aflatrem precursor 13-desoxypaxilline (13-dehydroxypaxilline) 
in A. oryzae RIB40, originally isolated from Penicillium paxilli [59–63]. Aflatrem is known from  
A. flavus and was discovered by Wilson and Wilson in 1964 [64] and structure elucidated by  
Gallagher et al. in 1978 and 1980 [65,66]. 13-desoxypaxilline was present in YES, CYA, OAT and 
WATM agar 7 day old micro-scale extracts. From the 14 days old YES 200 plate extract used for 
isolation, 13-desoxypaxilline was recovered as an intermediate metabolite. LC-MS, LC-MS/MS and 
NMR data analysis (Supplementary Material) confirmed the structure. Naturally the prospect of 
finding aflatrem itself was investigated, though no apparent peak was visible in HPLC-DAD data files. 
The use of a LC-MS/MS method further confirmed 13-desoxypaxilline as an end-product of A. oryzae 
RIB40 for the above cultivation conditions, since none of the proposed intermediate steps towards 
aflatrem could be detected (LC-MS/MS) and only one sample (WATM, 7d) showed traces of 
paspaline, a precursor for 13-desoxypaxilline (Figure 3). 
Figure 3. The final steps in the proposed biosynthesis of aflatrem (in A. flavus). A. oryzae 
RIB40 biosynthesis stops at 13-desoxypaxilline [38]. 
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A second extract was made from 100 plates of a 14-day old A. oryzae RIB40 culture grown on 
WATM agar with abundant sclerotia formation to validate the findings from the YES extract. The 
analysis of the WATM extract showed 13-desoxypaxilline as a major metabolite alongside other 
sclerotium-related metabolites, such as aflavinines (based on UV-data not shown). The discovery of 
13-desoxypaxilline as the apparent end-product of A. oryzae RIB40 is in agreement with the analysis 
of Nicholson et al. [38], who showed that a frameshift mutation in the atmQ gene presumably accounts 
for 13-desoxypaxilline not being converted into paspalicine and paspalinine. This mutation is therefore 
likely responsible for terminating the aflatrem biosynthesis in RIB40 prematurely, short of the acetal 
ring closure, C-13 hydroxylation and isoprene attachment. Nicholson et al. [38] demonstrated that 
AtmQ is a multifunctional cytochrome P450 monooxygenase likely to catalyze the several oxidative 
steps needed for biosynthesis of the acetal ring present in the structures of paspalicine, paspalinine and 
aflatrem, altogether pointing towards a more complex biosynthesis than shown here. Contrary to our 
discovery, Nicholson et al. did not find the aflatrem gene cluster of RIB40 to be transcribed during 
their fermentations [38]. 
The isolated 13-desoxypaxilline is a member of the paspalitrem tremorgens, a widely distributed 
group of metabolites that have been isolated from several genera: Penicillium, Eupenicillium, 
Claviceps, Emericella, Aspergillus and Phomopsis [67–69]. Besides the tremorgenic activity in 
animals, these metabolites have been shown to be insecticides [68], which is believed to be their 
ecological function together with aflatoxin and CPA for protection of the sclerotia against fungivorous 
insects [46,47]. 
In addition to 13-desoxypaxilline, two new analogues of parasiticolide A were also isolated and are 
here reported for the first time. The metabolites showed to be dide- and 14-deacetoxy analogues, and 
are most likely precursors to the sesquiterpene parasiticolide A (= astellolide A) (see Figure 4). The 
metabolites were present in CYA, YES and WATM extracts and isolated from the same 14 day old 
YES extract as 13-desoxypaxilline, and the dide- and 14-deacetyl analogues were also found in the 
sclerotia enriched WATM extract. Again the metabolites were analyzed using LC-MS and NMR. 
Several different extraction procedures were tested to verify the correctness of the compounds as 
genuine metabolites and not as in vitro degraded parasiticolide A products, but all samples showed 
only dide- and 14-deacetyl parasiticolide A and no traceable (LC-MS) levels of parasiticolide A itself, 
even with different non-acidic extractions. Parasiticolide A have been isolated from A. flavus var. 
columnaris (FKI-0739) once [71] and was originally isolated and characterized from A. parasiticus 
(IFO 4082) [72,73] and later also from a mutant of Emericella variecolor (= A. stellatus Curzi) [74]. 
Recently parasiticolides have been detected in the newly described species A. arachidicola (CBS 
117610) and A. minisclerotigenes (CBS 117635) [75]. There have to our knowledge not been 
published any toxic studies on the parasiticolides, but the related peniopholides from the fungus 
Peniophora polygonia have been reported to have antifungal properties [76]. 
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Figure 4. Structures of dide- and 14-deacetyl parasiticolide A and parasiticolide A. 
 
In our observations parasiticolides are more often detectable metabolites of A. oryzae than of  
A. flavus under the same fermentation conditions, suggesting that the pathway is partly silenced for  
A. flavus and may need epigenetic modification to be expressed under otherwise normal growth 
conditions. It is interesting that parasiticolide A is scarcely observed in A. flavus, when it is an 
important product of A. oryzae and also of A. parasiticus. As for 13-desoxypaxilline, dide- and  
14-deacetyl parasiticolide A are almost certainly products of a prematurely ended biosynthesis, here 
parasiticolide A. We also isolated and elucidated a third parasiticolide A analogue; a formyl variant of 
parasiticolide A, but it was not possible to exclude the possibility of in vitro chemistry due to the 
formic acid added during the ethyl acetate extraction, so the correctness of this metabolite remains 
tentative. (Hamasaki et al. used benzene to extract parasiticolide A [77]). All paraciticolide analogues 
were structure elucidated by NMR and shift values correlated with the published data for parasiticolide 
A, except for the missing signals of the acetate units and their minor influence on the chemical shifts 
values of adjacent protons and carbons (See Supplementary Material for NMR data). 
To further verify these observations, a MS/MS method was used to analyze several different 
microscale extracts of RIB40 for parasiticolide A itself. Trace amounts of parasiticolide A was found 
under these conditions and compared to an isolate of A. parasiticus (IBT 4387) capable of producing 
parasiticolide A. In the A. parasiticus isolate no dide- or 14-deacetyl parasiticolide A could be 
measured, indicating a complete transformation into the end-product (Figure 4). The small amount of 
parasiticolide A in RIB40 (roughly 1:1.000 ratio compared to 14-acetyl parasiticolide A, presuming the 
same response factor) might be the result of spontaneous acetylation involving the first acetylating 
enzyme. When the gene cluster of this metabolite is mapped, it is likely that the gene responsible for 
the last (specific) acetylation will be found to be mutated. Except for the section Nidulantes member 
Emericella variecolor, all other producers of these metabolites have been members of section Flavi. 
No indication points to these metabolites being part of the previously mentioned sclerotium 
metabolites since they are not found in selective sclerotium extracts, but are found for example in  
A. arachidicola, which is not known to produce sclerotia. 
Four new A. flavus related NRPS compounds were also isolated from A. oryzae RIB40 and 
characterized based on standard interpretation of 1H, COSY, HMQC and HMBC NMR data (see 
Supplementary Material). The compounds showed to be two isomeric metabolites named ditryptoleucine 
related to the ditryptophenalines [78–81] and the two indole-enamides named oryzamides A1-2 (cis- 
and trans-forms) structurally similar to the antibiotic miyakamide B1-2 [71] (Figure 5). 
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Figure 5. Structure of the new A. oryzae metabolites: Ditryptoleucine and oryzamide A1-2. 
 
It proved difficult to unambiguously isolate the cis- and trans-isomer of oryzamide A in a pure form 
due to isomerization around the double bond. Due to this the structure elucidation has been performed 
on mixtures of compounds. It is evident from the structure elucidation that oryzamides A1-2 only differ in 
the configuration around the double bond of the enamine as evident from the size of the coupling constant. 
Marfey analysis of the amino acid derived compounds only established the presence of L-tyrosine in 
the oryzamides. NMR structural data on the trans isomer (A1) is present in the supporting material. 
Intriguingly, these A. oryzae metabolites have apparently exchanged phenylalanine with leucine 
compared to the similar A. flavus metabolites, indicating either a common trait in the domestication 
process or a coupling between the two pathways. The diketopiperazine ditryptoleucine was isolated in 
two variants with 1H-NMR shifts varying around the C-C dimeric bond, but with the same base 
structure. This unspecific dimerization is in line with previously isolated compounds. A hybrid 
between the ditryptophenaline and ditryptoleucine was isolated from an Aspergillus sp. as WIN 64745, 
with both a phenylalanine and leucine moiety, but with no N-methylation [79]. These compounds were 
tested and proved antagonistic against substance P at the NK1 receptor [82]. The oryzamides A1-2 are 
variants of the miyakamides B1-2 [71]. The exchanged phenylalanine has been substituted with leucine 
between a tryptophan and a tyrosine in the oryzamides. However this exchange of phenylalanine and 
leucine has often been found for compounds produced within the same species. Penicillium polonicum 
(= P. fructigenum) [83-85] produces both fructigenine A = puberuline = rugulosuvine A, containing 
phenylalanine and fructigenine B = verrucofortine, containing leucine. We could also detect two 
slightly later eluting compounds in the A. oryzae RIB40 extracts likely to be two further indole-enamides 
having phenylalanine incorporated instead of tyrosine as evident from LC-DAD-MS analysis (data not 
shown) as also seen for the miyakamides [71]. 
3. Experimental 
General procedures and methods for analysis are described in [43,44,86]. 
Mass spectrometric analysis was performed using a Agilent HP 1100 liquid chromatograph with a 
DAD system (Waldbronn, Germany) on a LCT oaTOF mass spectrometer (Micromass, Manchester, 
UK) with a Z-spray ESI source and a LockSpray probe. For general procedures see [87]; method 1 for 
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LC-DAD-TOF was used in this study. All solvents used were HPLC grade from Sigma-Aldrich  
(St. Louis, MO, USA). 
3.1. Fungal Material and Fermentation 
A. oryzae RIB40 (IBT28103); A. flavus NRRL3357 (IBT3696), (IBT15934), NRRL 13462;  
A. parvisclerotigenus IBT16807 and A. minisclerotigenes IBT13353 were obtained from the IBT 
Culture Collection at DTU Systems Biology, Technical University of Denmark. The RIB40 isolate 
used for isolation of 13-dehydroxypaxilline was cultured for 14 days at 25 °C in the dark on 200 Petri 
dishes with Yeast Extract Sucrose agar (YES). All strains were grown for 1 week at 25 °C on YES, 
Czapek Yeast Autolysate (CYA), Wickerhams Antibiotic Test Medium (WATM) agar [88], YESBEE [89] 
(YES+50 g Bee pollen Type III, granulate, Sigma, P-8753, pr. 1 L medium), DRYES (Dichloran rose 
Bengal chloramphenicol agar), AFPA (Aspergillus flavus, A. parasiticus agar), CYAS (CYA + 50 g 
NaCl pr. 1 L medium), CY20 (CYA + 170 g sucrose pr. 1 L), CY40 (CYA with added 370 g sucrose 
pr. 1 L medium), DUL (Dulaney’s medium for Penicillin), GAK (Potato-carrot agar), GMMS (Glucose 
minimal media (GMM) + 2% sorbitol), MEA (Malt extract agar), OAT (Oat meal agar), PDA (Potato-
dextrose agar). For medium formulations see Samson et al. [90]. 
3.2. Extraction and Isolation of Pure Compounds 
13-Desoxypaxilline. The plates were homogenized using a Stomacher and 100 mL EtOAc with 1% 
HCO2H pr. 10 plates. The extract was filtered and dried down on a freeze drier. The crude extract was 
separated on a KP-C18-HS 60 g SNAP column using a Biotage Isolera One (Biotage, Uppsala, 
Sweden), resulting in a 22 mg fraction. The fraction was segmented with a 10 g ISOL Diol column, 
using 12 steps of stepwise Heptane-dichloromethane-EtOAc-MeOH. 13-desoxypaxilline was 
predominant in a 100% EtOAc fraction (6 mg), and purified on a Waters HPLC W600/996PDA 
(Milford, MA, USA) and a RP column (Phenomenex Luna C18(2), 250 × 10 mm, 5 μm, Torrance, CA, 
USA) using a gradient of 80% MeCN (H2O–Milli-Q (Millipore, MA, USA)) to 90% over 10 min. with 
50 ppm TFA added to the solvents. The collection was concentrated on a rotary evaporator (Büchi V-855/ 
R-215, Flawil, Switzerland) and dried under N2 to yield 0.5 mg of white, amorphous 13-desoxypaxilline. 
Dideacetyl-, 14-deacetyl-, and 18-formyl parasiticolide A. From the same fermentation described for 
13-desoxypaxilline a more polar, 90 mg fraction was fractionated with a 10 g ISOL Diol column, using 
12 steps of stepwise Heptane-dichloromethane-EtOAc-MeOH. The parasiticolide A-analogues were 
predominant in a 100% EtOAc fraction (10 mg), and purified on a Waters HPLC W600/996PDA 
(Milford, MA, USA) and a RP column (Phenomenex Luna C18(2), 250 × 10 mm, 5 μm, Torrance, CA, 
USA) using a gradient of 72% MeCN (H2O–Milli-Q (Millipore, MA, USA)) to 87% over 15 min. with 
50 ppm TFA. The collection was concentrated on a rotary evaporator (Büchi V-855/R-215) and dried 
under N2 to yield 0.3, 1.0 and 0.8 mg of white, amorphous di-, 14-deactyl- and 18-formyl 
parasiticolide A, respectively. See Supplemental Material for NMR data. 
Ditryptoleucine. 400 plates of A. oryzae RIB40 were cultured on YES medium. The plates were 
homogenized using a Stomacher and 100 mL EtOAc pr. 10 plates. The extract was filtered and dried 
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down on a freeze drier. The crude extract were separated into three phases by dissolving it in 9:1 
MeOH:H2O–Milli-Q and extracted into a heptan phase and afterwards a DCM phase. The DCM phase 
was separated on a KP-C18-HS SNAP column using a Biotage Isolera One (Biotage, Uppsala, 
Sweden) using a gradient of 10% MeOH (H2O–Milli-Q (Millipore, MA, USA)) to 100% over 15 CVs 
(column volumes) resulting in a 402 mg fraction. The fraction was further separated on another  
KP-C18-HS SNAP column using a Biotage Isolera One (Biotage, Uppsala, Sweden) using a gradient 
of 10% MeOH (H2O–Milli-Q (Millipore, Ma, USA)) to 25% over 2 CVs, 25% MeOH to 50% over 8 
CVs and 50% to 100% over 4 CVs resulting in a 60.1 mg fraction. The fraction was fractionated on a 
LH-20 column using 100% MeOH. The ditryptoleucines were present in the earlier fractions and were 
purified on a Waters HPLC W600/996PDA (Milford, MA, USA) using a RP column (Phenomenex 
Luna C18(2), 250 × 10 mm, 5 μm, Torrance, CA, USA) using a gradient of 50% MeCN (H2O–Milli-Q 
(Millipore, MA, USA)) to 100% over 20 min. with 50 ppm TFA and a flow of 4 mL/min. The 
collections were concentrated on a rotary evaporator (Büchi V-855/R-215) and dried under N2 to yield 
4.0 mg of the two isomers. See Supplemental Data for NMR data. 
Oryzamides A1-2. The remaining broth from the fermentation described for ditryptoleucine was 
extracted with EtOAc + 1% HCO2H for 24 h. The extract was filtered and dried down on a freeze 
drier. The crude extract were separated into three phases by dissolving it in 9:1 MeOH:H2O–Milli-Q 
and extracted into a heptan phase and afterwards a DCM phase. The DCM phase was separated on a  
KP-C18-HS SNAP column using a Biotage Isolera One (Biotage, Uppsala, Sweden) using a gradient 
of 10% MeOH (H2O–Milli-Q (Millipore, MA, USA)) to 100% over 15 CVs (column volumes) 
resulting in a 654 mg fraction. The fraction was fractionated with a 10 g ISOL Diol column, using  
13 steps of stepwise Hexane-dichloromethane-EtOAc-MeOH. The miyakamides were predominant in 
the 40:60 DCM:EtOAc and 20:80 DCM:EtOAc fractions (43.8 mg), and purified on a Waters HPLC 
W600/996PDA (Milford, MA, USA) and a RP column (Phenomenex Luna C18(2), 250 × 10 mm, 
5μm, Torrance, CA, USA) using a gradient of 45% MeCN (H2O–Milli-Q (Millipore, MA, USA)) to 
62% over 15 min. with 50 ppm TFA. The collection was concentrated on a rotarvap (Büchi V-855/ 
R-215) and dried down under N2 to yield 4.0 and 2.0 mg of oryzamide A1 and A2, respectively. See 
Supplemental Data for NMR data. 
3.3. Marfeys Method 
100 μg of each peptide was hydrolysed with 200 μL 6 M HCl at 110 °C for 20 h. To the hydrolysis 
products (or 50 μL (2.5 μmol) solutions of standard D- and L-amino acids) was added 50 μL water,  
20 μL 1 M NaHCO3 solution and 100 μL 1% FDAA in acetone, followed by reaction at 40 °C for 1 h. 
The reaction mixture was removed from the heat, neutralized with 10 μL 2 M HCl and the solution 
was diluted with 820 μL MeOH to a total volume of 1 mL. The FDAA derivatives were analysed by 
UHPLC-DAD on a Dionex Ultimate 3000 RS DAD equipped with a Kinetex C18 column (2.6 ȝm, 
150 × 2.10mm, Phenomenex). The analyses were run with a gradient elution of MeCN/H2O–Mili-Q 
(Millipore, MA,USA) added 50 ppm TFA from 15 to 100% MeCN over 7 min (60 °C, 0.8 mL/min). 
The retention times of the FDAA derivatives were compared to retention times of the standard amino 
acid derivatives. 
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3.4. Selective Extraction of Sclerotium Metabolites 
The selective extraction of sclerotia from IBT 15934, NRRL 13462, IBT 16807 and IBT 13353 was 
made from harvested sclerotia of a 7 day old cultivation on WATM and CYA agar (25 °C in dark). 
The sclerotia were washed several times with Milli-Q (Millipore, Millford, USA) 0.22 μm H2O and 
dried. The sclerotia were transferred to a 2 mL Eppendorf tube together with three stainless steel balls 
(2 × 1 mm and 1 × 5 mm) and frozen with liquid N2 before mechanical crushed. The pulverized 
sclerotia were suspended in 1mL methanol and transferred to a 2 mL vial with 1 mL of 1:2:3 
methanol:dichloromethane:ethylacetate and left for evaporation overnight in a fume hood. The dried 
extract was resolved in 1 mL methanol in ultrasonicated for 10 min and then filtered with a 0.45 μm 
PTFE filter to a clean vial for analysis. 
3.5. HPLC-DAD-TOF Method 
Mass was measured using a Agilent HP 1100 liquid chromatograph with a DAD system 
(Waldbronn, Germany) on a LCT oaTOF mass spectrometer (Micromass, Manchester, UK) with a  
Z-spray ESI source and a LockSpray probe. For general procedures see [86], method 1. 
3.6. NMR Instrumentation 
NMR spectra were recorded on a Varian Unity Inova 500 MHz spectrometer equipped with a 5 mm 
probe using standard pulse sequences. The signals of the residual solvent protons and solvent carbons 
were used as internal references (įH 2.50 and įC 39.5 ppm for DMSO). In cases where higher field was 
needed the NMR spectra were recorded on a Bruker Avance 800-MHz spectrometer equipped with a 
5-mm TCI Cryoprobe at the Danish Instrument Center for NMR Spectroscopy of Biological 
Macromolecules. 
3.7. MS/MS Method Used for Aflatrem and Parasiticolide Screening 
Liquid chromatography was performed on an Agilent (Torrence, CA, USA) 1100 HPLC system 
coupled to a triple-quadropole mass spectrometer (Waters-Micromass, Manchester, UK) with a Z-spray 
ESI operated in positive mode source using a flow of 700 L/h nitrogen desolvated at 350 °C. The 
hexapole was held at 50 V. The system was controlled by MassLynx v4.1 (Waters-Micromass). 
Nitrogen was used as collision gas, and the MS operated in MRM mode (dwell time = 100 ms) with 
the parameters listed in Table 2. Extracts of 2 μL were injected and separated on a Phenomenex 
Gemini C6-phenyl, 3 μm, 2 × 50 mm column with a flow of 0.3 μL/min. Water contained 20 mM 
ammonium formate. Oven temperature 40 °C. Two different methods were applied to the aflatrem- and 
parasiticolide screen: Aflatrem inlet method: Linearly gradient from 50 to 100% MeCN over 5 min, 
increased to 0.5 μL/min over 1.5 min. The column was washed additionally 1.5 min with 100% MeCN at 
0.5 μL/min, followed by a return to 50% MeCN over 2.5 min and kept at this level for another 1 min 
with a linearly decrease in flow to 0.3 μL/min, prior to the next sample. Standards used for analysis of 
this pathway were from Sigma-Aldrich Aldrich (St. Louis, MO, USA). Parasiticolides: linearly gradient 
from 20 to 90% MeCN over 15 min, increased to 0.5μL/min from 90 to 100% MeCN in additional  
1 min. The column was washed from 2 min with 100% MeCN at 0.5 μL/min, followed by a return to 
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20% MeCN over 1.5 min and kept at this level for another 3.5 min with a linearly decrease in flow to  
0.3 μL/min, before the next sample. Standards were internal standards from other extracts of the known 
parasiticolide A producer A. parasiticus: IBT 4387 (= CBS 260.67) and IBT 11863 (= CBS 115.37). 
Table 2. MS/MS method including scan event, retention times, transition ions and the cone 
and collision energies used. 
Compound Scan 
event 
RT 
(min) 
Ion type Transition 
(m/z) a 
Cone 
(V) 
Collision energy 
(eV) 
Paxilline 1 4.0 Quantifier 
Qualifier 
436 ĺ 130 
436 ĺ 182 
25 
25 
30 
30 
Paspalinine 2 4.3 Quantifier 
Qualifier 
434 ĺ 130 
434 ĺ 376 
25 
25 
20 
20 
13-
desoxypaxilline 
3 4.8 Quantifier 
Qualifier 
420 ĺ 182 
420 ĺ 130 
25 
25 
30 
30 
Aflatrem 4 5.2 Quantifier 
Qualifier 
502 ĺ 198 
502 ĺ 445 
25 
25 
20 
20 
Paspaline 5 5.5 Quantifier 
Qualifier 
422 ĺ 130 
422 ĺ 275 
25 
25 
20 
20 
Dideacetyl-
parasiticolide A 
1 7.0 Quantifier 
Qualifier 
387 ĺ 217 
387 ĺ 189 
30 
30 
40 
40 
14-deacetyl 
parasiticolide A 
2 8.7 Quantifier 
Qualifier 
429 ĺ 217 
429 ĺ 189 
30 
30 
40 
40 
Parasiticolide A 3 10.4 Quantifier 
Qualifier 
488 ĺ 229 
488 ĺ 247 
30 
30 
30 
30 
a All transitions were made from [M+H]+, except for paraciticolide A: [M+NH4]+. 
4. Conclusions 
The tremorgenic 13-desoxypaxilline has been isolated from A. oryzae RIB40 and verified under 
several different growth conditions contrary to previous studies. We believe that 13-desoxypaxilline is 
the end-product of the aflatrem biosynthesis for the RIB40 strain since no aflatrem could be detected in 
any fermentation using LC-MS/MS as detection. 
The new metabolites dide- and 14-deacetyl parasiticolide A were also found as genuine products 
from the RIB40 strain and the compounds were present in multiple fermentations, however 
parasiticolide A was only detected in trace amounts using a LC-MS/MS method. This indicates a 
defective acetylation of the 14-deacetyl parasiticolide A and the small amount of parasiticolide A in 
RIB40 could be the result of spontaneous acetylation in the cell cytosol. The mono-deacetylated analogue 
detected in both A. flavus and A. oryzae had same retention times, suggesting a selective acetylation. 
The new NRPS compounds ditryptoleucine and oryzamides A1-2 appear to be natural variants of 
known A. flavus metabolites. They share the exchange of a phenylalanine for a leucine, although they 
are believed to originate from two unrelated pathways. 
Altogether, our findings contribute to understanding why the overall chemical profiles of A. oryzae 
(RIB40) and A. flavus (NRRL 3357) appear quite different since some of the end-products usually seen 
in A. flavus are apparently not reached in A. oryzae. Whether the different chemical profiles are merely 
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the result of different regulation that can be overcome by the use of epigenetic modifiers or are a result 
of genuine mutations remains to be settled. A. oryzae RIB40 is clearly a chemically potent strain, and 
as more of its chemistry is unfolded we believe that most of the biosynthetic pathways of A. flavus will 
be found to be more or less functional. Future research will reveal whether the many different  
A. oryzae strains that are used as industrial workhorses are as chemically potent as the RIB40 strain. 
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13-Desoxypaxilline 
HRESIMS: m/z = 420.2551 [M+H]+, calculated for [C27H33NO3+H]+: 420.2533. 
NMR spectra were acquired in DMSO-d6 on a Bruker Avance 800 MHz spectrometer using standard 
pulse sequences. 1H-NMR (799.30 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.88 (3H, s, H-23), 1.00 (3H, s, 
H-25), 1.16 (3H, s, H-29), 1.20 (3H, s, H-28), 1.52 (1H, ddd, J = 25.4, 12.8, 4.4 Hz, H-14a), 1.60 (1H, 
m, H-14b), 1.65 (1H, m, H-15a), 1.74 (1H, d, J = 12.2 Hz, H-15b), 1.81 (1H, ddd, J = 17.9, 13.8, 4.2 Hz, 
H-6a), 1.98 (1H, ddd, J = 13.8, 13.6, 4.2 Hz, H-5a), 2.07 (1H, m, H-5b), 2.22 (1H, m, H-6b), 2.32 (1H, 
dd, J = 12.8, 11.0 Hz, H-17a), 2.53 (1H, m, H-13), 2.62 (1H, dd, J = 12.8, 6.3 Hz, H-17b), 2.71 (1H, 
m, H-16), 3.74 (1H, d, J = 1.6 Hz, H-9), 4.34 (1H, br. s, 27-OH), 4.41 (1H, m, H-7), 5.73 (1H, s, H-11), 
6.91 (1H, dd, J = 7.6, 7.6 Hz, H-21), 6.95 (1H, dd, J = 7.6, 7.6 Hz, H-22), 7.27 (1H, d, J = 7.6 Hz,  
H-23), 7.28 (1H, d, J = 7.6 Hz, H-20), 10.76 (1H, s, N-H). 
13C-NMR (201.00, DMSO-d6, 25 °C, 39.5 ppm): 14.4 (C-25), 15.4 (C-26), 23.5 (C-15), 24.8 (C-14), 
25.5 (C-28), 25.7 (C-29), 26.7 (C-17), 29.5 (C-6), 30.7 (C-5), 41.6 (C-13), 48.5 (C-16), 49.2 (C-3), 
49.8 (C-4), 70.7 (C-27), 74.0 (C-7), 82.4 (C-9), 111.6 (C-23), 115.8 (C-18), 117.5 (C-20), 118.1 (C-21), 
119.2 (C-22), 120.7 (C-11), 124.4 (C-19), 140.2 (C-24), 150.4 (C-2), 168.6 (C-12), 196.1 (C-10). 
 
14-Deacetyl parasiticolide A 
All NMR spectra of parasiticolide A analogues were acquired in DMSO-d6 on a Varian Unity Inova 
500 MHz spectrometer with 4 mm gHX Nano probe and with a spin rate of 2 kHz for all samples, 
using standard pulse sequences. The spectra were referenced to this solvent with resonances δH = 2.50 
and δC = 39.5. 
HRESIMS: m/z = 429.1901 [M+H]+, calculated for [C24H28O7+H]+: 429.1908. 
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1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.96 (1H, td, J = 13.6, 3.7 Hz, H-3a), 1.01 (3H, 
s, H-13), 1.36 (1H, td, J = 13.3, 3.3 Hz, H-1a), 1.45 (1H, m, H-2a), 1.63 (1H, m, H-2b), 1.91 (1H, s,  
H-5), 1.97 (1H, m, H-3b), 2.08 (3H, s, H-17), 2.11 (1H, d, J = 13.2, H-1b), 2.36 (1H, d, J = 19.0 Hz, 
H-7a), 2.76 (1H, ddt, J = 19.0, 6.0, 3.1 Hz, H-7b), 3.14 (1H, d, J = 10.6, H-14a), 3.61 (1H, d, J = 10.6 Hz, 
H-14b), 4.67 (1H, d, J = 11.0 Hz, H-15a), 4.80 (1H, d, J = 11.0, H-15b), 4.96 (2H, m, H-11), 5.83 (1H, 
d, J = 6.0 Hz, H-6), 7.52 (2H, m, H-4′/6′), 7.67 (1H, tt, J = 7.3, 1.2 Hz, H-5′), 7.97 (2H, m, H-3′/7′). 
13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 17.3 (C-2), 20.6 (C-17), 28.2 (C-7), 30.7 (C-1), 
34.6 (C-3), 39.4 (C-4), 39.8 (C-10), 52.5 (C-5), 62.9 (C-14), 65.4 (C-15), 66.5 (C-6), 71.1 (C-11), 
121.2 (C-8), 128.7 (4′/6′), 129.3 (3′/7′), 129.8 (C-2′), 133.5 (5′), 165.6 (C-1′), 166.8 (C-9), 170.5 (C-16), 
173.2 (C-12). 
 
Dideacetyl parasiticolide A 
HRESIMS: m/z = 387.1817 [M+H]+, calculated for [C22H26O6+H]+: 387.1802. 
1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.91 (1H, ddd, J = 13.4, 13.4, 3.7 Hz, H-3a), 
0.99 (3H, s, H-13), 1.17 (1H, dd, J = 12.9, 3.5 Hz, H-1a), 1.42 (1H, m, H-2a), 1.65 (1H, m, H-2b), 1.81 
(1H, s, H-5), 1.97 (1H, d, J = 13.4 Hz, H-3b), 2.28 (1H, d, J = 12.9 Hz, H-1b), 2.31 (1H, d, J = 19.3 Hz, 
H-7a), 2.73 (1H, m, H-7b), 3.09 (1H, dd, J = 10.5, 5.3 Hz), 3.60 (1H, dd, J = 10.5, 5.3 Hz, H-14b), 
4.07 (1H, m, H-15a), 4.12 (1H, m, H-15b), 4.42 (1H, dd, J = 5.3, 5.3 Hz, 14-OH), 4.86 (1H, dd,  
J = 17.5, 2.0 Hz, H-11a), 5.06 (1H, dt, J = 17.5, 2.5 Hz, H-11b), 5.10 (1H, dd, J = 5.2, 5.2 Hz, 15-OH), 
5.80 (1H, d, J = 5.8 Hz, H-6), 7.55 (2H, m, H-4′/6′), 7.67 (1H, m, H-5′), 7.90 (2H, m, H-3′/7′). 
13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 17.6 (C-2), 27.3 (C-13), 28.5 (C-7), 30.5 (C-1), 
34.9 (C-3), 39.4 (C-4), 42.9 (C-10), 52.7 (C-5), 62.4 (C-15), 63.1 (C-14), 66.9 (C-6), 72.0 (C-11), 
119.5 (C-8), 128.9 (C-4′/6′), 129.0 (C-3′/7′), 129.8 (C-2′), 133.5 (C-5′), 165.7 (C-1′), 169.4 (C-9), 
173.6 (C-12). 
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18-Formyl parasiticolide A 
HRESIMS: m/z = 457.1889 [M+H]+, calculated for [C25H28O8+H]+: 457.1857. 
1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 1.10 (3H, s, H-13), 1.18 (1H, ddd, J = 13.7, 
13.7, 3.3 Hz, H-3a), 1.43 (1H, ddd, J = 13.2, 13.2, 2.9 Hz, H-1a), 1.51 (1H, m, H-2a), 1.71 (1H, m,  
H-2b), 1.82 (1H, d, J = 13.7 Hz, H-3a), 2.06 (1H, s, H-5), 2.09 (3H, s, H-17), 2.16 (1H, d, J = 13.2 Hz, 
H-1b), 2.43 (1H, d, J = 19.3 Hz, H-7a), 2.80 (1H, m, H-7b), 3.99 (1H, d, J = 11.0 Hz, H-14a), 4.36 
(1H, d, J = 11.0 Hz, H-14b), 4.71 (1H, d, J = 10.8 Hz, H-15a), 4.78 (1H, d, J = 10.8 Hz, H-15b), 4.98 
(2H, m, H-11), 5.83 (1H, d, J = 5.6 Hz, H-6), 7.52 (2H, dd, J = 7.6, 7.6 Hz, H-4′/6′), 7.68 (1H, dd,  
J = 7.6, 7.6 Hz, H-5′), 7.98 (2H, d, J = 7.6 Hz, H-3′/7′), 8.06 (1H, s, H-18). 
13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 16.9 (C-2), 20.5 (C-17), 26.6 (C-13), 27.9 (C-7), 
30.5 (C-1), 35.4 (C-3), 36.9 (C-4), 39.6 (C-10), 52.1 (C-5), 65.0 (C-14), 65.1 (C-15), 66.5 (C-6), 71.1 
(C-11), 121.0 (C-8), 128.6 (C-4′/6′), 129.0 (C-3′/7′), 129.2 (C-2′), 133.4 (C-5′), 161.6 (C-18), 165.1 (C-1′), 
165.9 (C-9), 170.1 (C-16), 172.8 (C-12). 
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Ditryptoleucine A 
HRESIMS: m/z = 625.3472 [M+H]+, calculated for [C36H44N6O4+H]+: 625.3497. 
1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.81 (6H, d, J = 6.4 Hz, H-21), 0.83 (6H, d,  
J = 6.4 Hz, H-20), 1.42 (H2, m, H-18a), 1.48 (H2, m, H-18b), 1.58 (H2, m, H-19), 2.44 (H4, m, H-11), 
2.80 (H6, s, H-17), 3.76 (H2, dd, J = 10.4, 3.8 Hz, H-12), 3.81 (H2, dd, J = 7.9, 6.0 Hz, H-15), 5.09 
(H2, m, H-2), 6.61 (H2, d, J = 7.8, H-5), 6.66 (H2, t, J = 7.5, H-7), 6.68 (H2, s, H-3), 7.05 (H2, t, 7.8, 
H-6), 7.23 (H2, d, J = 7.8, H-8). 
13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 21.9 (C-20), 22.6 (C-21), 23.7 (C-19), 31.8 (C-17), 
36.1 (C-11), 39.4 (C-18), 56.7 (C-12), 57.9 (C-10), 61.6 (C-15), 76.7 (C-2), 108.7 (C-5), 117.2 (C-7), 
124.6 (C-8), 126.7 (C-9), 129.0 (C-6), 150.9 (C-4), 165.0 (C-16), 166.1 (C-13). 
Ditryptoleucine B 
1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.81 (6H, d, J = 6.1 Hz, H-21), 0.83 (6H, d,  
J = 6.2 Hz, H-20), 1.42 (H2, m, H-18), 1.49 (H2, m, H-19), 2.45 (H2, dd, J = 13.5, 4.7, H-11a), 2.75 
(H6, s, H-17), 3.13 (H2, m, H-11b), 3.33 (H2, s, H-2), 3.82 (H2, t, J = 6.9 Hz, H-15), 4.23 (H2, m,  
H-12), 6.58 (H2, d, J = 7.5, H-5), 6.65 (H2, t, J = 7.1, H-7), 6.70 (H2, s, H-3), 7.01 (H2, t, 7.2, H-6), 
7.37 (H2, d, J = 7.1, H-8). 
13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 21.5 (C-21), 22.5 (C-20), 23.6 (C-19), 31.6 (C-17), 
37.0 (C-11), 38.0 (C-18), 55.3 (C-12), 60.8 (C-10), 61.7 (C-15), 76.3 (C-2), 108.5 (C-5), 117.4 (C-7), 
124.0 (C-8), 130.2 (C-9), 128.3 (C-6), 149.6 (C-4) 166.9 (C-16), 166.6 (C-13). 
 
Oryzamide A1 
HRESIMS: m/z = 491.26526 [M+H]+, calculated for [C28H34 N4O4+H]+: 491.26525. 
1H-NMR (499.87 MHz, DMSO-d6, 25 °C, 2.50 ppm): 0.83 (3H, d, J = 6.5 Hz, H-5′), 0.88 (3H, d,  
J = 6.6 J, H-5′), 1.36 (1H, m, H-4′), 1.59 (2H, m, H-3′), 1.77 (3H, s, H-2′′′), 2.67 (1H, m, H-3′′), 2.83 
(1H, m, H-3′′), 2.87 (3H, s, N-CH), 4.76 (1H, m, H-2′′), 5.02 (1H, m, H-2′), 6.47 (1H, d, J = 14.8,  
H-2), 6.61 (2H, d, J = 8.4 Hz, H-6′′/8′′), 7.01 (2H, d, J = 8.4 Hz, H-5′′/9′′), 7.05 (1H, m, H-8), 7.10 
164
Metabolites 2012, 2        
 
 
5 
(1H, m, H-7), 7.26 (1H, m, H-1), 7.36 (1H, m, H-6), 7.41 (1H, s, H-4), 7.62 (1H, d, J = 7.9 Hz, H-9), 
8.24 (1H, d, J = 8.0 Hz, 2′′-NH), 9.16 (1H, s, 7′′-OH), 9.84 (1H, d, J = 9.8 Hz, 1-NH), 11.11 (1H, s, 4-NH). 
13C-NMR (125.70 MHz, DMSO-d6, 25 °C, 39.5 ppm): 21.6 (C-5′), 22.0 (C-2′′′), 22.7 (C-5′), 24.1 (C-4′), 
30.9 (C-N), 36.2 (C-3′′), 36.9 (C-3′), 50.5 (C-2′′), 54.2 (C-2′), 106.4 (C-2), 111.4 (C-3), 111.5 (C-6),114.6 
(C-6′′/8′′), 118.5 (C-9), 118.8 (C-8), 119.2 (C-1), 121.1 (C-7), 123.1 (C-4), 125.0 (C-10), 127.4 (C-4′′), 
129.7 (C-5′′/9′′), 136.9 (C-5), 156.0 (C-7′′), 167.7 (C-1′), 168.8 (C-1′′′), 172.3 (C-1′′). 
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Isolation and NMR Characterization of Fumonisin B2 and a
New Fumonisin B6 from Aspergillus niger
MARIA MA˚NSSON,† MARIE LOUISE KLEJNSTRUP,† RICHARD K. PHIPPS,†
KRISTIAN F. NIELSEN,† JENS C. FRISVAD,† CHARLOTTE H. GOTFREDSEN,‡ AND
THOMAS O. LARSEN*,†
†Department of Systems Biology, Center for Microbial Biotechnology, Technical University of Denmark,
Building 221, DK-2800 Kgs. Lyngby, Denmark and ‡Department of Chemistry, Kemitorvet,
Technical University of Denmark, Build. 201, DK 2800 Kgs. Lyngby, Denmark
A new fumonisin, fumonisin B6 (1), has been isolated by cation-exchange and reverse-phase
chromatography, together with fumonisin B2 (2), from stationary cultures of the fungus Aspergillus
niger NRRL 326. Analysis of mass spectrometric and NMR data determined that FB6 is a positional
isomer of FB1 and iso-FB1, having hydroxyl functions at C3, C4, and C5. Analysis of the NMR data
for FB2 showed very similar chemical shift values when compared to an authentic Fusarium FB2
standard, strongly indicating identical molecules despite that an absolute stereochemical assign-
ment of FB2 from A. niger was not possible.
KEYWORDS: Fumonisins; Aspergillus niger; mycotoxins; food safety; NMR
INTRODUCTION
Recently, our group was the first to report the production of
the mycotoxin fumonisin B2 (FB2) fromAspergillus nigerNRRL
3122, using HPLC-MS (1). The finding did not come as a great
surprise, since others (2,3) had already reported a fumonisin-like
gene cluster in the A. niger genome of two different strains of the
species. Later, we also reported FB4 from A. niger, generally
produced in amounts around 10-25% of the FB2 (4, 5). Until
these findings, fumonisin production has only been previously
reported in certain species within the Gibberella fujikuroi and
Fusarium oxysporum species complexes, which are common
fungal contaminants of maize-based foods and feeds (6-9).
The first fumonisins were described byGelderblom et al. (9) from
cultures of F. verticillioides. Since then, more than 25 fumonisins
have been identified by NMR (6) and a further 25 have been
putatively identified by LC-MSn (10). The most abundant and
most toxic fumonisins are the B-series analogues (11-13), which
contain a terminal 2-amino-3-hydroxy motif on an eicosane
backbone and two hydroxy groups esterified with tricarboxylic
acids (TCA). In most Fusaria, FB1 is predominant, usually
representing some 70% of the total fumonisin content. FB2 and
FB3 usually account for up to 15-25% and 3-8%, respectively,
while FB4 is normally present in insignificant amounts (14-16).
The recent documentation of fumonisin B-series production by
A. niger has raised the question of whether fumonisins might be
an overlooked health risk due to the ubiquitous presence of A.
nigeronawide range of food stuffs not usually contaminatedwith
Fusarium species (17). This includes grapes and thereby raisins
and wine, peanuts, coffee, tea, and several other products (1).
Moreover, one could be concerned that industrial products such
as enzymes and fine chemicals could be contaminated with traces
of fumonisins because of the wide application of A. niger as
“workhorse” in industrial fermentations (18-21).
Our recent LC-HRMS based investigations of fumonisin
production by A. niger and other black Aspergilli suggested that
besides FB2 andFB4A. niger can also produce an additional third
fumonisin with the same elementel composition as FB1 and iso-
FB1 but with a different retention time than the two latter
compounds. The present study reports the isolation and char-
acterization of this novel compound, which we named fumonisin
B6. In addition, we isolated and characterized FB2 from A. niger
by NMR in order to further validate that FB2 from A. niger is
indeed identical to that of FB2 previously reported from several
Fusarium species.
MATERIALS AND METHODS
Fungal Incubation. In a 10 L glass vessel, 2 L of still culture of 55%
ricemeal and 45%corn steep liquor (RC)mediumwas prepared according
to Bullermann (22) but with a reduced amount of agar (1.5 g/L). It was
inoculatedwith a spore suspension from7 d old ex-type cultures ofA. niger
NRRL 326, ex-tannin-gallic acid fermentation (=IBT 27876 = ATCC
16888=CBS 554.65) fromCYA. After incubation for 14 d in darkness at
25 C, the mycelia and media were homogenized with 2 L of MeCN/H2O
(50/50, v/v) and shaken overnight. After filtration the extract was
concentrated on a rotary evaporator and freeze-dried.
Preparative Chromatography. The raw extract, 9.3 g, was initially
subjected to flash chromatography on a 135 g, 50 μm C18 material
(Phenomenex, Torrance, CA) which was eluted with H2O-MeOH
mixtures in steps of 10%, starting from 10% MeOH. The 70% MeOH
fraction (163mg) was further enriched for fumonisins on a 1000mg, 33 μm
Strata X-C mixed-mode RP-cation-exchange material (Phenomenex),
which was washed with MeCN and eluted with MeCN-H2O
(containing 4% NH4OH) in steps of 20% from 4% NH4OH. The
fumonisin-containing fraction (20%MeCN, 19mg), was finally subjected
*To whom correspondence should be addressed. Phone: þ4525
2632. Fax: þ45 4588 4148. E-mail: tol@bio.dtu.dk.
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to RP separation on a 250 mm  10 mm i.d., 5 μm Luna C18 (II) column
(Phenomenex) using anMeCN-H2O gradient (starting at 30%MeCNþ
50 ppm TFA increasing to 70% over 15 min). Fractions were collected
automatically every 20 s and pooled for each chromatographic run after
analysis of the content of each fraction by LC-MS had shown which
fractions contained fumonisin B6 (1.8 mg) and fumonisin B2 (4.2 mg).
Analytical LC-MS. LC-DAD-HRMSwas performed as described
by Frisvad et al. (1) or by LC-tandemMS (MS/MS) on an Agilent 1100
liquid chromatograph (Waldbronn, Germany) coupled to a Quattro
Ultima triple mass spectrometer (Micromass, Manchester, U.K.) with
an ESI source. The separation was performed on a 50 mm  2 mm i.d.,
3 μmGemini C6-phenyl (Phenomenex) column fitted with a security guard
systemusing a linear gradient starting from20%MeCN inH2O (bothwith
20mM formic acid) to 55%MeCN for 6 min at a flow rate of 300 μL/min.
MS/MS was performed using nitrogen as collision gas and making
daughter ion scans of the protonated molecular ions (m/z 722 and 706),
using fragmentation potentials from 15 to 50 V. Solvents were HPLC
grade, and all other chemicals were analytical grade unless otherwise
stated. Fumonisin standards (FB1 and FB2 mixture 50 μg/mL) used for
MS analysis were acquired from Biopure (Tulln, Austria). FB3 was from
Chiron (Trondheim, Norway). FB2 used for NMR analysis was from
Alexis Biochemicals (Lausen, Switzerland).
NMR Spectroscopy. NMR spectra were recorded on a Bruker
Avance 800MHz spectrometer with a 5 mmTCI cryoprobe at the Danish
Instrument Center for NMRSpectroscopy of BiologicalMacromolecules.
The 2D DQF-COSY, NOESY, gHSQC, gH2BC, and gHMBC spectra
were acquired using standard pulse sequences. TheNMRdata used for the
structural assignmentof the fumonisinswereacquired inCD3OD(δH3.31ppm
and δC 49.15 ppm).
RESULTS AND DISCUSSION
In the current study, the ex-type culture ofA. nigerwas used, as
it has been found to be a strong producer strain of fumonisins (1).
With no published protocols for purification of fumonisins from
A. niger, we chose to use mixed-mode RP cation-exchange for
purification. This was done because A. niger produces high
amounts of acidic naphtho-γ-pyrones and organic acids, which
would likely also bind to a strong anion-exchanger (SAX), which
is the usual way to purify fumonisins (23).
Analytical LC-MS was used to compare the retention times
and daughter-ion spectra of the purified A. niger fumonisin
analogues to those of authentic standards of FB1, FB2, and
FB3. The daughter-ion spectra of the FB2 standard and FB2
from A. niger, eluting at the same time, were identical and
consistent with previously reported ESI-MS/MS data (24-26),
with losses of H2O and TCA groups from the alkyl backbone
dominating the spectra. This confirmed the presence of FB2 or an
isomer thereof in the A. niger extract. LC-HRMS analyses also
showed a peak with the same elemental composition as FB1,
however, eluting slightly later (Figure 1). LC-MS/MS also
confirmed this and showed that it eluted 0.6 min after the
authentic standard of FB1 and 0.15 min before FB2 on the C6-
phenyl column. Significant differences in the daughter-ion spectra
clearly showed that A. niger produces an FB1 analogue and not
FB1 (Figure 1). The same was observed in the crude A. niger
extract; thus, the FB1 analogue was not an artifact of the
purification process but proved to be the novel analogue fumo-
nisin B6 (FB6). FB6 displayed significantly less abundant losses of
H2O than FB1, which indicates the presence of adjacent hydroxyl
groups blocking the hydrogens from detaching, thereby allowing
the H2O loss. This is in agreement with our previous findings
during our studies of the fragmentation patterns of 474 microbial
metabolites using LC-MS ESIþ and ESI- MS (27), where we
have never observedH2O losses unless a β-hydrogen could be lost
because of double bond formation.
NMR Based Structural Investigations. To further validate that
the FB2 purified from A. niger is identical to that produced by
Fusarium, 1D and 2D homo- and heteronuclear NMR spectra of
the purified A. niger fumonisin FB2 were carefully inspected and
compared to those of an authentic standard of FB2. The NMR
data obtained in methanol-d4 displayed comparable chemical
shifts for the 34 expected 13C NMR chemical shift values except
for the resonances originating from the two TCA side chains and
their sites of attachment to the fumonisin backbone. In this
region, deviations in the 13C NMR chemical shifts of between
-1.8 to þ0.3 ppm were observed. These results could be
explained by a difference in the structural fold of the FB2 between
the two samples, likely to be caused by differences in pH and
thereby overall level of protonation of the four carboxylic acid
functionalities. The fact that FB2 does have a unique globular
Figure 1. Daughter-ion chromatogram (m/z 722) showing FB6 (4.57 min) and FB1 (retention time = 3.97 min) and the corresponding daughter-ion spectra
(25 eV) from the compound produced by A. niger (FB6) sample (A) and an authentic FB1 standard (B).
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folded structure has previously been addressed by Beier and
Stanker (28). In order to ensure that the two samples had been
subjected to the same purification protocol, the standard FB2
sample was run over a cation exchange column, in the same way
as the last purification step for the isolated A. niger FB2 sample.
This proved to be very important, since the spectra obtained for
FB2 from Fusarium after this procedure were now identical to
those from A. niger FB2, confirming that only minor changes in
the sample preparation (e.g., pH) can have a large effect on the
structural fold of the fumonisin molecules and thereby spectro-
scopic output. Comparisons of the J coupling constants for the
protons in the amino terminal part of the FB2 (C2-C5) and the
attactments of the TCA side chains (C14 and C15), fromA. niger
and Fusarium, showed that they are of the same size, proving that
the relative stereochemistry for these parts of the FB2 backbone is
the same for Aspergillus and Fusarium. On the other hand the
stereochemistry at positions C12 and C16 could not be elucidated
on the basis of the data available because of chemical shift
overlaps. The optical rotation of FB2 from A. niger ([R]D20
-11.36 (c 1 mg/mL, MeOH)) was similar to that known from
Fusarium; however, with several stereocenters in themolecule this
is not a direct proof of identical stereochemistry for FB2 originat-
ing from the two different genera.
Altogether, the presented data point toward identical stereo-
chemistry of the two FB2 molecules; however, a genetic compar-
ison of the fumonisin gene cluster in the two different genera
revealed several differences in the placement and orientation of
the different involved synthase genes (2). This could lead to
structural differences in the polyketide synthases and thereby
the final stereochemistry of fumonisins produced by A. niger,
Table 1. NMR Data for Fumonisin B6, B1, and Iso-B1
fumonisin B6 fumonisin B1 (16) fumonisin iso-B1 (29)
ID H (ppm) C (ppm) HMBCc H2BCc H (ppm) C (ppm) H (ppm) C (ppm)
1 1.34 (d, 7.0) 16.3 2, 3 2 1.27 (d, 6.7) 16.0 1.30 (d, 6.8) 14.2
2 3.67 (qd, 2.0, 7.0) 50.0 1, 3 1 3.14 (dq, 6.7, 6.8) 53.7 3.43 (dq, 4.3) 51.8
3 3.64 (dd, 2.0, 7.1) 71.8 1, 4 3.74 (ddd, 9.6, 6.8, 3.2) 70.3 3.55 (dd, 4.0) 73.2
4 3.46 (dd, 1.8, 7.1) 74.9 2, 5 1.55 (m) 41.7 3.65 (m) 72.2
5 3.71 (ddd, 1.8, 5.1, 8) 71.4 3.84 (m) 68.4 1.45 34.2
1.55
6 1.53 (m) 34.8 1.40-1.60 39.1 1.34 (br m) 30.6
1.59 (m)
7b 1.26-1.37 30.6 4, 8 1.30-1.50 26.6 1.38 26.3
1.54
8b 1.26-1.37 30.6 1.30-1.50 26.7 1.32 26.5
1.52
9b 1.26-1.37 30.6 10 1.40-1.60 39.0 1.4 38.9
10 1.25 27.5 9 3.62 (m) 69.8 3.62 (m) 70.0
11 1.04 (m) 36.1 1.15 (m) 44.6 1.08 44.5
1.40 (m) 1.45 (m) 1.5
12 1.50 (m) 29.9 15 21 1.81 (m) 26.9 1.83 (m) 27.0
13 1.43 (m) 36.1 14, 16, 21 12 1.55 (m) 36.6 1.45 37.0
1.62 (m) 14 1.70 (m) 1.66
14 5.18 (ddd,∼3, ∼4, 10.9)a 72.8 5.16 (ddd, 10.8, 3.7, 2.4) 72.8 5.16 (ddd, 11, 3, 4) 72.7
15 4.92 (dd, 3.5, 8.3) 78.7 13, 14, 16, 17, 22, 29 4.94 (dd, 8.1, 3.7) 78.7 4.94 (dd, 4, 8) 78.9
16 1.70 (m) 34.7 15 15, 22 1.70 (m) 34.8 1.70 (m) 34.9
17 1.09 (m) 32.9 16, 22 1.07 (m) 32.9 1.08 32.9
1.44 (m) 1.44(m) 1.43
18 1.18 (m) 29.5 1.18 (m) 29.5 1.18 29.8
1.13 (m) 1.33 (m) 1.33
19 1.31 (m) 23.7 17, 20 20 1.10 (m) 23.9 1.22 23.9
1.26 (m) 1.40 (m) 1.38
20 0.89 (t, 7.0) 14.2 18, 19 0.89 (t, 7.1) 14.4 0.89 (t, 7) 14.4
21 0.92 (d, 6.7) 20.8 12, 13 12 0.96 (d, 6.7) 20.8 0.96 (d, 6.7) 20.8
22 0.94 (d, 6.9) 15.7 14, 16 16 0.94 (d, 6.8) 16.0 0.93 (d, 6.8) 16.1
23 172.9 173.5 173.5
24 2.51 (dd, 6.7, 17.0) 36.3 23, 25, 26, 28 2.45 (dd, 16.7, 7.4) 37.1 2.45 37.3
2.72 (dd, 7.2, 17.0) 25, 26, 27 2.71 (dd, 16.7, 7.4) 2.71
25 3.15 (m) 38.7 23, 24, 28 3.10-3.20 (m) 39.6 3.14 39.7
26 2.55 (dd, 5.9, 17.0) 36.3 24, 25, 27 2.50 (dd, 16.5, 5.2) 37.8 2.48 38.0
2.68 (dd, 7.5, 16.8) 25, 27 2.66 (dd, 16.5, 8.3) 2.64
27 175.4 177.4 177.2
28 177.1 178.5 178.7
29 172.9 173.0 173.2
30 2.64 (dd, 6.3, 16.7) 36.3 29, 31, 32, 34 2.60 (dd, 16.6, 6.4) 36.9 2.59 37.0
2.80 (dd, 7.2, 16.9) 29, 31, 32, 34 2.79 (dd, 16.6, 7.2) 2.79
31 3.16 (m) 38.7 29, 30, 34 3.10-3.20 (m) 39.7 3.14 39.6
32 2.58 (dd, 6.2, 16.9) 36.1 30, 31, 33 2.52 (dd, 16.5, 6.0) 37.5 2.51 37.7
2.74 (dd, 7.2, 16.9) 31, 33 2.72 (16.5, 7.5) 2.7
33 175.2 177.0 176.7
34 176.8 178.0 178.2
aOnly approximate J coupling constants (in Hz) due to overlap in the region. bAmbigous assignment due to total overlap in the region. cHMBC and H2BC connectivities are
from the assigned proton to the indicated carbon atom(s).
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which is why we conclude that further structural studies such as
X-ray analysis need to be performed to establish the absolute
stereochemistry of FB2 from A. niger.
NMR studies of FB6 substantiated theMS analyses, indicating
a new fumonisin of the B type. Unambiguous assignments of the
proton and carbon resonances of FB6 could be obtained for most
of the resonances. However, spectral overlap hampered some
specific assignments in the alkane-like part of the molecule. The
assignment was compared to literature values for fumonisins
(16,29). A series of 2DDQF-COSY, HSQC, HMBC, andH2BC
experiments established partial assignment of the backbone as
well as the TCA side chains present in the structure. Thirty-four
carbon resonances could be identified comprising four CH3
groups, 14 CH2 groups, 10 CH groups, and 6 carboxyl carbon
resonances (Table 1). The two TCA side chains bound to
the backbone structure could be assigned as two separate
spin systems C23-C28 and C29-C34 (Figure 2) with only minor
differences in their chemical shifts. The attachment of the
C29-C34 TCA side chain to the backbone structure could be
confirmed by the presence of an HMBC correlation between
H15 and C29, whereas the position of the C23-C28 TCA side
chain is based on the chemical shift of H14/C14 and comparison
with the assignment obtained for FB1 and iso-FB1.Unambiguous
assignments of the fragments C1-C6 and C10-C20 were
obtained. In Table 1, a comparison of the chemical shifts of
FB6 to FB1 and iso-FB1 can be seen. Comparing the resonance
assignment of FB6 to FB1 and iso-FB1 showed only minor
deviations between the structures except at the positions of OH
attachment in the backbone structure. Where FB1 and iso-FB1
have OH groups attached to C3, C5, and C10 and to C3, C4,
and C10, respectively, the new fumonisin FB6 has OH groups at
C3, C4, and C5 (Figure 2). The chemical shift values of 1.25 ppm
for H10 and 27.5 ppm for C10, DQF-COSY connectivities from
H 11 to H 10 and HMBC correlations fromH 9 to C10 and from
H 10 to C9, confirm that no OH group is bound at this position
due to the large upfield shift of the resonances when compared
to FB1, where H 10 and C10 resonate at 3.62 and 69.8 ppm,
respectively. In the amino terminal portion of the backbone
structure, DQF-COSY connectivities can be traced along the
chain fromH3 at 3.64 ppm, H4 at 3.46 ppm, and H5 at 3.71 ppm
to H6 at 1.53/1.59 ppm. In addition, HMBC correlations can
be seen from H4 to C2/C5 and from H3 to C4, confirming the
presence of the third OH group at C4 in the structure. The
chemical shift obtained for H4/C4 of 3.46 ppm/74.9 ppm
compared to 3.65 ppm/72.2 ppm as seen in iso-FB1 and equiva-
lently for H5/C5 of 3.71 ppm/71.4 ppm compared to 3.84 ppm/
68.4 ppm for FB1 is in agreement with the proposed structure
for FB6.
Altogether, the analysis of these data proves FB6, with hydro-
xyl functionalities at C3, C4, and C5, to be a structural isomer of
FB1 and iso-FB1. As can be seen inFigure 2FB6 and iso-FB1 have
a hydroxyl at C4, which is rare for the B-series fumonisins and
only previously seen for iso-FB1 (29). As is the case for FB2, the
absolute stereochemistry ofFB6 still needs to be resolved, which is
work that is ongoing in our laboratory. Analysis of several A.
niger strains in our laboratory (results not shown) has shown that
the frequencies of production of fumonisins inA. niger on average
are 100% (FB2), 10-25% (FB4), and 5-10% (FB6). Testing of
the toxicological properties of not onlyFB2 andFB6 but alsoFB4,
including investigations of the different conformations that we
have seen for these A. niger fumonisins, is also in progress in our
laboratory.
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Abstract
Fungi possess an advanced secondary metabolism that is regulated and coordi-
nated in a complex manner depending on environmental challenges. To under-
stand this complexity, a holistic approach is necessary. We initiated such an
analysis in the important model fungus Aspergillus nidulans by systematically
deleting all 32 individual genes encoding polyketide synthases. Wild-type and all
mutant strains were challenged on different complex media to provoke induction
of the secondary metabolism. Screening of the mutant library revealed direct
genetic links to two austinol meroterpenoids and expanded the current under-
standing of the biosynthetic pathways leading to arugosins and violaceols. We
expect that the library will be an important resource towards a systemic under-
standing of polyketide production in A. nidulans.
Introduction
It is well known that ﬁlamentous fungi produce a large
number of bioactive secondary metabolites (Be´rdy, 2005;
Cox, 2007; Newman & Cragg, 2007). Polyketide (PK)
compounds constitute a major part of these metabolites
and have long been recognized as a valuable source of
diverse natural compounds of medical importance, for
example lovastatin (cholesterol lowering) (Lai et al., 2005),
griseofulvin (antibiotic) (Chooi et al., 2010) and myco-
phenolic acid (immunosuppressant) (Bentley, 2000). How-
ever, polyketides also include many toxic compounds that
pose a serious threat to human health, for example patulin,
ochratoxins, fumonisins and aﬂatoxin (Frisvad et al., 2004;
Ma˚nsson et al., 2010). Polyketides are biosynthesized by
large multidomain polyketide synthases (PKSs), which be-
sides acyl transferase, b-ketoacyl synthase and acyl carrier
domains may also contain keto reductase, dehydratase,
cyclization and methyl-transferase domains (Cox, 2007;
Smith & Tsai, 2007; Hertweck, 2009). In fungi, the different
catalytic activities often work in an iterative manner (fungal
type I) and it is generally difﬁcult to predict the exact
product formed by a given PKS from its sequence alone
(Keller et al., 2005). Product prediction is further compli-
cated by the fact that the resulting polyketide structure may
be decorated by tailoring enzymes. Such genes are often
physically associated with the PKS gene in a gene cluster
allowing for coordinated regulation (Schu¨mann & Hert-
weck, 2006). The fact that natural products may be of mixed
biosynthetic origin, combining elements such as polyketides
with terpenes (meroterpenoids) and/or nonribosomal pep-
tide units, adds to the complexity (Chang et al., 2009; Geris
& Simpson, 2009; Hertweck, 2009; Scherlach et al., 2010).
As a consequence of their bioactivity, societal importance
and also the prospect of reprogramming the biosynthetic
machinery for drug development (Cox, 2007), there is
tremendous interest in the discovery and understanding of
fungal polyketide biosynthesis. The availability of full gen-
ome sequences of a number of ﬁlamentous fungi has
provided a means to address the discovery of polyketides
because the PKS genes are large and contain several con-
served protein domains. Importantly, analysis of the
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genomic sequences from ﬁlamentous fungi (including Asper-
gillus nidulans, teleomorph, Emericella nidulans) predict num-
bers of individual PKS genes that exceeds signiﬁcantly the
number of polyketides that these fungi are known to produce
(Galagan et al., 2005). In fact, the genome of A. nidulans
(Galagan et al., 2005) appears to contain as many as 32
individual PKS genes (Nierman et al., 2005; Szewczyk et al.,
2008; von Do¨hren, 2009), but until now only nine genes have
been linked to eight polyketides (Yamazaki & Maebayas, 1982;
Bergmann et al., 2007; Chiang et al., 2008; Szewczyk et al.,
2008; Bok et al., 2009; Chiang et al., 2009; Schroeckh et al.,
2009) (see Supporting Information, Fig. S1). This may reﬂect
that many polyketides are either produced in small amounts,
under special conditions, or in developmental stages that are
rarely observed under laboratory conditions.
Towards a more complete genetic mapping of the second-
ary metabolism in A. nidulans, we ﬁrst cultivated a reference
strain on an array of different growth media to uncover
polyketides that were not previously linked to a gene cluster.
This analysis revealed several compounds, including austinols,
violaceols, arugosins and prenylated xanthones. Next, genetic
links to these compounds were established by constructing
and screening an A. nidulans mutant library containing
individual deletions of 32 putative PKS genes.
Materials and methods
Strains
The A. nidulans strain IBT29539 (argB2, pyrG89, veA1,
nkuAD) (Nielsen et al., 2008) was used as the reference
strain and for deletion-strain constructions. Escherichia coli
strain DH5a was used for cloning.
Media
Fungal minimal medium (MM) was as described in Cove
(1966), but with 1% glucose, 10mM NaNO3 and 2% agar.
Medium for alcA promoter induction consisted of MM
supplemented with 100mM L-threonine and 100mM glycerol
as carbon source instead of 1% glucose. Polyketide screening
media variants CYA, CYAs, YES and RTwere prepared as per
Frisvad & Samson (2004). CY20 medium consisted of CYA
with 170 g sucrose; RTO contained RT with 30g organic oat
meal; and YE was made as YES but without sucrose. All media
variants were supplemented with 10mM uridine, 10mM
uracil and/or 4mM L-arginine where appropriate.
Construction of A. nidulans gene deletion
library
Individual PKS gene deletions were carried out as described
previously (Nielsen et al., 2006), except that the targeting
fragments were assembled using Gateway technology (Hartley
et al., 2000) (see Table S1 for PCR oligonucleotide and
Fig. S2 for an overview of the procedure). The A. nidulans
transformants were streak puriﬁed and rigorously screened
through three complementing diagnostic PCRs. Subse-
quently, the Aspergillus fumigatus pyrG marker was elimi-
nated from all strains by selecting on 5-ﬂuoroorotic acid
medium before ﬁnal veriﬁcation by two additional comple-
menting diagnostic PCRs (see Fig. S3 and Table S2). All
strains have been deposited in the IBT strain collection,
DTU, (http://www.fbd.dtu.dk/straincollection/).
Construction of the ausA-S1660A strain
The amino acid substitution of serine to alanine, S1660A, in
ausA (AN8383) was created by USER fusion (Geu-Flores
et al., 2007) according to the method described by Hansen
et al. (2011). The allele was transferred to IBT29539 and the
pyrGmarker was eliminated by direct repeat recombination,
creating strain IBT31032 containing only the desired point
mutation. The strain was veriﬁed to contain the ausA-
S1660A allele by sequencing (StarSEQ, Germany). See Table
S3 for primer details.
Ectopic integration of ausA into IS1
The gene, ausA, was PCR ampliﬁed by USER fusion (Geu-
Flores et al., 2007) and inserted into both pU1111-1 and
pU1211-1 (Hansen et al., 2011) creating pDH23 (gpdA
promoter) and pDH24 (alcA promoter), respectively. For both
plasmids, the gene-targeting substrate was excised by NotI
digestion and transformed into IBT28738 using A. nidulans
argB as a selectable marker. Transformants were streak puriﬁed
and veriﬁed for correct integration into the IS1 site (Hansen
et al., 2011) by two complementing diagnostic PCRs.
Chemical analysis of the mutants
Strains were inoculated as three point stabs on solid media
and incubated for 7 days at 37 1C in the dark. Metabolite
extraction was performed according to the micro extraction
procedure (Smedsgaard, 1997). Extracts were analyzed by two
methods: (1) Ultra-high performance liquid chromatography-
diode array detection (UHPLC-DAD) analyses using a Dionex
RSLC Ultimate 3000 (Dionex, Sunnyvale, CA) equipped with
a diode-array detector. Separation of 1mL extract was obtained
on a Kinetex C18 column (150 2.1mm, 2.6mm; Phenomen-
ex, Torrence, CA) at 60 1C using a linear water–acetonitrile
gradient starting from 15% CH3CN to 100% (50ppm
triﬂuoroacetic acid) over 7min at a ﬂow rate of 0.8mLmin1.
(2) Exact mass, HPLC-DAD-HRMS, was performed on a
5 cm 3mm, Luna C18(2) column (Phenomenex) using a
water–acetonitrile gradient from 15% CH3CN to 100% over
20min (20mM formic acid). LC-DAD-MS analysis was
performed on a LCT oaTOF mass spectrometer (Micromass,
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Manchester, UK) as in Nielsen & Smedsgaard (2003) and
Nielsen et al. (2009).
Isolation and structure elucidation of secondary
metabolites
3,5-Dimethylorsellinic acid and dehydroaustinol were pur-
iﬁed from large-scale ethyl acetate extracts prepared from
100 MM agar plates after 4 days’ cultivation in darkness at
37 1C. The compounds were puriﬁed using a 10 250mm
Phenomenex pentaﬂuorophenyl column (5mm particles)
with a water–acetonitrile gradient from 15% to 100%
CH3CN in 20min using a ﬂow of 5mLmin
1. Arugosin A
was isolated from an ethyl acetate extract of the reference
strain grown on 200 CYAs agar plates using a Waters
19 300mm C18 Delta Pak column (15 mm particles),
gradient from 80% to 90% CH3CN in 10min, and a ﬂow of
30mLmin1. The NMR spectra were acquired on a Varian
Unity Inova 500MHz spectrometer using standard pulse
sequences. Additional details about the compound identiﬁ-
cation can be found in the supporting information.
Results and discussion
Selecting media that support secondary
metabolite production in A. nidulans
The principle of using different media and/or incubation
conditions for fungal secondary metabolite production has
often been promoted (Oxford et al., 1935; Davis et al., 1966;
Pitt et al., 1983; Bode et al., 2002; Scherlach & Hertweck,
2006). Based on our previous experiences (Frisvad, 1981;
Frisvad & Filtenborg, 1983; Filtenborg et al., 1990; Frisvad
et al., 2007), eight different media, CYA, CYAs, CY20, MM,
RT, RTO, YE and YES, were initially selected for the analysis
(Fig. 1a). HPLC analyses revealed a large number of different
secondary metabolites produced by the A. nidulans reference
strain on CYA, CYAs, CY20, RT, RTO and YES (Fig. 1b) and
these metabolites served as a source for further investigation.
Fig. 1. (a) The appearance of the Aspergillus nidulans reference strain, IBT29539, cultivated on different media. (b) UV-chromatograms (210 nm) of
extracts of the reference strain provides an excellent demonstration of the profound effect different media compositions have on production of
secondary metabolites. From the bottom: minimal media (MM), yeast extract (YE), Raulin-Thom oatmeal (RTO), yeast extract sucrose (YES), Czapek
yeast salt (CY20), Raulin-Thom (RT), Czapek yeast agar salt (CYAs), and Czapek yeast agar (CYA). The metabolite proﬁles on MM and YE media were
considered to be redundant and these two media were therefore not used for further screening. Numbers above peaks correspond to compound
identity as follows: monodictyphenone (1), orsellinic acid (2), sterigmatocystin (4), arugosin A (5), arugosin H (6), 2-o-dihydroxyemodin (7), o-
hydroxyemodin (8), emodin (9), emericellin (10), shamixanthone (11), epi-shamixanthone (12), violaceol I (13), violaceol II (14), lecanoric acid (15),
F9775A (16), F9775B (17), austinol (18) and dehydroaustinol (19).
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Construction and initial characterization of a
genome-wide PKS gene deletion library
To investigate whether any of the compounds observed in
Fig. 1 could be genetically linked to a PKS gene, we decided
to take a global approach and individually deleted all 32
(putative and known) PKS genes in the A. nidulans genome
(see Fig. S4), as deﬁned from the annotation of the genome
databases at the Broad Institute of Harvard and MITand the
Aspergillus Genome Database at Stanford (Arnaud et al.,
2010). All genes were individually deleted by replacing the
entire ORFs using gene-targeting substrates based on the pyrG
marker from A. fumigatus for selection. Before analyzing the
deletion mutant strains, the pyrGmarker was excised by direct
repeat recombination (Nielsen et al., 2006) in each case. This
was carried out to ensure that the analyses of individual
mutant strains were comparable to and not inﬂuenced by
differences in the primary metabolism due to gene cluster-
speciﬁc expression levels of the pyrG marker. All 32 deletion
mutant strains (see Table S4) were viable and able to sporulate,
showing that none of the 32 genes are essential for growth and
that no polyketide product is essential for conidiation. As
expected, the one strain carrying the wAD mutation formed
white conidiospores as it fails to produce the naphthopyrone,
YWA1, the precursor of green conidial pigment (Watanabe,
1998; Watanabe et al., 1999).
In addition to wA, eight additional PKS genes have
previously been linked to metabolites. In our analysis, key
compounds representing four of these gene clusters could be
detected: monodictyphenone (1) (observed on RTO, YES
and CY20), orsellinic acid (2) (observed on YES, CY20, RT,
CYAs and CYA), emericellamide (A) (3) (observed on all
media) and sterigmatocystin (4) (observed on RTO, CYAs
and CYA). To verify the previously published gene links to
these compounds, we individually compared the metabolic
proﬁles of the reference strain to the corresponding proﬁles
obtained with the single PKS gene deletion mutant strains.
In agreement with previous analyses, these four compounds
Fig. 2. The late portion of the UV-chromatogram (210 nm) of the
Aspergillus nidulans reference strain and mdpGD on RTO medium. The
deletion abolishes formation of arugosin A (5), arugosin H (6), emericellin
(10), shamixanthone (11) and epi-shamixanthone (12) and a few
unidentiﬁed peaks.
Fig. 3. Proposed biosynthetic route of the
arogusins and shamixanthones. As seen in Fig. 2,
arugosin A is produced in large amounts relative
to the expected end products: emericellin (10)
and shamixanthones (11 and 12). DMAPP,
dimethylallylpyrophosphate. MdpG and XptA
are enzymatic activities as proposed by Sanchez
et al. (2011).
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disappeared in mdpG (Bok et al., 2009), orsA (Schroeckh
et al., 2009), easB (Chiang et al., 2008) and stcA (Yu &
Leonard, 1995) deletion strains of our library (Fig. S5).
Compounds resulting from the remaining four PKS genes
were identiﬁed by activating the gene clusters by controlled
expression of the transcription factor gene in the cluster
(Bergmann et al., 2007; Chiang et al., 2009) or by deleting
sumO that inﬂuences regulation of biological processes at
many different levels (Szewczyk et al., 2008). Expression
from these clusters is apparently not triggered by growth on
any of our media, and natural conditions provoking their
activation remain to be discovered.
Next, we performed a comparison of the metabolite
proﬁles from the 32 deletion mutants with those obtained
with the reference strain with the aim of uncovering novel
genetic links between PKS genes and polyketides. The most
signiﬁcant changes are described below.
mdpG is involved in the biosynthesis of
arugosins
First we focused our attention on the most prominent
compound produced on RTO, YES, CY20 and RT media,
which eluted as a broad peak around 7.2min. This compound
completely disappeared in the mdpGD strain (Fig. 2 and
Fig. S6). Moreover, it had a characteristic UV spectrum in
the UHPLC analysis indicating an arugosin-like metabolite.
MS analysis indicated the compound to be arugosin A
(m/z 425 a.m.u. for [M1H]1), which to our knowledge has
not been reported before from A. nidulans. We therefore
decided to conﬁrm the structure of this compound (5). A
large-scale extraction was performed and the metabolite was
puriﬁed. The NMR data in dimethyl sulfoxide are in agree-
ment with the literature (Kawahara et al., 1988) for the
hemiacetal form of arugosin A except that the equilibrium
was shifted completely to the open form (Fig. 3). In methanol,
the NMR data showed that the compound exists in equili-
brium between the closed and open ring form (data not
shown), explaining the broad peak observed in Fig. 2. Aminor
peak could be assigned as a mono-prenylated arugosin as
[M1H]1 at m/z 357 a.m.u. The MS data of this compound
did not indicate loss of a prenyl moiety, suggesting that it is
arugosin H (6), a likely immediate precursor of arugosin A
(Fig. 3). Hence, our data show thatmdpG, which is known for
its role in formation of monodictyphenone, is also involved in
formation of arugosins.
It is not unusual that one PKS gene cluster is responsible
for the biosynthesis of a family of structurally similar
compounds (Walsch, 2002; Kroken et al., 2003; Frisvad
et al., 2004; Amoutzias et al., 2008). In the original analysis
of themdpG gene cluster, it was activated due to remodeling
of the chromatin landscape, which occurs in a cclA deletion
strain (Chiang et al., 2010). That study genetically linked the
mdpG gene cluster to eight emodin analogues, including
several aminated species, which were detected and tenta-
tively identiﬁed. In our analyses, we also detected several
emodins including 2-o-dihydroxyemodin (7), o-hydroxye-
modin (8) and emodin (9), as well as the more apolar
compounds emericellin (10), shamixanthone (11) and epi-
shamixanthone (12) (Fig. 1 and Fig. S7). Like in the original
study, all emodins disappear in our mpdGD strain.
Recently, it was demonstrated that the polyketide part of
prenylated xanthones also could be coupled to mpdG
(Sanchez et al., 2011). Our ﬁnding that mpdG is involved in
formation of arugosins indicates that these compounds
serve as intermediates in the conversion of monodictyphe-
none into xanthones, Fig. 3. In agreement with this,
previous studies have reported arugosins to be precursors
for emericellin (10) and shamixanthones (11) and (12)
(Ahmed et al., 1992; Kralj et al., 2006; Ma´rquez-Ferna´ndez
et al., 2007), but have not established a genetic link tompdG.
AN7903 and orsA are involved in violaceol
production
Our reference strain produces the antibiotic violaceol I (13)
and II (14), in signiﬁcant amounts (Fig. 4 and Fig. S8).
These two diphenyl ethers have been identiﬁed in Emericella
min6.00 8.00
Reference
orsAΔ
AN7903Δ
Violaceol II, I stdReference
AN7903Δ
2.50 5.00
Reference
(a) (b)
(c) (d)
AN7903Δ
min 5.00 7.50 min
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AN7903Δ
8.00 10.00min
2
15
16
14
17
13
orsAΔorsAΔ
orsAΔ
Fig. 4. Extracted ion chromatograms of metabolic extracts from the
reference strain and the two mutants orsAD and AN7903D after
cultivation on YES medium. Compounds shown are (a) m/z 167 [M-H],
orsellinic acid (2), (b) m/z 397 [M1H]1, F9775A and B (16 and 17,
respectively), (c) m/z 317 [M-H], lecanoric acid (15) and (d) m/z 261 [M-
H], violaceol I and II (13 and 14). An extracted ion chromatogram of a
violaceol I and II in house standard is included in (d).
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violacea, Aspergillus sydowi and Aspergillus funiculosus
(Taniguchi et al., 1978; Yamazaki & Maebayas, 1982) and
recently also in A. nidulans (Nahlik et al., 2010). Our
analysis now links the biosynthesis of the two violaceols to
orsA as they disappear in our orsAD strain. It has previously
been shown that orsA (AN7909) is involved in the formation
of orsellinic acid (2), lecanoric acid (15), the two colored
compounds F-9775A (16) and F-9775B (17), orcinol, dior-
cinol, gerfeldin and deoxy-gerfeldin. (Schroeckh et al., 2009;
Sanchez et al., 2010). Our analysis conﬁrms the link between
orsellinic acid, lecanoric acid, diorcinol, F-9775A, F-9775B
to orsA as these compounds are missing in the orsAD strain.
However, we have not been able to detect the gerfeldins in
any of our strains, and apparently our conditions favor
violaceol and not gerfeldin formation.
The violaceols are formed by dimerization of two C7
monomers of 5-methylbenzene-1,2,3-triol, a compound
that we could tentatively detect as [M-H] at m/z 139 in
cultivation extracts. The C7 backbone of 5-methylbenzene-
1,2,3-triol, may conceivably be formed by decarboxylation
of a C8 aldol intermediate as suggested by Turner 40 years
ago (Turner, 1971) (Fig. 5). This C8 intermediate also serves
as a branch point towards orsellinic acid.
Interestingly, the same compounds that disappear in the
orsAD strain also disappear in AN7903D, a strain missing a
PKS gene separated from orsA by only 20 kb (Fig. 4). This
result does not contradict the original assignment of orsA as
the PKS gene responsible for production of orsellinic acid.
Although the enzymes encoded by the two genes are
predicted to share many of the same functional domains,
AN7903 is larger by around 500 amino acid residues and
contains a methyl-transferase domain, which is not required
for orsellinic acid production. Moreover, we note that
Schroeckh et al. (2009) observed that both AN7903 and
orsA were upregulated when orsellinic acid was induced by
co-cultivation with Streptomyces hygroscopicus, indicating
cross-talk between the two clusters. Surprisingly, what
appear to be trace amounts of orsellinic acid can be detected
as m/z 167 [M-H] in both the AN7903D and the orsAD
strains (Fig. 4). The source of this residual orsellinic acid
remains elusive, but it could possibly stem from unmethy-
lated byproducts from the PKS, AN8383, that produces 3,5-
dimethylorsellinic acid, see below.
AN8383 is responsible for austinol and
dehydroaustinol biosynthesis
Interestingly, production of austinol (18) and dehydroaus-
tinol (19) was observed in the reference strain on several
media (Fig. 1). Despite the fact that the production of these
compounds is known from A. nidulans (Szewczyk et al.,
2008), they have not yet been assigned to a speciﬁc gene.
O O
SCoA
O
O
O
O OH
O
OH
–CO 2
[O]
HO
OH O
OH
HO
OH
OH
Orsellinic acid (5)
5-Methyl-benzene-1,2,3-triol
HO
OH O
O
OH O
OH
Lecanoric acid (17)
HO
OH
O
OH
OH
Violaceol I (20)
Aldol
O
O
OHO
HO
O
HO
O
F-9775A (18)
O
O
O
HO
O
HO
O
OH
F-9775B (19)
HO
OH
O
OH
HO
Violaceol II (21)
Dimerization
Fig. 5. Proposed biosynthetic pathways related
to the orsA gene cluster. A common C8 aldol
intermediate, presented in the bracket, can by
loss of water and enolization lead to orsellinic
acid and by further esteriﬁcation to lecanoric
acid, or be decarboxylated and further oxidized
to yield the C7 compound 5-methyl-benzene-
1,2,3-triol. This compound is the precursor of the
two diphenyl ethers violaceol I and II and the
pigments F-9775A and B.
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Only the AN8383D strain failed to produce the two austinols
on all the media, which triggered austinol production in the
reference strain (Fig. 6a). This, phenotype could be rescued
by inserting the structural gene of AN8383 under the control
of the gdpA promoter into an ectopic locus, IS1 (Hansen
et al., 2011) (Fig. 6a). Moreover, a point mutant strain
AN8383-S1660A also failed to produce austinols on these six
media (Fig. 6a). In this strain, the DSL motif of the AN8383
PKS has been mutated to DAL, preventing the phospho-
pantetheine moiety of coenzyme A to attach to the acyl
carrier protein domain of the PKS, thus disrupting polyke-
tide synthesis (Evans et al., 2008). The lack of austinols can
thus be linked directly to an AN8383-encoded function
rather than to silencing of another gene caused by chroma-
tin changes provoked by the AN8383 deletion.
To conﬁrm the role of AN8383 in austinol production, we
constructed a new strain that expresses the AN8383 ORF
controlled by the inducible alcA promoter from the ectopic
locus, IS1 (Hansen et al., 2011). On inductive medium, the
subsequent LC-MS analysis showed a large novel peak
eluting at ca. 6min (see Fig. S9). The corresponding
compound was puriﬁed and the structure was elucidated
by NMR (Fig. S10), identifying 3,5-dimethylorsellinic acid
(20), which is in good agreement with the route of synthesis
previously proposed for austinol (Fig. 6b; Geris & Simpson,
2009). In a parallel analysis using a strain expressing
AN8383 under the control of the constitutive gpdA promo-
ter we obtained the same result (data not shown).
Together, the results strongly indicate that AN8383
encodes a PKS producing 3,5-dimethylorsellinic acid and
that this compound serves as the ﬁrst intermediate in the
complex biosynthesis of austinol and dehydroaustinol that
also involves a yet unidentiﬁed prenyl transferase(s). Based
on these results, we have named the locus AN8383, ausA.
Concluding remarks
In the present study, we constructed a genome-wide PKS
deletion library, which we screened for effects on polyketide
production on a variety of media. This analysis has provided
novel links between PKS genes and polyketide products
demonstrating the strength of this approach. Many PKS
genes still remain to be functionally connected to products,
as many gene clusters have not yet been activated. As the
repertoire of tools and methods to induce gene expression is
rapidly increasing, new polyketide compounds will likely
soon be uncovered in A. nidulans. To this end, the genome-
wide PKS gene deletion library presented here will undoubt-
edly serve as a useful resource.
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Aspyridone (adpA), asperfuranone (afoE/G), asperthecin (aptA), YWA1 (wA), (1) 3 
monodictypheonone (mdpG), (2) orsellinic acid (orsA), (3) emericellamide (A) (easB) and (4) 4 
sterigmatocystin (stcA). 5 
 6 
7 
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 9 
Fig. S2. A graphical illustration of the procedure employed to make the gene targeting fragments 10 
for the PKS deletions. Genomic DNA serves as template for two separate PCR reactions (A) that 11 
amplify the UP-stream and DOWN-stream regions of the PKS gene targeted for deletion. The 12 
oligonucleotide pairs contain approx. 20 nucleotide attB sequences that allow BP-recombination 13 
according to the Gateway cloning system (Invitrogen). (B) The PCR products with the specific attB 14 
sequences are incorporated into donor vectors (C) that contain A. fumigatus pyrG flanked by a 15 
sequence (DR) that serves as a direct repeat in the final mutant. The resulting plasmids (D) are 16 
purified from E. coli, and used as template to amplify gene-targeting substrates by PCR. Universal 17 
oligonucleotides U1 & U2 are used to amplify the UP-stream targeting fragments; and D1 and D2 18 
are used to amplify DOWN-stream targeting fragments. The final targeting substrates (E) are co-19 
transformed as bipartite gene-targeting substrates. 20 
21 
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 23 
Fig. S3. Illustration of the diagnostic PCR procedure. A standard repertoire of PCR reactions were 24 
used in the analysis of PKS deletion mutant strains. (A) shows PCR check of a targeting event for a 25 
given PKS locus. Up and Dw depicts the up- and downstream flanks of the PKS, respectively. The 26 
forward primer, P1, anneals outside the targeting sequence and the reverse primer, P2, is placed 27 
within the A. fumigatus pyrG (AFpyrG) marker gene. (B) the marker gene has been excised from 28 
the locus and the primer pair, P1 or P3 with P4, binds on either side of the remaining direct repeat 29 
sequence. The reaction can also occur on reference strain genomic DNA template, but in this case to 30 
produce a significantly larger fragment as illustrated in (C). In addition to this, a PCR reaction (C) 31 
using P1 or P3 with P5 positioned inside the PKS gene, identifies false positives. The PKS gene is 32 
shown as a blue arrow, the marker gene as a light grey arrow and the direct repeat as black squares. 33 
Drawing is not to scale. A control PCR reaction with reference strain genomic DNA as template is 34 
always included. (D) shows a typical agarose gel result for the PCR verification of a deletion strain 35 
(AN0150 (mdpG) in this case). Lanes are indicated by numbers 1-8 below the wells. Lane 1 & 8, 1 36 
kb ladder from New England Biolabs. Lane 2 shows the test for correct replacement of mdpG with 37 
the AFpyrG marker by P1 & P2 (test A) in the deletion strain candidate giving the 3.5 kb band, and 38 
the expected absence of a band in the WT control reaction in lane 3. Lanes 4 and 5, confirms 39 
marker loss after counter-selecting on 5-FOA via primers P1 and P4 (test B), the pop-out event is 40 
verified by the 2.9 kb band in lane 4 whereas WT gave the expected larger 7.9 kb band. Lane 6 and 41 
7 with primers P1 & P5 confirm that the deletion strain is pure and does not contain WT nuclei 42 
(intact mdpG sequence). All spore PCR reactions were run in triplicates. 43 
  44 
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 45 
Fig. S4. Chromosome map showing the position of the 32 PKS genes on the eight chromosomes of 46 
A. nidulans. The map was generated based mainly on information from the Aspergillus Genome 47 
Database at Stanford. The approximate location of the centromere is shown for each of the eight 48 
chromosomes. Telomeres are indicated as black tips and are not to scale. PKS genes that have 49 
previously been linked to polyketide compounds have been marked in red with the corresponding 50 
gene names. The scale bar on the left indicates size in mega bases (Mb). a In the present study, we 51 
name the PKS gene AN8383, ausA, (marked in green) due to its role in the biosynthesis of 52 
austinols. b These ORFs have been removed from the genome annotation of the Aspergillus 53 
Genome Database at Stanford during preparation of Version 5. We have made the deletions 54 
according to Version 4 of annotation. c The annotation of this gene was taken from the genome 55 
databases at the Broad Institute of Harvard and MIT. 56 
57 
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 59 
Fig. S5. Verification that the polyketide is absent in selected deletion mutants by either positive or 60 
negative mode extracted ion chromatograms. The mdpGΔ, orsAΔ, easBΔ and stcAΔ mutants are 61 
compared to the reference strain for the mass corresponding to the metabolites these genes are 62 
known to be involved in.  (A) Monodictyphenone m/z 287 [M-H]-, (B) orsellinic acid m/z 167 [M-63 
H]-, (C) sterigmatocystin m/z 325 [M+H]+ and (D) emericellamide A m/z 610 [M+H]+, 64 
emericellamide C/D m/z 596 [M+H]+,  emericellamide E/F m/z 624 [M+H]+. * Chiang et al, 65 
(Chiang et al. 2008) also observed a minor compound with the same mass.66 
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 68 
Fig. S6. Positive mode extracted ion chromatograms for the mdpGΔ strain cultivated on RTO, 69 
identifying arugosin A m/z 425 [M+H]+. 70 
71 
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 73 
Fig. S7. Additional polyketides that were detected in metabolite extracts in this study. 74 
75 
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 76 
 77 
Fig. S8. (A) UHPLC profiles (UV 210 nm) of orsAΔ, AN7903Δ compared to the reference strain. 78 
The peaks are numbered as follows: orsellinic acid (2), ω-hydroxyemodin (8), violaceol I (13), 79 
violaceol II (14), lecanoric acid (15), F9775A (16), F9775B (17), austinol (18), dehydroaustinol 80 
(19). (B) UV-spectra of violaceol I (left panel) and II (right panel) standard are shown in black, with 81 
an overlay shown in red of the UV-spectra of the sample representing peak 14 (left panel) and peak 82 
13 (right panel). There is agreement between standards and samples. 83 
84 
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 86 
Fig. S9. Extracted ion chromatograms (detection of 3,5-dimethyl orsellinic acid as [M-H]- at m/z 87 
195) of metabolic extracts from (A) the reference strain and the ausAΔ (AN8383Δ) strain on RTO 88 
medium and (B) the reference and the ausA overexpression strain on induction medium (glycerol 89 
with threonine). 90 
91 
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 93 
Fig. S10. 1H NMR spectrum of 3,5-dimethyl orsellinic acid in DMSO-d6. 94 
95 
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 97 
Fig. S11. 1H NMR spectrum of dehydroaustinol in CDCl3. 98 
99 
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 101 
Fig. S12. 1H NMR spectrum of arugosin A open form in DMSO-d6. 102 
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Text S1. Details about compound identification.  
Compound Identification 
3,5-dimethyl orsellinic acid. yellow/brownish powder; High resolution electron spray ionization mass 
spectra, HRESIMS, m/z 197.0818 [M+H]+, calculated for [C10H12O4+H]+: 197.0814. 1H NMR (DMSO-d6): δ 
(ppm) = 2.01 (3H, s), 2.05 (3H, s), 2.36 (3H, s), 8.89 (1H, s), 11.85 (1H, s), 13.43 (1H, s); 13C (DMSO-d6): δ 
(ppm) = 8.7, 12.0, 18.1, 106.0, 108.2, 115.7, 136.4, 157.5, 158.9, 173.9. These 1H and 13C NMR data are in 
good agreement with published data (Hirota et al., 1997; Andres et al., 1967) (see supplemental Fig. S10). 
Dehydroaustinol. Pale reddish compound; HRESIMS m/z 457.1867 [M+H]+, calculated for [C25H28O8 +H]+: 
457.1857. 1H NMR (CDCl3): δ (ppm) = 6.89 (1H, d, J = 9.8 Hz*), 6.32 (1H, s), 5.89 ((1H, d, J = 9.8 Hz), 
5.83 (1H, s), 5.75 (1H, s), 5.65 (1H, s), 5.26 (1H, q, J = 6.8), 4.35 (s, 1H), 2.30 (1H, br. s), 2.10 (1H, ddd, J 
= 13.8, 13.8, 3.8 Hz*), 1.77 (1H, ddd, J = 13.8, 13.8, 3.8 Hz*), 1.72 (1H, m), 1.71 (3H, s), 1.63 (3H, d, J = 
6.8 Hz), 1.51 (3H, s), 1.49 (3H, s), 1.32 (1H, ddd, J = 3.8, 13.8, 13.8 Hz), 1.24 (3H, s). These 1H NMR data 
are in good agreement with published data (Márquez-Fernández et al., 2007) except for the coupling 
constants reported for protons resonating at 6.89 ppm, 1.71 ppm and 2.10 ppm that were 2, 27.7 and 27.7 Hz, 
respectively (the discrepancy is indicated by asterisk above). A coupling constant of 27.7 Hz is not possible 
due to Karplus equation and dihedral angles, and upon closer inspection, we observed that the signals for 
protons at 1.71 and 2.10 ppm should have been listed as a ddd, not a dt, thus making the third coupling 
constant equivalent to the second one. The coupling constant listed in (Márquez-Fernández et al., 2007) for 
6.89 ppm does not match up with that given for its partner at 5.89 ppm, both of which should be around 10 
Hz, due to cis coupling (see supplemental Fig. S11), indicating that our data is correct. 
Arugosin A open form. Yellow compound; HRESIMS m/z 425.1936 [M+H]+, calculated for [C25H28O6 
+H]+: 425.1959. 1H NMR (DMSO-d6): δ (ppm) = 10.08 (1H, s), 7.07 (1H, d, J = 8.3 Hz), 6.98 (1H, s), 6.10 
(1H, d, J = 8.3 Hz), 5.49 (1H, t, J = 7.0 Hz), 5.29 (1H, t, J = 7.1 Hz), 4.39 (2H, d, J = 7.0 Hz), 3.17 (2H, d, J 
= 7.0 Hz), 2.26 (3H, s), 1.71 (3H, s), 1.70 (3H, s), 1.68 (3H, s), 1.56 (3H, s); 13C (DMSO-d6): δ (ppm) = 
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15.3, 17.4, 17.6, 25.3, 25.3, 26.7, 71.6, 105.4, 110.3, 118.4, 119.1, 122.5, 124.0, 126.9, 128.5, 131.1, 132.5, 
135.7, 139.3, 148.6, 152.3, 158.4, 160.5, 190.1, 201.4 (see supplemental Fig. S12).  
Violaceol I and II. De-replicated and validated against in-house standards of both compounds. HRESIMS 
m/z 263.0886 [M+H]+, calculated for [C14H14O5 +H]+: 263.0914. 
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Table S1. PCR primers for Gateway assembly. 
Primer name Oligonucleotide sequencea 
AN0150-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTggactgaagtagactgtaatctgcg 
AN0150-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTAACAACAGGAttctgaggcgatggaaccacc 
AN0150-D-3 GGGGACAACTTTGTATAATAAAGTTGggcagtatgttaaccggtagtgaaaggg 
AN0150-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTcaatccacgtgaatggaaccatgacgat 
AN0523-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTctgtatggtggggacgaaaa 
AN0523-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTctaccccggcacattcgata 
AN0523-D-3 GGGGACAACTTTTCTATACAAAGTTGgctgcgtgtttttactgttg 
AN0523-D-4 GGGGACAACTTTATTATACAAAGTTGTgtactaagtcatcagcaggc 
AN1034-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTcagctaagcaagtacgccat 
AN1034-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTggagggtagctaggtagttg 
AN1034-D-3 GGGGACAACTTTTCTATACAAAGTTGgatgcaggggctaacaggaa 
AN1034-D-4 GGGGACAACTTTATTATACAAAGTTGTgttcaggagggaggacatta 
AN1036-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTcatcacctacctccagcaca 
AN1036-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTGtgccttgtggatggggatt 
AN1036-D-3 GGGGACAACTTTTCTATACAAAGTTGggtttgtagtttgctctgg 
AN1036-D-4 GGGGACAACTTTATTATACAAAGTTGttttatcttcttccctgccc 
AN10430-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTcggccttcgttgtgtcattt 
AN10430-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTGgcgagtagggtgtcaatggt 
AN10430-D-3 GGGGACAACTTTTCTATACAAAGTTGagcatgtaatgagtcagtgg 
AN10430-D-4 GGGGACAACTTTATTATACAAAGTTGatatatagagcgcgtctcgt 
AN11191-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTCGGAACCATCCTCAAGCAC 
AN11191-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTCCTGGAGGGTTTTGCTTGGAG 
AN11191-D-3 GGGGACAACTTTGTATAATAAAGTTGGATTTTGGCTATACCACATGGC 
AN11191-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTGAACGGAGGTCTTCTGCAC 
AN1784-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTGACGCCATGAAGACCATGAC 
AN1784-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTGGTGGGCCGATATTTGCAG 
AN1784-D-3 GGGGACAACTTTGTATAATAAAGTTGACATTCATCGAGTCTCTCTTTCG 
AN1784-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTGCTGTCTCGTTGGCGGAG 
AN2032-U-1 GGGGACAACTTTGTATAGAAAAGTTGGGTgacgcaatatctttcgcgcagaagg 
AN2032-U-2 GGGGACAAGTTTGTACAAAAAAGCAGGCTtacctccagtggtacatctggccca 
AN2032-D-3 GGGGACAACTTTATTATACAAAGTTGaactggctgagtattgtaagacgagggagca 
AN2032-D-4 GGGGACAACTTTTCTATACAAAGTTGtctctgatatgtatgtttctgggtagccgac 
AN2035-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTtatatgggagtgggggcttg 
AN2035-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTGaggtagaagtagagtggatgg 
AN2035-D-3 GGGGACAACTTTTCTATACAAAGTTGaccctaccctctgattcaaact 
AN2035-D-4 GGGGACAACTTTATTATACAAAGTTGcatgcctcgaacacctcaaac 
AN2547-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTatcccacaaattccagatagcc 
AN2547-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTAACAACACGTatctcttggatgctcacacatg 
AN2547-D-3 GGGGACAACTTTGTATAATAAAGTTGaggtacggctaatcgttgaccgtctg 
AN2547-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTtgatgcgctgaaataccaggtgctt 
AN3230-U-1 GGGGACAACTTTGTATAGAAAAGTTGGGTgggagggtagaattaaagagcggaaggatggca 
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AN3230-U-2 GGGGACAAGTTTGTACAAAAAAGCAGGCTtaactgtggcgactggagggctc 
AN3230-D-3 GGGGACAACTTTATTATACAAAGTTGaaggctgcaatttctacgctgagc 
AN3230-D-4 GGGGACAACTTTTCTATACAAAGTTGagtgggccattctggccttgc 
AN3273-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTcgaaaagccgaacaaggaca 
AN3273-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTcccggataccgtcacactct 
AN3273-D-3 GGGGACAACTTTTCTATACAAAGTTGtgctaagacgacgatactgt 
AN3273-D-4 GGGGACAACTTTATTATACAAAGTTGTcgcgaggaagggagtatttt 
AN3386-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTccatgttgatgttcgctcgt 
AN3386-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTcgtaactggcttggatctca 
AN3386-D-3 GGGGACAACTTTTCTATACAAAGTTGcgcaaaaggctggagacgag 
AN3386-D-4 GGGGACAACTTTATTATACAAAGTTGTgcgccgtctactatccaagc 
AN3612-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTGCTCCTGTTGGAGAAGCTGG 
AN3612-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTGACAGAAAACAGCAGGTTTGAGC 
AN3612-D-3 GGGGACAACTTTGTATAATAAAGTTGCGGAAAATATGGAGGATCGGC 
AN3612-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTGAAGACGGCAGCAAGGATG 
AN5475-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTacagtacttgaagaatcgaagtcctgccacc 
AN5475-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTgtaccgactctgggagaagcaagccca 
AN5475-D-3 GGGGACAACTTTTCTATACAAAGTTGcgtggctcaccgcctaagca 
AN5475-D-4 GGGGACAACTTTATTATACAAAGTTGatcagagaacacaacacagccctacc 
AN6000-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTtcaatgcgaaaaagctgggagaacc 
AN6000-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTggagggcaaaatgcccgcac 
AN6000-D-3 GGGGACAACTTTTCTATACAAAGTTGggtgttatggtatacagagtgctcgactcg 
AN6000-D-4 GGGGACAACTTTATTATACAAAGTTGagcggttcatttgcacaccgagg 
AN6431-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTCAAGGTGGAGGAGGCAGC 
AN6431-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTCTTCACGATCTCTACCTCTGGTC 
AN6431-D-3 GGGGACAACTTTGTATAATAAAGTTGGTGAAGGGCTTGGTCGGAC 
AN6431-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTGTGGTCACCTACCTGCGTG 
AN6448-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTgaaacccgttcagccaacca 
AN6448-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTgaaaggactgaacgaccggg 
AN6448-D-3 GGGGACAACTTTTCTATACAAAGTTGagaggagataccacgaagat 
AN6448-D-4 GGGGACAACTTTATTATACAAAGTTGTgaacaattggggggtctaac 
AN6791-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTcacgccatgagacggatggcac 
AN6791-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTgaagtacctcccggataggggctcc 
AN6791-D-3 GGGGACAACTTTTCTATACAAAGTTGgacctgatatacattgccactaacgaaccca 
AN6791-D-4 GGGGACAACTTTATTATACAAAGTTGatcagaaggcgactgcgaagc 
AN7022-U-1 GGGGACAACTTTGTATAGAAAAGTTGGGTggggaattcagactgggtggtgttgtgc 
AN7022-U-2 GGGGACAAGTTTGTACAAAAAAGCAGGCTtcgatccagacgttcattctgttcggaggagg 
AN7022-D-3 GGGGACAACTTTATTATACAAAGTTGacgcattgatttctgcgcgaggactgg 
AN7022-D-4 GGGGACAACTTTTCTATACAAAGTTGggacacgtcaacagtattggcattcagg 
AN7071-U-1 GGGGACAACTTTGTATAGAAAAGTTGGGTgtcgcagatgtctcccatctcgcca 
AN7071-U-2 GGGGACAAGTTTGTACAAAAAAGCAGGCTttactcgtcgcccttctgggctg 
AN7071-D-3 GGGGACAACTTTATTATACAAAGTTGaaccccaatctcactgcagacctc 
AN7071-D-4 GGGGACAACTTTTCTATACAAAGTTGccgtctatcaatggaataacacggatgccca 
AN7084-U-1 GGGGACAACTTTGTATAGAAAAGTTGGGTgagactgaggtccaactccgacg 
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AN7084-U-2 GGGGACAAGTTTGTACAAAAAAGCAGGCTccgtctctgagcgtgctggaa 
AN7084-D-3 GGGGACAACTTTATTATACAAAGTTGagggttacctgtgccggagac 
AN7084-D-4 GGGGACAACTTTTCTATACAAAGTTGccctcgtaaccaaatcacaccactcc 
AN7825-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTtcatcccagatactcggattgcgctgaa 
AN7825-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTAACAACCAGTagctaacggtgagattcagattgcct 
AN7825-D-3 GGGGACAACTTTGTATAATAAAGTTGggttctcaggtattctgtgtcgagtgc 
AN7825-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTagtggtcaggccatatttctgggcgat 
AN7838-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTgacactgaaagatgggacgagtgtgcga 
AN7838-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTgtggtgaaggaggagacctgagtgca 
AN7838-D-3 GGGGACAACTTTTCTATACAAAGTTGcgcgactgtttagtaagtagtgctgtaggcga 
AN7838-D-4 GGGGACAACTTTATTATACAAAGTTGactgctaacgaggaaaagctgtgtggctc 
AN7903-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTggctctactcgagctgacgt 
AN7903-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTAACAACAATGgtgatcgaactgatcatggccgtcaata 
AN7903-D-3 GGGGACAACTTTGTATAATAAAGTTGcggccattaaggctactcctgcagacaa 
AN7903-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTtgatatggcctcggatgagcttgtcgta 
AN7909-U-1 GGGGACAACTTTGTATAGAAAAGTTGGGTgtgccgtgaagagtcaagctccgtg 
AN7909-U-2 GGGGACAAGTTTGTACAAAAAAGCAGGCTgagatgcttccctatatgctcgaacgagcca 
AN7909-D-3 GGGGACAACTTTATTATACAAAGTTGaaatagtcgcggcggcatttcc 
AN7909-D-4 GGGGACAACTTTTCTATACAAAGTTGgcatgcgacatagttgggggacc 
AN8209-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTacccaaggttgacaacacgatatctgc 
AN8209-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTAACAACGAGAgactgcatctaagtgttcagccacaa 
AN8209-D-3 GGGGACAACTTTGTATAATAAAGTTGaatacgccgcgatcttctatgagcag 
AN8209-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTggctagacggaacattccatcttacg 
AN8383-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTGCGATCTCTCTGGCGAAAG 
AN8383-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTGGAATGAGACACAGTCGCTTA 
AN8383-D-3 GGGGACAACTTTGTATAATAAAGTTGGTTCCTGCGAAGACACGTTG 
AN8383-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTGGGTGTTGACTGAGGAGC 
AN8412-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTaagacggtgcgctttcatagatgtcagc 
AN8412-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTAACAACGCGCagctggtacctatactgcatcaccaagg 
AN8412-D-3 GGGGACAACTTTGTATAATAAAGTTGatcaccgctctgatctacagtagctgc 
AN8412-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTgtcggcttcatcattctcggggtcatgt 
AN8910-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTcccaagacggactacgcagc 
AN8910-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTggtgcaggatacgcggaggac 
AN8910-D-3 GGGGACAACTTTGTATAATAAAGTTGgtcctcgatggggtcatagtaagccaacagtg 
AN8910-D-4 GGGGACCACTTTGTACAAGAAAGCTGGGTatgggctgcgtacccgagagaa 
AN9005-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTgccatatctgggaagcggagga 
AN9005-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTggaccaaacacttcctttgcggggtacaa 
AN9005-D-3 GGGGACAACTTTTCTATACAAAGTTGgtgcagtaagggtttgtggttgaggga 
AN9005-D-4 GGGGACAACTTTATTATACAAAGTTGaacgaagaagacatacctgcggctg 
anid_12168-U-1 GGGGACAAGTTTGTACAAAAAAGCAGGCTggaggacgctttggtgaagg 
anid_12168-U-2 GGGGACAACTTTGTATAGAAAAGTTGGGTcaccggcaagaacacacaat 
anid_12168-D-3 GGGGACAACTTTTCTATACAAAGTTGctgcccgcaaatcggaatat 
anid_12168-D-4 GGGGACAACTTTATTATACAAAGTTGTcccttatcagctttgctctc 
Uni-U1b cttttgctggccttttgctc 
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Uni-U2b tgctgtccaagcttatctcc 
Uni-D1c tacatcgccgtcatcaag 
Uni-D2c gattttgagacacgggccag 
 
a For each oligonucleotide, the attB sequence required for Gateway recombination is capitalized. 
b Oligonucleotide for amplifying the final upstream gene targeting substrate from the Gateway upstream plasmid . 
These oligonucleotides are labeled U1 and U2 in Fig. S2, respectively.  
c Oligonucleotide for amplifying the final downstream gene targeting substrate from the Gateway downstream plasmid. 
These oligonucleotides are labeled D1 and D2 in Fig. S2, respectively.
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Table S4. The constructed A. nidulans strains have been deposited into the IBT Culture Collection. 1 
  IBT Strain Genotype a 
 
29539 b argB2, pyrG89, nkuAΔ 
 
28738c argB2, pyrG89, nkuA-trS::AFpyrG 
 
30995 argB2, pyrG89, nkuAΔ, mpdGΔ 
 
30996 argB2, pyrG89, nkuAΔ, AN0523Δ 
 
30997 argB2, pyrG89, nkuAΔ, afoEΔ 
 
30998 argB2, pyrG89, nkuAΔ, afoGΔ 
 
30999 argB2, pyrG89, nkuAΔ, AN10430Δ 
 
31000 argB2, pyrG89, nkuAΔ, AN11191Δ 
 
31001 argB2, pyrG89, nkuAΔ, AN1784Δ 
 
31002 argB2, pyrG89, nkuAΔ, AN2032Δ 
 
31003 argB2, pyrG89, nkuAΔ, AN2035Δ 
 
31004 argB2, pyrG89, nkuAΔ, easBΔ 
 
31005 argB2, pyrG89, nkuAΔ, AN3230Δ 
 
31006 argB2, pyrG89, nkuAΔ, AN3273Δ 
 
31007 argB2, pyrG89, nkuAΔ, AN3386Δ 
 
31008 argB2, pyrG89, nkuAΔ, AN3612Δ 
 
31009 argB2, pyrG89, nkuAΔ, AN5475Δ 
 
31010 argB2, pyrG89, nkuAΔ, aptAΔ 
 
31011 argB2, pyrG89, nkuAΔ, AN6431Δ 
 
31012 argB2, pyrG89, nkuAΔ, AN6448Δ 
 
31013 argB2, pyrG89, nkuAΔ, AN6791Δ 
 
31014 argB2, pyrG89, nkuAΔ, AN7022Δ 
 
31015 argB2, pyrG89, nkuAΔ, AN7071Δ 
 
31016 argB2, pyrG89, nkuAΔ, AN7084Δ 
 
31017 argB2, pyrG89, nkuAΔ, stcAΔ 
 
31018 argB2, pyrG89, nkuAΔ, AN7838Δ 
 
31019 argB2, pyrG89, nkuAΔ, AN7903Δ 
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31020 argB2, pyrG89, nkuAΔ, orsAΔ 
 
31021 argB2, pyrG89, nkuAΔ, wAΔ 
 
31022d argB2, pyrG89, nkuAΔ, ausAΔ 
 
31023 argB2, pyrG89, nkuAΔ, adpAΔ 
 
31024 argB2, pyrG89, nkuAΔ, AN8910Δ 
 
31025 argB2, pyrG89, nkuAΔ, AN9005Δ 
 
31026e argB2, pyrG89, nkuAΔ, anid_12168Δ 
 
31030f argB2, pyrG89, IS1::PalcA::ausA::TtrpC::argB 
 
31031g argB2, pyrG89, IS1::PgpdA::ausA::TtrpC::argB 
  31032h argB2, pyrG89, nkuAΔ, ausA-S1660A 
 
31281i argB2, pyrG89, nkuAΔ, ausAΔ, IS1::PgpdA::ausA::TtrpC::argB 
a all strains carry the veA1 mutation 2 
b nkuAΔ deletion strain (Nielsen et al., 2008) 3 
c transient small repeat in nkuA (Nielsen et al., 2008) 4 
d AN8383 was designated ausA in this study 5 
e The annotation of this gene was from the Aspergillus Comparative Sequencing 6 
  Project, Broad Institute of Harvard and MIT 7 
f Strain contains inducible expression (alcA promoter) of ausA in IS1 8 
g Strain constitutive expression (gpdA promoter) of ausA in IS1 9 
h Strain contains a point mutation in ausA with S166A (serine to alanine) 10 
i The ausA deletion (strain, IBT31022) was complemented by the expression of ausA from IS1 11 
 12 
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Introduction. Filamentous fungi are reservoirs of bioactive natural products, i.e. secondary metabolites that 
are classified into groups such as polyketides, nonribosomal peptides, terpenoids, and hybrid molecules 
mixing moieties of these classes. The selection of secondary metabolites produced by one fungus inevitably 
pinpoints to the environmental niche and the challenges it faces. As these products display high chemical 
diversity, the bioactivities are similarly broad ranged, in extremes ranging from harmful mycotoxins to 
beneficial drugs. This fuels the interest to link secondary metabolites to their corresponding genes often 
residing in gene clusters to ultimately map the full biosynthetic pathway. This task has however shown to be 
cumbersome due to the expression of most gene clusters responsible for secondary metabolite production has 
been challenging to stimulate under lab conditions. Even in a well-studied fungus as Aspergillus nidulans, 
the biosynthetic pathways of many clusters are still unidentified regarding if they are active at all. Moreover, 
in several cases only a few metabolites have been coupled to a specific PKS and the remaining products 
remains to be found (Ahuja 2012). 
In A. nidulans at least four PKSs have been shown to produce variants based on an orsellinic acid backbone, 
namely orsellinic acid (OrsA; Schroeckh 2009), 3,5-dimethylorsellinic acid (3,5-DMOA, AusA; Nielsen 
2011), 3-methylorsellinic acid (3-MOA; Hansen 2011; Ahuja 2012) and orsellinic acid aldehyde (PkfA; 
Ahuja  2012) . Moreover, Hansen and co-workers showed that 5-MOA could be heterologously produced by 
transferring the PKS, mpaC, the first step in mycophenolic acid production from Penicillium 
brevicompactum (Hansen 2011). Furthermore, Nielsen et al. reported that small amounts of orsellinic acid 
were still present in extracts of orsAΔ (Nielsen 2011). This could indicate that synthesis of orsellinic acid 
variants as potentially leaky, which could complicate characterization of these pathways. Recently, 3-MOA 
and cichorine were reported to be produced by AN6448, PkbA (Ahuja 2012). We set out to map and 
characterize the biosynthetic activities present in the pkbA gene cluster. In addition to determining several of 
the biochemical steps, we found that nitrogen was incorporated by a to our knowledge novel mechanism by 
the NRPS-like enzyme AN6444. Moreover a novel carbon skeleton was discovered in the metabolites 
cichonidulol/demethylcichonidulol.  
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Results and Discussion 
Ectopic overexpression of the putative transcription factor AN6446 results in production of 3-MOA 
and associated metabolites. 32 putative PKS ORFs were deleted and challenged in an OSMAC approach by 
Nielsen et al., 2011. Through analysis of the data we also found loss of 3-methylorsellinic acid production in 
the pkbAΔ mutant strain grown on CYA, CY20 and RT compared to the reference strain by UHPLC-MS 
analysis employing a 3-MOA standard, see Fig 1 for comparison on CYA. All of the remaining 31 PKS 
deletion strains produced 3-MOA under these conditions (data not shown). Our observation corresponds to 
the finding recently published by Ahuja et al (Ahuja 2012) that the PKS encoding pkbA is required to 
produce 3-MOA. The complete loss of 3-MOA production also showed that 3-MOA cannot be derived from 
the three other orsellinic acid producing gene clusters in A. nidulans, ors, pkf and aus under the tested 
conditions.  
 
Figure 1 Extracted ion chromatograms of 3-methylorsellinic acid [M+H]+ (calc. m/z 183.06483±0.001) of a standard, 
the reference strain and pkbAΔ strains on CYA medium cultivated for seven days at 37°C.  
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As 3-MOA production was relatively low in the reference strain extracts and no other metabolites were 
found to be significantly differentiated in the pkbAΔ extracts compared to the reference, we decided to 
induce production of potential metabolites from PkbA, and searched the genome sequence for neighbor 
ORFs predicted to encompass transcriptional regulator activity. AN6446 was predicted to have a DNA 
binding domain of the Myb/SANT family both associated with transcriptional regulation, e.g. the SANT 
domain is present in numerous chromatin remodeling enzymes. We speculated that AN6446 could be a 
cluster-specific activator or repressor, and thus constructed an AN6446 overexpression strain (AN6446-Oex) 
based on ectopic expression from the IS1 site (Hansen 2011). The overexpression of AN6446 clearly had an 
effect on A. nidulans, since the AN6446-Oex compared to the reference displayed a decrease in pigmentation 
of conidia to a dusty green appearance and a light brown center of the colony after seven days growth on 
MM, see Fig 2. 
 
Figure 2. The reference strain compared to the AN6446-Oex strain cultivated on MM at 37°C for three, five and seven 
days.  
UHPLC-TOF-MS analysis revealed several new peaks appearing in the AN6446-Oex strain compared to the 
reference indicating that the overexpression had indeed turned on the likely 3-MOA biosynthetic pathway. 3-
MOA was, as in the reference strain, present in trace amounts in the AN6446-Oex strain. 
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 Figure 3 UHPLC-TOFMS ESI+ BPC of the micro-extracts of the reference (black) and AN6446-Oex (blue) strains 
cultivated on MM media at 37°C for a) three, b) five, and c) seven days.  
a)
b)
c)
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Extracts of the AN6446-Oex strain cultivated for three different periods, i.e. 3, 5 and 7 days, displayed 
highly similar metabolite profiles, albeit some metabolite were not visible before 5 days. Consequently, the 
strains were grown for seven days throughout the study. Moreover this showed that MM medium was a 
suited growth medium for isolation of candidate metabolites under the artificial conditions encountered in 
the overexpression strain.   
Overexpression of AN6446 resulted in production of two dimers having a novel 
carbonskeleton 
A large-scale extract of 200 MM dishes cultivating the AN6446-Oex strain was prepared for isolation and 
structure elucidation of several metabolites. In figure 3, the UHPLC-TOF-MS ESI+ BPC of the large-scale 
extract versus the micro-extracts showed that several of the peaks were not present in the large extracts.  
Sample preparations and cultivation conditions of a large number of plates could influence this loss of 
metabolites observed, however further analysis revealed more compounds than visible in the chromatogram 
as cichorine eluting at 3.2 min was in high concentrations. 
 
Figure 4 UHPLC-TOF-MS ESI+ BPC of the micro-extract (bottom) and 200 plate extract (top) of the overexpression of 
AN6446-Oex strain cultivated on MM medium for seven days at 37°C.  
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Isolation and structure elucidation by NMR revealed the presence of several metabolites; cichorine, 
demethylnidulol and 4-hydroxy-3,5-dimethyl-2-pyrone and two dimers of cichorine and 
nidulol/demethylnidulol, named cichonidulol and demethylcichonidulol, see figure 5. Although present in 
the extract of AN6446-Oex, nidulol was isolated from the singular deletion mutant strain, AN6444Δ. Both 
cichorine and nidulol have been reported previously in literature. Cichorine have been isolated from A. 
silvaticus (Kawahara 1988), Alternaria cichorii (Stierle 1993) and A. nidulans (Ahuja 2012) whereas nidulol 
have been reported from A. nidulans (Aucamp 1968), A. silvaticus (Fujita 1984), and Emericella desertorum 
(Nozawa 1987).   
 
Figure 5 Structures of metabolites isolated and elucidated throughout this study. 3-methylorsellinic acid, cichorine, 
demethylcichorine, nidulol, demethylnidulol, cichonidulol, demethylcichonidulol, 4-hydroxy-3,6-dimethyl-2-pyrone.  
The structures were elucidated using 2D NMR-spectra, where especially heteronuclear HSQC and HMBC 
spectra were extensively used due to the absence of proton-proton couplings and low proton density of the 
metabolites. In addition the results were in accordance with chemical shift values reported in literature for 
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cichorine (Monreau 2005), 3-methylorsellinic acid (Ahuja 2012), demethylnidulol (El-Feraly 1985), and 4-
hydroxy-3,6-dimethyl-2-pyrone (Savard 1994).  
The resemblance of the molecular formulas of cichorine (C10H11NO4) and nidulol (C10H10O4) and initial 
comparison of the 1H-spectra suggested that these metabolites could be related. The main issue in structure 
elucidation of these two metabolites was whether the carbonyl was situated on C7 or C8. This problem was 
solved by comparison of the carbon chemical shift of cichorine to the shifts reported in the obtained after 
total synthesis of cichorine (Moreau 2005). For all the metabolites key HMBC correlations from H5 the C7 
and/or C8 and from H7/H8 to the carbons present in the aromatic ring, figure 6, aided in the structure 
elucidation. A NOESY correlation between H8 and H10 in cichorine which were missing in nidulol confirmed 
the difference in the two structures 
 
Figure 6 Key HMBC correlations of cichorine, nidulol, cichonidulol and 4-hydroxy-3,6-dimethyl-2-pyrone. 
The UV spectrum of demethylnidulol was identical to the one of nidulol and the molecular formula C9H8O4 
showed that the difference between the two metabolites was a carbon and two protons. Through analysis of 
the NMR-spectra it was confirmed that the two metabolites were related and that the difference was a 
demethylation of C3 in nidulol which gave demethylnidulol.  
Through the analysis of the large-scale AN6446-Oex extract we noticed two small peaks eluting around five 
minutes which had UV-spectra that resembled the ones of nidulol and cichorine. These metabolites were 
present in small amounts in the large extract and based on the molecular formular of these metabolites 
C20H21NO6 and C19H19NO6 we speculated whether they could be dimers of cichorine, 3-MOA, nidulol or 
demethylnidulol through condensation and the formation of e.g. an ester as seen with the formation of 
lecanoric acid in the orsellinic acid pathway (Schroeckh 2009). 2.0 mg of C20H21NO6 and 0.6 mg of 
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C19H19NO6 were isolated from the extract and the structure of C19H19NO6 were elucidated based on 2D NMR 
analysis to be a dimer of cichorine and nidulol, named cichonidulol. Analysis of the HMBC spectrum, key 
HMBC couplings of cichonidulol shown in figure 6, revealed that the link of the two molecules was not 
through an ester formation but interestingly through a C-N bond formed at the carbonyl position in nidulol. 
A search of the literature showed that cichonidulol and demethylnidulol were novel metabolites with a new 
carbon skeleton. The metabolite which showed the closest resemblance was the plant metabolite, capaurine, 
which contains the C-N condensation bond between two ringsystems; however, the nitrogen containing ring 
is a six membered ring and the substitution patterns of are quite different (Manske 1945).      
Table 1 13C-chemical shifts (ppm) of 3-methylorsellinic acid, cichorine, nidulol, demethylnidulol, cichonidulol and 
demethylcichonidulol. All data obtained in DMSO-d6 (referenced to 39.5 ppm) 
ID 3-MOA Cichorine Nidulol Demethyl-nidulol Cichonidulol Demethylcichonidulol 
1/1’ 103.7/- 123.1/- 107.2/- 92.9/- 121.3/116.1  
2/2’ 163.0/- 153.6/- 157.5/- 159.6/- 153.6/153.8  
3/3’ 107.7/- 118.9/- 117.5/- 101.1/- 120.5/115.3  
4/4’ 159.7/- 156.3/- 162.7/- 168.8/- 156.9/158.1  
5/5’ 109.9/- 102.9/- 103.0/- 103.2/- 103.4/102.4  
6/6’ 139.4/- 131.9/- 148.6/- 151.4/- 131.0/139.5  
7/7’ 23.4/- 169.8/- 68.2/- 66.9/- 167.1/71.7  
8/8’ 173.8/- 43.1/- 168.5/- 178.1/- 43.2/83.5  
9/9’ 7.9/- 9.1/- 8.2/- -/- 9.3/8.6  
10/10’ -/- 58.9/- 53.9/- 53.9/- 59.0/59.2  
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Table 4.1 lists the 13C-chemical shifts of the above mentioned isolated metabolites where it is seen that the 
largest differences in shift values occur around at C1 and C6 differs depending on the position of the 
carbonyl.  
The amount of C19H19NO6 isolated was not sufficient for full 2D analysis; however, comparison of the 1H-
specrum to the one of cichonidulol revealed the only difference between the two were a demethylation in 
nidulol on C3 thereby generating a dimer of cichorine and demethylnidulol, named demethylcichonidulol.   
The final metabolite isolated was 4-hydroxy-3,6-dimethyl-2-pyrone whose chemical shifts were in close 
resemblance to those in the literature (Savard 1994). This metabolite is different from the above mentioned 
compounds having a completely different carbon skeleton. We therefore speculated if this metabolite was a 
product of pkbA or we could have activated another PKS encoding gene. We overexpressed pkbA and 
extracts of pkbA-Oex grown on MM showed high production of both 3-MOA and 4-hydroxy-3,6-dimethyl-2-
pyrone (data not shown). Moreover, screening the data from all the PKS deletion strain grown on CYA 
medium revealed that only the pkbAΔ strain lost the ability to produce 4-hydroxy-3,6-dimethyl-2-pyrone. 
 
Delineation of the cluster by gene expression analysis in overexpression and deletion strains of 
AN6446. 
To verify that AN6446p had an activator effect on the surrounding genes, relative gene expression 
measurement by qRT-PCR analysis was performed. A deletion of AN6446, which displayed the same 
phenotype, as the reference was added to the analysis with the hypothesis that this would have the inverse 
effects from the overexpression strain minimizing the risk of picking false cluster members. Moreover, none 
of the peaks observed as an effect of the overexpression strains were present in the extracts of AN6446Δ 
(data not shown).  
RNA was extracted from the reference strain as well as the deletion and overexpression strain of AN6446 
grown on MM for four days. Relative gene expression levels were monitored by qRT-PCR on all 25 ORFs 
ranging from AN6435 to AN6457 both included. In Figure 7 the average fold change (fc) of the three runs 
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for all genes in the AN6446 overexpression and deletion strains compared to the reference are shown. A 
level of 1 in fc denotes unaltered expression in respect to the reference strain. One criterion for genes to be a 
putative cluster member was for AN6446-Oex to have fc above 1 coupled to fc close to 0 for AN6446Δ. As 
shown in Figure 7, the two levels of AN6446 expression had dramatic effects on the expression of numerous 
genes in the study. However, based on fc criteria as stated above the number of candidates was narrowed 
down to six genes besides AN6446: AN6444, AN6447, AN6448, AN6449, AN6450, AN6451. AN6445 and 
AN6452 both have fc’s close to 1 for AN6446-Oex considering the standard deviation, and will thus not be 
considered cluster members, though they both have fcs close to 0 for the AN6446Δ, which could reflect local 
organization in the chromatin. In both mutant strains, the expression of distant neighbor genes were 
influenced, since only AN6435, AN6440, AN6441 and AN11921 were unchanged from the wild type with 
fc=1 in both mutant strains. AN6453 and AN6454 were significantly downregulated in respect to the 
reference strain. AN6438 to AN6439 were increased 4-6 fold in fc AN6446-Oex, but did not respond to the 
deletion of the AN6446-Oex. These examples indicate that the genetic alterations did affect the expression in 
the locus, and therefore some changes could be artifacts and not cluster specific reactions. Taken together the 
qRT-PCR data suggests the action of seven gene products.  
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Figure 7 Results of the qRT-PCR analysis of AN6446-Oex and AN6446Δ on the genes from AN6435-AN6457 
compared to the reference strain. An expression of 1 means unaltered expression, over 1 means higher expression and 
below 1 means lower expression. These data show that AN6444, AN6446, AN6447, AN6448, AN6449, AN6450 and 
AN6451 are upregulated in the overexpression strain and downregulated in the deletionstrain indicating that the pkbA 
cluster contains these genes.    
Deletion of all genes spanning AN6435-AN6457 to confirm results from gene expression analysis 
Gene deletions of all the 25 initial candidate genes were performed in the AN6446-Oex background to 
confirm the conclusions obtained from qRT-PCR and to elucidate on the biosynthetic role of the gene 
products. The six most distant genes in each side of the cluster were deleted in triplets (AN6435-AN6437; 
AN6438-AN6440; AN6452-AN6454; AN6455-AN6457) and the gene in between as singular deletion 
mutants.  
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Figure 8 The phenotypes of the AN6446-Oex, pkbA-Oex, AN6446-Oex AN6435-6437Δ, AN6446-Oex AN6438-
6440Δ, AN6446-Oex AN6441Δ, AN6446-Oex AN11920Δ, AN6446-Oex AN11921Δ, AN6446-Oex AN6443Δ, 
AN6446-Oex AN6444Δ, AN6446-Oex AN6445Δ, AN6446-Oex AN6446Δ, AN6446-Oex AN6447Δ, AN6446-Oex 
AN6448Δ, AN6446-Oex AN11922Δ, AN6446-Oex AN6449Δ, AN6446-Oex AN6450Δ, AN6446-Oex AN6451Δ, 
AN6446-Oex AN6452-6454Δ, AN6446-Oex AN6455-6457Δ and AN6446-Oex AN6435-6457Δ strains cultivated on 
MM medium for seven days at 37°C.  
To see whether AN6446 had regulatory effects on secondary metabolite production outside the cluster, a full 
cluster deletion (AN6435-AN6457) in the overexpression strain was constructed as well. The phenotypes can 
be compared in figure 8, and the loss of genes, predicted to form the gene cluster of PkbA, indeed stood out 
from the others in the phenotype display. The phenotypes varied greatly, indicating altered metabolism in the 
respective strains. To investigate which metabolites originated from this cluster and if correlated with the 
phenotype of the mutant strains plug micro-extraction was performed (Frisvad 1987, Smedsgaard 1997) and 
the extracts were analyzed by UHPLC-TOF-MS. In figure 9, 10 and 11 ESI+ BPC of all the extracts can be 
seen, and they are grouped based on their metabolic patterns.  
Interestingly, in figure 9, a number of deletion strains, from AN6435 to AN11921, are displayed where all 
the key metabolites appearing in the AN6446-Oex strain had disappeared. Since the qRT-PCR data did not 
support that these genes belonged to the cluster, we speculated that this effect links to local chromosomal 
aberration due to change in the strain. Inactivating one or some of the genes instead with point mutations 
would test this hypothesis. In the whole cluster deletion strain, AN6446-Oex AN6435-AN6457Δ, all 
metabolite production is eliminated including 4-hydroxy-3,6-dimethyl-2-pyrone strongly indicating that this 
metabolite is a product of the cluster. However, the eliminated production may reflect the deletions of 
AN6435 to AN11921. A cluster deletion from AN6444 to AN6451 would be an alternative. Moreover, the 
phenotypes of these strains were very similar as the metabolic profiles were. The strains all showed the same 
differences from the reference strain, namely the massive production of the siderophore triacetylfusarinine.  
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 Figure 9 UHPLC-TOF-MS ESI+ BPC of the micro-extracts of the (from bottom to top) reference, AN6446-Oex, 
AN6446-Oex AN6435-6437Δ, AN6446-Oex AN6438-6440Δ, AN6446-Oex AN6441Δ, AN6446-Oex AN11920Δ, 
AN6446-Oex AN11921Δ, AN6446-Oex AN6435-6457Δ strains cultivated on MM medium for seven days at 37°C.  
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 Figure 10 UHPLC-TOF-MS ESI+ BPC of the micro-extracts of the (from bottom to top) AN6446-Oex, AN6446-Oex 
AN6443Δ, AN6446-Oex AN6445Δ, AN6446-Oex AN11922Δ, AN6446-Oex AN6452-6454Δ, AN6446-Oex AN6454-
6457Δ strains cultivated on MM medium for seven days at 37°C. The figure illustrates that these genes are not 
involved in the pkbA gene cluster in agreement with the qRT-PCR data. 
The ESI+ BPC chromatograms of the micro-extracts of the second group of strains are collected in figure 10. 
These mutant strains all have chromatograms mimicking the profile of AN6446-Oex. In this group, the 
colonies of the strains in figure 8 resembled the overexpression strain, and these results are in agreement 
with the qRT-PCR data, which excluded these genes to be part of 3-MOA gene cluster.    
The last group of mutant strains collected in figure 11 as BPC chromatograms of the micro-extracts, actually 
constitute the strains pointing out from the gene expression analysis as belonging to the cluster as depicted in 
figure 12. The metabolites isolated in this study are listed in table 1 if present in the extracts of mutant 
strains. There are also other peaks appearing in the chromatograms, however no metabolite have been 
assigned to these at the present time.   
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 Figure 11 UHPLC-TOF-MS ESI+ BPC of the micro-extracts of the AN6446-Oxe, AN6448-Oex, AN6446-Oex 
AN6444Δ, AN6446-Oex AN6446Δ, AN6446-Oex AN6447Δ, AN6446-Oex pkbAΔ, AN6446-Oex AN6449Δ, 
AN6446-Oex AN6450Δ and AN6446-Oex AN6451Δ strains cultivated on MM medium for seven days at 37°C. 
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Table 2 Detection of metabolites (through EIC+) in the micro-extracts of the deletion and overexpression strains 
constructed and identified as belonging to the 3-methylorsellinic clusters in this study; (from bottom to top) AN6446-
Oex, AN6448-Oex, AN6446-Oex AN6444Δ, AN6446-Oex AN6447Δ, AN6446-Oex pkbAΔ, AN6446-Oex AN6449Δ, 
AN6446-Oex AN6450Δ, AN6446-Oex AN6451Δ. Parenthesis indicates the metabolites are present in trace amounts. 
*A metabolite eluting close to cichorine with a small mass difference makes further analysis needed for clarification. 
*A metabolite eluting close to cichorine with a small mass difference makes further analysis needed for 
clarification.**Eluting at 2.9 minutes.***Eluting at 4.7 minutes   
Metabolite AN6446-Oex pkbA -Oex AN6444Δa AN6447Δa pkbAΔa AN6449Δa AN6450Δa AN6451Δa 
3-methyl-
orsellinic acid 
 
(+) 
 
+ 
 
+ 
 
+ 
 
- 
 
+ 
 
(+) 
 
+ 
Cichorine* + + - - - - + - 
Nidulol + + - - - - + - 
Demethyl-
nidulol 
+ - + - (+) - + - 
Cichonidulol (+) - - - - - - - 
Demethyl-
cichonidulol 
- - - - - - - - 
4-hydroxy-
3,6-dimethyl-
2-pyrone 
 
+ 
 
+ 
 
+ 
 
(+) 
 
- 
 
+ 
 
+ 
 
+ 
C9H10O3 - - - + - - - - 
C9H10O4 - - - + - (+) - (+) 
C10H12O3** - - - - - + - - 
C10H12O3*** + - - - - + - + 
C10H12O4 - - - - - + - + 
C15H19NO5 + (+) - - - + + - 
a strain having AN6446-Oex allele 
In the deletion of pkbA in the AN6446-Oex strain the isolated metabolites are all, except demethylnidulol, 
missing confirming that these metabolites are part of the 3-MOA gene cluster. Demethylnidulol were 
detected in trace amount and could be due to the conversion of orsellinic acid into the product, however this 
metabolite cannot be detected in several of the mutants.  
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AN6450 is predicted to encode an oxidoreductase, and showed in the qRT-PCR analysis to be regulated by 
AN6446, however the metabolite profile of AN6446-Oex AN6450Δ was equal to that of AN6446-Oex 
indicating that either it does not take part in the biosynthesis, or the product this enzymatic step was not 
detected. 
Figure 12. The 3-MOA, pkbA, gene cluster and the nearest neighbor genes. Arrows in black denotes cluster members 
and grey are genes not supported by data to be cluster members. 
Interestingly, AN6451 is predicted to be a transporter of the Major Facilitator Superfamily (MFS) having 
close to full sequence coverage and more than 50 % sequence identity to transporters from other fungi, e.g. 
the CtnC transporter of the citrinin biosynthesis in Monascus purpureus, and this deletion mutant is heavily 
impaired in growth. This indicates that some compartmentalization of the biosynthesis may occur and failure 
to transport either 3-MOA or 4-hydroxy-3,6-dimethyl-2-pyrone, or even other products in the pathway can 
be toxic, at least under the artificial conditions that overexpression of AN6446 offers.      
Table 3 Predicted function of the genes identified as belonging to the 3-methylorsellinic acid cluster. 
Gene Predicted function 
AN6444 NRPS-like 
AN6446 Transcription factor 
AN6447 O-methyltransferase 
pkbA PKS 
AN6449 Cytochrome P450 
AN6450 Oxidoreductase 
AN6451 Transporter 
 
Based on the metabolic profile of the deletion strains a biosynthetic pathway from 3-methylorsellinic acid to 
cichonidulol is proposed, figure 13. 4-hydroxy-3,6-dimethyl-2-pyrone disappears in the AN6446-Oex pkbAΔ 
strain and are only present in trace amounts in the AN6446-Oex AN6447Δ strain. As opposed to 3-
methylorsellinic acid the polyketide backbone seems to be C6 and not C8 and may be a shunt product of 
PkbA. If the methylation pattern in the assembly of the polyketide backbones of 3-methylorsellinic acid and 
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4-hydroxy-3,6-dimethyl-2-pyrone were the same one would expect the latter to be methylated at C5 and not 
C3 as is observed. This shows that there are several differences between the assembly of the two metabolites. 
Other metabolites with the same UV-spectrum as 4-hydroxy-3,6-dimethyl-2-pyrone were detected in the 
deletion strains but have not yet been isolated. Ahuja and co-workers (Ahuja 2012) isolated two products of 
the PkgA enzyme, dehydrocitreoisocoumarin and 6,8-dihydroxy-3-(2-oxopropyl)-isocoumarin where the 
difference of the polyketide backbone also was the incorporation of one malonyl-CoA less in the latter.    
The first step of the biosynthesis is likely to be oxidation and reduction of 3-MOA. The proposed 
intermediates are the 3-MOA in which the carboxylic acid has been reduced to an aldehyde (C9H10O3) and 
the 6-methyl oxidated (C9H10O3). Due to the appearance of metabolites identified to have these molecular 
formulas in the AN6447Δ strain the next step is proposed to be O-methylation of the 2-OH catalyzed by the 
enzyme encoded by AN6447. This metabolite could then undergo ring closure to form nidulol. The C7-
carbonyl of nidulol, silvaticol, has also been reported in the literature isolated from A. silvaticus (Fujita 1984) 
and Kawahara and co-workers (Kawahara 1988) suggest quadrilineatin as the intermediate before ring 
closure thereby explaining that both metabolites nidulol and silvaticol are present in A. silvaticus. Neither 
silvaticol nor quadrilineatin have been detected in any of the examined extracts yet.    
The metabolic profile of the AN6446-Oex AN6449Δ and AN6446-Oex AN6451Δ appear to be similar. 
Several peaks appear in these two deletions where the molecular formula for one of these is equal to the 
proposed methylated product of AN6447 (C10H12O4) indicating that these enzymes are involved in the next 
steps of the biosynthesis. The roles for these two enzymes in the biosynthesis are still unknown but 
identification of the intermediates could provide helpful answers. AN6449 encodes for a cytochrome P450 
which could be responsible for the oxidation of the C10H12O4 to a quadrilineatin proposed in figure 13 which 
could then undergo further modifications to cichorine.  
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Figure 13 Proposed biosynthetic route of the elucidated metabolites of the pkbA cluster. The metabolites in boxes have 
all been identified through NMR-analyses, whereas the metabolites in brackets are proposed intermediates which have 
been detected through MS-analysis and the rest have not been detected.  
In the AN6444Δ strain the production of several metabolites have terminated including cichorine and other 
nitrogen containing metabolites for example a metabolite eluding at 4.2 minutes with the molecular formula 
C15H19NO5 (identified through LC-TOF-MS). The role of AN6444 strongly indicates contribution of the 
nitrogen to the molecule and ring closure. As no new intermediates were detected in the extracts the exact 
role of the enzyme remains elusive. The nitrogen incorporated in the structure could arise from either 
transamination as seen in the biosynthesis of amino acids or from an amino acid which reacts with the 
dialdehyde. This reaction could yield a lactam where the rest of the amino acid is still attached to the 
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nitrogen followed by decarboxylation as seen for erinacerin A, figure 14, where the residual part of 
decarboxylated phenyalalanine is attached to the lactam-N (Yaoita 2005). The above mentioned metabolite, 
C15H19NO5, which was present in the AN6446-Oex and AN6446-Oex AN6449Δ strains could indeed 
resemble the product, figure 14, of these reactions if the amino acid was 2-aminoadipic acid. Bioinformatic 
analysis of AN6444 supports this hypothesis since predicts the adenylation domain of AN6444 to encode for 
this amino acid. This amino acid residue would then have to be cleaved from the molecule to reach 
cichorine. A way to test this hypothesis is to do feeding experiments with labeled 2-aminoadipic acid. 
Aspernidine A and B (not detected in these extracts) are two other metabolites reported from A. nidulans by 
Scherlach and co-workers (Scherlach 2010) where nitrogen is incorporated into aromatic part of the structure 
and is proposed to be derived from an orsellinic acid. The nitrogen of these metabolites could also arise from 
AN6444 or other NRPS-like enzymes.   
 
Figure 4.32 The structure of erinacerin A, 2-aminoadipic acid and proposed structure of C15H19NO5. 
It remains unknown whether the dimers, cichonidulol and demethylcichonidulol, were catalyzing by an 
enzyme or the dimerization occurred non-enzymatic. Due to the small production of the metabolites in the 
overexpression strain the data obtained is not sufficient for identifying the enzyme.  
This study has through qRT-PCR and subsequent chemical analysis identified the genes belonging to the 3-
methylorsellinic acid gene cluster. Several metabolites have been isolated, structure elucidated and linked to 
the gene cluster e.g. nidulol, cichonidulol, demethylcichonidulol and 4-hydroxy-3,6-dimethyl-2-pyrone. The 
function of AN6447 has been shown to be O-methylation and data strongly suggests that AN6444 is 
involved in the incorporation of a nitrogen atom into the structure which might occur through an aminoadipic 
intermediate. Several interesting intermediates have been identified through QTOF-MS analysis and remain 
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to be isolated and structure elucidated to shed more light over the biosynthesis. A shunt product of the PKS 
has been identified and through analysis of the PKS deletion library and data of the strains constructed in this 
work it have been linked to PkbA.   
Materials and methods 
Strains and media. The A. nidulans strain IBT29539, nkuAΔ, (argB2, pyrG89, veA1, nkuAΔ) was used for 
overexpressing AN6446, and the IBT28738 (nkuA-trS) was used as reference in qRT-PCR experiments as 
well as a control in metabolite analysis (argB2, pyrG89, veA1, nkuA-trS::AFpyrG) (Nielsen 2008). In table 1, 
all strains available and constructed in this study are listed. Escherichia coli strain DH5α was used for 
cloning.  
Fungal minimal medium (MM) was as described in (Cove 1966), but with 1% glucose, 10 mM NaNO3 and 
2% agar (Sorbigel, Hendaye, France), when necessary supplemented with 10 mM uridine (Uri), 10 mM 
uracil (Ura) and 4 mM L-arginine (Arg). Elimination of the pyrG marker was done on 5-FOA (1.3 mg/ml) 
supplemented MM, as previously described in Nielsen (2006). All chemicals were from Sigma-Aldrich (St. 
Louis, Mo, USA) unless otherwise stated. 
Table 4. List of strains used in this study 
Strain Genotype 
nkuAΔa nkuAΔ 
nkuA-trSa nkuA-trS::AFpyrG 
AN6444Δ nkuAΔ, AN6444Δ 
AN6445Δ nkuAΔ, AN6445Δ 
AN6446Δ nkuAΔ, AN6446Δ 
AN6446-Oex nkuAΔ, IS1::PgpdA-AN6446-TtrpC::AFpyrG  
AN6446-Oex AN6451Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6451Δ::AFpyrG 
AN6446-Oex AN6450Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6450Δ::AFpyrG 
AN6446-Oex AN6449Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6449Δ::AFpyrG 
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AN6446-Oex AN11922Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN11922Δ::AFpyrG 
AN6446-Oex AN6448Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6448Δ::AFpyrG 
AN6446-Oex AN6447Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6447Δ::AFpyrG 
AN6446-Oex AN6446Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6446Δ::AFpyrG 
AN6446-Oex AN6445Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6445Δ::AFpyrG 
AN6446-Oex AN6444Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6444Δ::AFpyrG 
AN6446-Oex AN6443Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6443Δ::AFpyrG 
AN6446-Oex AN11921Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN11921Δ::AFpyrG 
AN6446-Oex AN11920Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN11920Δ::AFpyrG 
AN6446-Oex AN6441Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6441Δ::AFpyrG 
AN6446-Oex AN6457-55Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC, AN6457-AN6455Δ::AFpyrG 
AN6446-Oex AN6454-52Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC::AFpyrG, AN6454-AN6452Δ::AFpyrG 
AN6446-Oex AN6440-38Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC::AFpyrG, AN6440-AN6438Δ::AFpyrG 
AN6446-Oex AN6437-35Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC::AFpyrG, AN6437-AN6435Δ::AFpyrG 
AN6446-Oex AN6437-57Δ nkuAΔ, IS1::PgpdA-AN6446-TtrpC::AFpyrG, AN6437-AN6457Δ::AFpyrG 
pkbA-Oex nkuAΔ, IS1::PgpdA-pkbA-TtrpC::argB 
a Strain from Nielsen et al., 2008 
 
Primers used in this study 
USER Deletion Primers 
AN6451-DL-Up-FU GGGTTTAAUTGTCAGAGAAGCGAGGAAC 
AN6451-DL-Up-RU GGACTTAAUGGCCGGCGAACAATAGATA 
AN6451-DL-Dw-FU GGCATTAAUCCTCGGTTCTTGACAACG 
AN6451-DL-Dw-RU GGTCTTAAUCACATTCTCCATCGCTCTC 
AN6450-DL-Up-FU GGGTTTAAUAGAGTGATCAGTTGGAGGAT 
AN6450-DL-Up-RU GGACTTAAUGAGACTGCTACGCCTGATAT 
AN6450-DL-Dw-FU GGCATTAAUGGCTGTTCATCTTCGTACTC 
AN6450-DL-Dw-RU GGTCTTAAUTCTAGCCATCGTTCTGGTC 
AN6449-DL-Up-FWD GGGTTTAAUGGCTATATTGTTGGTGGTGT 
AN6449-DL-Up-RU GGACTTAAUGAGTACGAAGATGAACAGCC 
AN6449-DL-Dw-FU GGCATTAAUGGTTGATGAAGTAGTCTGAG 
AN6449-DL-Dw-RU GGTCTTAAUCCAATATAGAAGCGACGGTC 
AN11922-DL-Up-FU GGGTTTAAUCATCCACTGTTTCGTCTCAT 
AN11922-DL-Up-RU GGACTTAAUAGGCGAAGACACATTGATG 
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AN11922-DL-Dw-FU GGCATTAAUGGCCAATCATCCATACAGTG 
AN11922-DL-Dw-RU GGTCTTAAUTGGCTCGACTACTTCTGGAA 
AN6448-DL-Up-FU GGGTTTAAUCGGCTAGACTCCACTTACAA 
AN6448-DL-Up-RU GGACTTAAUGGCTCGAACACACCTATGAA 
AN6448-DL-Dw-FU GGCATTAAUAGAGGAGATACCACGAAGAT 
AN6448-DL-Dw-RU GGTCTTAAUACAGACTCCTTGATATGACG 
AN6447-DL-Up-FU GGGTTTAAUTAGACTGAATTGAACGACGC 
AN6447-DL-Up-RU GGACTTAAUAAGAATGCTTGGAGTGGACA 
AN6447-DL-Dw-FU GGCATTAAUGGTGTCTGTCCACTTGTTG 
AN6447-DL-Dw-RU GGTCTTAAUGTACTGGTAATGGTTGAGGTG 
AN6446-DL-Up-FU GGGTTTAAUCCAGCTCCGATATATTGTGC 
AN6446-DL-Up-RU GGACTTAAUTTGGAGGTATTCTGGAAGGT 
AN6446-DL-Dw-FU GGCATTAAUGTTCTTGGTGTCGTGTCGTA 
AN6446-DL-Dw-RU GGTCTTAAUCATCGAAGACAGCATACCT 
AN6445-DL-Up-FU GGGTTTAAUGGTGGCAAGAACAATCGTAT 
AN6445-DL-Up-RU GGACTTAAUAGATGATGAAGCTGTAGTGTG 
AN6445-DL-Dw-FU GGCATTAAUGAGAGGAGATAGAAGGCTTG 
AN6445-DL-Dw-RU GGTCTTAAUTCATCCTTCATCGCCATTCA 
AN6444-DL-Up-FU GGGTTTAAUGGATACCATAACGCTCAAGA 
AN6444-DL-Up-RU GGACTTAAUTCTCACGCGATCTGACACTA 
AN6444-DL-Dw-FU GGCATTAAUCGGTTGCTAGACGTTATCT 
AN6444-DL-Dw-RU GGTCTTAAUGCGGTCCAAGAGATGTGA 
AN6443-DL-Up-FU GGGTTTAAUTCCGACCAGAAGATTCGT 
AN6443-DL-Up-RU GGACTTAAUAATAGCCTTGACGTGGAC 
AN6443-DL-Dw-FU GGCATTAAUTTGGAACAGCTGAAGACTC 
AN6443-DL-Dw-RU GGTCTTAAUCTCGTCTTCTCTTAACCTCG 
AN6441-DL-Up-FU GGGTTTAAUTGGGTTAGCCACGCTCAG 
AN6441-DL-Up-RU GGACTTAAUGGCTCTAGAAGTTGAAGACTGCTG 
AN6441-DL-Dw-FU GGCATTAAUGTGGTTTGGCGTCTTGAGTGG 
AN6441-DL-Dw-RU GGTCTTAAUCAGAGTGTCAGGGGCTGAG 
AN11921-DL-Up-FU GGGTTTAAUCAGCTGAGGCATGCAGAG 
AN11921-DL-Up-RU GGACTTAAUGGGGTTGTTGAAATCGAGTGTTGG 
AN11921-DL-Dw-FU GGCATTAAUGTATGAGTCATAGCGCGCG 
AN11921-DL-Dw-RU GGTCTTAAUGTCACGTGCGCAAGCTAATCG 
AN11920-DL-Up-FU GGGTTTAAUCGCCGCCCTTACCCAACG 
AN11920-DL-Up-RU GGACTTAAUCGTCCAGAACCGCATAGTCTAGC 
AN11920-DL-Dw-FU GGCATTAAUGAGACTGGAGAATGGGTCTGG 
AN11920-DL-Dw-RU GGTCTTAAUGTCTAATTCGGTTTGGAACAGCTG 
Fusion PCR Deletion Primers 
AN6457-DL-Dw-Fad aattccagctgaccaccatgGCGTACACGCTGCGCGGAC 
AN6457-DL-Dw-R GCTGACCAGGCCGTATCTTCC 
AN6454-DL-Dw-Fad aattccagctgaccaccatgGCGAGATGATGGGCAGGA 
AN6454-DL-Dw-Rad gatccccgggaattgccatgGCTCTGTTGGACCCCACCT 
AN6452-DL-Up-F GCTGATTGCAGTCTGCCTG 
AN6452-DL-Dw-Rad gatccccgggaattgccatgCGAGGGGGATGTAAACAGC 
AN6440-DL-Dw-Fad aattccagctgaccaccatgGCAAGCAAGGCAGCTGTTC 
AN6440-DL-Dw-R GACACGAGCCTCCACGATG 
AN6438-DL-Up-F GCAGCGTCTCTATCGGATG 
AN6438-DL-Up-Rad gatccccgggaattgccatgGCCATCACTCGGTATGAGC 
AN6437-DL-Dw-Fad aattccagctgaccaccatgGCATGTGCATATGAAAGCTCT 
AN6437-DL-Dw-R GCTGTGAACCAGCGTGTC 
AN6435-DL-Up-F GCCATTCTTGCTTGGAAGC 
AN6435-DL-Up-Rad gatccccgggaattgccatgCGTTTCAAGGTCAGACCCTG 
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Check Primers 
AN64TT-CHK-F GCCGATTCAAGCACTCTGC 
AN64TT-CHK-R GCGTCTGCCTTCACTTGC 
AN6457-CHK-Int-R GCAAGCAAGGACAACTCG 
AN6455-CHK-Dw-F GCTGCAGATCGTCTGCTCAG 
AN6455-CHK-Dw-R CCTGCAGAAGCGCCCAGT 
AN6454-CHK-F GGCGTATACGACCGAGAAGC 
AN6454-CHK-Int-R GCTCCCGTGGACGAACC 
AN6453-CHK-F GCGAGGTTACATCGACATGG 
AN6452-CHK-F GCACCAGTGATGAGAGCGAC 
AN6451-CHK-F TGTGAATCGTGTGGGCTCTA 
AN6451-CHK-R CTGCGATTCATGAGCTTTG 
AN6450-CHK-F GGGTGCGGGTAAAGTAGAAA 
AN6450-CHK-R GGCGTAGCAGTCTCCCAGTG 
AN6450-CHK-R CAATCTGCAGCCGTCACTA 
AN6449-CHK-F TGGCCGCACTAAAGACTGA 
AN6449-CHK-R GAGGTAAAGCAAGGCGTAT 
AN6448-CHK-F GCAGAGACCGAACTTGCGG 
AN6448-CHK-R GCCGCCACCATATGCAGAG 
AN6448-CHK-F TAATCGACATCATCGCCAGA 
AN6448-CHK-R GAATTTCGCCCATTGTACTG 
AN6447-CHK-F TGGGCTCTGAAGTCTGTATT 
AN6447-CHK-R GACACGACACCAAGAACTT 
AN6446-CHK-F GCAACTGACGACTTAGACT 
AN6446-CHK-R TAAGTGACGAGAGCTGGAAT 
AN6445-CHK-F GCACACCAATCTCAAACTG 
AN6445-CHK-R TACAACTTGGCGGACATCA 
AN6445-CHK-F GCGTCTAGCAGGGATGAAGG 
AN6445-CHK-R GCACCAGAGACCGAGGGC 
AN6444-CHK-F TTGTATTGTCTTTGCGCCTC 
AN6444-CHK-R CACGGCATAAGTCAGAAAGG 
AN6443-CHK-F CTCTCACTGTCTGCTCTCT 
AN6443-CHK-R TCAGGCTCAGTGTTACATC 
AN11922-CHK-F ATGGGAGTTGCTAACGAAAG 
AN11922-CHK-R TGTCAAACCTCGTCTCGTT 
AN11920-CHK-F GCTCAACGGATACGCCAGAG 
AN11920-CHK-R GCCGACGATCGTCTCCTG 
AN6441-CHK-F GCAGCGAACGTGACTGTGTG 
AN6441-CHK-R GCCAACAGCCGCGGAG 
AN6439-CHK-Int-F GCCTATACGCATCCTTTGC 
AN6438-CHK-F GCACCTTACAGACACGGACTGG 
AN6436-CHK-R GCGCCTGGACGAGACTC 
AN6435-CHK-F GCCAGCTGCACACCACTC 
qRT-PCR Primers 
AN6457-3-qRT-F CCTCCAAGAAGACGAACCCTG 
AN6457-3-qRT-R CTTGATCCGCTCAGAGCCC 
AN6456-3-qRT-F GCGACATGGGAGCAAAGAAGG 
AN6456-3-qRT-R GAATACTGGTGTAGGGGCTGG 
AN6455-3-qRT-F CCTATCCTCACCGTCTTCACC 
AN6455-3-qRT-R CCACACTGGCCCCAACCATATTC 
AN6454-3-qRT-F CAGCCGATATCATAGACGCC 
AN6454-3-qRT-R CCTCACCCTTACCCTGCTC 
AN6453-3-qRT-F CGAGAAGTCGGCAGTTGCG 
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AN6453-3-qRT-R GGACAAAAGGCTTGAGGGGG 
AN6452-3-qRT-F CACGACAATCATCCTCGCG 
AN6452-3-qRT-R CCTTTCAGTCCCACTAGCCC 
AN6451-3-qRT-F CGCCCATGTACCATCGACT 
AN6451-3-qRT-R CAACTTGCGGACCCTCTCG 
AN6450-3-qRT-F CTTCCTGAACGGCAAGTCAGAC 
AN6450-3-qRT-R GTCCCGAAACCCAGCTGC 
AN6449-3-qRT-F CAAGACGCTGTACAACTCGTTGC 
AN6449-3-qRT-R CCACCGGTTCTCCAAGTGC 
AN11922-3-qRT-F CCAACACCGCACGATTCTCC 
AN11922-3-qRT-R CACTGTCGTCAGCAGTCAAATCC 
AN6448-3-qRT-F GTCCCTACGCGCAGATCC 
AN6448-3-qRT-R CTTCCCAGACACCTCCTCCTTC 
AN6447-3-qRT-F TACATGCGGTACCCGCAC 
AN6447-3-qRT-R GCCAATCTCCACAATCCCAACC 
AN6446-3-qRT-F GGAGATACCAGACTGGACGG 
AN6446-3-qRT-R GGTACTGGTAATGGTTGAGGTGG 
AN6445-3-qRT-F GATGAGATCGTCGAGTGGCTG 
AN6445-3-qRT-R CTGGGGGAAGGAAAGGCATG 
AN6444-3-qRT-F GACAACCCAGCGAAGAAACTCC 
AN6444-3-qRT-R CTTCAACCACCCAATCTCCTTCCA 
AN6443-3-qRT-F GTATTGCGCATCGACTGAAGAC 
AN6443-3-qRT-R CTCCACCTGTCCGACAATATCC 
AN11921-3-qRT-F CTGCTCTCCATTTCCTCTTCGC 
AN11921-3-qRT-R CCACGAGTGTCACGACACC 
AN11920-3-qRT-F CCTGTTCTACCTCCACCATGC 
AN11920-3-qRT-R CACCAGCCCGTTCATCCAC 
AN6441-3-qRT-F GGCGATGGATATACCTGCGG 
AN6441-3-qRT-R GAGGCAGCTGAGGCTTGAG 
AN6440-3-qRT-F CCGACACAATCAGCTGCC 
AN6440-3-qRT-R CCGCCTTCGATATCCTATCCAC 
AN6439-3-qRT-F CCAGTACCTATATTTGCCGCCC 
AN6439-3-qRT-R GTCATCCATCGCAGGCAC 
AN6438-3-qRT-F CAGACTCGGATCATAGCATCC 
AN6438-3-qRT-R CCAGTCCTGGCTCCTCTTG 
AN6437-3-qRT-F CACCCGTACCTCGCACAC 
AN6437-3-qRT-R CCAGAGACTGCAGCCCTC 
AN6436-3-qRT-F GAGAGCGAGCAAGTGGTGC 
AN6436-3-qRT-R GGTTCACCAGGTCGTAGTAGTG 
AN6435-qRT-3-F GCCTCAACGTATTTCCCCTGG 
AN6435-qRT-3-R GAGCCCCTTCTTTGCGCC 
Overexpression Primers 
AN6446-Oex-FU AGAGCGAUATGAACGACACTTCTGGTCGAC 
AN6446-Oex-RU TCTGCGAUTCAGGACCCCGTGTTGTAC 
AN6448-Oex-5-FU AGAGCGAUATGGCTCCGGCACCATCC 
AN6448-Oex-5-RU AGCGGGAGAACUCGGCCGCTGTTTTAGTGTC 
AN6448-Oex-3-FU AGTTCTCCCGCUTTGGCCGCCTGGTAAGCA 
AN6448-Oex-3-RU TCTGCGAUTTACTTCCCAGACACCTCCTC 
 
PCR and DNA substrate construction.  
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The annotation of AspGD was used for retrieving gene sequence information. Oligonucletides were 
produced by IDT (Integrated DNA Technologies Inc, Coralville, IA, USA) or Sigma-Aldrich, see table x for 
list. The PfuX7 polymerase (Nørholm, 2010) was used in all PCR reactions as described in Hansen et al. 
(Hansen 2011). All DNA fragments for gene deletion and overexpression were assembled into 
transformation ready cassettes via the USER cloning technology as presented in Hansen et al., 2011, except 
for the triplet gene deletions, which were constructed by fusion-PCR as described in Nielsen et al., 2008. 
Overexpression construct for AN6446 were propagated in pU2111 having AsiSI/Nb.BtsI USER cassettes 
and AFpyrG flanked by direct repeats (Hansen 2011). The pU2002A vector designed to incorporate gene-
targeting sequences flanking DR-AFpyrG-DR was digested with PacI/Nt.BbvCI prior to mixing with 
appropriate PCR fragments and USER cloning. All gene-targeting substrates were liberated from their vector 
backbone with SwaI (1U/μl). Overexpression of pkbA was established in a modified pU1111 vector 
employing A. nidulans argB as genetic marker (Hansen et al., 2011), pDH57. The pDH57 vector carries the 
ccdB suicide gene from the GatewayTM cloning system (Invitrogen, Carlsbad, CA, USA), allowing 
elimination of background from uncut plasmid from the USERTM cloning reaction. The ccdB::camR cassette 
was amplified from pDONR (Invitrogen) using primers containing USER tails that were designed to restore 
the AsiSI/Nb.BtsI cassette. Furthermore, a silent point mutation was introduced in order to eliminate an 
Nb.BtsI nicking site in ampR. Primers for pkbA-Oex construct, split in two parts for USER fusion, were 
designed using the PHUSER program (Olsen 2011). The transformation substrate was excised from the 
vector by NotI digestion after manufacturer’s protocol.  
USER mix, restriction and nicking enzymes were purchased from New England Biolabs, Ipswich, MA, 
USA. Protoplasting and gene-targeting procedures were performed as described previously (Johnstone 2005, 
Nielsen 2006). Gene targeting events were verified by diagnostic spore-PCR in 40 μL reaction volume 
applying 20 min of initial denaturation. 
Relative gene expression by qRT-PCR. The AN6446-Oex, AN6446Δ and the reference strain were 
inoculated as three-points on MM+Arg for 5 days in the dark at 37 °C. Cultivations for plug extraction were 
done in parallel to confirm that the levels of gene expression also were resulting in appearance or absence of 
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metabolites as expected. Total RNA from the three strains was isolated with Qiagen Plant RNAeasy kit 
(Qiagen, Hilden, Germany). The samples were disrupted by a TissueLyser LT (Qiagen) using 45 Hz for 1 
min. 10 μg of RNA was DNAse I (Qiagen) treated after manufacturer’s protocol, with addition of 10U of 
RNAguard RNAse inhibitor (Amersham Biosciences, Nassau, NY, USA). 1 μg of DNAse I treated RNA 
samples were used in cDNA synthesis by the Phusion RT-PCR Kit (Finnzymes, Vantaa, Finland) according 
to manufacturer’s protocol. The subsequent qRT-PCR was performed in a Chromo 4TM Detector/PTC-200 
(MJ Research, St. Bruno, Canada) using the SYBR® Green JumpStart Taq ReadyMix (Sigma). hhtA 
(AN0733) encoding histone protein H3 was chosen as internal standard for normalization of expression 
levels. Only one of them, hhtA, was used for the fold change calculations. Primer combinations for the qPCR 
and sequences are listed in Supplementary table1. Moreover, two types of control samples were initially 
included for the qPCR; the DNAse treated RNA sample used for the reverse transcriptase reaction, and a 
template-free reaction to test for primer-dimer influence on the overall fluorescence. The final individual 
cDNA samples were added to the reactions as 5 times diluted samples. Samples were run in triplicates. The 
program was 94 °C for 2 min and cycling conditions 40 times; 94 °C for 10 s, 60 °C for 15 s, 72 °C for 30 s. 
A melting curve from 65 °C to 95 °C with reads every 0.2 min was ending the program to evaluate the purity 
of the reaction products. The fluorescence threshold values, C(t), was determined through the 
OpticonMonitor 3.1 software (MJ Research). The relative expression levels was approximated by 2-ΔΔC(t) as 
ΔΔC(t) = ΔC(t)normalized-ΔC(t)calibrator. The ΔC(t)normalized=ΔC(t)target gene-ΔC(t)internal_std and 
the calibrator C(t) values were the corresponding values from the reference strain. 
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Chemical characterization of mutant strains by LC-DAD-MS: All strains were grown as three point 
inoculations for 7 days at 37 degrees in the dark on solid media. Extraction of metabolites were performed 
by the agar plug extraction method (Smedsgaard 1997) using three 6mm agar plugs/extract. Extracts were 
analyzed by LC-HRMS. LC-HRMS analysis were made on a MaXis 3G QTOF (Bruker Daltronics) coupled to a 
Dionex Ultimate 3000 UHPLC system equipped with a 100 x 2.0 mm, 2.6 μm, Kinetex C-18 column. The 
separation column was held at a temperature of 40°C and a gradient system composed of A: 20 mM formic 
acid in water, and B: 20 mM formic acid in acetonitrile was used. The flow was 0.4 ml/min, 85% A 
graduating to 100% B in 0-10 min, 100% B 10-13 min, 85% A 13.1-15 minutes.  For calibration, a mass 
spectrum of sodium formate was recorded at the beginning of each chromatogram using the divert valve 
(0.3-0.4 min). Samples were analyzed both in positive and negative ionization mode. De-replication of 
induced compounds were performed by comparison of accurate mass to the metabolite database 
Antibase2009 (Laatsch 2010) as well as comparison of UV spectra to published data.  
 
Isolation of 3-methylorsellinic acid 
AN6444Δ was cultured on 100 MM plates for 7 days at 37°C in the dark. The plates were homogenized 
using a Stomacher and 100 mL ethyl acetate (EtOAc) + 1% formic acid (FA) pr. 10 plates. The extract was 
filtered after 1 hour and the remaining broth was extracted with EtOAc + 1% FA for 24 hours. The extract 
was filtered and the two fractions pooled and dried down on a freeze drier. The crude extract were 
separated into three phases by dissolving it in 9:1 MeOH:H2O – Milli-Q and extracted into a heptane phase 
followed by addition of H2O-Milli-Q to 1:1 methanol(MeOH):H2O – Milli-Q and extracted into a 
dicloromethane (DCM) phase and a aqueous phase. The aqueous phase was separated on a KP-C18-HS 
SNAP column using a Biotage Isolera One (Biotage, Uppsala, Sweden) using a gradient of 10% MeOH (H2O-
Milli-Q (Millipore, MA, USA)) to 100% over 15 CVs (column volumes) resulting in 22 fractions. Fraction 17 
contained 9.2 mg of pure 3-methylorsellinic acid and were concentrated on a rotarvap (Büchi V-855/R-215) 
and dried down under N2(g).  
 
Isolation of cichorine (X1) 
AN6446-Oex was cultured on 200 MM plates for 7 days at 37°C in the dark. The plates were homogenized 
using a Stomacher and 100 mL EtOAc + 1% FA pr. 10 plates. The extract was filtered after 1 hour and the 
remaining broth was extracted with EtOAc + 1% FA for 24 hours. The extract was filtered and the two 
fractions pooled and dried down on a freeze drier. The crude extract were separated into three phases by 
dissolving it in 9:1 MeOH:H2O – Milli-Q and extracted into a heptane phase followed by addition of H2O-
Milli-Q to 1:1 MeOH:H2O – Milli-Q and extracted into a DCM phase and a aqueous phase. The DCM phase 
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was separated on a KP-C18-HS SNAP column using a Biotage Isolera One (Biotage, Uppsala, Sweden) using a 
gradient of 10% MeOH (H2O-Milli-Q (Millipore, MA, USA)) to 100% over 15 CVs (column volumes) resulting 
in 22 fractions. Cichorine was present in fractions 12 and 13 and was purified on a Waters HPLC 
W600/996PDA (Milford, MA, USA ) using a RP column (Phenomenex Luna C18(2), 250 x 21.20 mm, 5 μm, 
Torrance, CA, USA) using an isocratic gradient of 20% MeCN (H2O – Milli-Q (Millipore, MA, USA)) over 20 
minutes with a flow of 15 mL/min. The collections were concentrated on a rotarvap (Büchi V-855/R-215) 
and dried down under N2(g) to yield 9.3 mg of cichorine. 
 
Isolation of nidulol 
AN6445Δ was cultured on 100 MM plates for 7 days at 37°C in the dark. The plates were homogenized 
using a Stomacher and 100 mL EtOAc + 1% FA pr. 10 plates. The extract was filtered after 1 hour and the 
remaining broth was extracted with EtOAc + 1% FA for 24 hours. The extract was filtered and the two 
fractions pooled and dried down on a freeze drier. The crude extract were separated into three phases by 
dissolving it in 9:1 MeOH:H2O – Milli-Q and extracted into a heptane phase followed by addition of H2O-
Milli-Q to 1:1 MeOH:H2O – Milli-Q and extracted into a DCM phase and a aqueous phase. The DCM and 
MeOH:H2O phases were separated seperately on a KP-C18-HS SNAP column using a Biotage Isolera One 
(Biotage, Uppsala, Sweden) using a gradient of 10% MeOH (H2O-Milli-Q (Millipore, MA, USA)) to 100% over 
15 CVs (column volumes) resulting in 22 fractions each. Nidulol was present in fraction 17 of both the 
phases and was purified on a Waters HPLC W600/996PDA (Milford, MA, USA ) using a RP column 
(Phenomenex Luna C18(2), 250 x 10 mm, 5 μm, Torrance, CA, USA) using a gradient of 15% MeCN (H2O – 
Milli-Q (Millipore, MA, USA)) to 30% MeCN over 5 min followed by 15 minutes of isocratic flow of 30% 
MeCN with 50 ppm TFA added to the solvents and a flow of 5 mL/min. The collections were concentrated 
on a rotarvap (Büchi V-855/R-215) and dried down under N2(g) to yield 1.2 mg of nidulol. 
 
Isolation of demethylnidulol  
The MeOH:H2O phase of the extract of the AN6446-Oex described for the isolation of cichorine was 
separated on a KP-C18-HS SNAP column using a Biotage Isolera One (Biotage, Uppsala, Sweden) using a 
gradient of 10% MeOH (H2O-Milli-Q (Millipore, MA, USA)) to 100% over 15 CVs (column volumes) resulting 
in 22 fractions. Demethylnidulol was present in fractions 12 and was purified on a Gilson 322 liquid 
chromatograph with a 215 liquid handler/injector (BioLab, Risskov, Denmark) using a RP column 
(Phenomenex Luna C18(2), 250 x 10 mm, 5 μm, Torrance, CA, USA) using a flow of 15% MeCN (H2O – Milli-
Q (Millipore, MA, USA)) over 10 minutes followed by a gradient from 15% to 95% MeCN with a flow of 5 
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mL/min. The collections were concentrated on a rotarvap (Büchi V-855/R-215) and dried down under N2(g) 
to yield 1.0 mg of cichorine.  
 
Isolation of cichonidulol 
Cichonidulol was present in fraction 18 of the separated DCM phase described in the isolation of cichorine 
and was purified on a Gilson 322 liquid chromatograph with a 215 liquid handler/injector (BioLab, Risskov, 
Denmark) using a RP column (Phenomenex Luna C18(2), 250 x 10 mm, 5 μm, Torrance, CA, USA) using a 
flow of 15% MeCN (H2O – Milli-Q (Millipore, MA, USA)) over 10 minutes followed by a gradient from 15 % 
to 95 % MeCN over 30 minutes with a flow of 5 mL/min. The collections were concentrated on a rotarvap 
(Büchi V-855/R-215) and dried down under N2(g) to yield 2.0 mg of cichonidulol. 
 
Isolation of demethylcichonidulol 
One of the fractions from the last purification step of cichonidulol contained demethylcichonidulol and was 
purified on a Gilson 322 liquid chromatograph with a 215 liquid handler/injector (BioLab, Risskov, Denmark) 
using a RP column (Phenomenex Luna C18(2), 250 x 10 mm, 5 μm, Torrance, CA, USA) using a flow of 15% 
MeCN (H2O – Milli-Q (Millipore, MA, USA)) over 10 minutes followed by a gradient from 15 % MeCH to 95 % 
MeCN over 20 minutes with a flow of 5 mL/min. The collections were concentrated on a rotarvap (Büchi V-
855/R-215) and dried down under N2(g) to yield 0.6 mg of demethylcichonidulol. 
 
Isolation of 4-hydroxy-3,6-dimethyl-2-pyrone  
4-hydroxy-3,6-dimethyl-2-pyrone was present in an earlier fraction than demethylnidulol in the purification 
procedure described previously. The collections were concentrated on a rotarvap (Büchi V-855/R-215) and 
dried down under N2(g) to yield 1.0 mg of cichorine. 
 
NMR studies and structure elucidation: NMR spectra were acquired in DMSO-d6 on a Varian Unity Inova 
500 MHz spectrometer for cichorine, 3-methylorsellinic acid, nidulol and 4-hydroxy-3,6-dimethyl-2-pyrone  
and on a Bruker Avance 800 MHz spectrometer at the Danish Instrument Center for NMR Spectroscopy of 
Biological Macromolecules for demethylnidulol, cichonidulol and demethylcichonidulol using standard 
pulse sequences. The spectra were referenced to this solvent with resonances δH = 2.49 and δC = 39.5. 
 
Characterization data of 3-methylorsellinic acid. 1H NMR (500 MHz, DMSO-d6): δ 13.06 (1H, br. s, 8-OH), 
9.98 (1H, s, 4-OH), 6.23 (1H, s, H-5), 2.38 (3H, s, H-7), 1.91 (3H, s, H-9); 13C NMR (125 MHz): δ 173.8 (C-8), 
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163.0 (C-2), 159.7 (C-4), 139.4 (C-6), 109.9 (C-5), 107.7 (C-3), 103.7 (C-1), 23.4 (C-7), 7.9 (C-9). HRMS (m/z): 
[M+H]+ calcd. for C9H11O4, 183.0652; found, 183.0648. 
 
NMR-table: 
Number 1H (ppm) 13C (ppm) Multiplicity  
(J/Hz) 
Integral HMBC 
1 - 103.7 - - - 
2 - 163.0 - - - 
3 - 107.7 - - - 
4 - 159.7 - - - 
4-OH 9.98 - s 1  
5 6.23 109.9 s 1 1, 3, 4, 7 ,8 ,9 
6 - 139.4 - - - 
7 2.38 23.4 s 3 1, 2, 5 , 6, 8 
8 - 173.8 - - - 
9 1.91 7.9 s 3 2, 3, 4, 6 
8-OH 13.06 - br. s 1 - 
 
Characterization data of cichorine. 1H NMR (500 MHz, DMSO-d6): δ 9.71 (1H, s, 4-OH), 8.41 (1H, s, N-H), 
6.81 (1H, s, H-5), 4.40 (2H, s, H-8), 3.84 (3H, s, H-10), 2.05 (3H, s, H-9); 13C NMR (125 MHz): δ 169.8 (C-7), 
156.3 (C-4), 153.6 (C-2), 131.9 (C-6), 123.1 (C-1), 118.9 (C-3), 102.9 (C-5), 58.9 (C-10), 9.1 (C-9). HRMS (m/z): 
[M+H]+ calcd. for C10H12NO3, 194.08117; found, 194.08123. 
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Number 1H (ppm) 13C (ppm) Multiplicity  
(J/Hz) 
Integral HMBC 
1 - 123.1 - - - 
2 - 153.6 - - - 
3 - 118.9 - - - 
4 - 156.3 - - - 
4-OH 9.71 - s 1 3, 4 
5 6.81 102.9 s 1 1, 2, 3, 4, 6, 7, 9  
6 - 131.9 - - - 
7 - 169.8 - - - 
8 4.40 43.1 s 2 1, 2, 4, 5, 6, 7, 10  
9 2.05 9.1 s 3 1, 2, 3, 4, 5, 6 
10 3.84 58.9 s 3 2, 8 
N-H 8.41 - s 1 1, 6, 7, 8 
 
 
Characterization data of nidulol. 1H NMR (500 MHz, DMSO-d6): δ 10.72 (1H, s, 4-OH), 6.73 (1H, s, H-5), 5.17 
(2H, s, H-7), 3.87 (3H, s, H-10), 2.05 (3H, s, H-9); 13C NMR (125 MHz): δ 168.5 (C-8), 162.7 (C-4), 157.5 (C-2), 
148.6 (C-6), 117.5 (C-3), 107.2 (C-1), 103.0 (C-5), 68.2 (C-7), 61.1 (C-10), 8.2 (C-9). HRMS (m/z): [M+H]+ 
calcd. for C10H11O4, 195.0652; found, 195.0652. 
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NMR-table: 
Number 1H (ppm) 13C (ppm) Multiplicity  
(J/Hz) 
Integral HMBC 
1 - 107.2 - - - 
2 - 157.5 - - - 
3 - 117.5 - - - 
4 - 162.7 - - - 
4-OH 10.72 - s 1 3, 4 
5 6.73 103.0 s 1 1, 3, 7 
6 - 148.6 - - - 
7 5.17 68.2 s 2 1, 6, 8 
8 - 168.5 - - - 
9 2.02 8.2 s 3 2, 3, 4 
10 3.87 61.1 s 3 2 
 
Characterization data of demethylnidulol: 1H NMR (800 MHz, DMSO-d6): δ 5.67 (1H, s, H-5), 5.64 (1H, s, H-
3), 4.82 (2H, s, H-7), 3.61 (3H, s, H-10); 13C NMR (200 MHz): δ 178.1 (C-8), 168.8 (C-4), 159.6 (C-2), 151.4 (C-
6), 103.2 (C-5), 101.1 (C-3), 92.9 (C-1), 66.9 (C-7), 53.9 (C-10). HRMS (m/z): [M+H]+ calcd. for C9H9O4, 
181.0495; found, 181.0497. 
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NMR-table: 
Number 1H (ppm) 13C (ppm) Multiplicity  
(J/Hz) 
Integral HMBC 
1 - 92.9 - - - 
2 - 159.6 - - - 
3 5.64 101.1 s 1 5, 6 
4 - 168.8 - - - 
5 5.67 103.2 s 1 3, 6 
6 - 151.4 - - - 
7 4.82 66.9 s 2 1, 2, 4, 5, 6, 8 
8 - 178.1 - - - 
10 3.61 53.9 s 3 2, 3 
 
Characterization data of cichonidulol. 1H NMR (800 MHz, DMSO-d6): δ 9.74-10.11 (1H, br. s), 7.21 (1H, d, J 
= 1.8 Hz, H-8’), 6.91 (1H, s, H-5), 6.59 (3H, s, H-5’), 5.17 (1H, d, J = 12.3 Hz, H-7’b), 4.88 (1H, d, J = 12.3 Hz, 
7’a), 4.28 (1H, d, J = 16.3 Hz, H-8b), 3.75 (1H, d, J = 16.3 Hz, H-8a), 3.70 (3H, s, H-10), 3.56 (3H, s, H-10’), 2.05 
(3H, s, H-9), 1.98 (3H, s, H-9’); 13C NMR (200 MHz): δ 167.1 (C-7), 158.1 (C-4’), 156.9 (C-4), 153.8 (C-2’), 
153.6 (C-2), 139.5 (C-6’), 131.0 (C-6), 121.3 (C-1), 120.5 (C-3), 116.1 (C-1’), 115.3 (C-3’), 103.4 (C-5), 102.4 
(C-5’), 83.5 (C-8’), 71.7 (C-7’), 95.2 (C-10’), 59.0 (C-10), 43.2 (C-8), 9.3 (C-9), 8.6 (C-9’). HRMS (m/z): [M+H]+ 
calcd. for C20H22NO6, 372.1442; found, 372.1441. 
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NMR-table: 
Number 1H (ppm) 13C (ppm) Multiplicity  
(J/Hz) 
Integral HMBC DQF-COSY 
1 - 121.3 - - - - 
2 - 153.6 - - - - 
3 - 120.5 - - - - 
4 - 156.9 - - - - 
5 6.91 103.4 s 1 1, 4, 7 - 
6 - 131.0 - - - - 
7 - 167.1 - - - - 
8a 3.75 43.2 d (16.3) 1 1, 6 8b 
8b 4.28 43.2 d (16.3) 1 1, 6 8a 
9 2.05 9.3 s 3 2, 3, 4 - 
10 3.70 59.0 s 3 2 - 
1’ - 116.1 - - - - 
2’ - 153.8 - - - - 
3’ - 115.3 - - - - 
4’ - 158.1 - - - - 
5’ 6.59 102.4 s 1 1’, 4’, 7’ - 
6’ - 139.5 - - - - 
7’a 4.88 71.7 d (12.3) 1 1’, 6’, 8’ 7’b 
7’b 5.17 71.7 d (12.3) 1 6’ 7’a, 8’ 
8’ 7.21 83.5 d (1.8) 1 1’, 7’, 8 7’b 
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9’ 1.98 8.6 s 3 2’, 3’, 4’, 5’ - 
10’ 3.56 59.2 s 3 2’ - 
 
Characterization data of demethylcichonidulol. 1H NMR (500 MHz, DMSO-d6): δ  HRMS (m/z): 6.97 (1H, d, J 
= 2.2, H-8’), 6.90 (1H, s, H-5), 6.35 (1H, s, H-3’ or H-5’), 6.34 (1H, s, H-3’ or H-5’), 5.16 (1H, dd, J =12.8, 2.2 
Hz, H-7’a), 4.86 (1H, d, J = 12.8 Hz, H-7’b), 4.25 (1H, d, J = 16.0 Hz, H-8a), 3.78 (1H, d, J = 16 Hz, H-8b), 3.71 
(3H, s, H-10), 3.63 (3H, s, H-10’), 2.05 (3H, s, H-9). HRMS (m/z): [M+H]+ calcd. for C19H20O6, 358.1285; found 
358.1283. 
 
 
 
Characterization data of 4-hydroxy-3,6-dimethyl-2-pyrone. 1H NMR (500 MHz, DMSO-d6): δ 5.46 (1H, s, H-
5), 1.93 (3H, s, 3-CH3), 1.56 (3H, s, 6-CH3); 13C NMR (125 MHz): δ 174.9 (C-4), 166.0 (C-2), 156.0 (C-6), 106.6 
(C-5), 91.0 (C-3), 19.0 (6-CH3), 9.1 (3-CH3). HRMS (m/z): [M+H]+ calcd. for C7H9O3, 141.0546; found, 
141.0543.  
 
NMR-table: 
Number 1H (ppm) 13C (ppm) Multiplicity  
(J/Hz) 
Integral HMBC 
2 - 166.0 - - - 
3 - 91.0 - - - 
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4 - 174.9 - - - 
5 5.46 106.0 s 1 3, 6, 6-CH3 
6 - 156.0 - - - 
6-CH3 1.93 19.1 s 3 5, 6 
3-CH3 1.56 9.1 s 3 3, 4, 5 
 
 
 
1H NMR spectrum 3-methylorsellinic acid in DMSO-d6 
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1H NMR spectrum cichorine in DMSO-d6 
 
 
1H NMR spectrum nidulol in DMSO-d6 
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1H NMR spectrum demethylnidulol in DMSO-d6 
 
1H NMR spectrum cichonidulol in DMSO-d6 
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1H NMR spectrum demethylcichonidulol in DMSO-d6 
 
1H NMR spectrum 4-hydroxy-3,6-dimethyl-2-pyrone in DMSO-d6 
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Introduction 
The construction of a deletion library of 32 putative PKS encoding genes constructed in our group by 
Nielsen et al. (Nielsen 2011) made us look into the production of polyketides in other strains of A. nidulans 
to identify candidates to isolate, structure elucidate and, if possible, link to their synthase genes. Linking of 
metabolites present in small quantities in the reference strain could be possible due to the possibility of 
comparison with an isolated standard. In the search of new secondary metabolites of A. nidulans we 
investigated the IBT culture collection at CMB. The strain chosen for the study IBT24909 produced, among 
others, four metabolites of which three, asperugin B, nidubenzal A, and B were isolated and structure 
elucidated and the last, asperugin A were putatively identified through LC-MS analysis. These metabolites 
were detected in trace amounts in the reference strains of the above mentioned deletion study and 
candidates were chosen for a deletion study in a cclAΔ strain which also produced these metabolites. 
Asperugin A and B were linked to the PKS encoding gene AN3230, pkfA, which have been shown by Ahuja 
and co-workers (Ahuja 2012) to catalyze the production of orsellinaldehyd. The biosynthetic origin of the 
novel metabolites nidubenzal A and B remains to be clarified.  
Materials and methods 
Strains 
Nine strains of A. nidulans strains were used in a cclA deletion series, see supplementary table 1. 
Protoplasting and genetic transformation was as described in Johnstone et al. (Johnstone 1985) and Nielsen 
et al. (Nielsen 2006). IBT28738 was used as reference strain for chemical analysis (argB2, pyrG89, veA1, 
nkuA-trS::AFpyrG) (Nielsen 2008). Escherichia coli strain DH5α was used for cloning. The IBT24909 was used 
for isolation of aspuridone B and nidubenzal A and B. 
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Media 
Fungal minimal medium (MM) was as described in (Cove 1966), but with 1% glucose, 10 mM NaNO3 and 2% 
agar (Sorbigel, Hendaye, France), when necessary supplemented with 10 mM uridine (Uri), 10 mM uracil 
(Ura) and 4 mM L-arginine (Arg). For transformation medium, glucose was replaced with 1 M sucrose. 
Elimination of the Aspergillus fumigatus pyrG marker was done on 5-FOA (1.3 mg/ml) supplemented MM, 
as previously described by Nielsen et al. 2006 (Nielsen 2006). All chemicals were from Sigma-Aldrich (St. 
Louis, Mo, USA) unless otherwise stated. CYA, CYAs, YES, RT, CY20, RTO, and YE were prepared as described 
in Nielsen et al. (Nielsen 2011).  
PCR and DNA substrate construction 
The Aspergillus genome database (AspGD) was used for retrieving gene sequence information. 
Oligonucletides were produced by IDT (Integrated DNA Technologies Inc, Coralville, IA, USA) or Sigma-
Aldrich, see supplementary table 2 for list. The PfuX7 polymerase (Nørholm, 2010) was used in all PCR 
reactions as described in Hansen et al., 2011. Deletion of qutC was based on bipartite gene targeting 
substrates by fusion-PCR and the recyclable AFpyrG marker with direct repeats (Nielsen et al., 2006; 2008), 
whereas the cclAΔ DNA substrate for the deletion series was based on the USER technology. The pU2002A 
vector designed to incorporate gene-targeting sequences flanking the AFpyrG marker with direct repeats 
was digested with PacI/Nt.BbvCI prior to mixing with appropriate PCR fragments and USER cloning. The 
cclAΔ deletion substrate was linearized prior to transformation with SwaI (1U/μl) according to 
manufacturer’s protocol. USER mix, restriction and nicking enzymes were from New England Biolabs, 
Ipswich, MA, USA. 
Chemical analysis 
All cclAΔ strains were grown as three point inoculations for 7 days at 37 degrees in the dark on solid media. 
Extraction of metabolites were performed by the agar plug extraction method (Smedsgaard 1997) using 
three 6mm agar plugs/extract. Extracts were analyzed by UHPLC-DAD and LC-HRMS. UHPLC-DAD analysis 
was performed on a Dionex RSLC Ultimate 3000 (Dionex, Sunnyvale, CA) equipped with a diode-array 
detector. Separation was performed at 60°C on a 150 mm × 2.1 mm ID, 2.6 μm Kinetex C18 column 
(Phenomenex, Torrence, CA) using a linear water/MeCN (both buffered with 50 ppm tri-fluoroacetic acid 
(TFA)) gradient starting from 15% MeCN to 100% over 7 min at a flow rate of 0.8 mL min-1. LC-HRMS 
analysis were made on a MaXis 3G QTOF (Bruker Daltronics) coupled to a Dionex Ultimate 3000 UHPLC 
system equipped with a 100 x 2.0 mm, 2.6 μm, Kinetex C-18 column. The separation column was held at a 
temperature of 40°C and a gradient system composed of A: 20 mM formic acid in water, and B: 20 mM 
formic acid in acetonitrile was used. The flow vas 0.4 ml/min, 85% A graduating to 100% B in 0-10 min, 
100% B 10-13 min, 85% A 13.1-15 min.  For calibration, a mass spectrum of sodium formate was recorded 
at the beginning of each chromatogram using the divert valve (0.3-0.4 min). Samples were analyzed both in 
positive and negative ionization mode. De-replication of induced compounds were performed by 
comparison of accurate mass to the metabolite database Antibase2010 (Laatsch 2010) as well as 
comparison of UV spectra to published data. 
The IBT24909 extract was analyzed by a HPLC-DAD-HRMS on a 5 cm x 3 μm, Luna C18 (2) column 
(Phenomenex) using a water-acetonitrile gradient from 15 % CH3CN to 100 % over 20 minutes (20 mM 
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formic acid). LC-DAD-MS analysis was performed on a LCT oaTOF mass spectrometer (Micromass, 
Manchester, UK) as in Nielsen et al. (Nielsen 2003, Nielsen 2009)   
Isolation of nidubenzal A and B 
IBT24909 was cultured on 200 CYAs plates for 13 days at 25°C in the dark. The plates were homogenized 
using a Stomacher and 100 mL ethyl acetate (EtOAc) + 1% formic acid (FA) pr. 10 plates. The extract was 
filtered after 1 hour and the remaining broth was extracted with EtOAc + 1% FA for 24 hours. The extract 
was filtered and the two fractions pooled and dried down on a freeze drier. The extract was separated on a 
KP-C18-HS SNAP column using a Biotage Isolera One (Biotage, Uppsala, Sweden) using a gradient of 10% 
MeOH (H2O-Milli-Q (Millipore, MA, USA)) to 100% over 15 CVs (column volumes) resulting in 27 fractions. 
Asperugin B was present in fractions 20 to 23 which were pooled and purified on a Waters HPLC 
W600/996PDA (Milford, MA, USA) using a RP column (Phenomenex Luna C18(2), 250 x 10 mm, 5 μm, 
Torrance, CA, USA) using a gradient of 80% MeCN (H2O – Milli-Q (Millipore, MA, USA)) to 100 % over 20 
minutes with a flow of 4 mL/min. The collections were concentrated on a rotarvap (Büchi V-855/R-215) and 
dried down under N2(g) to yield 3.7 mg of nidubenzal A/B. 
Isolation of asperugin B 
Asperugin was collected in a later fraction than nidubenzal A/B in the last purification step described above. 
The collections were concentrated on a rotarvap (Büchi V-855/R-215) and dried down under N2(g) to yield 
4.3 mg of asperugin.  
NMR studies and structure elucidation 
NMR spectra were acquired in DMSO-d6 on a Varian Unity Inova 500 MHz spectrometer for asperugin B and 
on a Bruker Avance 800 MHz spectrometer at the Danish Instrument Center for NMR Spectroscopy of 
Biological Macromolecules for nidubenzal A/B using standard pulse sequences. The spectra were 
referenced to this solvent with resonances δH = 2.49 and δC = 39.5. 
Characterization data of nidubenzal A 
1H NMR (800 MHz, DMSO-d6): δ 9.72 (1H, s, H-7), 7.38 (1H, m, H-6), 7.36 (1H, m, H-2), 6.92 (1H, d, J = 7.9 
Hz, H-5), 5.42 (1H, t, J = 6.2 Hz, H-2’), 5.06 (1H, m, H-6’), 5.03 (1H, m, H-10’), 4.61 (2H, d, J = 6.2 Hz, H-1’), 
2.06 (2H, m, H-5’), 2.03 (2H, m, H-4’), 1.98 (2H, m, H-9’), 1.89 (2H, t, J = 7.3 Hz, H-8’), 1.71 (3H, s, H-15’), 
1.61 (3H, s, H-12’), 1.54 (3H, s, H-14’), 1.53 (3H, s, H-13’); 13C NMR (200 MHz): δ 190.9 (C-7), 153.7 (C-4), 
147.1 (C-3), 140.0 (C-3’), 130.4 (C-11’), 128.2 (C-1), 125.8 (C-6), 123.8 (C-10’), 119.5 (C-2’), 115.4 (C-5), 112.3 
(C-2), 64.9 (C-1’), 38.7 (C-4’), 25.4 (C-5’), 25.3 (C-12’), 17.3 (C-13’), 16.1 (15’), 15.5 (C-14’). HRMS (m/z): 
[M+H]+ calcd. for C24H32O5, 343.2268; found, 343.2267. 
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Number 1H (ppm) 13C (ppm) Multiplicity  
(J/Hz) 
Integral HMBC DQF-COSY H2BC 
1 - 128.2 - - - - - 
2 7.36 112.3 m 1 3, 4, 6, 7 6 - 
3 - 147.1 - - - - - 
4 - 153.7 - - - - - 
5 6.92 115.4 d (J = 7.9 Hz) 1 1, 3, 4 6 6 
6 7.38 125.8 m 1 2, 4, 7 2, 5 5 
7 9.72 190.9 s 1 1, 2, 3, 6 - 1 
1’ 4.61 64.9 d (J = 6.2 Hz) 2 3, 2’, 3’, 4’, 
5’, 15’ 
2’ 2’ 
2’ 5.42 119.5 t (J = 6.2 Hz) 1 1’, 4’, 5’, 15’ 1’ 1’ 
3’ - 140.0 - - - - - 
4’ 2.03 38.7 m 2 2’, 3’, 5’, 15’ 5’ 5’ 
5’ 2.06 25.4 m 2 3’, 4’, 6’, 7’ 4’, 6’ 4’, 6’ 
6’ 5.06 123.3 m 1 5’, 8’, 14’ 5’ 5’ 
7’ - 134.5 - - - - - 
8’ 1.89 39.0 t (J = 7.3 Hz) 2 6’, 7’, 9’, 14’ 9’ 9’ 
9’ 1.98 26.0 m 2 7’, 8’, 10’, 11’ 8’, 10’ 8’, 10’ 
10’ 5.03 128.8 m 1 12’, 13’ 9’ 9’ 
11’ - 130.4 - - - - - 
12’ 1.61 25.3 s 3 8’, 9’, 10’, 
11’, 13’ 
- - 
13’ 1.53 17.3 s 3 10’, 11’, 12’ - - 
14’ 1.54 15.5 s 3 6’, 7’, 8’ - - 
15’ 1.71 16.1 s 3 1’, 2’, 3’, 4’ - - 
 
Characterization data of nidubenzal B 
1H NMR (800 MHz, DMSO-d6): δ 9.72 (1H, s, H-7), 7.35 (1H, d, J = 1.7 Hz, H-6), 7.24 (1H, d, J = 1.8 Hz, H-2), 
7.09 (1H, d, J = 8.2 Hz, H-5), 5.42 (1H, t, J = 6.2 Hz, H-2’), 5.06 (1H, m, H-6’), 5.03 (1H, m, H-10’), 4.66 (2H, d, 
J = 6.2 Hz, H-1’), 2.06 (2H, m, H-5’), 2.03 (2H, m, H-4’), 1.98 (2H, m, H-9’), 1.89 (2H, t, J = 7.3 Hz, H-8’), 1.71 
(3H, s, H-15’), 1.61 (3H, s, H-12’), 1.54 (3H, s, H-14’), 1.53 (3H, s, H-13’); 13C NMR (200 MHz): δ 191.4 (C-7), 
152.4 (C-4), 147.0 (C-3), 140.0 (C-3’), 130.4 (C-11’), 129.6 (C-1), 124.0 (C-6), 123.8 (C-10’), 119.5 (C-2’), 115.4 
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(C-5), 112.3 (C-2), 64.9 (C-1’), 38.7 (C-4’), 25.4 (C-5’), 25.3 (C-12’), 17.3 (C-13’), 16.1 (15’), 15.5 (C-14’). HRMS 
(m/z): [M+H]+ calcd. for C24H32O5, 343.2268; found, 343.2267. 
 
Number 1H (ppm) 13C (ppm) Multiplicity  
(J/Hz) 
Integral HMBC DQF-COSY H2BC 
1 - 129.6 - - - - - 
2 7.24 113.4 d (J = 1.8 Hz) 1 3, 4, 6, 7 6 - 
3 - 147.0 - - - - - 
4 - 152.4 - - - - - 
5 7.09 112.6 d (J = 8.2 Hz) 1 1, 3, 4 6 6 
6 7.35 124.0 m 1 2, 4, 7 2, 5 5 
7 9.74 191.4 s 1 1, 2, 3, 6 - - 
1’ 4.66 65.0 d (J = 6.2 Hz) 2 4, 2’, 3’, 4’ 2’ 2’ 
2’ 5.42 119.5 t (J = 6.2 Hz) 1 1’, 4’, 5’, 15’ 1’ 1’ 
3’ - 140.0 - - - - - 
4’ 2.03 38.7 m 2 2’, 3’, 5’, 15’ 5’ 5’ 
5’ 2.06 25.4 m 2 3’, 4’, 6’, 7’ 4’, 6’ 4’, 6’ 
6’ 5.06 123.3 m 1 5’, 8’, 14’ 5’ 5’ 
7’ - 134.5 - - - - - 
8’ 1.89 39.0 t (J = 7.3 Hz) 2 6’, 7’, 9’, 14’ 9’ 9’ 
9’ 1.98 26.0 m 2 7’, 8’, 10’, 11’ 8’, 10’ 8’, 10’ 
10’ 5.03 128.8 m 1 12’, 13’ 9’ 9’ 
11’ - 130.4 - - - - - 
12’ 1.61 25.3 s 3 8’, 9’, 10’, 
11’, 13’ 
- - 
13’ 1.53 17.3 s 3 10’, 11’, 12’ - - 
14’ 1.54 15.5 s 3 6’, 7’, 8’ - - 
15’ 1.71 16.1 s 3 1’, 2’, 3’, 4’ - - 
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Characterization data of asperugin A 
HRMS (m/z): [M+H]+ calcd. for C24H32O5, 401.2322; found, 401.2314. 
Characterization data of asperugin B 
1H NMR (500 MHz, DMSO-d6): 10.49 (1H, s, H-7), 10.16 (1H, s, H-8), 6.99 (1H, s, H-3), 5.46 (1H, t, J = 7.1 Hz, 
H-2’), 5.03 (1H, m, H-10’), 5.02 (1H, m, H-6’), 4.62 (2H, d, J = 7.1, H-1’), 1.99 (2H, m, H-5’), 1.98 (2H, m, H-9’), 
1.95 (2H, m, H-4’), 1.89 (2H, t, J = 7.6 Hz, H-8’), 1.62 (3H, s, H-13’), 1.58 (3H, s, H-15’), 1.54 (3H, s, H-12’),  
1.52 (3H, s, H-14’); 13C NMR (125 MHz): δ 193.1 (C-7), 192.5 (C-8), 157.6 (C-6), 157.0 (C-4), 141.4 (C-3’), 
136.9 (C-5), 134.6 (C-7’), 133.3 (C-2), 130.7 (C-11’), 124.1 (C-10’), 123.6 (C-6’), 119.9 (C-2’), 113.7 (C-1), 
112.6 (C-3), 68.0 (C-1’), 39.2 (C-8’), 39.1 (C-4’), 26.2 (C-9’), 25.8 (C-5’), 25.5 (C-13’), 17.6 (C-12’), 16.1 (C-15’), 
15.7 (C-14’). HRMS (m/z): [M+H]+ calcd. for C23H30O5, 387.2166; found, 387.2154. 
 
Number 1H (ppm) 13C (ppm) Multiplicity  
(J/Hz) 
Integral HMBC DQF-COSY 
1 - 113.7 - - - - 
2 - 133.3 - - - - 
3 6.99 112.6 s 1 1, 2, 4, 5, 8 - 
4 - 157.0 - - - - 
5 - 136.9 - - - - 
6 - 157.6 - - - - 
7 10.49 193.1 s 1 1, 2, 5, 6 - 
8 10.16 195.5 s 1 1, 2, 5, 6 - 
1’ 4.62 68.0 d (J = 7.1 Hz) 2 5, 2’, 3’, 4’, 5’ 2’ 
2’ 5.46 119.9 m 1 1’, 4’, 15’ 1’ 
3’ - 141.4 - - - - 
4’ 1.95 39.1 m 2 2’, 3’, 5’, 6’, 
15’ 
5’ 
5’ 1.99 25.8 m 2  4’, 6’ 
6’ 5.02 123.6 m 1 5’, 8’, 14’ 5’ 
7’ - 134.6 - - - - 
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8’ 1.89 26.2 m 2 overlap 9’ 
9’ 1.98 26.2 m 2 overlap 8’, 10’ 
10’ 5.03 124.1 m 1 12’, 13’ 9’ 
11’ - 130.7 - - - - 
12’ 1.54 17.6 s 3 8’, 10’, 11’, 
13’ 
- 
13’ 1.62 25.5 s 3 8’, 10’, 11’, 
12’ 
- 
14’ 1.52 15.7 s 3 6’, 7’, 8’ - 
15’ 1.58 16.1 s 3 2’, 3’, 4’ - 
 
 
Results and discussion 
The strain chosen for this study was IBT24909 which was cultivated on 200 plates of CYAs for 13 days at 
25°C for optimal production of 1, 2, and 3. The LC-DAD chromatogram at 210 nm of the extract can be seen 
in figure 1.   
 
Figure 1 LC-DAD chromatogram (210 nm) of 200 plate extract of IBT24909 cultivated on CYAs for 13 days. The two 
peaks 1 and 2 were identified as potential PKs. The large peak at 10.5 minutes is sterigmatocystin.   
After inspection of the chromatogram two rather large peaks, 1 and 2, were identified as putative PKs 
based on their UV-spectra which had absorption maxima at wavelengths over 300 nm indicating that the 
metabolite or part of it contained a highly conjugated system. 
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The metabolites were isolated and structure elucidated by 2D NMR (DQF-COSY, HSQC, HMBC, H2BC and 
NOESY). 
 
Figure 2 Structures of nidubenzal A and B (1), asperugin A, B (2), and C, and aspernidine A and B 
NMR analysis of A revealed that two isomers, that we named nidubenzal A and B, figure 2, were present in 
the solution in a 5:1 ratio. The difference of the chemical shift values of the two isomers were small and 
only visible for H1’/C1’ and in the aromatic moiety of the molecule. 
The structure of the farnesyl side chain was deduced based on DQF-COSY, HSQC, HMBC and H2BC 
correlations and comparison with literature data from the related structures aspernidine A and B (Scherlach 
2010). The attachment of the farnesyl side chain to the two isomers was based on HMBC correlations of H1’ 
to C3 and C4 for nidubenzal A and B, respectively. Nidubenzal A has been reported in a synthetic screening 
library (Aurora Fine Chemicals LLC); however, neither nidubenzal A nor B has previously been reported 
from nature.     
The structure of 2 was also solved through 2D-NMR analysis (DQF-COSY, HSQC, and HMBC) which showed 
that it was asperugin B a metabolite previously isolated from the related fungus A. rugulosus (Ballantine 
1967). Two other asperugins, A and C, have been isolated from A. rugulosus (Ballantine 1964, 1965, and 
1971) and through LC-TOF-MS-analysis we tentatively identified asperugin A (3) but not asperugin C in the 
A. nidulans IBT24909 extract. We have not yet been able to isolate asperugin A in quantities sufficient for 
NMR-analysis. In 2005 An et al. (An 2005) reported production of asperugin A and B (also with B as the 
major product), as well as violaceol, in a strain where cosmid-size DNA from slow growing fungi was cloned 
and introduced into A. nidulans. During the course of this study Scherlach et al. reported the 
characterization of aspernidine A and B isolated from A. nidulans (Scherlach 2010); however, we were not 
able to trace these metabolites through LC-TOF-MS analysis of our extract. 
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All the isolated metabolites, nidubenzal A and B, asperugin A-C and the related aspernidines, seem to be 
hybrid metabolites which consist of a farnesyl side chain and an aromatic moiety, which may be of PK 
origin. The aromatic nature of the metabolites indicated that the pathway could be initiate with formation 
of a NR-PK catalyzed by a NR-PKS. The products of the NR-PKS could be orsellinic acid or even more likely 
orsellinaldehyde, figure 3, which have, just recently, been shown to be a metabolite of A. nidulans from the 
AN3230 (PkfA) NR-PKS (Ahuja 2012). The only difference between the aromatic part of asperugin A and B, 
and aspernidine A and B, are an O-methylation indicating that the two metabolites in each group are 
derived from the same biosynthetic pathway. Scherlach et al. (Scherlach 2010) suggests that the 
aspernidines are formed by either orsellinic acid or the corresponding aldehyde which traps ammonia 
nitrogen in an intermediary aldehyde, where oxidoreduction and condensation steps leads to the 
isoindolinone moiety. The precursor of the aromatic moiety of asperugin C could also be orsellinaldehyde 
which, in a shunt pathway, will be methylated instead of oxidated. The two new metabolites nidubenzal A 
and B differs in the aromatic moiety which containing seven carbons instead of the eight of the backbone of 
the other metabolites. This could indicate a different biosynthetic pathway or a decarboxylation from a C8-
PK product. We speculated whether these metabolites might be a product of the shikimic acid pathway 
since the substitution pattern resembles protocatechuic acid, figure 3, a shunt product from the 
biosynthesis of shikimic acid, differing only by the aldehyde in the place of the carboxylic acid. 
 
Figure 3 Structures of orsellinaldehyde, protocatechuic acid and 2-ethyl-4,6-dihydroxy-3,5-dimethylbenzaldehyde 
Since the metabolites might be of PK origin we went back to the reference strain of the PKS deletion library 
(Nielsen 2011) to see if we could trace the metabolites through extracted ion chromatograms (EICs) on any 
of the media used in the study.    
Nidubenzal A and B were present in small quantities on the CYAs medium so we went back to the deletion 
library to see whether we could identify a possible PKS to link to these metabolites. In two of the PKS 
deletions, ausAΔ and AN11191Δ, the production seemed to have been abolished; however, due to the 
small quantities of metabolites present in the extract it was, in some cases, difficult to determine the 
presence of the metabolites.  
Asperugin A could not be detected in any of the strains whereas asperugin B could be traced. The same 
procedure for identification of putative PKSs as for the nidubenzals was done and six PKS candidates were 
identified, AN0523 (pkdA), AN11191, AN3230 (pkfA), ausA, AN6791, and AN9005. It has recently been 
reported that AN3230 produces orsellinaldehyde and AN0523 2-ethyl-4,6-dihycroxy-3,5-
dimethylbenzaldehyde, figure 4.37 (Ahuja 2012). ausA, pkfA and pkdA are NR-PKSs whereas AN11191, 
AN6791 and AN9005 are PR-PKSs (Sanchez 2012). These results gave several possible genes so we were not 
able to link the metabolites to their synthase genes. 
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At the same time as this study we were also working on a strain where the cclA gene had been deleted 
which activated the production of the asperugins and nidubenzals. It had already been shown that this 
deletion strain increased the production of secondary metabolites in A. nidulans (Bok 2009). We wanted to 
investigate whether challenging the cclAΔ strain on complex media could activate even more secondary 
metabolite production.   
 
Figure 4 The appearance of the reference strain compared to the cclAΔ strain cultivated for seven days at 37°C on 
RTO, RT, CY20. CYAs, CYA, YES, YE, and MM medium. 
Figure 4 show the phenotypical appearance of the cclAΔ strain compared to the reference strain when 
grown on the same eight media as used initially in the deletion study. It is evident that the fungus was 
affected by the deletion and as the reference strain it responded differently to the different medium 
conditions. Generally it seems that the cclAΔ strains grow slower than the reference. To analyze the 
metabolite production micro-extraction was performed (Frisvad 1987, Smedsgaard 1997) and the extracts 
were analyzed by both UHPLC-DAD and UHPLC-TOF-MS. The UHPLC analysis revealed a diverse and 
different production of secondary metabolites on the eight media compared to the reference strain, figure 
5. 
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 Figure 5 UHPLC-DAD chromatograms (210 nm) of micro-extracts of the cclAΔ strain cultivated on eight different media 
compositions for seven days at 37°C compared to the reference strain. From top to bottom RTO, RT, CY20, CYAs, CYA, 
YES, YE and MM.*This peak corresponds to an internal standard of chloroamphenicol added to the extracts. The 
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concentration of chloroamphenicol is the same in all the samples. Metabolites were identified through comparison 
with standards or based on exact mass and UV-data.  
In all of the media except YE and CYAs there seemed to be an activation of secondary metabolite 
production. It was especially noticeable that many of the metabolites produced in the cclAΔ strain are 
derived from the orsellinic acid and monodictyphenone pathway, which was also the gene clusters 
activated by Bok et al. (Bok 2009). Arugosin A which was linked to the monodictyphenone pathway in 
section 4.3.1.2 seemed to disappear in the cclAΔ strain whereas intermediates in this pathway, for example 
emodin, seemed to accumulate. Most noticeable for our study, and what is focused on in this section, was 
the increased production of asperugin A and B as well as nidubenzal A and B on several of the media; YES, 
CY20, CYAs, CYA, RTO and MM, figure 6.  
 
Figure 6 UHPLC-DAD chromatograms (210 nm) from seven to eight minutes of micro-extracts of the cclAΔ on the eight 
different media. From top to bottom: RTO, RT, CY20, CYAs, CYA, YES, YE and MM. 
The increased production of asperugin A and B, and nidubenzal A and B in this strain allowed for creating 
double deletions of cclA and the putative candidate PKS genes in order to understand the changes in 
production of the metabolites. Therefore cclA was deleted in the respective PKS gene deletions identified 
previously. We included both the NR- and PR-PKSs in the study since it seemed like they might have an 
effect on asperugin production. Since it was originally thought that these products could be derived from 
orsellinic acid, and due to the activation of several orsellinic acid derived metabolites in the cclAΔ strain, a 
deletion of cclA in orsAΔ was also created to see if there were an effect on the production of the 
nidubenzals and asperugins. As described previously we wondered whether the nidubenzal A and B could 
be shikimic derived so we also made a deletion mutant of the qutC gene which has been shown to encode 
for an enzyme, dehydroshikimic acid dehydratase that catalyzes the production of protocatechius acid from 
3-dehydroshikimic acid in A. nidulans (Lamb 1992).  
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 Figure 7 UHPLC chromatograms (210 nm) of micro-extracts of the qutCΔcclAΔ, ausAΔcclAΔ, AN11191ΔcclAΔ and cclAΔ 
strains after cultivation for seven days at 37°C on CY20 medium. The other parts of the chromatogram were also 
identical.  
The double deletion mutants made were analyzed on both UHPLC-DAD and UHPLC-TOF-MS on all eight 
media. As seen in figure 7 nidubenzal A and B were present in all the deletion strains and on the different 
media; however, spore-PCR analysis of the AN11191ΔcclAΔ strain showed presence WT AN11191 nuclei 
indicating this strain was not suited for analysis. A new double deletion based on the original confirmed 
AN11191Δ strain is in progress of being constructed. As the qutCΔcclAΔ strain also produced nidubenzal A 
and B it indicates that they are derived from either AN11191 or an alternative route to protocatechuic acid 
exists in A. nidulans.  
 
Figure 8 EIC of a) asperugin A (calc. [M-H]- 401.23225±0.002]) and b) asperugin B (calc. [M+H]+ 387.21660±0.002]) of 
micro-extracts of the (from top to bottom) pkdAΔcclAΔ, pkfAΔcclAΔ, ausAΔcclAΔ, AN6791ΔcclAΔ, AN9005ΔcclAΔ and 
cclAΔ strains after cultivation on CY20 medium for seven days at 37°C.  
a) b)
273
The extracted ion chromatograms (EIC) of asperugin A and B in the double deletion mutants and the 
reference strain can be seen in figure 8. As the AN11191ΔcclAΔ strain was not correct it have been 
removed from the study, however a correct strain will be included in the analysis for the presence of the 
asperugins. As can be seen on the figure production of asperugin A and B are abolished in the pkfAΔcclAΔ 
strain and this was consistent on the eight analyzed media. Ahuja et al. (Ahuja 2012) recently showed that 
overexpression of this PKS with an inducible promoter led to the production of orsellinaldehyde. Further 
biosynthesis of orsellinaldehyde to the asperugins would require several tailoring enzymes catalyzing 
oxidation of a methyl to an aldehyde, oxidation of the aromatic ring, a terpene synthase and an O-
methyltransferase. As suggested by Scherlach et al. (Scherlach 2010) further modifications to the aromatic 
moiety of the metabolites could lead to the biosynthesis of the aspernidines. This biosynthetic pathway 
resembles in some ways the proposed biosynthesis of the cichorine gene cluster. Preliminary 
bioinformatics studies indicated the presence of O-methyltransferase, prenyltransferase, oxidase, 
cytochrome P450, and monooxidase enzymatic functions surrounding the pkfA gene. Construction of the 
double deletions of cclA and the surrounding genes to determine the biosynthetic pathway of these 
metabolites including identifying intermediates are ongoing. In the AN6791ΔcclAΔ stain it appears that the 
production of asperugin A and B have increased compared to the other strains. This is interesting due to 
the fact that the deletion was constructed based on analysis of the deletion library where the metabolites 
were missing in the single deletion strain, AN6791Δ. This phenomena is seen in several media (YES, CY20, 
CYAs and MM); however, the reason for this apparently increase in production is so far unknown. 
 
Figure 9 UHPLC chromatograms (210 nm) of micro-extracts of the orsAΔcclAΔ strain compared to the cclAΔ strain on 
CY20 medium.   
Due to the orsellinic acid like nature of asperugins we included a double deletion of orsA and cclA in the 
study. As seen from figure 9 the deletions did not abolish the production of the asperugins; however, the 
metabolites which have been shown to be derived from the orsellinic acid biosynthetic pathway were 
indeed absent in the double deletion strain (Bok 2009, Schroeckh 2009, Sanchez 2010, Nahlik 2010). 
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Supplementary material 
Supplementary table 1: Strains used for deletions of cclA 
Strain Genotype Reference 
IBT29539 argB2, pyrG89, veA1, nkuAΔ Nielsen et al., 2008 
IBT30996 argB2, pyrG89, veA1, nkuAΔ, AN0523Δ Nielsen et al., 2011 
- argB2, pyrG89, veA1, nkuAΔ, qutCΔ This study 
IBT31005 argB2, pyrG89, veA1, nkuAΔ, pkfAΔ Nielsen et al., 2011 
IBT31013 argB2, pyrG89, veA1, nkuAΔ, AN6791Δ Nielsen et al., 2011 
IBT31020 argB2, pyrG89, veA1, nkuAΔ, orsAΔ Nielsen et al., 2011 
IBT31022 argB2, pyrG89, veA1, nkuAΔ, ausAΔ Nielsen et al., 2011 
IBT31025 argB2, pyrG89, veA1, nkuAΔ, AN9005Δ Nielsen et al., 2011 
IBT31000 argB2, pyrG89, veA1, nkuAΔ, AN11191Δ Nielsen et al., 2011 
Supplementary table 2: Primers used in this study 
ANqutC-DL-Up-F 
 
CTTACAGCCCTAGTCATTCC Deletion fragment Up 
ANqutC-DL-Up-Rad 
 
gatccccgggaattgccatgGAGCTGATTGAGTTGAAGAC Deletion fragment Up 
ANqutC-DL-Dw-Fad 
 aattccagctgaccaccatgGGTAATGATGGCTCATGCACG 
Deletion fragment Dw 
ANqutC-DL-Dw-R 
 GATGTTGACGGTGCTGGATATTG 
Deletion fragment Dw 
ANqutC-CHK-Up-F 
 CACCACTAGAACAACTACATACGG 
Strain verification 
ANqutC-CHK-Dw-R 
 GTGCTGGGGAAATTTTGGGTG 
Strain verification 
ANcclA-DL-Up-FU 
 GGGTTTAAUGTGATCACTTCGCAGGGTAG 
Deletion fragment Up 
ANcclA-DL-Up-RU 
 GGACTTAAUCCTTTGCGGATAGGTATTTCAC 
Deletion fragment Up 
ANcclA-DL-Dw-FU 
 GGCATTAAUCAGCTGGGTCATGGATTGG 
Deletion fragment Dw 
ANcclA-DL-Dw-RU 
 GGTCTTAAUGACGGAGCTTGAGCTTTACG 
Deletion fragment Dw 
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ANcclA-CHK-Up-F 
 CGGTTTCTCTCTGTGTCTCC 
Strain verification 
ANcclA-CHK-Dw-R 
 CGCCTCACATCCGACTAC 
Strain verification 
 
1H NMR of nidubenzal A and B in DMSO-d6 
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 1H NMR of asperugin B in DMSO-d6 
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Abstract 17 
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Fungal natural products are considered a rich, underexplored resource of bioactive compounds. A 18 
combined heterologous expression and growth condition variation approach using Aspergillus nidulans as 19 
model induced insect juvenile hormone III and methyl farnesoate, essential developmental hormones 20 
previously unobserved in fungi. The approach is of general relevance in endeavors to uncover metabolites 21 
produced by silent gene clusters while the finding of juvenile hormones is of ecological relevance. 22 
Introduction 23 
Filamentous fungi are capable of synthesizing a wide range of bioactive molecules important for growth in 24 
a complex and competitive ecological niche. These compounds have been found to have diverse 25 
pharmaceutical applications 1. With the release of full genome sequences of several filamentous fungi it 26 
became apparent that the number of predicted secondary metabolite synthases by far exceeds the number 27 
of known metabolites 2, 3. These observations hints that specific environmental stimuli are required for 28 
induction of the majority of secondary metabolites, thus coining the terms silent and orphan synthases 4. 29 
Despite attempts to identify or mimic these stimuli in order to unravel the secondary metabolism of the 30 
model organism Aspergillus nidulans, the majority of predicted synthases are still considered silent 5, 6. 31 
Genetic approaches have been somewhat successful through manipulation of histone methylation 7 or 32 
specific regulators 8. The latter approach is particularly attractive as it is a targeted approach and therefore 33 
promises rapid linking of induced metabolites to genes. Moreover, as biosynthetic pathways towards 34 
secondary metabolites tend to be clustered in the genome 2, 3, specific regulators may be identified by 35 
genomic co-localization. However, the number of successful applications of this approach is limited, 36 
possibly because far from all predicted gene clusters contain regulatory proteins. We decided to investigate 37 
whether induction of secondary metabolites could be achieved through heterologous expression of 38 
regulatory genes from other filamentous fungi using A. niger as test case. A selection of putative pathway 39 
specific regulators was constitutively expressed individually from a defined locus 9. This genetic approach 40 
was combined with a screen of several complex media recently demonstrated to influence A. nidulans 41 
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secondary metabolism 10. The combinatorial approach resulted in the identification of one regulatory 42 
protein that strongly induced metabolites not previously reported from A. nidulans. Among the induced 43 
metabolites were insect juvenile hormone III and methyl farnesoate, sesquiterpene hormones crucial for 44 
correct development of insects and crustaceans respectively 11-13. To the best of our knowledge, this is the 45 
first observation of juvenile hormones in fungi as well as the first example of transcriptional activation of 46 
secondary metabolism between distantly related species. 47 
Materials & Methods: 48 
Strains and media. Escherichia coli strain DH5ɲ was used to propagate all plasmids. All A. niger genes were 49 
amplified from strain ATCC1015. The A. nidulans strain NID74 (argBȴ, veA1, pyrG89, nkuAȴ) were used as 50 
background strain for all transformations as it allows gene targeting with the argB marker due to a 51 
complete deletion of the A. nidulans argb-open reading frame. NID74 was generated from NID1 using the 52 
fusion PCR technique essentially as described previously 14. E/ϱϰϱ ;ĂƌŐȴ͕ ƉǇƌ'ϴϵ͕ ǀĞϭ͕ ŶŬƵȴ53 
IS1::pgpdA-LacZ-TtrpC::argB) were used as reference strain for metabolite analysis. Genotypes of all strains 54 
are summarized in supplementary table 2. All A. nidulans strains were propagated on solid glucose minimal 55 
medium (MM) (1 % glucose, 10 mM NaNO3, 1x salt solution, 2 % agar (Bie & Berntsen, BBB 10030,SO-BI-56 
GEL,Agar)), supplemented with 10 mM uridine (Uri), 10 mM uracil (Ura). Complex media used for chemical 57 
analysis were prepared as described by Frisvad and Samson 15 and supplemented with 10 mM Uri and 58 
10mM Ura:  59 
- CYAs (Yeast extract 5,0 g/l (Biokar, A1202HA), Czapek dox broth 35,0 g/l (Difco, 233810), NaCl  50,0 g/l (J.T 60 
Baker, 0277), 1x trace metals, 1,5 % agar(Bie & Berntsen, BBB 10030,SO-BI-GEL,Agar)).  61 
- OAT (Oatmeal 30g/l, 1x trace metals, 1,5 % agar(Bie & Berntsen, BBB 10030,SO-BI-GEL,Agar)).  62 
- RTO (Oatmeal 30g/l, (NH4) H2PO4 0,4 g/l (Merck, 1126), K2CO3 0,4 g (Merck, 4928), ZnSO4,7H2O 0,06 g/l 63 
(Merck, 8883), FeSO4,7H2O 0,06 g (Merck, 3965), (NH4)2SO4 0,16 g/l (Merck, 1217), MgCO3 0,25 g (Riedel-de 64 
Haën, 13118), Tartaric acid (C4H6O6)  2,6 g (Merck, 804), di-Ammonium tartrate (C4H12N2O6) 2,6 g (Merck, 65 
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1222), Glucose (D+) 50,0 g (BHD, 10117), 1x trace metals, 2 % agar (Bie & Berntsen, BBB 10030,SO-BI-66 
GEL,Agar)),  67 
- YES (Yeast extract 20 g/l (Biokar, A1202HA), Sucrose 150 g/l (Fluka, 84100), MgSO4,7H2O 0,5 g/l (Merck, 68 
5886), 1x trace metals, 2 % agar (Bie & Berntsen, BBB 10030,SO-BI-GEL,Agar) 69 
 70 
PCR, USER cloning and A. nidulans strain construction. USER cloning compatible PCR products were 71 
amplified with 30 PCR cycles in 50 μl reaction mixtures using proof-reading PfuX7 polymerase 16. USER 72 
vectors are denoted according to the nomenclature introduced by Hansen et al 9. Putative A. niger genes 73 
were USER cloned into pU1111-IS1 and transformed into A. nidulans as described previously 9. In order to 74 
generate the NID545 reference strain the E. coli lacZ was cloned into a pU1014-IS1 vector generating 75 
pU1011-IS1:LacZ which was transformed to an pU1110-IS1-LacZ vector by insertion of A. nidulans gpdA 76 
promoter in the AsiSI/Nb.BtsI cassette. DNA sequences of LacZ and all inserted A. niger ORFs were verified 77 
by sequencing of the corresponding expression plasmids. Gene targeting events were verified in all A. 78 
nidulans transformants by analytical PCR as described previously 9. Supplementary table 3 summarizes the 79 
PCR primers used in this study. 80 
  81 
Chemical characterization of mutant strains by LC-DAD-MS: All strains were grown as three point 82 
inoculations for 7 days at 37 degrees in the dark on solid media. Extraction of metabolites were performed 83 
by the agar plug extraction method 17 using three 6mm agar plugs/extract. Extracts were analyzed by 84 
UHPLC-DAD and LC-HRMS. UHPLC-DAD analysis was performed on a Dionex RSLC Ultimate 3000 (Dionex, 85 
Sunnyvale, CA) equipped with a diode-array detector. Separation was performed at 60°C on a 150 mm × 2.1 86 
mm ID, 2.6 μm Kinetex C18 column (Phenomenex, Torrence, CA) using a linear water/MeCN (both buffered 87 
with 50 ppm tri-fluoroacetic acid (TFA)) gradient starting from 15% MeCN to 100% over 7 min at a flow rate 88 
of 0.8 mL min-1. LC-HRMS analysis were made on a MaXis 3G QTOF (Bruker Daltronics) coupled to a Dionex 89 
Ultimate 3000 UHPLC system equipped with a 100 x 2.0 mm, 2.6 μm, Kinetex C-18 column. The separation 90 
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column was held at a temperature of 40°C and a gradient system composed of A: 20 mM formic acid in 91 
water, and B: 20 mM formic acid in acetonitrile was used. The flow vas 0.4 ml/min, 85% A graduating to 92 
100% B in 0-10 min, 100% B 10-13 min, 85% A 13.1-15 min.  For calibration, a mass spectrum of sodium 93 
formate was recorded at the beginning of each chromatogram using the divert valve (0.3-0.4 min). Samples 94 
were analyzed both in positive and negative ionization mode. De-replication of induced compounds were 95 
performed by comparison of accurate mass to the metabolite database Antibase2009 18 as well as 96 
comparison of UV spectra to published data.  97 
 98 
Chemical characterization of mutant strains by GC-MS: Volatile metabolites were collected during days 5-7 99 
for the strains inoculated in CYAs. To collect the volatiles, a stainless steel Petri dish lid with a standard 1/4 100 
Swagelock™ replaced the usual lid 19. This lid possessed a standard 1/4 Swagelok fitting with PTFE insert in 101 
the centre that is used to hold a charcoal tube (SKC, 226-01). The collected volatiles were extracted from 102 
the charcoal tube with 0.3 mL of ether (Sigma Aldrich). The samples were concentrated to approximately 103 
0.1 mL using a nitrogen flow in a GC vial and analysed using a Finnigan Focus GC coupled to a Finnigan 104 
Focus DSQ mass selective detector. The separation of the volatiles was done on a Supelco SLB™-5 MS 105 
capillary column, using He as carrier gas, at 1.2 mL/min. The injection and detection temperature was set to 106 
220 °C. One microlitre of each sample was injected into the GC–MS system. Chromatographic conditions 107 
were set to an initial temperature of 35 °C for 1 min, raised at 6 °C/min to 220 °C and then 20 °C/min to 260 108 
°C for 1 min. The separated compounds were characterized by their mass spectra generated by electron 109 
ionization (EI) at 70 eV at a scan range from m/z 35–300. 110 
 111 
Isolation of methyl (2E,6E)-10,11-dihydroxy-3,7,11-trimethyl-2,6-dodecadienoate (X1).   112 
NID477 was cultured on 100 CYAs plates for 7 days at 37°C in the dark. The plates were homogenized using 113 
a Stomacher and 100 mL ethyl acetate (EtOAc) + 1% formic acid (FA) pr. 10 plates. The extract was filtered 114 
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after 1 hour and the remaining broth was extracted with EtOAc + 1% FA for 24 hours. The extract was 115 
filtered and the two fractions pooled and dried down on a freeze drier. The crude extract were separated 116 
into three phases by dissolving it in 9:1 MeOH:H2O – Milli-Q and extracted into a heptane phase followed 117 
by a dicloromethane (DCM) phase. The DCM phase was fractionated with a 10g ISOL Diol column, using 13 118 
steps of stepwise Hexane-dichloromethane-EtOAc-MeOH. X1 was present in the DCM fraction (9.5 mg) and 119 
was purified on a Waters HPLC W600/996PDA (Milford, MA, USA ) using a RP column (Phenomenex Luna 120 
C18(2), 250 x 10 mm, 5 μm, Torrance, CA, USA) using a gradient of 40% MeCN (H2O – Milli-Q (Millipore, MA, 121 
USA)) to 100% over 20 min. with 50 ppm TFA and a flow of 4 mL/min. The collections were concentrated on 122 
a rotarvap (Büchi V-855/R-215) and dried down under N2(g) to yield 2.0 mg of X1. 1 and 2D NMR 123 
characterization (1H, DQF-COSY, H2BC, HMBC and HSQC) of the compound showed that the compound 124 
present is a 2:3 mixture of X1a:X1b. The NMR data of X1 indicated that two diastereomers were present in 125 
the sample. The 1H- and 13C-chemical shifts differ most in the reduced end of X1 where a stereocenter (C10) 126 
is present. The chemical shifts of H1/C1 to H5/C5 are identical. The difference of chemical shifts of the two 127 
methyl groups (H12/C12 and H13/C13) and the two CH2 groups next to the stereocenter are due to the 128 
presence of the chiral center. The two diastereomers present in the X1 solution must be due to the 129 
presence of X1 in both the E- and Z-conformation at the C6 and C7 double bond. The presence of both an E 130 
and a Z double bond conformation could a result from chemical modifications due to the presence of 131 
formic acid in the extraction process. The carbon shifts are in good agreement with published data 20 132 
 133 
Isolation of methyl (2E,6E)-10-hydroxy-11-formyl-3,7,11-trimethyl-2,6-dodecadienoate (X2). 134 
 X2 was present in the 60:40 DCM:EtOAc fraction (13.1 mg) of the Diol fractionation as described above and 135 
was purified on a Waters HPLC W600/996PDA (Milford, MA, USA ) using a RP column (Phenomenex Luna 136 
C18(2), 250 x 10 mm, 5 μm, Torrance, CA, USA) using a gradient of 40% MeCN (H2O – Milli-Q (Millipore, MA, 137 
USA)) to 100% over 20 min. with 50 ppm TFA and a flow of 4 mL/min. The collections were concentrated on 138 
a rotarvap (Büchi V-855/R-215) and dried down under N2(g) to yield 2.6 mg of X2.  139 
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Isolation of methyl (2E,6E)-10,11-epoxid-3,7,11-trimethyl-2,6-dodecadienoate (JH III). JH-III was present in 140 
the 46:60 DCM:EtOAc fraction (26.2 mg) of the Diol fractionation as described for X1 and was purified on a 141 
Waters HPLC W600/996PDA (Milford, MA, USA ) using a RP column (Phenomenex Luna C18(2), 250 x 10 142 
mm, 5 μm, Torrance, CA, USA) using a gradient of 55% MeCN (H2O – Milli-Q (Millipore, MA, USA)) to 65% 143 
over 20 min. with 50 ppm TFA and a flow of 4 mL/min. The collections were concentrated on a rotarvap 144 
(Büchi V-855/R-215) and dried down under N2(g) to yield 1.4 mg of JH-III.  145 
 146 
NMR studies and structure elucidation: NMR spectra were acquired in DMSO-d6 on a Varian Unity Inova 147 
500 MHz spectrometer for X1 and JH-III and on a Bruker Avance 800 MHz spectrometer at the Danish 148 
Instrument Center for NMR Spectroscopy of Biological Macromolecules for X2 using standard pulse 149 
sequences. The spectra were referenced to this solvent with resonances ɷH = 2.49 and ɷC = 39.5. 150 
 151 
Characterization data of methyl (2E,6E)-10,11-dihydroxy-3,7,11-trimethyl-2,6-dodecadienoate (X1). NMR 152 
data for X1a: 1H NMR (500 MHz, DMSO-d6): ɷ 5.65 (s, 1 H), 5.07 (m, 1 H), 4.25 (d, J = 5.6 Hz, 1 H), 4.01 (s, 1 153 
H), 3.57 (s, 3 H), 3.02 (ddd, J = 10.0, 5.6, 2.5 Hz, 1 H), 2.15 (m, 2 H), 2.15-2.11 (m, 2 H), 2.09 (s, 3 H), 1.87 (m, 154 
2 H), 1.60 (m, 1 H), 1.56 (s, 3 H), 1.15 (m, 1 H), 1.02 (s, 3 H), 0.97 (s, 3 H); 13C NMR (125 MHz): ɷ 166.1, 155 
159.7, 135.9, 122.2, 114.7, 76.6, 71.5, 50.4, 39.7, 36.2, 29.4, 26.1, 25.1, 24.2, 18.2, 15.7. NMR data for X1b: 156 
1H NMR (500 MHz, DMSO-d6): ɷ 5.65 (s, 1 H), 5.08 (m, 1 H), 3.74 (dd, J = 10.0, 3.0 Hz, 1 H), 3.57 (s, 3 H), 2.15 157 
(m, 2 H), 2.15-2.11 (m, 2 H), 2.10 (m, 1 H), 2.09 (s, 3 H), 1.96 (m, 1 H), 1.57 (s, 3 H), 1.48 (m, 1 H), 1.41 (m, 1 158 
H), 1.21 (s, 3 H), 1.08 (s, 3 H); 13C NMR (125 MHz): 166.1, 159.7, 134.9, 123.0, 114.7, 82.6, 79.4, 50.4, 39.7, 159 
35.7, 29.2, 27.7, 25.1, 22.8, 18.2, 15.6. HRMS (m/z): [M+H]+ calcd. For C16H29O4, 285.2060; found, 285.2025; 160 
[M+Na]+ calcd. For C16H28O4Na, 307.1885; found, 307.1887; [ɲ]D = 0.0 (MeOH). 161 
 162 
Characterization data of methyl (2E,6E)-10-hydroxy-11-formyl-3,7,11-trimethyl-2,6-dodecadienoate (X2). 163 
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1H NMR (800 MHz, DMSO-d6): ɷ8.23 (s, 1 H), 5.65 (q, J = 1.0 Hz, 1H), 5.05 (t, J = 6.9, 1 H), 4.62 (s, 1 H), 4.52 164 
(d, J = 10.2 Hz, 1 H), 3.57 (s, 3 H), 2.15 (m, 2 H), 2.11 (m, 2 H), 2.09 (d, J = 1 Hz, 3 H), 1.93 (m, 1 H), 1.84 (m, 1 165 
H), 1.75 (m, 1 H), 1.55 (s, 3 H), 1.46 (m, 1 H), 1.04 (s, 3 H), 1.03 (s, 3 H); 13C NMR (200 MHz): ɷ 166.2, 162.3, 166 
159.9, 134.6, 123.4, 114.7, 79.7, 70.2, 50.4, 39.6, 35.7, 26.9, 25.2, 25.1, 25.1, 18.3, 15.6; HRMS (m/z): 167 
[M+H]+ calcd. for C17H29O5, 313.2010; found, 313.2010. [M+Na]+ calcd. for C17H28O5Na, 335.1828; found, 168 
335.1831.  169 
 170 
Characterization data of methyl (2E,6E)-10,11-epoxid-3,7,11-trimethyl-2,6-dodecadienoate (JH III). 1H 171 
NMR data of purified compound in DMSO-d6 showed that the compound had degraded. 172 
HRMS (m/z): [M+H]+ calcd. for C16H27O3, 267.1955; found, 267.1957.; [M+Na]+ calcd. For C16H26O3Na, 173 
289.1780; found,289.1774. 174 
 175 
Characterization data of methyl (2, 6, 10) -3,7,11-trimethyl-2,6-dodecadienoate (MF).  176 
HRMS (m/z): [M+H]+ calcd. for C16H27O2, 251.2006; found, 251.2007. 177 
 178 
Authentic standard of JH-III was purchased from Sigma Aldrich (J2000-10MG) 179 
 180 
Results and discussion 181 
Selection of candidate pathway specific regulators was based on genomic co-localization of gene clusters. 182 
We utilized a collection of microarray experiments from A. niger grown under diverse conditions to identify 183 
regulatory genes associated with predicted secondary metabolite gene clusters using a local co-expression 184 
algorithm.  Seven candidate genes associated with predicted gene clusters containing either polyketide 185 
synthases or non-ribosomal peptide synthases, were identified (supplementary table 1). All seven putative 186 
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transcription factors belonged to the binuclear zinc finger class, a class often associated with secondary 187 
metabolism in fungi 21. BLAST analysis using the predicted protein sequences against the annotated A. 188 
nidulans genome (Aspergillus Comparative Database, BROAD Institute) revealed that only one candidate 189 
(fge1_pg_C_4000037) had a potential ortholog (ANID_06396, 62% amino acid identity, supplementary 190 
table 1). All seven putative regulators were expressed individually in A. nidulans under control of the strong 191 
constitutive pgpdA-promoter from the defined loci Integration Site-1 9. The resulting mutant strains were 192 
grown on minimal glucose media as well as four complex media representing diverse physiological 193 
conditions. Metabolites profiles were analyzed with LC-HRMS as well as UHPLC-DAD and compared to a 194 
reference strain constitutively expressing the Escherichia coli ɴ-galactosidase from the same locus. Of all 195 
combinations of candidate genes and growth media, only est_fge1_pg_C_150220 (annotation from 196 
Aspergillus Comparative Database, BROAD institute) grown under high salt conditions had a significant 197 
impact on secondary metabolism resulting in increased accumulation of several metabolites not previously 198 
reported to be produced by A. nidulans (figure 1A). Hence we renamed est_fge1_pg_C_150220 Secondary 199 
Metabolism associated Regulatory protein A (SmrA). Two of the induced metabolites, X1 and X2 had similar 200 
UV spectra indicating a biosynthetic relationship. The two compounds were isolated and identified by NMR 201 
analysis as a methyl (2E,6E)-10,11-epoxid-3,7,11-trimethyl-2,6-dodecadienoate (X1) 20 and its formylated 202 
analogue (X2) (figure 1B). The formylation, however, was subsequently demonstrated to occur during the 203 
extraction procedure thus X2 is a derivative of X1. The NMR data of X1 indicated that two diastereomers 204 
were present in the sample. The 1H- and 13C-chemical shifts differ most in the reduced end of X1 where a 205 
stereocenter (C10) is present. The chemical shifts of H1/C1 to H5/C5 are identical. The difference of chemical 206 
shifts of the two methyl groups (H12/C12 and H13/C13) and the two CH2 groups next to the stereocenter are 207 
due to the presence of the chiral center. The two diastereomers present in the X1 solution must be due to 208 
the presence of X1 in both the E- and Z-conformation at the C6 and C7 double bond. The presence of both 209 
an E and a Z double bond conformation could a result from chemical modifications due to the presence of 210 
formic acid in the extraction process. The sesquiterpene X1 closely resemble the Insect Juvenile Hormone 211 
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(JH-III), a well-established hormone thought to be unique for insects with essential developmental roles 212 
and hence an important target of insecticides 12, 13. The finding of X1 prompted us to search for related 213 
induced metabolites. The accurate mass of JH-III and the related crustacean hormone methyl-farnesoate 214 
(MF) 11 were used as input for targeted LC-HRMS analysis. Indeed, both searches revealed the presence of a 215 
single induced metabolite with accurate mass practically identical to the predicted mass of JH-III and MF, 216 
respectively (JH-III HRMS (m/z): [M+H]+ calculated. 267.1955; found, 267.1957, MF HRMS (m/z): [M+H]+ 217 
calculated 251.2006; found, 251.2007 supplementary figure 1). Identification of these metabolites as JH-III 218 
and MF (figure 1B) was established by comparison of retention time and mass spectra with an authentic 219 
standard (supplementary figure 1) or the metabolite database of the Xcalibur software package (Thermo 220 
Scientific), respectively. The strongest metabolite induction was observed when A. nidulans was grown 221 
under high salt conditions, however, close inspection of the LC-HRMS data of the remaining media revealed 222 
the presence of JH-III as well as increased levels of X1 in the SmrA expressing strain on rich yeast extract 223 
based media (supplementary figure 2). In order to establish whether the newly discovered terpenes were 224 
retained intracellularly or released to the environment we analyzed the composition of collected volatiles 225 
as well as the growth media. In the volatile fraction, MF constituted a major metabolite in the SmrA 226 
expressing strain as well as the reference (supplementary figure 3), whereas JH-III and X1 undetectable. 227 
None of the three terpenes were detectable in the growth media. The discovery of JH-III and MF represent 228 
to our knowledge the first report of production of juvenile hormones in fungi. It is tempting to speculate 229 
that accumulation of JH-III and release of MF may serve as a defense strategy against insect competitors or 230 
predators. Fungal secondary metabolites are known to play an important role in fungal/insect interactions 231 
22, 23 and JHs constitute attractive targets due to their critical role in insect development and the fact that 232 
both absence and overexposure are detrimental 12. Previous examples of both JH biosynthesis inhibition 233 
and overexposure as defense strategies are known as Penicillium brevicompactum synthesize the JH 234 
biosynthesis inhibitor brevioxime 24, whereas the plant Cyperus iria synthesize JH-III and MF 25. As A. 235 
nidulans is generally believed to inhabit a great variety of ecological niches, among those dead plant 236 
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materials, it is most likely that competing or predating insects will be part of the natural environment. 237 
However, it cannot be excluded that X1, JH-III and/or MF could also serve hormonal functions in A. 238 
nidulans. A similar dual purpose has been demonstrated for the JH-III precursor farnesol 26 in C. albicans, as 239 
it regulate the transition from yeast to filamentous growth 27 as well as induce apoptosis in competing 240 
fungal species 28. Clarification of the distribution of JHs in fungi and their biological function in A. nidulans 241 
will improve our understanding of fungal/insect interactions and perchance fungal morphology regulation. 242 
Moreover, the finding that heterologous expression of transcription factors may influence secondary 243 
metabolism is of general relevance for characterization of secondary metabolites. As the genomes of a 244 
large number of fungal species are currently being sequenced (www.genomesonline.org) a similar 245 
approach may be undertaken for these species using well-characterized regulatory proteins to induce 246 
previously uncharacterized metabolites.  247 
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Figure legends:  327 
Figure 1: Induction of metabolites by SmrA 328 
Top panel: UHPLC-QTOFMS extracted ion chromatogram of m/z 251 (MF, [M+H]+), 289 (JH-III, [M+Na]+), 307 (X1, 329 
[M+H]+) and 335 (X2, [M+H]+) recorded in positive mode of extracts from the strain constitutively expressing SmrA 330 
(top) and reference (bottom) grown under high salt conditions. Chromatograms are normalized by intensity. Bottom 331
panel: Structures of X1+2, JH-III and MF.  332 
 333 
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Supplementary figure legends:  19 
Supplementary figure 1 Targeted LC-MS analysis of induced metabolites. 20 
Extracted ion chromatogram traces of the accurate mass and corresponding mass spectra of X1, X2, JH-III 21 
and MF in the mutant strain constitutively expressing SmrA as well as the authentic JH-III standard(65% 22 
pure) purchased from Sigma Aldrich. Note that the standard contains several impurities. 23 
Supplementary figure 2 Detection of induced metabolites on Yeast based media 24 
Extracted ion chromatogram of X1 or JH-III of SmrA (top) and refenrece (bottom) grown on YES media. MS 25 
spectra of the 8.3 area are embedded. Characteristic ions from JH-III are m/z [M+H]+ 267.1957 & [M+Na] + 26 
289.1774 Da. 27 
Supplementary figure 3 Excretion of MF by A. nidulans. 28 
(top) Total MS chromatogram of the collected volatiles from the SmrA expressing strain and the reference. 29 
(bottom) mass spectrum of the compound eluting at 26.19 minutes. The compound was identified as MF by 30 
comparison to the metabolite library of the Xcalibur software package (Thermo Scientific).  31 
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